<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Bone Mineral Density on VitaminDWiki</title><link>/tags/bone-mineral-density.html</link><description>Recent content in Bone Mineral Density on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sat, 08 Apr 2017 00:00:00 +0000</lastBuildDate><atom:link href="/tags/bone-mineral-density/index.xml" rel="self" type="application/rss+xml"/><item><title>Bones need at least 30 nanograms of Vitamin D – 2 medical groups in Japan</title><link>/posts/bones-need-at-least-30-nanograms-of-vitamin-d-2-medical-groups-in-japan.html</link><pubDate>Sat, 08 Apr 2017 00:00:00 +0000</pubDate><guid>/posts/bones-need-at-least-30-nanograms-of-vitamin-d-2-medical-groups-in-japan.html</guid><description>&lt;h4 id="assessment-criteria-for-vitamin-d-deficiencyinsufficiency-in-japan--proposal-by-an-expert-panel-supported-by-research-program-of-intractable-diseases-ministry-of-health-labour-and-welfare-japan-the-japanese-society-for-bone-and-mineral-research-and-the-japan-endocrine-society">Assessment criteria for vitamin D deficiency/insufficiency in Japan — proposal by an expert panel supported by Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, The Japanese Society for Bone and Mineral Research and The Japan Endocrine Society&lt;/h4>
&lt;p>Endocrine Journal 2017, 64 (1), 1-6, Opinion&lt;/p>
&lt;img src="/attachments/d3.mock.jpg" alt="image">
&lt;p>Ryo Okazaki1), Keiichi Ozono, Seiji Fukumoto, Daisuke Inoue, Mika Yamauchi,&lt;/p>
&lt;p>Masanori Minagawa5), Toshimi Michigami6), Yasuhiro Takeuchi7), Toshio Matsumoto3) and Toshitsugu Sugimoto4)&lt;/p>
&lt;p>1 Third Department of Medicine, Teikyo University Chiba Medical Center, Ichihara 299-0111, Japan&lt;/p></description></item><item><title>Vitamin D and pregnancy workshop in South Carolina</title><link>/posts/vitamin-d-and-pregnancy-workshop-in-south-carolina.html</link><pubDate>Sat, 08 Apr 2017 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-pregnancy-workshop-in-south-carolina.html</guid><description>&lt;p>&lt;strong>&lt;a href="http://academicdepartments.musc.edu/sctr/programs/retreats/2017_Scientific_Workshop_Vitamin_D/2017_Scientific_Workshop_Vitamin_D">2017 Scientific Workshop on Vitamin D&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Full Video and slides prevented are all online&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Vitamin D in the Prevention of Health Disparities During Pregnancy and Early Infancy&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Abstracts and Posters&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/sc-workshop-abstracts.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#moving-vitamin-d-research-into-practice-through-nutrient-field-trials">Moving Vitamin D Research Into Practice Through Nutrient Field Trials&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a-survey-of-placental-pathologic-findings-observed-in-123-singleton-placentas">A Survey of Placental Pathologic Findings Observed in 123 Singleton Placentas&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nutrigenomic-profiling-for-early-risk-stratification-and-preventive-intervention-to-decrease-disparities-in-spontaneous-preterm-birth">Nutrigenomic Profiling for Early Risk Stratification and Preventive Intervention to Decrease Disparities in Spontaneous Preterm Birth&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-placenta-two-sides-to-the-story">Vitamin D and the Placenta: Two Sides to the Story&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mouse-models-to-characterize-the-impact-of-maternal-vitamin-d-deficiency-on-offspring-epigenetic-outcomes">Mouse models to characterize the impact of maternal vitamin D deficiency on offspring epigenetic outcomes&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#adiponectin-and-vitamin-d-binding-protein-are-independently-associated-at-birth-in-both-mothers-and-neonates">Adiponectin and Vitamin D-binding Protein are Independently Associated at Birth in Both Mothers and Neonates&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#immune-mediators-and-vitamin-d-status-in-the-development-of-comorbidities-of-pregnancy">Immune Mediators and Vitamin D Status in the Development of Comorbidities of Pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#improved-vitamin-d3-status-is-associated-with-increases-in-circulating-t-regulatory-cells-during-pregnancy">Improved Vitamin D3 Status is Associated with Increases in Circulating T-regulatory Cells during Pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#preliminary-results-from-a-vitamin-d-screening-and-supplementation-field-trial-to-prevent-preterm-birth">Preliminary Results from a Vitamin D Screening and Supplementation Field Trial to Prevent Preterm Birth&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-of-bacterial-vaginosis-and-vitamin-d-deficiency-in-pregnancy">Association of Bacterial Vaginosis and Vitamin D Deficiency in Pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#maternal-vitamin-d3-supplementation-during-pregnancy-and-pediatric-dental-enamel-hypoplasia">Maternal Vitamin D3 Supplementation during Pregnancy and Pediatric Dental Enamel Hypoplasia&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#technology-assisted-medication-adherence-in-pregnancy">Technology Assisted Medication Adherence in Pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#maternal-obesity-25ohd-concentration-and-bone-density-in-breastfeeding-dyads">Maternal Obesity, 25(OH)D Concentration and Bone Density in Breastfeeding Dyads&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#functional-indicators-of-vitamin-d-adequacy-for-very-low-birth-weight-infants">Functional Indicators of Vitamin D Adequacy for Very Low Birth Weight Infants&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-asthma-health-disparities">Vitamin D and Asthma Health Disparities&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#------------posters--------------">- - - - - - Posters: – – – – – – – – – – – – -&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-vitd-and-other-factors-effects-on-bone-mineral-density-bmd-in-lactating-women">Vitamin D (VitD) and other factors&amp;rsquo; effects on bone mineral density (BMD) in lactating women&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#effects-of-maternal-vitamin-d-vitd-supplementation-on-bone-mineral-content-bmcbone-mineral-density-bmd-in-the-first-year-of-life">Effects of Maternal Vitamin D (VitD) Supplementation on Bone Mineral Content (BMC)/Bone Mineral Density (BMD) in the First Year of Life&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-relationship-between-physical-activity-and-vitamin-d-status-in-lactating-women">The Relationship Between Physical Activity and Vitamin D Status in Lactating Women&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-effects-of-vitamin-d-binding-protein-genotypes-on-circulating-25ohd-and-vdbp-levels-during-pregnancy">The Effects of Vitamin D Binding Protein Genotypes on Circulating 25(OH)D and VDBP Levels During Pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#preventing-health-disparities-during-pregnancy-through-vitamin-d-vitd-supplementation-preliminary-results-of-an-rct">Preventing Health Disparities During Pregnancy Through Vitamin D (VITD) Supplementation: Preliminary Results of an RCT&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="moving-vitamin-d-research-into-practice-through-nutrient-field-trials">Moving Vitamin D Research Into Practice Through Nutrient Field Trials&lt;/h4>
&lt;p>Carole Baggerly, Director, Grassroots Health&lt;/p></description></item><item><title>Vitamin D injection is far better than oral for diabetics (poor gut) – RCT</title><link>/posts/vitamin-d-injection-is-far-better-than-oral-for-diabetics-poor-gut-rct.html</link><pubDate>Tue, 14 Mar 2017 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-injection-is-far-better-than-oral-for-diabetics-poor-gut-rct.html</guid><description>&lt;p>:: &lt;strong>&lt;span style="color:#00F;">See also similar studies at the bottom of this page&lt;/span>&lt;/strong> ::&lt;/p>
&lt;!-- ~tc~ start ~/tc~ -->
&lt;p>&lt;strong>Guesses of Vitamin D response if poor gut&lt;/strong>&lt;/p>
&lt;p>&lt;strong>| | | | |
| &amp;mdash; | &amp;mdash; | &amp;mdash; | &amp;mdash; |
| Bio | Form | Speed | Duration |
| 10 | Injection ($$$)&lt;br> or Calcidiol or Calcitriol | D - Slow&lt;br>C -Fast | Long |
| 10 | Sun/((Vitamin D from low-cost UVB lamps | UVB)) | Slow | Long |
| 10 | Topical &lt;br>(skin patch/cream, vagina) | Slow&lt;br>Fast nano | Normal |
| 9 | Nanoemulsion -mucosal&lt;br>perhaps activates VDR | Fast | Normal |
| 9? | Inhaled (future) | Fast | Normal |
| 8 | Bio-D-Mulsion Forte | Normal | Normal |
| 6 | Water soluble (Bio-Tech) | Normal | Normal |
| 4 | Sublingual/spray &lt;br>(some goes into gut) | Fast | Normal |
| 3 | Coconut oil based | Slow | Normal |
| 2 | Food (salmon etc.) | Slow | Normal |
| 2 | Olive oil based (majority) | Slow | Normal |&lt;/strong>&lt;/p></description></item><item><title>Woman with rare allergy to vitamin D was desensitized in a single day</title><link>/posts/woman-with-rare-allergy-to-vitamin-d-was-desensitized-in-a-single-day.html</link><pubDate>Wed, 21 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/woman-with-rare-allergy-to-vitamin-d-was-desensitized-in-a-single-day.html</guid><description>&lt;h4 id="successful-desensitization-to-vitamin-d-in-a-patient-with-vitamin-d-deficiency">Successful Desensitization to Vitamin D in a Patient With Vitamin D Deficiency.&lt;/h4>
&lt;p>J Investig Allergol Clin Immunol. 2016;26(6):392-393. &lt;a href="https://doi.org/10.18176/jiaci.0108.">doi: 10.18176/jiaci.0108.&lt;/a>&lt;/p>
&lt;p>Unal D1, Coskun R1, Demir D1, Gelincik A1, Colakoglu B1, Buyukozturk S1.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-rare-allergic-reaction-to-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Rare Allergic reaction to vitamin D">Overview Rare Allergic reaction to vitamin D&lt;/a> which has the following section&lt;/p>
&lt;ul>
&lt;li>Perspective: 3X more likely to be allergic to Aspirin than to Vitamin D&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/some-people-have-problems-with-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Some people have problems with vitamin D">Some people have problems with vitamin D&lt;/a>&lt;/p></description></item><item><title>Alchoholics have low Calcium and low Vitamin D, increasing Vit D might help</title><link>/posts/alchoholics-have-low-calcium-and-low-vitamin-d-increasing-vit-d-might-help.html</link><pubDate>Tue, 29 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/alchoholics-have-low-calcium-and-low-vitamin-d-increasing-vit-d-might-help.html</guid><description>&lt;p>:: &lt;strong>2 studies on this page&lt;/strong> ::&lt;/p>
&lt;h4 id="association-of-plasma-calcium-concentrations-with-alcohol-craving-new-data-on-potential-pathways">Association of plasma calcium concentrations with alcohol craving: New data on potential pathways.&lt;/h4>
&lt;p>Eur Neuropsychopharmacol. 2016 Nov 24. pii: S0924-977X(16)31982-4. &lt;a href="https://doi.org/10.1016/j.euroneuro.2016.11.007">doi: 10.1016/j.euroneuro.2016.11.007&lt;/a>&lt;/p>
&lt;p>Schuster R1, Koopmann A2, Grosshans M2, Reinhard I3, Spanagel R4, Kiefer F2.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-alcohol-and-vitamin-d">Overview Alcohol and Vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/alcoholic-liver-disease-8x-more-likely-among-alcoholics-if-very-low-vitamin-d">Alcoholic liver disease 8X more likely among alcoholics if very low vitamin D – May 2015&lt;/a>&lt;/p>
&lt;/li>
&lt;/ul>
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/schuster2016-sci-hub.pdf">Download the PDF from sci-hub via VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Overview Gut and vitamin D</title><link>/posts/overview-gut-and-vitamin-d.html</link><pubDate>Thu, 24 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/overview-gut-and-vitamin-d.html</guid><description>&lt;h4 id="4-gut-problems-are-associated-with-low-vitamin-d-levels---perplexity-ai-june-2024">4 gut problems are associated with low vitamin D levels - Perplexity AI June 2024&lt;/h4>
&lt;ul>
&lt;li>Inflammatory Bowel Disease (IBD), including Crohn&amp;rsquo;s Disease and Ulcerative Colitis:&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>Vitamin D deficiency is more common among those with IBD.&lt;/p>
&lt;/blockquote>
&lt;blockquote>
&lt;p>Lower vitamin D levels are associated with higher disease activity and severity in Crohn&amp;rsquo;s disease.&lt;/p>
&lt;/blockquote>
&lt;blockquote>
&lt;p>Vitamin D deficiency may be implicated in the etiology and severity of IBD.&lt;/p>
&lt;/blockquote>
&lt;blockquote>
&lt;p>Individuals with higher serum vitamin D have a lower incidence of IBD, particularly Crohn&amp;rsquo;s disease.&lt;/p></description></item><item><title>NASA vitamin D deficiency treatment guidelines - 2013</title><link>/posts/nasa-vitamin-d-deficiency-treatment-guidelines-2013.html</link><pubDate>Tue, 15 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/nasa-vitamin-d-deficiency-treatment-guidelines-2013.html</guid><description>&lt;h4 id="from-way-back-in-2013">From way back in 2013&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/nasa-2013.jpg" alt="image" width="600">
&lt;p>Vitamin D and its metabolites have clinical significance because they play a critical function in calcium homeostasis and bone metabolism. Although not all of the pathologic mechanisms have been adequately described, vitamin D insufficiency and deficiency, as measured by low levels of 25-OH vitamin D, are associated with a variety of clinical conditions including osteoporosis, falls and fractures in the elderly, decreased immune function, bone pain, and possibly colon cancer and cardiovascular health.2 Apart from inadequate dietary intake, patients may present with low levels of vitamin D if they receive inadequate sunlight.&lt;/p></description></item><item><title>Both Spinal cord injury and stroke with one side disabled have similar low levels of vitamin D</title><link>/posts/both-spinal-cord-injury-and-stroke-with-one-side-disabled-have-similar-low-levels-of-vitamin-d.html</link><pubDate>Wed, 02 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/both-spinal-cord-injury-and-stroke-with-one-side-disabled-have-similar-low-levels-of-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-profile-of-patients-with-spinal-cord-injury-and-post-stroke-hemiplegia-all-in-the-same-boat">Vitamin D profile of patients with spinal cord injury and post-stroke hemiplegia: All in the same boat.&lt;/h4>
&lt;p>J Back Musculoskelet Rehabil. 2016 Apr 27;29(2):205-210.&lt;/p>
&lt;p>Coskun Benlidayi I1, Basaran S1, Seydaoglu G2, Guzel R1.&lt;/p>
&lt;p>1Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Cukurova University, Adana, Turkey.&lt;/p>
&lt;p>2Department of Biostatistics, Faculty of Medicine, Cukurova University, Adana, Turkey.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-repaired-nerve-in-rat-50000-iu-daily-dose-equivalent-for-human">Vitamin D repaired nerve in rat (50,000 IU daily dose equivalent for human) – June 2013&lt;/a>&lt;/p></description></item><item><title>18th Vitamin D Workshop (of March 2016) abstracts</title><link>/posts/18th-vitamin-d-workshop-of-march-2016-abstracts.html</link><pubDate>Tue, 01 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/18th-vitamin-d-workshop-of-march-2016-abstracts.html</guid><description>&lt;p>&lt;strong>The Journal of Steroid Biochemistry and Molecular Biology, &lt;a href="http://www.sciencedirect.com/science/journal/09600760/164/supp/C%20">Volume 164, Pages 1-394 (November 2016) &lt;/a>&lt;/strong>&lt;/p>
&lt;p>Note: 19th conf will be in Orlando March 2017&lt;/p>
&lt;p>&lt;strong>Most of the PDFs cost $35.95 each, only 4 are free (author had to pay?)&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="/posts/international-congress-on-vitamin-d-vitamind-workshop-ny" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: International Congress on Vitamin D (VitaminD Workshop) – NY May 2019">International Congress on Vitamin D (VitaminD Workshop) – NY May 2019&lt;/a> has links to many previous workshops&lt;/strong>&lt;/p></description></item><item><title>Vitamin D and Boron</title><link>/posts/vitamin-d-and-boron.html</link><pubDate>Wed, 19 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-boron.html</guid><description>&lt;h4 id="a-hrefpostsways-to-improve-health-stylecolor-red-text-decoration-underline-titlethis-postcategory-does-not-exist-yet-ways-to-improve-healthways-to-improve-healtha---includes-boron">&lt;a href="/posts/ways-to-improve-health" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Ways to improve health">Ways to improve health&lt;/a> - includes Boron&lt;/h4>
&lt;img src="/attachments/d3.mock.jpg" alt="image" width="600">
&lt;hr>
&lt;h3 id="span-stylecolor00fsee-also-webspan">&lt;span style="color:#00F;">See also web&lt;/span>&lt;/h3>
&lt;p>&lt;strong>Boron is important for health – March 2018&lt;/strong>&lt;/p>
&lt;p>&lt;strong>The Physiological Role of Boron on Health&lt;/strong>&lt;/p>
&lt;p>Biological Trace Element Research, pp 1–21, First Online: 15 March 2018&lt;/p>
&lt;p>Haseeb Khaliq, Zhong Juming, Peng Ke-Mei&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/boron-and-health-sci-hub.pdf">Download the PDF from Sci-Hub via VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Boron is an essential mineral that plays an important role in several biological processes. Boron is required for growth of plants, animals, and humans. There are increasing evidences of this nutrient showing a variety of pleiotropic effects, ranging from&lt;/p></description></item><item><title>Vitamin D review</title><link>/posts/vitamin-d-review.html</link><pubDate>Wed, 19 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-review.html</guid><description>&lt;p>&lt;strong>Beneficial Effects of UV-Radiation: Vitamin D and beyond&lt;/strong>&lt;/p>
&lt;p>International Journal of Environmental Research and Public Health; 2016,13,1028; doi:10.3390/ijerph13101028&lt;/p>
&lt;p>Christian Trammer, Marlene Pandis 1, Nicolas Verheyen , Martin R. Grubler 1,s,&lt;/p>
&lt;p>Martin Gaksch 1, Barbara Obermayer-Pietsch 1, Andreas Tomaschitz , Thomas R. Pieber 1, Stefan Pilz h* and Verena Schwetz 1&lt;/p>
&lt;p>Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz 8036, Austria; &lt;a href="mailto:christian.trummer@medunigraz.at">christian.trummer@medunigraz.at&lt;/a> (C.T.); &lt;a href="mailto:marlene.pandis@medunigraz.at">marlene.pandis@medunigraz.at&lt;/a> (M.P.); &lt;a href="mailto:martin.gruebler@gmx.net">martin.gruebler@gmx.net&lt;/a> (M.R.G.); &lt;a href="mailto:martin.gaksch@gmail.com">martin.gaksch@gmail.com&lt;/a> (M.G.); &lt;a href="mailto:barbara.obermayer@medunigraz.at">barbara.obermayer@medunigraz.at&lt;/a> (B.O.-P.); &lt;a href="mailto:thomas.pieber@medunigraz.at">thomas.pieber@medunigraz.at&lt;/a> (T.R.P.); &lt;a href="mailto:verena.schwetz@medunigraz.at">verena.schwetz@medunigraz.at&lt;/a> (V.S.)&lt;/p></description></item><item><title>UK patients given vitamin D for 3 months were 16 percent less likely to be readmitted</title><link>/posts/uk-patients-given-vitamin-d-for-3-months-were-16-percent-less-likely-to-be-readmitted.html</link><pubDate>Sat, 01 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/uk-patients-given-vitamin-d-for-3-months-were-16-percent-less-likely-to-be-readmitted.html</guid><description>&lt;h4 id="vitamin-d-deficiency-in-medical-inpatients-a-retrospective-study-of-implications-of-untreated-versus-treated-deficiency">Vitamin D Deficiency in Medical Inpatients: A Retrospective Study of Implications of Untreated Versus Treated Deficiency.&lt;/h4>
&lt;p>Nutr Metab Insights. 2016 Sep 21;9:65-9. &lt;a href="https://doi.org/10.4137/NMI.S33747.">doi: 10.4137/NMI.S33747.&lt;/a> eCollection 2016.&lt;/p>
&lt;p>Zaidi SA1, Singh G2, Owojori O3, Kela R4, Spoors S5, Abbas M1, Barton F6, Rogers C6.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:750px">
&lt;ul>
&lt;li>
&lt;p>“57.4% of the moderate/severe patients had their vitamin D deficiency treated, according to local Trust guidelines.”&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Nothing to indicate who got supplemented other than “Trust guidelines”&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Unlikely that supplementation was random.&lt;/p></description></item><item><title>COPD, Osteoporosis, and low Vitamin D</title><link>/posts/copd-osteoporosis-and-low-vitamin-d.html</link><pubDate>Wed, 14 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/copd-osteoporosis-and-low-vitamin-d.html</guid><description>&lt;p>&lt;strong>Osteoporosis Associated with Chronic Obstructive Pulmonary Disease&lt;/strong>&lt;/p>
&lt;p>J Bone Metab 2016;23:111-120 &lt;a href="http://dx.doi">http://dx.doi&lt;/a>.Org/10.11005/jbm.2016.23.3.111 pISSN 2287-6375 eISSN 2287-7029&lt;/p>
&lt;p>Ryo Okazaki, Reiko Watanabe, Daisuke Inoue&lt;/p>
&lt;p>Third Department of Medicine, Teikyo University Chiba Medical Center, Japan&lt;/p>
&lt;p>Corresponding author: Ryo Okazaki, Third Department of Medicine, Teikyo University Chiba Medical Center, 3426-3 Anesaki Ichihara, Chiba 299-0111, Japan Tel: +81-436-62-1211, Fax: +81-436-7340, E-mail: &lt;a href="mailto:rokazaki@med.teikyo-u.ac.jp">rokazaki@med.teikyo-u.ac.jp&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/copd-fought-by-vitamin-d-many-studies">COPD fought by Vitamin D - many studies&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=Glucocorticoid&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com">Search VitaminDWiki for Glucocorticoids&lt;/a> 311 items as of Sept 2016&lt;/p></description></item><item><title>Leg bone (tibia) grew thicker with 4,000 IU of vitamin D and Calcium – RCT</title><link>/posts/leg-bone-tibia-grew-thicker-with-4000-iu-of-vitamin-d-and-calcium-rct.html</link><pubDate>Fri, 19 Aug 2016 00:00:00 +0000</pubDate><guid>/posts/leg-bone-tibia-grew-thicker-with-4000-iu-of-vitamin-d-and-calcium-rct.html</guid><description>&lt;h4 id="three-doses-of-vitamin-d-bone-mineral-density-and-geometry-in-older-women-during-modest-weight-control-in-a-1-year-randomized-controlled-trial">Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial.&lt;/h4>
&lt;p>Osteoporos Int. 2016 Aug 17. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>After 1 year of daily Vitamin D and Calcium (1.2 grams)&lt;/p>
&lt;p>&lt;strong>| | | |
| &amp;mdash; | &amp;mdash; | &amp;mdash; |
| Dose | Thickness | Vitamin D level |
| 600 IU | -2% (loss) | 27 nanograms |
| 2000 IU | &amp;gt; 1% (gain) | 36 nanograms |
| 4000 IU | &amp;gt; 2% (gain) | 42 nanograms |&lt;/strong>&lt;/p></description></item><item><title>Majority of heritable diseases are associated with vitamin D (from 4 million health records)</title><link>/posts/majority-of-heritable-diseases-are-associated-with-vitamin-d-from-4-million-health-records.html</link><pubDate>Thu, 04 Aug 2016 00:00:00 +0000</pubDate><guid>/posts/majority-of-heritable-diseases-are-associated-with-vitamin-d-from-4-million-health-records.html</guid><description>&lt;h4 id="estimate-of-disease-heritability-using-47-million-familial-relationships-inferred-from-electronic-health-records">Estimate of disease heritability using 4.7 million familial relationships inferred from electronic health records&lt;/h4>
&lt;p>&lt;strong>bioRxiv preprint first posted online Jul. 28, 2016&lt;/strong>&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>&lt;strong>&lt;a href="/posts/health-problems-that-run-in-families-are-often-associated-with-low-vitamin-d">Health problems that run in families are often associated with low vitamin D&lt;/a>&lt;/strong>&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>Note: Association can be due to low blood levels and/or poor Vitamin D genes&lt;/p>
&lt;/blockquote>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/reasons-for-low-response-to-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Reasons for low response to vitamin D">Reasons for low response to vitamin D&lt;/a>&lt;/p></description></item><item><title>UTI associated with low Vitamin D as well as treated - many studies</title><link>/posts/uti-associated-with-low-vitamin-d-as-well-as-treated-many-studies.html</link><pubDate>Tue, 05 Jul 2016 00:00:00 +0000</pubDate><guid>/posts/uti-associated-with-low-vitamin-d-as-well-as-treated-many-studies.html</guid><description>&lt;h4 id="uti-is-associated-with-low-vitamin-d-supplementation-helps---review-sept-2021">UTI is associated with low Vitamin D, supplementation helps - Review Sept 2021&lt;/h4>
&lt;p>&lt;strong>The effect of vitamin D deficiency and supplementation on urinary incontinence: scoping review&lt;/strong>&lt;/p>
&lt;p>International Urogynecology Journal (2021) &lt;a href="https://doi.org/10.1007/s00192-021-04963-z">https://doi.org/10.1007/s00192-021-04963-z&lt;/a>&lt;/p>
&lt;p>Ronnie Baer, Lea Tene &lt;a href="mailto:leatene1@gmail.com">leatene1@gmail.com&lt;/a>, Adi Y. Weintraub &amp;amp; Leonid Kalichman&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/uti-review-sept-2021.jpg" alt="image" width="600">
&lt;p>Introduction and hypothesis&lt;/p>
&lt;p>Vitamin D receptors are found in skeletal and smooth muscle cells throughout the body, specifically in the bladder detrusor muscle. We reviewed the current literature on the association between vitamin D deficiency and urinary incontinence (UI), and whether vitamin D supplementation plays a role in the treatment of UI symptoms.&lt;/p></description></item><item><title>Vitamin D should improve rotator cuff surgery success rate</title><link>/posts/vitamin-d-should-improve-rotator-cuff-surgery-success-rate.html</link><pubDate>Sat, 02 Jul 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-should-improve-rotator-cuff-surgery-success-rate.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-the-immunomodulation-of-rotator-cuff-injury">Vitamin D and the immunomodulation of rotator cuff injury.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-and-the-immunomodulation-of-rotator-cuff-injury">Vitamin D and the immunomodulation of rotator cuff injury.&lt;/h4>
&lt;p>J Inflamm Res. 2016 Jun 14;9:123-31. &lt;a href="https://doi.org/10.2147/JIR.S106206.">doi: 10.2147/JIR.S106206.&lt;/a> eCollection 2016.&lt;/p>
&lt;p>Dougherty KA1, Dilisio MF2, Agrawal DK1.&lt;/p>
&lt;p>1Department of Clinical &amp;amp; Translational Science, Creighton University School of Medicine, Omaha, NE, USA.&lt;/p>
&lt;p>2Department of Orthopedic Surgery, Creighton University School of Medicine, Omaha, NE, USA.&lt;/p>
&lt;p>Tendon-to-bone healing after &lt;strong>rotator cuff repair surgery has a failure rate of 20%-94%&lt;/strong> . There has been a recent interest to determine the factors that act as determinants between successful and unsuccessful rotator cuff repair. Vitamin D level in patients is one of the factors that have been linked to bone and muscle proliferation and healing, and it may have an effect on tendon-to-bone healing. The purpose of this article is to critically review relevant published research that relates to the effect of vitamin D on rotator cuff tears and subsequent healing. A review of the literature was conducted to identify all studies that investigate the relationship between vitamin D and tendon healing, in addition to its mechanism of action. The data were then analyzed in order to summarize what is currently known about vitamin D, rotator cuff pathology, and tendon-to-bone healing. The activated metabolite of vitamin D, 1α,25-dihydroxyvitamin D3, affects osteoblast proliferation and differentiation. Likewise, vitamin D plays a significant role in the tendon-to-bone healing process by increasing the bone mineral density and strengthening the skeletal muscles. The 1α,25-dihydroxyvitamin D3 binds to vitamin D receptors on myocytes to stimulate growth and proliferation. The form of vitamin D produced by the liver, calcifediol, is a key initiator of the myocyte healing process by moving phosphate into myocytes, which improves function and metabolism. Investigation into the effect of vitamin D on tendons has been sparse, but limited studies have been promising. Matrix metalloproteinases play an active role in remodeling the extracellular matrix (ECM) of tendons, particularly deleterious remodeling of the collagen fibers. Also, the levels of transforming growth factor-β3 positively influence the success of the surgery for rotator cuff repair. In the tendon-to-bone healing process, vitamin D has been shown to successfully influence bone and muscle healing, but more research is needed to delve into the mechanisms of vitamin D as a factor in skeletal tendon health and healing.&lt;/p></description></item><item><title>Children with fracture history have lower vitamin D levels</title><link>/posts/children-with-fracture-history-have-lower-vitamin-d-levels.html</link><pubDate>Sat, 18 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/children-with-fracture-history-have-lower-vitamin-d-levels.html</guid><description>&lt;h4 id="serum-25-hydroxyvitamin-d-status-among-saudi-children-with-and-without-a-history-of-fracture">Serum 25-hydroxyvitamin D status among Saudi children with and without a history of fracture.&lt;/h4>
&lt;p>J Endocrinol Invest. 2016 Jun 16. &lt;a href="https://doi.org/10.1007/s40618-016-0496-7">https://doi.org/10.1007/s40618-016-0496-7&lt;/a>&lt;/p>
&lt;p>Al-Daghri NM1,2, Aljohani N3,4, Rahman S5,3, Sabico S5,3, Al-Attas OS5,3, Alokail MS5,3, Al-Ajlan A6, Chrousos GP7.&lt;/p>
&lt;ul>
&lt;li>
&lt;p>1Biomarkers Research Program, Biochemistry Department, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia. &lt;a href="mailto:aldaghri2011@gmail.com">aldaghri2011@gmail.com&lt;/a>.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>2Prince Mutaib Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia. &lt;a href="mailto:aldaghri2011@gmail.com">aldaghri2011@gmail.com&lt;/a>.&lt;/p></description></item><item><title>Bone loss not stopped by monthly 48,000 IU of vitamin D – RCT</title><link>/posts/bone-loss-not-stopped-by-monthly-48000-iu-of-vitamin-d-rct.html</link><pubDate>Tue, 14 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/bone-loss-not-stopped-by-monthly-48000-iu-of-vitamin-d-rct.html</guid><description>&lt;h4 id="vitamin-d-supplementation-for-12-months-in-older-people-prevents-bone-loss-and-suppresses-parathyroid-hormone-levels">Vitamin D supplementation for 12 months in older people prevents bone loss and suppresses parathyroid hormone levels&lt;/h4>
&lt;p>Bone Abstracts (2016) 5 P221b | DOI:10.1530/boneabs.5.P221b&lt;/p>
&lt;p>43rd Annual European Calcified Tissue Society Congress, Rome, Italy, May 2016&lt;/p>
&lt;p>Terry J Aspray1, Roger M Francis1, Elaine McColl2, Thomas Chadwick2, Elaine Stamp2, Ann Prentice3 &amp;amp; Inez Schoenmakers3&lt;/p>
&lt;p>1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK;&lt;/p>
&lt;p>2Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK;&lt;/p></description></item><item><title>Fibromyalgia helped by Vitamin D – still not sure how much, and why</title><link>/posts/fibromyalgia-helped-by-vitamin-d-still-not-sure-how-much-and-why.html</link><pubDate>Wed, 08 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/fibromyalgia-helped-by-vitamin-d-still-not-sure-how-much-and-why.html</guid><description>&lt;h4 id="vitamin-d-in-fibromyalgia-a-causative-or-confounding-biological-interplay">Vitamin D in Fibromyalgia: A Causative or Confounding Biological Interplay?&lt;/h4>
&lt;p>Nutrients 2016, 8(6), 343; doi:10.3390/nu8060343&lt;/p>
&lt;p>Spyridon Karras * , Eleni Rapti, Stauros Matsoukas and Kalliopi Kotsa&lt;/p>
&lt;p>First Department of Internal Medicine, Division of Endocrinology and Metabolism, AHEPA Hospital, Thessaloniki 54636, Greece&lt;/p>
&lt;p>&lt;strong>FM suplementation with Vitamin D&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/fm-supplementation.jpg" alt="image" width="900">
&lt;p>Fibromyalgia (FM) is a chronic syndrome with an increasing prevalence, characterized by widespread musculoskeletal pain in combination with a variety of cognitive symptoms and fatigue. A plethora of scientific evidence that has accumulated during the last decades, resulted in a significant improvement of the understanding of the pathophysiology of the disease. However, current therapeutic approaches in patients with FM remains a multidimensional approach including patient education, behavioral therapy, exercise, pain management, and relief of chronic symptoms, rather than the use drug therapies, based on the mechanisms of disease development. Vitamin D, a fat-soluble vitamin derived mainly from skin synthesis through ultraviolet radiation, has been recognized to manifest a plethora of extraskeletal actions, apart from its fundamental role in skeletal and calcium homeostasis, including modulation of cell growth, neuromuscular actions, and potential anti-inflammatory properties. Recent findings indicate that hypovitaminosis D to be highly prevalent in patients with FM. Supplementation studies are limited so far, indicating potential beneficial effects on pain and severity of the disease, however specific recommendations are lacking. This review aims to summarize and critically appraise data regarding the pathophysiological interplay between vitamin D and FM, available results from observational and supplementation studies so far, with a clinical discourse on current knowledge gaps and future r&lt;/p></description></item><item><title>Vitamin D and Calcium report for IoM - not much change - updated 2014</title><link>/posts/vitamin-d-and-calcium-report-for-iom-not-much-change-updated-2014.html</link><pubDate>Wed, 04 May 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-calcium-report-for-iom-not-much-change-updated-2014.html</guid><description>&lt;h4 id="i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfvitamin-d-calcium-report-pdfdownload-the-entire-pdf-from-vitamindwikia">&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vitamin-d-calcium-report-.pdf">Download the entire PDF from VitaminDWiki&lt;/a>&lt;/h4>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-deficiency">Vitamin D Deficiency&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/is-the-institute-of-medicine-report-on-calcium-and-vitamin-d-good-science" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Is the Institute of Medicine Report on Calcium and Vitamin D Good Science - Jan 2011">Is the Institute of Medicine Report on Calcium and Vitamin D Good Science - Jan 2011&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/wonder-about-conflict-of-interest-of-iom-panel-members" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Wonder about conflict of interest of IoM panel members">Wonder about conflict of interest of IoM panel members&lt;/a>&lt;/p></description></item><item><title>Drugs that may harm bone (vitamin D needed)</title><link>/posts/drugs-that-may-harm-bone-vitamin-d-needed.html</link><pubDate>Fri, 08 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/drugs-that-may-harm-bone-vitamin-d-needed.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#drugs-that-may-harm-bone-mitigating-the-risk">Drugs that may harm bone: Mitigating the risk&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#glucocorticoids">GLUCOCORTICOIDS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#table-1-drugs-that-may-harm-bone">TABLE 1: Drugs that may harm bone&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bone-mineral-density-declines-quickly">Bone mineral density declines quickly&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#oral-therapy-increases-fracture-risk">Oral therapy increases fracture risk&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#managing-the-risk-of-glucocorticoid-induced-osteoporosis">Managing the risk of glucocorticoid-induced osteoporosis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#proton-pump-inhibitors">PROTON PUMP INHIBITORS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#selective-serotonin-reuptake-inhibitors-ssri">SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#antiepileptic-drugs">ANTIEPILEPTIC DRUGS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#aromatase-inhibitors">AROMATASE INHIBITORS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">REFERENCES&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="drugs-that-may-harm-bone-mitigating-the-risk">Drugs that may harm bone: Mitigating the risk&lt;/h4>
&lt;p>CCJM 2016 Apr;83(4):281-288. 10.3949/ccjm.83a.15066&lt;/p>
&lt;p>FAYE N. HANT, DO, MSCR; Associate Professor of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC,&lt;/p></description></item><item><title>Infants getting up to 1600 IU did not increase blood level of vitamin D – RCT</title><link>/posts/infants-getting-up-to-1600-iu-did-not-increase-blood-level-of-vitamin-d-rct.html</link><pubDate>Sun, 13 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/infants-getting-up-to-1600-iu-did-not-increase-blood-level-of-vitamin-d-rct.html</guid><description>&lt;h4 id="vitamin-d-supplementation-in-breastfed-infants-from-montréal-canada-25-hydroxyvitamin-d-and-bone-health-effects-from-a-follow-up-study-at-3-years-of-age">Vitamin D supplementation in breastfed infants from Montréal, Canada: 25-hydroxyvitamin D and bone health effects from a follow-up study at 3 years of age.&lt;/h4>
&lt;p>Osteoporos Int. 2016 Mar 11. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Gallo S1, Hazell T2, Vanstone CA3, Agellon S3, Jones G4, L&amp;rsquo;Abbé M5, Rodd C6, Weiler HA7.&lt;/p>
&lt;p>Author information&lt;/p>
&lt;p>1Department of Nutrition and Food Studies, George Mason University, Fairfax, VA, 22030, USA.&lt;/p>
&lt;p>2Department of Kinesiology and Physical Education, Wilfrid Laurier University, Waterloo, ON, Canada.&lt;/p></description></item><item><title>Centenarians have good Vitamin D Receptor genes (or take lots of vitamin D)</title><link>/posts/centenarians-have-good-vitamin-d-receptor-genes-or-take-lots-of-vitamin-d.html</link><pubDate>Wed, 09 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/centenarians-have-good-vitamin-d-receptor-genes-or-take-lots-of-vitamin-d.html</guid><description>&lt;h4 id="impact-of-vitamin-d-receptor-polymorphisms-in-centenarians">Impact of vitamin D receptor polymorphisms in centenarians&lt;/h4>
&lt;p>Cristina Gussago , Beatrice Arosio , Franca Rosa Guerini, Evelyn Ferri, Andrea Saul Costa, Martina Casati, Elisa Mariadele Bollini, Francesco Ronchetti, Elena Colombo and 3 more&lt;/p>
&lt;p>Endocrine, pp 1-7, First online: 08 March 2016&lt;/p>
&lt;p>Vitamin D is a seco-sterol produced endogenously in the skin or obtained from certain foods. It exerts its action through binding to intracellular vitamin D receptor (VDR). Lately, the role of vitamin D has been revised regarding its potential advantage on delaying the process of aging. The aim of this study was to assess the contribution of VDR gene polymorphisms in healthy aging and longevity.&lt;/p></description></item><item><title>More calcium in bones in those teenage girls getting 2,000 IUs daily – RCT</title><link>/posts/more-calcium-in-bones-in-those-teenage-girls-getting-2000-ius-daily-rct.html</link><pubDate>Wed, 03 Feb 2016 00:00:00 +0000</pubDate><guid>/posts/more-calcium-in-bones-in-those-teenage-girls-getting-2000-ius-daily-rct.html</guid><description>&lt;h4 id="persistent-effect-of-vitamin-d-supplementation-on-musculoskeletal-parameters-in-adolescents-one-year-after-trial-completion">Persistent Effect of Vitamin D Supplementation on Musculoskeletal Parameters in Adolescents One Year after Trial Completion&lt;/h4>
&lt;p>Journal of Bone and Mineral Research, &lt;a href="10.1002/jbmr.2802">10.1002/jbmr.2802&lt;/a>&lt;/p>
&lt;p>Nisrine Ghazal MD1,3, Laila Al-Shaar MS, MPH1,5,6, Joyce Maalouf MS1,2, Mona Nabulsi MD, MSc1,4, Asma Arabi MD, MSc1,3, Mahmoud Choucair MD1,3, Hani Tamim PhD1, Ziad Mahfoud PhD7 andGhada El-Hajj Fuleihan MD, MPH1,2,3,5,*&lt;/p>
&lt;p>1American University of Beirut Medical Center&lt;/p>
&lt;p>2Calcium Metabolism and Osteoporosis Program&lt;/p>
&lt;p>3Department of Internal Medicine, Division of Endocrinology&lt;/p></description></item><item><title>Silicosis reduces vitamin D levels</title><link>/posts/silicosis-reduces-vitamin-d-levels.html</link><pubDate>Sun, 31 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/silicosis-reduces-vitamin-d-levels.html</guid><description>&lt;h4 id="evaluation-of-bone-mineral-density-and-25-hydroxyvitamin-d-levels-in-subjects-with-silica-exposure">Evaluation of bone mineral density and 25-hydroxyvitamin D levels in subjects with silica exposure.&lt;/h4>
&lt;p>Environ Health Prev Med. 2016 Jan 29. &lt;a href="https://doi.org/10.1007/s12199-016-0509-3">https://doi.org/10.1007/s12199-016-0509-3&lt;/a>&lt;/p>
&lt;p>Yıldızgören MT1, Öziş TN2, Baki AE3, Tutkun E4, Yılmaz H4, Tiftik T5, Ekiz T5, Özgirgin N5.&lt;/p>
&lt;p>1Department of Physical Medicine and Rehabilitation, Ankara Occupational Diseases Hospital, Ankara, Turkey. &lt;a href="mailto:ftr.mustafaturgut@hotmail.com">ftr.mustafaturgut@hotmail.com&lt;/a>.&lt;/p>
&lt;p>2Department of Chest Diseases, Ankara Occupational Diseases Hospital, Ankara, Turkey.&lt;/p>
&lt;p>3Department of Physical Medicine and Rehabilitation, Ankara Occupational Diseases Hospital, Ankara, Turkey.&lt;/p></description></item><item><title>Myasthenia Gravis remission with 100,000 IU vitamin D daily – one person</title><link>/posts/myasthenia-gravis-remission-with-100000-iu-vitamin-d-daily-one-person.html</link><pubDate>Sat, 30 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/myasthenia-gravis-remission-with-100000-iu-vitamin-d-daily-one-person.html</guid><description>&lt;h4 id="remission-of-severe-myasthenia-gravis-after-massive-dose-vitamin-d-treatment">Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.&lt;/h4>
&lt;p>Am J Case Rep. 2016 Jan 29;17:51-4.&lt;/p>
&lt;p>Cadegiani FA Endocrinology Unit, Corpometria, Brasilia, Brazil.&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mg.jpg" alt="image">
&lt;p>BACKGROUND Vitamin D has been shown to be related to autoimmune diseases, such as multiple sclerosis and psoriasis. Correlations have been reported between vitamin D levels and prevalence and severity of other autoimmune disorders, and also between vitamin D therapy and disease improvement and remission.&lt;/p>
&lt;p>CASE REPORT This is a case report of a patient with severe and refractory myasthenia gravis (MG) who followed a &amp;ldquo;high-dose vitamin D treatment&amp;rdquo;, a massive-dose treatment (80 000 to 120 000 IU/day) promoted by a medical center in Brazil (but still not proven), and she had her first complete remission after this type of treatment with increased vitamin D serum levels ( &lt;strong>400 to 700 ng/mL&lt;/strong> ).&lt;/p></description></item><item><title>Is a health problem associated with Low vitamin D, Low Magnesium, or too much Calcium</title><link>/posts/is-a-health-problem-associated-with-low-vitamin-d-low-magnesium-or-too-much-calcium.html</link><pubDate>Sun, 17 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/is-a-health-problem-associated-with-low-vitamin-d-low-magnesium-or-too-much-calcium.html</guid><description>&lt;h4 id="essential-nutrient-interactions-does-low-or-suboptimal-magnesium-status-interact-with-vitamin-d-andor-calcium-status">Essential Nutrient Interactions: Does Low or Suboptimal Magnesium Status Interact with Vitamin D and/or Calcium Status?&lt;/h4>
&lt;p>Adv Nutr. 2016 Jan 15;7(1):25-43. &lt;a href="https://doi.org/10.3945/an.115.008631.">doi: 10.3945/an.115.008631.&lt;/a> Print 2016 Jan.&lt;/p>
&lt;p>Rosanoff A1, Dai Q2, Shapses SA3.&lt;/p>
&lt;p>1 &lt;a href="http://www.magnesiumeducation.com/">Center for Magnesium Education and Research&lt;/a>, Pahoa, HI; &lt;a href="mailto:arosanoff@gmail.com">arosanoff@gmail.com&lt;/a>.&lt;/p>
&lt;p>2 Vanderbilt Epidemiology Center, Department of Medicine, School of Medicine, Vanderbilt University, Nashville, TN&lt;/p>
&lt;p>3 Rutgers University, New Brunswick, NJ.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:750px">
&lt;p>Optimum Calcium somewhere 1.7 - 2.5 X Magnesium &lt;a href="/posts/calcium-2x-of-magnesium-seems-good-china">China says 2.0 X&lt;/a>&lt;/p></description></item><item><title>France restricts payments for Vitamin D tests</title><link>/posts/france-restricts-payments-for-vitamin-d-tests.html</link><pubDate>Thu, 31 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/france-restricts-payments-for-vitamin-d-tests.html</guid><description>&lt;h4 id="recommendations-for-the-measurement-of-blood-25-oh-vitamin-d">Recommendations for the measurement of blood 25-OH vitamin D&lt;/h4>
&lt;p>Ann Biol Clin (Paris). 2015 Dec 29. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Souberbielle JC1, Deschenes G2, Fouque D3, Groussin L4, Guggenbuhl P5, Jean G6, Linglart A7, Thomas T8.&lt;/p>
&lt;p>The 25-hydroxyvitamin D (25OHD) serum concentration should not be measured to everybody but recommendations for this measurement in several clinical situations are available from numerous guidelines and expert positions. It can be proposed to measure 25OHD in diseases where a target range of 25OHD concentrations associated with better outcomes is defined with a sufficient level of evidence, and when this target concentration is difficult to reach without previous measurement (or may be exceeded in case of too large doses are provided). Many National and International Medical Societies recommend to measure 25OHD at least in any situation of « bone fragility » (defined by a low bone mineral density and/or a low energy fracture), in malabsorptions, in chronic kidney disease, in any « phosphocalcic pathology, in patients with clinical signs of profound vitamin D deficiency or excess, and, more generally in any biological exploration of calcium/phosphorus metabolism that includes the measurement of PTH. Although these recommandations may seem discordant with the &lt;strong>recent French restriction in the reimbursment of 25OHD measurement,&lt;/strong> they may still be reimbursed.&lt;/p></description></item><item><title>Lots of vitamin D supplementation by those with Primary Hyperparathyroidism</title><link>/posts/lots-of-vitamin-d-supplementation-by-those-with-primary-hyperparathyroidism.html</link><pubDate>Wed, 16 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/lots-of-vitamin-d-supplementation-by-those-with-primary-hyperparathyroidism.html</guid><description>&lt;h4 id="seasonal-variability-in-vitamin-d-levels-no-longer-detectable-in-primary-hyperparathyroidism">Seasonal Variability in Vitamin D Levels No Longer Detectable in Primary Hyperparathyroidism.&lt;/h4>
&lt;p>J Clin Endocrinol Metab. 2015 Sep;100(9):3452-9. &lt;a href="https://doi.org/10.1210/JC.2015-2105.">doi: 10.1210/JC.2015-2105.&lt;/a> Epub 2015 Jun 29.&lt;/p>
&lt;p>Cong E1, Walker MD1, Kepley A1, Zhang C1, McMahon DJ1, Silverberg SJ1.&lt;/p>
&lt;p>.1Department of Medicine, Columbia University, College of Physicians and Surgeons, New York City, New York 10032.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:500px">
&lt;p>100 patients with Primary Hyperparathyroidism in NE US&lt;/p>
&lt;p>No seasonal difference in % with &amp;lt; 30 ng of Vitamin D&lt;/p></description></item><item><title>Cataracts prevented and perhaps treated by Vitamin D - 2015</title><link>/posts/cataracts-prevented-and-perhaps-treated-by-vitamin-d-2015.html</link><pubDate>Sun, 06 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/cataracts-prevented-and-perhaps-treated-by-vitamin-d-2015.html</guid><description>&lt;h4 id="cataracts-dissolved-by-5000-iu-of-vitamin-d---dec-2015">Cataracts dissolved by 5,000 IU of vitamin D - Dec 2015&lt;/h4>
&lt;p>&lt;strong>Communications of VitaminDWiki with Dr. Brown - author of June 2015 article (below)&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Quick summary by VitaminDWiki&lt;/strong>&lt;/p>
&lt;p>ALL 5 of his patients who:&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Had mild early stage posterior subcapsular cataracts (without calcification)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Took 5,000 IU vitamin D daily&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Could be tracked for 2 years (did not move away, die, etc.)&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>Had their cataracts resolved&lt;/p>
&lt;p>&lt;strong>Later email from Dr. Brown, Dec 2015&lt;/strong>&lt;/p></description></item><item><title>Same dose of vitamin D for everyone is virtually impossible</title><link>/posts/same-dose-of-vitamin-d-for-everyone-is-virtually-impossible.html</link><pubDate>Fri, 04 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/same-dose-of-vitamin-d-for-everyone-is-virtually-impossible.html</guid><description>&lt;p>&lt;strong>Interpretation of portions of Table 2 by VitaminDWiki&lt;/strong>&lt;/p>
&lt;p>&lt;strong>To get 80% &lt;span style="color:#F06;">&amp;gt;40 ng&lt;/span> level&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/40-ng-80-percent.jpg" alt="image" width="300">
&lt;table>
 &lt;thead>
 &lt;tr>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;/tr>
 &lt;/thead>
 &lt;tbody>
 &lt;tr>
 &lt;td>&lt;/td>
 &lt;td>IU&lt;/td>
 &lt;td>X vs Normal weight&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Normal weight&lt;/td>
 &lt;td>10,000&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Overweight&lt;/td>
 &lt;td>11,120&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Obese&lt;/td>
 &lt;td>16,112&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;/tbody>
&lt;/table>
&lt;p>&lt;strong>To get 80% &lt;span style="color:#F06;">&amp;gt;30 ng &lt;/span>level&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/hi-lo-30-ng.jpg" alt="image" width="300">
&lt;table>
 &lt;thead>
 &lt;tr>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;/tr>
 &lt;/thead>
 &lt;tbody>
 &lt;tr>
 &lt;td>&lt;/td>
 &lt;td>IU&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Normal weight&lt;/td>
 &lt;td>2,650&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Overweight&lt;/td>
 &lt;td>3,156&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Obese&lt;/td>
 &lt;td>7,250&lt;/td>
 &lt;/tr>
 &lt;/tbody>
&lt;/table>
&lt;hr>
&lt;p>Abstract: The Recommended Dietary Allowance (RDA) is the nutrient intake considered to be sufficient to meet the requirements of 97.5% of the population. Recent reports revealed a statistical error in the calculation of the RDA for vitamin D opening the question of what the recommendation should be. We took a dual approach to answer this question: (1) we aggregated &lt;strong>108 published estimates&lt;/strong> on vitamin D supplementation and vitamin D status; and (2) we analyzed &lt;strong>13,987 observations of program participants&lt;/strong> . The aggregation of published data revealed that&lt;/p></description></item><item><title>Fish in school lunches added 36 IU of vitamin D and raised blood level in winter by 2 ng</title><link>/posts/fish-in-school-lunches-added-36-iu-of-vitamin-d-and-raised-blood-level-in-winter-by-2-ng.html</link><pubDate>Tue, 27 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/fish-in-school-lunches-added-36-iu-of-vitamin-d-and-raised-blood-level-in-winter-by-2-ng.html</guid><description>&lt;h4 id="effects-of-school-meals-with-weekly-fish-servings-on-vitamin-d-status-in-danish-children-secondary-outcomes-from-the-opus-optimal-well-being-development-and-health-for-danish-children-through-a-healthy-new-nordic-diet-school-meal-study">Effects of school meals with weekly fish servings on vitamin D status in Danish children: secondary outcomes from the OPUS (Optimal well-being, development and health for Danish children through a healthy New Nordic Diet) School Meal Study.&lt;/h4>
&lt;p>J Nutr Sci. 2015 Jul 17;4:e26. &lt;a href="https://doi.org/10.1017/jns.2015.15.">doi: 10.1017/jns.2015.15.&lt;/a> eCollection 2015.&lt;/p>
&lt;p>Petersen RA1, Damsgaard CT1, Dalskov SM1, Sørensen LB1, Hjorth MF1, Andersen R2, Tetens I2, Krarup H3, Ritz C1, Astrup A1, Michaelsen KF1, Mølgaard C1.&lt;/p></description></item><item><title>Vitamin D papers from European Vitamin D Association Conference</title><link>/posts/vitamin-d-papers-from-european-vitamin-d-association-conference.html</link><pubDate>Mon, 26 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-papers-from-european-vitamin-d-association-conference.html</guid><description>&lt;p>Most of the ENGLISH presentations of the conference follow&lt;/p>
&lt;p>Polish Presentations and Polish abstracts are in the &lt;span>[dl3144]&lt;/span>&lt;/p>
&lt;p>Graphics and table are generally in the &lt;span>[dl3144]&lt;/span>&lt;/p>
&lt;p>References are generally in the &lt;span>[dl3144]&lt;/span> as well&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-update-2015-what-we-need-to-know-about-its-health-benefits-and-potential-for-toxicity">Vitamin D Update 2015: What We Need to Know about Its Health Benefits and Potential for Toxicity?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#spanskin-synthesis-of-vitamin-d---pros-and-consspan-english-abstract">&lt;span>[Skin synthesis of vitamin D - pros and cons]&lt;/span> English Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nutritional-rickets---global-guidelines-for-prevention-and-treatment">Nutritional Rickets - global guidelines for prevention and treatment&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-vitamin-d-supplementation-in-treating-health-conditions-and-diseases-common-among-those-with-intellectual-andor-developmental-disabilities">The role of vitamin D supplementation in treating health conditions and diseases common among those with intellectual and/or developmental disabilities&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#spanvitamin-d-in-dermatologists-practicespan-english-abstract">&lt;span>[Vitamin D in dermatologists&amp;rsquo; practice]&lt;/span> English abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-vdr-gene-polymorphisms-in-basal-cell-carcinoma-development">The role of VDR gene polymorphisms in basal cell carcinoma development&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-melanoma">Vitamin D and melanoma&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#potential-use-of-vitamin-d-analogs-in-the-treatment-of-skin-diseases">Potential use of vitamin D analogs in the treatment of skin diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#biomarkers-of-vitamin-d-metabolism-current-state-of-knowledge">Biomarkers of Vitamin D Metabolism: Current State of Knowledge&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#standardization-of-vitamin-d-assays">Standardization of Vitamin D Assays:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#assays-for-vitamin-d-metabolites-performance-in-the-real-world">Assays for vitamin D metabolites; performance in the real world&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#comparison-of-two-immunoassays-for-vitamin-d-measurement-is-age-a-confounder">Comparison of two immunoassays for vitamin D measurement is age a confounder?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pleiotropic-action-of-vitamin-d-in-light-of-recent-meta-analyzes">Pleiotropic action of vitamin D in light of recent meta-analyzes&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-requirements-during-pregnancy-and-lactation">Vitamin D Requirements during Pregnancy and Lactation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#25-hydroxyvitamin-d-insufficiency-in-extraskeletal-diseases">25-hydroxyvitamin D insufficiency in extraskeletal diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-cardiovascular-disorders">Vitamin D and Cardiovascular disorders&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#endothelial-function-and-pulse-wave-velocity-in-patients-with-chronic-heart-failure-and-d-deficiency">Endothelial function and pulse wave velocity in patients with chronic heart failure and D-deficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-insufficiency-in-young-children-in-russia-the-results-of-the-multicentre-cohort-study-rodnichok-2013-2014">Vitamin D Insufficiency in Young Children in Russia: the Results of the Multicentre Cohort Study RODNICHOK (2013-2014)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-in-residents-of-belarus-analysis-of-the-three-year-data">Vitamin D status in residents of Belarus: analysis of the three-year data&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-correction-in-elderly-people">Vitamin D deficiency correction in elderly people&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00postersspan">&lt;span style="color:#F00;">POSTERS&lt;/span>&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-status-in-north-west-russian-region">Vitamin D status in north-west russian region&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-ways-of-vitamin-d-deficiency-correction-in-ukraine">The ways of vitamin d deficiency correction in ukraine&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#high-dose-vitamin-d3-supplementation-as-a-novel-strategy-in-clinical-management-of-wintertime-preeclampsia">High-dose vitamin D3 supplementation as a novel strategy in clinical management of wintertime preeclampsia&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-of-bsmi-polymorphism-of-vdr-gene-with-vitamin-d-status-in-children-with-vitamin-d---deficient-rickets">Association of BsmI polymorphism of VDR gene with vitamin D status in children with vitamin D - deficient rickets&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-levels-may-influence-microarchitecture-of-bone-tissue-in-men">Vitamin D levels may influence microarchitecture of bone tissue in men&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ameliorative-effect-of-vitamin-d3-against-liver-disorders-and-impaired-bone-remodeling-associated-with-experimental-type-1-diabetes">Ameliorative effect of vitamin D3 against liver disorders and impaired bone remodeling associated with experimental type 1 diabetes&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-and-inflammation-in-copd-patients-preliminary-findings-from-a-seasonal-observation-study">Vitamin D status and inflammation in COPD patients: preliminary findings from a seasonal observation study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#effect-of-a-primary-prevention-program-incorporating-vitamin-and-mineral-supplementation-on-glycemic-status-an-observational-study">Effect of a primary prevention program incorporating vitamin and mineral supplementation on glycemic status: an observational study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation---positive-effects-on-lipid-profile-in-patients-with-hypertension">Vitamin D supplementation - positive effects on lipid profile in patients with hypertension&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-effects-of-a-preventive-health-program-and-vitamin-d-status-on-metabolic-syndrome">The Effects of a Preventive Health Program and Vitamin D Status on Metabolic Syndrome&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#serum-vitamin-d-status-a-threat-neither-for-hypercalcemia-nor-for-inflammation">Serum Vitamin D Status, a Threat neither for Hypercalcemia nor for Inflammation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#synthesis-of-novel-vitamin-d-analogs-and-their-biological-evaluation">Synthesis of novel vitamin D analogs and their biological evaluation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#tissue-in-children-with-ergocalciferol-deficiency-in-anamnesis">Tissue in children with ergocalciferol deficiency in anamnesis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#correlation-between-vitamin-d-level-and-behcets-disease-activity-in-patients-in-west-region-of-ukraine">Correlation between Vitamin D level and Behcet&amp;rsquo;s disease activity in patients in West region of Ukraine&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#dynamics-of-the-vitamin-d-and-of-the-bones-metabolism-other-indicators-in-the-pregnant-women-with-perinatal-infection">Dynamics of the vitamin D and of the bone&amp;rsquo;s metabolism other indicators in the pregnant women with perinatal infection&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-intakes-among-pregnant-women-in-an-urban-and-rural-population-of-western-ukraine">Vitamin d intakes among pregnant women in an urban and rural population of Western Ukraine&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-curious-situation-of-europeans-and-vitamin-d---an-environmental-mismatch">The Curious Situation of Europeans and Vitamin D - an Environmental Mismatch?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-among-healthy-infants-in-poland---assessment-based-on-randomly-selected-sample-from-the-population">Vitamin D status among healthy infants in Poland - assessment based on randomly selected sample from the population&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-protective-effect-of-vitamin-d3-against-prednisolone-induced-liver-injury-in-rats">The protective effect of vitamin D3 against prednisolone-induced liver injury in rats&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#effect-of-cholecalciferol-on-plasma-rennin-activity-in-women-with-arterial-hypertension-in-premenopausal-and-early-postmenopausal-periods">Effect of cholecalciferol on plasma rennin activity in women with arterial hypertension in premenopausal and early postmenopausal periods&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-mechanisms-by-which-both-vitamin-d-deficiency-and-toxicity-affect-cardiovascular-health">Multiple mechanisms by which both vitamin D deficiency and toxicity affect cardiovascular health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-undifferentiated-connective-tissue-dysplasia-provide-the-vitamin-d3-for-adolescent-children">The undifferentiated connective tissue dysplasia provide the vitamin D3 for adolescent children&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#prevalence-of-25-hydroxyvitamin-d-deficiency-in-children-on-dialysis-and-after-kidney-transplantation">Prevalence of 25-Hydroxyvitamin D Deficiency in Children on Dialysis and After Kidney Transplantation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-in-children-with-bronchial-asthma">Vitamin D status in children with bronchial asthma&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#prevalence-of-vitamin-d-deficiency-in-adult-outpatients-with-schizophrenia-or-bipolar-disorder">Prevalence of vitamin D deficiency in adult outpatients with schizophrenia or bipolar disorder&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rickets-in-premature-infants-with-very-low-birth-weight-clinical-features-and-course-of-the-disease">Rickets in Premature Infants with Very Low Birth Weight: Clinical Features and Course of the Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-undifferentiated-connective-tissue-dysplasia-provide-the-vitamin-d3-for-adolescent-children-1">The undifferentiated connective tissue dysplasia provide the vitamin D3 for adolescent children&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#influence-of-125oh2d3-and-its-derivatives---pri-2191-and-pri-2205">Influence of 1,25(OH)2D3 and its derivatives - PRI-2191 and PRI-2205&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-in-patients-with-subclinical-and-overt-hypothyroidism">Vitamin d deficiency in patients with subclinical and overt hypothyroidism&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d3-supplementation-using-an-oral-spray-solution-resolves-deficiency-but-has-no-significant-effect-on-vo2max-in-gaelic-athletes-results-from-a-randomised-doubleblind-placebo-controlled-trial__">Vitamin D3 supplementation using an oral spray solution resolves deficiency but has no significant effect on VO2max in Gaelic athletes:** results from a randomised, doubleblind, placebo-controlled trial__&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#maternal-obesity-and-associated-vitamin-d-status-in-pregnancy-data-from-the-fasstt-study">Maternal obesity and associated vitamin D status in pregnancy: data from the FASSTT study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#immunoglobulin-g-in-children-with-recurrent-respiratory-infections">immunoglobulin G in children with recurrent respiratory infections&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-cancer-diseases">Vitamin d and cancer diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#correction-of-hypovitaminosis-d-with-vitamin-d-supplements-in-patients-with-psoriasis">Correction of hypovitaminosis D with vitamin D supplements in patients with psoriasis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-between-vitamin-d-and-lipid-accumulation-product-in-community-dwelling-elderly-persons">Association Between Vitamin D and Lipid Accumulation Product in Community Dwelling Elderly Persons&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementary-intake-throughout-3rd-trimester-of-pregnancy">Vitamin D supplementary intake throughout 3rd trimester of pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#evaluation-of-the-current-vitamin-d-content-of-ni-milk-and-its-efficacy-to-increase-vitamin-d-intake-of-the-population-through-fortification">Evaluation of the current vitamin D content of NI milk and its efficacy to increase vitamin D intake of the population through fortification&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#can-vitamin-d-influence-bmd-in-hyperthyroid-patients-with-and-without-silent-vertebral-fractures">Can Vitamin D influence BMD in hyperthyroid patients with and without silent vertebral fractures?&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="vitamin-d-update-2015-what-we-need-to-know-about-its-health-benefits-and-potential-for-toxicity">Vitamin D Update 2015: What We Need to Know about Its Health Benefits and Potential for Toxicity?&lt;/h4>
&lt;p>Michael F. Holick&lt;/p></description></item><item><title>Overview Epileptic children and Vitamin D</title><link>/posts/overview-epileptic-children-and-vitamin-d.html</link><pubDate>Sun, 18 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/overview-epileptic-children-and-vitamin-d.html</guid><description>&lt;!-- ~tc~ start ~/tc~ -->
&lt;p>&lt;strong>Fact:&lt;/strong> Vitamin D supplementation helps epileptics in 6 ways&lt;/p>
&lt;p>&lt;strong>Fact:&lt;/strong> Anti-epilepsy drugs lower vitamin D levels&lt;/p>
&lt;p>&lt;strong>Fact:&lt;/strong> Epilepsy 5X more likely if preterm birth (low vitamin D)&lt;/p>
&lt;p>&lt;strong>Fact:&lt;/strong> Preterm greatly decreased if add vitamin D and/or Omega-3&lt;/p>
&lt;p>&lt;strong>Recommendation:&lt;/strong> Epileptics should take vitamin D to:&lt;/p>
&lt;p>      Improve Quality of Life&lt;/p>
&lt;p>     Avoid having health problems associated with low vitamin D, such as low bone density&lt;/p>
&lt;p>&lt;strong>Epilepsy = 4,000 years of ignorance, superstition and stigma&lt;br>
     followed by 100 years of knowledge, superstition and stigma.&lt;/strong>&lt;/p></description></item><item><title>Rotterdam Vitamin D dissertation text</title><link>/posts/rotterdam-vitamin-d-dissertation-text.html</link><pubDate>Sun, 18 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/rotterdam-vitamin-d-dissertation-text.html</guid><description>&lt;p>&lt;strong>Summary and PDF is at &lt;a href="/posts/more-vitamin-d-makes-for-better-health-dissertation-based-on-rotterdam-studies">More vitamin D makes for better health – dissertation based on Rotterdam studies – Oct 2015&lt;/a>&lt;/strong>&lt;/p>
&lt;p>The following is a rough dump of the text from the dissertation - for ease of translation&lt;/p>
&lt;p>&lt;strong>Vitamin D and Cardio-metabolic Health in the Elderly - The Rotterdam Study&lt;/strong>&lt;/p>
&lt;p>Vitamine D en cardiometabole gezondheid in ouderen: De - Rotterdam Studie&lt;/p>
&lt;p>Thesis&lt;/p>
&lt;p>to obtain the degree of Doctor from the&lt;/p>
&lt;p>Erasmus University Rotterdam&lt;/p></description></item><item><title>Vitamin D, Calcium and protein very important to bone health</title><link>/posts/vitamin-d-calcium-and-protein-very-important-to-bone-health.html</link><pubDate>Wed, 07 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-calcium-and-protein-very-important-to-bone-health.html</guid><description>&lt;p>&lt;strong>Life-course approach to nutrition&lt;/strong>&lt;/p>
&lt;p>Osteoporos Int DOI 10.1007/s00198-015-3288-6&lt;/p>
&lt;p>P. J. Mitchell1,2 • C. Cooper3,4 • B. Dawson-Hughes • C. M. Gordon • R. Rizzoli, &lt;a href="mailto:cc@mrc.soton.ac.uk">cc@mrc.soton.ac.uk&lt;/a>&lt;/p>
&lt;p>Synthesis Medical NZ Ltd, Auckland, New Zealand&lt;/p>
&lt;p>University of Notre Dame Australia, Sydney, Australia&lt;/p>
&lt;p>NIHR Musculoskeletal Biomedical Research Unit, Nuffield Dept of Orthopaedics, Rheumatology and Musculoskeletal Sciences, U. of Oxford, Oxford, UK&lt;/p>
&lt;p>MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK&lt;/p>
&lt;p>Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA&lt;/p></description></item><item><title>Breast Feeding increased risk of low bone density by 24 percent</title><link>/posts/breast-feeding-increased-risk-of-low-bone-density-by-24-percent.html</link><pubDate>Tue, 06 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/breast-feeding-increased-risk-of-low-bone-density-by-24-percent.html</guid><description>&lt;h4 id="breast-feeding-is-associated-with-postmenopausal-bone-loss-findings-from-the-korea-national-health-and-nutrition-examination-survey">Breast Feeding Is Associated with Postmenopausal Bone Loss: Findings from the Korea National Health and Nutrition Examination Survey.&lt;/h4>
&lt;p>Korean J Fam Med. 2015 Sep;36(5):216-20. &lt;a href="https://doi.org/10.4082/kjfm.2015.36.5.216.">doi: 10.4082/kjfm.2015.36.5.216.&lt;/a> Epub 2015 Sep 18.&lt;/p>
&lt;p>Kim HJ1, Kwon H2, Oh SW2, Lee CM2, Joh HK3, Kim Y1, Um YJ1, Ahn SH1.&lt;/p>
&lt;p>1Department of Family Medicine, Seoul National University Hospital, Seoul, Korea.&lt;/p>
&lt;p>2Department of Family Medicine, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea.&lt;/p>
&lt;p>3Health Service Center, Seoul National University, Seoul, Korea.&lt;/p></description></item><item><title>Infant not helped by 200 IU of vitamin D during pregnancy (no surprise)</title><link>/posts/infant-not-helped-by-200-iu-of-vitamin-d-during-pregnancy-no-surprise.html</link><pubDate>Sat, 19 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/infant-not-helped-by-200-iu-of-vitamin-d-during-pregnancy-no-surprise.html</guid><description>&lt;h4 id="calcium-plus-vitamin-d-supplementation-during-the-third-trimester-of-pregnancy-in-adolescents-accustomed-to-low-calcium-diets-does-not-affect-infant-bone-mass-at-early-lactation-in-a-randomized-controlled-trial">Calcium Plus Vitamin D Supplementation During the Third Trimester of Pregnancy in Adolescents Accustomed to Low Calcium Diets Does Not Affect Infant Bone Mass at Early Lactation in a Randomized Controlled Trial.&lt;/h4>
&lt;p>J Nutr. 2015 Jul;145(7):1515-23. &lt;a href="https://doi.org/10.3945/jn.114.208140.">doi: 10.3945/jn.114.208140.&lt;/a> Epub 2015 May 27.&lt;/p>
&lt;p>Diogenes ME1, Bezerra FF2, Rezende EP2, Donangelo CM3.&lt;/p>
&lt;p>BACKGROUND:&lt;/p>
&lt;p>Pregnancy and lactation in adolescents with low calcium intake may impair fetal growth and infant bone mass.&lt;/p>
&lt;p>OBJECTIVE:&lt;/p>
&lt;p>We investigated the effects of calcium plus vitamin D supplementation during pregnancy in Brazilian adolescent mothers consuming low calcium diets (∼600 mg/d) on fetal biometry and infant bone mass, and the relation between infant and maternal bone mass during early lactation.&lt;/p></description></item><item><title>Bio-available Vitamin D following mega-doses (up to 500,000 IU) – Clinical trial due 2018</title><link>/posts/bio-available-vitamin-d-following-mega-doses-up-to-500000-iu-clinical-trial-due-2018.html</link><pubDate>Thu, 17 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/bio-available-vitamin-d-following-mega-doses-up-to-500000-iu-clinical-trial-due-2018.html</guid><description>&lt;h4 id="change-in-free-25ohd-after-high-dose-in-vitamin-d-deficient-postmenopausal-women">Change in Free 25(OH)D After High Dose in Vitamin D Deficient Postmenopausal Women&lt;/h4>
&lt;p>This study is not yet open for participant recruitment. (see Contacts and Locations)&lt;/p>
&lt;p>Verified September 2015 by Sheffield Teaching Hospitals NHS Foundation Trust&lt;/p>
&lt;p>Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust&lt;/p>
&lt;p>Collaborator: National Osteoporosis Society&lt;/p>
&lt;p>Information provided by (Responsible Party):&lt;/p>
&lt;p>Sheffield Teaching Hospitals NHS Foundation Trust&lt;/p>
&lt;p>ClinicalTrials.gov Identifier: NCT02553044, First received: September 16, 2015&lt;/p>
&lt;p>We currently use total 25(OH)D as a biomarker of vitamin D status. However, there is some debate as to whether total 25(OH)D is the best marker to use.&lt;/p></description></item><item><title>A vitamin D study which found virtually no benefits for seniors – probably due to candidate rejection</title><link>/posts/a-vitamin-d-study-which-found-virtually-no-benefits-for-seniors-probably-due-to-candidate-rejection.html</link><pubDate>Fri, 04 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/a-vitamin-d-study-which-found-virtually-no-benefits-for-seniors-probably-due-to-candidate-rejection.html</guid><description>&lt;h3 id="treatment-of-vitamin-d-insufficiency-in-postmenopausal-women-a-randomized-clinical-trial">Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial.&lt;/h3>
&lt;p>JAMA Intern Med. 2015 Aug 3. &lt;a href="https://doi.org/10.1001/jamainternmed.2015.3874.">doi: 10.1001/jamainternmed.2015.3874.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Hansen KE1, Johnson RE2, Chambers KR1, Johnson MG1, Lemon CC1, Vo TN3, Marvdashti S1.&lt;/p>
&lt;p>1Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison.&lt;/p>
&lt;p>2Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison2Quality and Patient Safety Analysis, Saint Luke&amp;rsquo;s Health System, Kansas City, Missouri.&lt;/p></description></item><item><title>Benefits of vitamin D experienced then described by retired Biologist</title><link>/posts/benefits-of-vitamin-d-experienced-then-described-by-retired-biologist.html</link><pubDate>Fri, 28 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/benefits-of-vitamin-d-experienced-then-described-by-retired-biologist.html</guid><description>&lt;p>&lt;strong>Retired German Biologist had typical problems of elderly&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/goering.jpg" alt="image" width="200">
&lt;p>He got lots of vitamin D in 2013 and his health problems went way&lt;/p>
&lt;p>He currently takes 50,000 IU vitamin D3 weekly&lt;/p>
&lt;p>He researched vitamin D (while retired)&lt;/p>
&lt;p>He published the following excellent Vitamin D overview in 2014&lt;/p>
&lt;p>Appears that the overview was also published in Russian&lt;/p>
&lt;p>Many excellent ideas and observations &lt;strong>(VitaminDWiki has bolded some of them)&lt;/strong>&lt;/p>
&lt;p>This version uses an incorrect English word &amp;lt; 1% of the time.&lt;/p></description></item><item><title>Neurofibromatosis – 1 in 3500 have it, associated with low vitamin D</title><link>/posts/neurofibromatosis-1-in-3500-have-it-associated-with-low-vitamin-d.html</link><pubDate>Sat, 08 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/neurofibromatosis-1-in-3500-have-it-associated-with-low-vitamin-d.html</guid><description>&lt;p>NF is similar to Multiple Sclerosis:&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Both have brain lesions&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Both are treated by Vitamin D&lt;/p>
&lt;/li>
&lt;/ol>
&lt;blockquote>
&lt;p>See NF - Vitamin D Clinical Trial listed below - results due ~2021&lt;/p>
&lt;/blockquote>
&lt;ol>
&lt;li>
&lt;p>Both are treated by UVB&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Both have more problems if poor Vitamin D Receptor&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Both have similar cormorbidities (autism, ADHD, etc)&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>Note: Multiple Sclerosis rate is 3X that of NF about 1 in 1,000&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#overview-nf">Overview NF&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-lower-in-children-with-nf--perhaps-because-indoors">Vitamin D lower in children with NF – perhaps because indoors&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-level-similar-in-siblings">Vitamin D level similar in siblings&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nf-idential-twins---2019">NF Idential Twins - 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nf-14-ng-controls-31-ng-number-of-dermal-neurofibromas-inversely-proportional-to-vitamin-d">NF: 14 ng, controls 31 ng, number of dermal neurofibromas inversely proportional to Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nf-clinical-trial-using-4000-iu-of-vitamin-d">NF Clinical trial using 4,000 IU of Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#one-of-the-natural-cures-for-nf-is-vitamin-d">One of the natural cures for NF is Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nf-has-more-seasonal-variation-in-vitamin-d-levels-than-controls--wonder-why">NF has MORE seasonal variation in vitamin D levels than controls – wonder why&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#more-dermal-neurofibromas-if-poor-vitamin-d-receptor---oct-2018">More dermal neurofibromas if poor Vitamin D Receptor - Oct 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-vdr-did-not-vary-between-nf1-and-controls---2015">Vitamin D and VDR did not vary between NF1 and controls - 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nih-overview-of-nf">NIH overview of NF&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nf-skin-pictures-and-skin-is-only-a-small-part-of-nf-problems">NF skin pictures (and skin is only a small part of NF problems)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#wikipedia-on-rare-diseases">Wikipedia on Rare Diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#neurofibromatosis-chronological-history-and-current-issues---may-2013">Neurofibromatosis: chronological history and current issues - May 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#intellectual-problems-adhd-autism-spectrum-disorder-and-migraine-are-major-neurological-comorbidities-in-nf1---jan-2018">Intellectual problems, ADHD, autism spectrum disorder, and migraine are major neurological comorbidities in NF1 - Jan 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d3--and-uv-treat-neurofibromatosis---1---2017-book-chapter">Vitamin D3 and UV treat Neurofibromatosis - 1 - 2017 book Chapter&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/nf-5minutes.jpg" alt="image" width="600">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/nf-chart.jpg" alt="image" width="600">
&lt;h3 id="overview-nf">Overview NF&lt;/h3>
&lt;p>Neurofibromatosis has a 50 percent chance of developing in a child who has one parent with the mutated gene.&lt;/p></description></item><item><title>Review of Osteoarthritis and vitamin D</title><link>/posts/review-of-osteoarthritis-and-vitamin-d.html</link><pubDate>Sun, 02 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/review-of-osteoarthritis-and-vitamin-d.html</guid><description>&lt;p>&lt;strong>Role of Vitamin D in Osteoarthritis: Molecular, Cellular, and Clinical Perspectives&lt;/strong>&lt;/p>
&lt;p>International Journal of Endocrinology, Volume 2015 (2015), Article ID 383918, 14 pages, &lt;a href="http://dx.doi.org/10.1155/2015/383918">http://dx.doi.org/10.1155/2015/383918&lt;/a>&lt;/p>
&lt;p>Thomas Mabey1 and Sittisak Honsawek1,2&lt;/p>
&lt;p>1Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand&lt;/p>
&lt;p>2Department of Orthopaedics, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand&lt;/p>
&lt;p>&lt;strong>Figure 4&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/oa-f2.jpg" alt="image" width="800">
&lt;p>Osteoarthritis is a debilitating and degenerative disease which affects millions of people worldwide. The causes and mechanisms of osteoarthritis remain to be fully understood. Vitamin D has been hypothesised to play essential roles in a number of diseases including osteoarthritis. Many cell types within osteoarthritic joints appear to experience negative effects often at increased sensitivity to vitamin D. These findings contrast clinical research which has identified vitamin D deficiency to have a worryingly high prevalence among osteoarthritis patients. Randomised-controlled trial is considered to be the most rigorous way of determining the effects of vitamin D supplementation on the development of osteoarthritis. Studies into the effects of low vitamin D levels on pain and joint function have to date yielded controversial results. Due to the apparent conflicting effects of vitamin D in knee osteoarthritis, further research is required to fully elucidate its role in the development and progression of the disease as well as assess the efficacy and safety of vitamin D supplementation as a therapeutic strategy.&lt;/p></description></item><item><title>Spinal non fusion 3.5 X more likely if low vitamin D</title><link>/posts/spinal-non-fusion-35-x-more-likely-if-low-vitamin-d.html</link><pubDate>Wed, 15 Jul 2015 00:00:00 +0000</pubDate><guid>/posts/spinal-non-fusion-35-x-more-likely-if-low-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-levels-and-one-year-fusion-outcomes-in-elective-spine-surgery-a-prospective-observational-study">Vitamin D Levels and One-Year Fusion Outcomes in Elective Spine Surgery: A Prospective Observational Study.&lt;/h4>
&lt;p>Spine (Phila Pa 1976). 2015 Jul 10.&lt;/p>
&lt;p>Ravindra VM1, Godzik J, Dailey AT, Schmidt MH, Bisson EF, Hood RS, Cutler A, Ray WZ.&lt;/p>
&lt;p>1Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah&lt;/p>
&lt;p>2Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona&lt;/p>
&lt;p>3University of Florida School of Medicine, Gainesville, Florida 4Department of Neurosurgery, Washington University in St. Louis, St. Louis, Missouri.&lt;/p></description></item><item><title>40 percent lower vitamin D level if work other shifts (Italy)</title><link>/posts/40-percent-lower-vitamin-d-level-if-work-other-shifts-italy.html</link><pubDate>Thu, 02 Jul 2015 00:00:00 +0000</pubDate><guid>/posts/40-percent-lower-vitamin-d-level-if-work-other-shifts-italy.html</guid><description>&lt;h4 id="shift-work-and-serum-25-oh-vitamin-d-status-among-factory-workers-in-northern-italy-cross-sectional-study">Shift work and serum 25-OH vitamin D status among factory workers in Northern Italy: Cross-sectional study.&lt;/h4>
&lt;p>Chronobiol Int. 2015 Jun 30:1-6. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Romano A1, Vigna L, Belluigi V, Conti DM, Barberi CE, Tomaino L, Consonni D, Riboldi L, Tirelli AS, Andersen LL.&lt;/p>
&lt;p>1Department of Clinical Sciences and Community Health, Post-graduate School of Occupational Medicine, Università degli Studi di Milano , Milan , Italy .&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>Was this just 2nd or 2nd and 3rd shift?&lt;/p></description></item><item><title>1000 IU vitamin D not enough in winter to restore levels in children - RCT</title><link>/posts/1000-iu-vitamin-d-not-enough-in-winter-to-restore-levels-in-children-rct.html</link><pubDate>Wed, 24 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/1000-iu-vitamin-d-not-enough-in-winter-to-restore-levels-in-children-rct.html</guid><description>&lt;p>&lt;strong>Effect of vitamin D3 supplementation in black and in white children: a randomized, placebo-controlled trial&lt;/strong>&lt;/p>
&lt;p>Kumaravel Rajakumar, MD, MS,1 Charity G Moore, PhD, MSPH2,6,&lt;/p>
&lt;p>Jonathan Yabes, PhD,2,6, Flora Olabopo, BS1&lt;/p>
&lt;p>Mary Ann Haralam, MSN1&lt;/p>
&lt;p>Diane Comer, BA,2,6, Jaimee Bogusz, BS,3&lt;/p>
&lt;p>Anita Nucci, PhD, MPH, RD, LD,4&lt;/p>
&lt;p>Susan Sereika, PhD,5&lt;/p>
&lt;p>Jacqueline Dunbar-Jacob, PhD5&lt;/p>
&lt;p>Michael F Holick, PhD, MD3&lt;/p>
&lt;p>and Susan L Greenspan, MD6&lt;/p>
&lt;p>1 Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, United States;&lt;/p></description></item><item><title>Vitamin D levels increasing 7 percent per year, bones denser in Japan (probably supplementation)</title><link>/posts/vitamin-d-levels-increasing-7-percent-per-year-bones-denser-in-japan-probably-supplementation.html</link><pubDate>Sat, 20 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-levels-increasing-7-percent-per-year-bones-denser-in-japan-probably-supplementation.html</guid><description>&lt;h4 id="factors-affecting-changes-in-the-serum-levels-of-25-hydroxyvitamin-d-a-3-year-follow-up-of-the-road-study">Factors affecting changes in the serum levels of 25-hydroxyvitamin D: a 3-year follow-up of the ROAD study.&lt;/h4>
&lt;p>Osteoporos Int. 2015 Jun 19. DOI: 10.1007/s00198-015-3184-0&lt;/p>
&lt;p>Yoshimura N1, Muraki S, Oka H, Tanaka S, Kawaguchi H, Nakamura K, Akune T.&lt;/p>
&lt;p>1Department of Joint Disease Research, 22nd Century Medical and Research Center, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan, &lt;a href="mailto:YOSHIMURAN-ORT@h.u-tokyo.ac.jp">YOSHIMURAN-ORT@h.u-tokyo.ac.jp&lt;/a>.&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/road-chart.jpg" alt="image" width="300">
&lt;p>In this 3-year population-based cohort study, among 1346 subjects, the mean annual change in the serum 25-hydroxyvitamin D levels was &lt;strong>7.6 %/year&lt;/strong> , which tended to increase during the 3-year period. Multivariate regression analysis indicated that the L2-4 bone mineral density and total daily energy intake were significant independent associated factors.&lt;/p></description></item><item><title>Links between Vitamin D Deficiency and Cardiovascular Diseases</title><link>/posts/links-between-vitamin-d-deficiency-and-cardiovascular-diseases.html</link><pubDate>Wed, 10 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/links-between-vitamin-d-deficiency-and-cardiovascular-diseases.html</guid><description>&lt;p>Biomed Res Int. 2015;2015:109275. Epub 2015 Apr 27.&lt;/p>
&lt;p>Mozos I1, Marginean O2&lt;/p>
&lt;p>1 Department of Functional Sciences, &amp;ldquo;Victor Babes&amp;rdquo; University of Medicine and Pharmacy, 300173 Timisoara, Romania.&lt;/p>
&lt;p>2 Department of Pediatrics, &amp;ldquo;Victor Babes&amp;rdquo; University of Medicine and Pharmacy, 300173 Timisoara, Romania.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:400px">
&lt;p>&lt;a href="/posts/overview-cardiovascular-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Cardiovascular and vitamin D">Overview Cardiovascular and vitamin D&lt;/a>&lt;/p>
&lt;p>&lt;a href="/posts/overview-stroke-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Stroke and vitamin D">Overview Stroke and vitamin D&lt;/a>&lt;/p></description></item><item><title>Spinal muscular atrophy (rare disease) might be helped with vitamin D</title><link>/posts/spinal-muscular-atrophy-rare-disease-might-be-helped-with-vitamin-d.html</link><pubDate>Wed, 10 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/spinal-muscular-atrophy-rare-disease-might-be-helped-with-vitamin-d.html</guid><description>&lt;p>&lt;strong>Vitamin D has been proven many times to fight &lt;a href="/posts/bone-health">bone&lt;/a> and &lt;a href="/posts/muscles-and-vitamin-d-many-studies">muscle&lt;/a> problems&lt;br>
Vitamin D might fight many aspects of Spinal Muscular Atrophy&lt;br>
Maintence dosing typically does not show any benefit for 2-8 months&lt;br>
Starting with a &lt;a href="/posts/overview-loading-of-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Loading of vitamin D">Vitamin D loading dose&lt;/a> often shows benefits in weeks&lt;/strong>&lt;/p>
&lt;hr>
&lt;h4 id="bone-and-spinal-muscular-atrophy">Bone and spinal muscular atrophy.&lt;/h4>
&lt;p>Bone. 2015 Jun 5. pii: S8756-3282(15)00220-3. &lt;a href="https://doi.org/10.1016/j.bone.2015.05.039.">doi: 10.1016/j.bone.2015.05.039.&lt;/a>&lt;/p>
&lt;p>Vai S1, Bianchi ML2, Moroni I3, Mastella C4, Broggi F2, Morandi L5, Arnoldi MT6, Bussolino C6, Baranello G6.&lt;/p></description></item><item><title>Bone fractures after a burn - none if vitamin D, 6 if no vitamin D – RCT</title><link>/posts/bone-fractures-after-a-burn-none-if-vitamin-d-6-if-no-vitamin-d-rct.html</link><pubDate>Sun, 31 May 2015 00:00:00 +0000</pubDate><guid>/posts/bone-fractures-after-a-burn-none-if-vitamin-d-6-if-no-vitamin-d-rct.html</guid><description>&lt;h4 id="an-investigation-of-bone-health-subsequent-to-vitamin-d-supplementation-in-children-following-burn-injury">An Investigation of Bone Health Subsequent to Vitamin D Supplementation in Children Following Burn Injury.&lt;/h4>
&lt;p>Nutr Clin Pract. 2015 May 29. &lt;a href="https://doi.org/10.1177/0884533615587720">doi: 10.1177/0884533615587720&lt;/a>&lt;/p>
&lt;p>Mayes T1, Gottschlich MM2, Khoury J3, Kagan RJ4.&lt;/p>
&lt;p>1Department of Nutrition, Shriners Hospitals for Children, Cincinnati, Ohio Division of Nutrition Therapy, Cincinnati Children&amp;rsquo;s Hospital Medical Center, Cincinnati, Ohio &lt;a href="mailto:theresa.mayes@cchmc.org">theresa.mayes@cchmc.org&lt;/a>.&lt;/p>
&lt;p>2Department of Nutrition, Shriners Hospitals for Children, Cincinnati, Ohio Department of Research, Shriners Hospitals for Children, Cincinnati, Ohio Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio.&lt;/p></description></item><item><title>Cardiovascular Diseases and Vitamin D – Review</title><link>/posts/cardiovascular-diseases-and-vitamin-d-review.html</link><pubDate>Sun, 31 May 2015 00:00:00 +0000</pubDate><guid>/posts/cardiovascular-diseases-and-vitamin-d-review.html</guid><description>&lt;p>&lt;strong>Links between Vitamin D Deficiency and Cardiovascular Diseases - Review Article&lt;/strong>&lt;/p>
&lt;p>BioMed Research International, Volume 2015 (2015), Article ID 109275, 12 pages&lt;/p>
&lt;p>&lt;a href="http://dx.doi.org/10.1155/2015/109275">http://dx.doi.org/10.1155/2015/109275&lt;/a>&lt;/p>
&lt;p>Ioana Mozos 1 and Otilia Marginean 2&lt;/p>
&lt;p>1Department of Functional Sciences, “Victor Babes” University of Medicine and Pharmacy, 300173 Timisoara, Romania&lt;/p>
&lt;p>2Department of Pediatrics, “Victor Babes” University of Medicine and Pharmacy, 300173 Timisoara, Romania&lt;/p>
&lt;p>Received 31 October 2014; Accepted 8 February 2015&lt;/p>
&lt;p>&lt;strong>Abstract&lt;/strong>&lt;/p>
&lt;p>The aim of the present paper was to review the most important mechanisms explaining the possible association of vitamin D deficiency and cardiovascular diseases, focusing on recent experimental and clinical data. Low vitamin D levels favor atherosclerosis enabling vascular inflammation, endothelial dysfunction, formation of foam cells, and proliferation of smooth muscle cells. The antihypertensive properties of vitamin D include suppression of the renin-angiotensin-aldosterone system, renoprotective effects, direct effects on endothelial cells and calcium metabolism, inhibition of growth of vascular smooth muscle cells, prevention of secondary hyperparathyroidism, and beneficial effects on cardiovascular risk factors. Vitamin D is also involved in glycemic control, lipid metabolism, insulin secretion, and sensitivity, explaining the association between vitamin D deficiency and metabolic syndrome. Vitamin D deficit was associated in some studies with the number of affected coronary arteries, postinfarction complications, inflammatory cytokines and cardiac remodeling in patients with myocardial infarction, direct electromechanical effects and inflammation in atrial fibrillation, and neuroprotective effects in stroke. In peripheral arterial disease, vitamin D status was related to the decline of the functional performance, severity, atherosclerosis and inflammatory markers, arterial stiffness, vascular calcifications, and arterial aging. Vitamin D supplementation should further consider additional factors, such as phosphates, parathormone, renin, and fibroblast growth factor 23 levels.&lt;/p></description></item><item><title>Bone strength (more accurate than BMD) is inversely associated with vitamin D level</title><link>/posts/bone-strength-more-accurate-than-bmd-is-inversely-associated-with-vitamin-d-level.html</link><pubDate>Sat, 30 May 2015 00:00:00 +0000</pubDate><guid>/posts/bone-strength-more-accurate-than-bmd-is-inversely-associated-with-vitamin-d-level.html</guid><description>&lt;h4 id="the-association-of-vitamin-d-with-femoral-neck-strength-an-additional-evidence-of-vitamin-d-on-bone-health">The Association of Vitamin D with Femoral Neck Strength: an Additional Evidence of Vitamin D on Bone Health&lt;/h4>
&lt;p>J Clin Endocrinol Metab &lt;a href="https://doi.org/10.1210/jc.2014-4320">doi: 10.1210/jc.2014-4320&lt;/a>&lt;/p>
&lt;p>Hyeonmok Kim, Seung Hun Lee, JinJu Kim, Kyeong-Hye Lim, Seong Hee Ahn, Beom-Jun Kim, Jung-Min Koh&lt;/p>
&lt;p>Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, 138-736, Seoul, Korea&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>&lt;a href="/posts/hypothesis-increased-bone-mineral-density-needs-protein-ca-mg-vitamin-d-and-k">Hypothesis: increased bone mineral density needs protein, Ca, Mg, Vitamin D and K&lt;/a>&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>If bone matrix is broken down, adding more bone only increases bone density, not bone strength&lt;/p></description></item><item><title>Kawasaki disease (strawberry tongue) associated with very low vitamin D</title><link>/posts/kawasaki-disease-strawberry-tongue-associated-with-very-low-vitamin-d.html</link><pubDate>Mon, 25 May 2015 00:00:00 +0000</pubDate><guid>/posts/kawasaki-disease-strawberry-tongue-associated-with-very-low-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#kd-has-had-a-recent-seasonal-cycle">KD has had a recent seasonal cycle&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamindwiki-reasons-to-suspect-that-kd-can-be-prevented-with-vitamin-d-supplementation">VitaminDWiki reasons to suspect that KD can be prevented with Vitamin D supplementation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#snips--from-wikipedia-entry--with-vitamindwiki-comments">Snips from Wikipedia entry – with VitaminDWiki comments&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;ul>
&lt;li>&lt;a href="https://articles.mercola.com/kawasaki-disease.aspx?utm_source=dnl&amp;amp;utm_medium=email&amp;amp;utm_content=secon&amp;amp;utm_campaign=20180828Z1_UCM&amp;amp;et_cid=DM231077&amp;amp;et_rid=404851681">Introduction to Kawasaki Disease: Discover About This Illness That Primarily Affects Children&lt;/a> Mercola Aug 2018, nice overview, no mention of Vitamin D&lt;/li>
&lt;/ul>
&lt;h4 id="kd-has-had-a-recent-seasonal-cycle">KD has had a recent seasonal cycle&lt;/h4>
&lt;p>which has gotten worse as vitamin D levels have been dropping&lt;/p>
&lt;p>Note: the KD season is now in Winter-Spring - when vitamin D levels are the lowest&lt;/p></description></item><item><title>African immigrants: half are vitamin D deficient (based on Caucasian measures)</title><link>/posts/african-immigrants-half-are-vitamin-d-deficient-based-on-caucasian-measures.html</link><pubDate>Sun, 24 May 2015 00:00:00 +0000</pubDate><guid>/posts/african-immigrants-half-are-vitamin-d-deficient-based-on-caucasian-measures.html</guid><description>&lt;h4 id="biochemical-and-clinical-deficiency-is-uncommon-in-african-immigrants-despite-a-high-prevalence-of-low-vitamin-d-the-africans-in-america-study">Biochemical and clinical deficiency is uncommon in African immigrants despite a high prevalence of low vitamin D: the Africans in America study.&lt;/h4>
&lt;p>Osteoporos Int. 2015 May 23. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Thoreson CK1, Chung ST, Ricks M, Reynolds JC, Remaley AT, Periwal V, Li Y, Sumner AE.&lt;/p>
&lt;p>Author information&lt;/p>
&lt;p>1Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bld 10-CRC, Rm 6-5940, MSC 1612, 9000 Rockville Pike, Bethesda, MD, 20892-1612, USA.&lt;/p></description></item><item><title>Long bone fracture – prediction by low vitamin D is better than low BMD</title><link>/posts/long-bone-fracture-prediction-by-low-vitamin-d-is-better-than-low-bmd.html</link><pubDate>Sat, 16 May 2015 00:00:00 +0000</pubDate><guid>/posts/long-bone-fracture-prediction-by-low-vitamin-d-is-better-than-low-bmd.html</guid><description>&lt;h4 id="serum-25-hydroxyvitamin-d-below-25-ngml-is-a-risk-factor-for-long-bone-fracture-comparable-to-bone-mineral-density-in-japanese-postmenopausal-women">Serum 25-hydroxyvitamin D below 25 ng/mL is a risk factor for long bone fracture comparable to bone mineral density in Japanese postmenopausal women.&lt;/h4>
&lt;p>J Bone Miner Metab. 2014 Sep;32(5):514-23. &lt;a href="https://doi.org/10.1007/s00774-013-0520-3.">doi: 10.1007/s00774-013-0520-3.&lt;/a>&lt;/p>
&lt;p>Tanaka S1, Kuroda T, Yamazaki Y, Shiraki Y, Yoshimura N, Shiraki M.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:500px">
&lt;p>Long bone fracture prediction for women – age 64&lt;/p>
&lt;p>41% had osteoporosis, 50% had &amp;lt; 20 ng of vitamin D&lt;/p>
&lt;p>2.2 X if &amp;lt; 25 ng of vitamin D&lt;/p></description></item><item><title>Role of vitamins in gastrointestinal diseases – review</title><link>/posts/role-of-vitamins-in-gastrointestinal-diseases-review.html</link><pubDate>Wed, 13 May 2015 00:00:00 +0000</pubDate><guid>/posts/role-of-vitamins-in-gastrointestinal-diseases-review.html</guid><description>&lt;p>World J Gastroenterol. 2015 May 7; 21(17): 5191–5209., &lt;a href="https://doi.org/10.3748/wjg.v21.i17.5191">doi: 10.3748/wjg.v21.i17.5191&lt;/a>&lt;/p>
&lt;p>Omar A Masri, Jean M Chalhoub, and Ala I Sharara&lt;/p>
&lt;p>A tremendous amount of data from research was published over the past decades concerning the roles of different vitamins in various gastrointestinal diseases. For instance, most vitamins showed an inverse relationship with the risk of colorectal carcinoma as well as other malignancies like gastric and esophageal cancer in observational trials, however interventional trials failed to prove a clear beneficial preventive role. On the other hand, more solid evidence was obtained from high quality studies for a role of certain vitamins in specific entities. Examples for this include the&lt;/p></description></item><item><title>Improved muscle function in postmenopausal women with just 1,000 IU of vitamin D daily – RCT</title><link>/posts/improved-muscle-function-in-postmenopausal-women-with-just-1000-iu-of-vitamin-d-daily-rct.html</link><pubDate>Sun, 10 May 2015 00:00:00 +0000</pubDate><guid>/posts/improved-muscle-function-in-postmenopausal-women-with-just-1000-iu-of-vitamin-d-daily-rct.html</guid><description>&lt;h4 id="effect-of-vitamin-d-supplementation-alone-on-muscle-function-in-postmenopausal-women-a-randomized-double-blind-placebo-controlled-clinical-trial">Effect of vitamin D supplementation alone on muscle function in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial.&lt;/h4>
&lt;p>Osteoporos Int. 2015 May 9. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Cangussu LM 1 &lt;a href="mailto:lucianacangussu@gmail.com">lucianacangussu@gmail.com&lt;/a>, Nahas-Neto J, Orsatti CL, Bueloni-Dias FN, Nahas EA.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:500px">
&lt;p>postmenopausal women with a history of falls (associated with low vitamin D)&lt;/p>
&lt;p>1,000 IU daily for 9 months&lt;/p>
&lt;h4 id="--vitamin-dplacebo">|| | Vitamin D|Placebo&lt;/h4>
&lt;p>Vitamin D at start|15 ng|17 ng&lt;/p>
&lt;p>Vitamin D after 9 months|28 ng| 14 ng&lt;/p></description></item><item><title>Vitamin D and fertility – Lerchbaum 2012, 2014</title><link>/posts/vitamin-d-and-fertility-lerchbaum-2012-2014.html</link><pubDate>Sun, 03 May 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-fertility-lerchbaum-2012-2014.html</guid><description>&lt;p>The 2012 study was referenced by the book &lt;strong>&lt;a href="http://smile.amazon.com/Mommy-Me-Vitamin-Eugene-Heyden/dp/0982827636/ref=sr_1_2?ie=UTF8&amp;amp;qid=1430676754&amp;amp;sr=8-2&amp;amp;keywords=mommy%2Cme+and+vitamin+d">Mommy, Me &amp;amp; Vitamin D&lt;/a>&lt;/strong> - Heyden 2014&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-fertility-a-systematic-review--may-2012">Vitamin D and fertility: a systematic review – May 2012&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#abstract">Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-metabolism">Vitamin D metabolism&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#figure-1-vitamin-d-effects">Figure 1 Vitamin D Effects&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#vdr-expression-in-reproductive-tissues">VDR expression in reproductive tissues&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-fertility-in-animal-studies">Vitamin D and fertility in animal studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficient-animals">Vitamin D-deficient animals&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-fertility-in-humans">Vitamin D and fertility in humans&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#women">Women&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#figure-2-the-proposed-associations-of-vitamin-d-status-with-female-reproduction">Figure 2: The proposed associations of vitamin D status with female reproduction.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#men">Men&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#figure-3-the-proposed-associations-of-vitamin-d-deficiency-with-male-reproduction">Figure 3: The proposed associations of vitamin D deficiency with male reproduction.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#pregnancy">Pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation">Vitamin D supplementation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#clinical-consequences-and-summary">Clinical consequences and summary&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-menopause--a-narrative-review--sept-2014">Vitamin D and menopause&amp;ndash;a narrative review – Sept 2014&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="vitamin-d-and-fertility-a-systematic-review--may-2012">Vitamin D and fertility: a systematic review – May 2012&lt;/h2>
&lt;p>Eur J Endocrinol May 1, 2012 166 765-778&lt;/p></description></item><item><title>Many more people now have vitamin D levels above 50 ng, especially seniors</title><link>/posts/many-more-people-now-have-vitamin-d-levels-above-50-ng-especially-seniors.html</link><pubDate>Fri, 01 May 2015 00:00:00 +0000</pubDate><guid>/posts/many-more-people-now-have-vitamin-d-levels-above-50-ng-especially-seniors.html</guid><description>&lt;p>&lt;strong>Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 ng/mL: A 10-Year Population-Based Study&lt;/strong>&lt;/p>
&lt;p>Daniel V. Dudenkov, MD; Barbara P. Yawn, MD, MS, FAAFP;&lt;/p>
&lt;p>Sara S. Oberhelman, MD; Philip R. Fischer, MD; RavinderJ. Singh, PhD;&lt;/p>
&lt;p>Stephen S. Cha, MS; Julie A. Maxson, BA; Stephanie M. Quigg, MS; and Tom D. Thacher, MD&lt;/p>
&lt;p>Objective: To determine the incidence trend of 25-hydroxyvitamin D (25(OH)D) values above 50 ng/mL and associated toxicity.&lt;/p>
&lt;p>Patients and Methods: We conducted a retrospective population-based study in Olmsted County, Minnesota, in the 10-year period from January 1, 2002, through December 31, 2011, by using the Rochester Epidemiology Project. Individuals were eligible if they resided in Olmsted County during the study period and had a measured 25(OH)D value above 50 ng/mL. The date of the first 25(OH)D value above 50 ng/mL was considered the index date for incidence determination. Hypercalcemia, the primary vitamin D toxicity, was considered potentially associated with the 25(OH)D concentration if it was measured within 3 months of the 25(OH)D measurement, and such cases had a medical record review.&lt;/p></description></item><item><title>Vitamin D and Inflammatory Bowel Disease – review</title><link>/posts/vitamin-d-and-inflammatory-bowel-disease-review.html</link><pubDate>Mon, 27 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-inflammatory-bowel-disease-review.html</guid><description>&lt;p>&lt;strong>Note: Several studies on this page&lt;/strong>&lt;/p>
&lt;p>BioMed Research International, Volume 2015 (2015), 16 pages, &lt;a href="http://dx.doi.org/10.1155/2015/470805">http://dx.doi.org/10.1155/2015/470805&lt;/a>&lt;/p>
&lt;p>Marco Ardesia,1 Guido Ferlazzo,2 and Walter Fries 3 &lt;a href="mailto:fwalter@unime.it">fwalter@unime.it&lt;/a>&lt;/p>
&lt;p>1 Internal Medicine, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy&lt;/p>
&lt;p>2 Laboratory of Immunology and Biotherapy, Department of Human Pathology, University of Messina, Messina, Italy&lt;/p>
&lt;p>3 Clinical Unit for Chronic Bowel Disorders, IBD-UNIT, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria 1, 98125 Messina, Italy&lt;/p></description></item><item><title>Off Topic: More than 800 mg of Calcium increases risk of Macular Degeneration in seniors by 2.6X – JAMA</title><link>/posts/off-topic-more-than-800-mg-of-calcium-increases-risk-of-macular-degeneration-in-seniors-by-26x-jama.html</link><pubDate>Wed, 15 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/off-topic-more-than-800-mg-of-calcium-increases-risk-of-macular-degeneration-in-seniors-by-26x-jama.html</guid><description>&lt;h4 id="self-reported-calcium-supplementation-and-age-related-macular-degeneration-online-first">Self-reported Calcium Supplementation and Age-Related Macular Degeneration ONLINE FIRST&lt;/h4>
&lt;p>JAMA Ophthalmol. Published online April 09, 2015. doi:10.1001/jamaophthalmol.2015.0514 Caitlin L. M. Kakigi, BA1; Kuldev Singh, MD, MPH2; Sophia Y. Wang, MD3; Wayne T. Enanoria, PhD, MPH4; Shan C. Lin, MD1&lt;/p>
&lt;p>Importance Despite widespread use of calcium supplementation among elderly people, little is known about the association between such consumption and the prevalence of age-related macular degeneration (AMD) in the United States.&lt;/p></description></item><item><title>Bone strength increased when sow and piglets had enough Vitamin D and Phosphorus</title><link>/posts/bone-strength-increased-when-sow-and-piglets-had-enough-vitamin-d-and-phosphorus.html</link><pubDate>Tue, 07 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/bone-strength-increased-when-sow-and-piglets-had-enough-vitamin-d-and-phosphorus.html</guid><description>&lt;h4 id="neonatal-pig-femur-integrity-responses-to-dietary-vitamin-d-and-p-depend-on-maternal-dietary-vitamin-d">Neonatal Pig Femur Integrity Responses to Dietary Vitamin D and P Depend on Maternal Dietary Vitamin D&lt;/h4>
&lt;p>L Amundson1 and T Crenshaw1&lt;/p>
&lt;p>1Dept Anim Sci Univ of Wisconsin Madison Wisconsin United States&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/bone-strength.jpg" alt="image" width="650">
&lt;p>Kyphosis, an idiopathic disease, occurs in swine and humans. We induced kyphosis by altering maternal dietary vitamin D (D) and pig dietary D, Ca and P. The objective was to characterize bone traits and gene expression in the kyphosis model and assess maternal carryover effects. Traits from mechanical tests to characterize femur integrity are reported herein. Sows were fed diets with 0, 325 or 1750 IU D/kg (n = 6, 8, or 9/diet). At weaning (23 ± 2 d) pigs were fed diets with 0 (-D) or 280 (+D) IU D/kg, each with 95% (95P) or 120% (120P) of the P requirement. Pigs were killed at birth (n = 23), weaning (n = 22), and at the end of nursery (n = 185) for bone and tissue analysis. Excised femurs were subjected to a 4-point bending test to determine bending moment (BM), stress, strain, and modulus of elasticity (ME) at the yield point of load deformation curves. Mass moment of inertia (MOI) was derived from CT scans. ME encompasses of BM, stress, strain and MOI and is assumed to be a constant property of a material. No differences in ME were detected at birth. At weaning ME increased in pigs produced by sows fed 1750 (P &amp;lt; 0.05). At the end of nursery ME depended on maternal diets (interaction, P &amp;lt; 0.05). ME increased in pigs fed +D95P if produced by sows fed 0 or 325 but decreased if produced by sows fed 1750. As previously reported, DXA whole body bone mineral density also indicated maternal carryover effects, but the pattern differed among diets. Therefore whole body bone and femur integrity traits differ, but provide unique characterization of the model. As previously reported, the kyphosis model was further characterized by molecular analysis of bone and D homeostatic cell signaling mechanisms. All traits contribute to the characterization of the kyphosis model but a specific mechanism by which the deformity is induced has yet to be determined.&lt;/p></description></item><item><title>Vitamin D can probably augment or replace many vaccines</title><link>/posts/vitamin-d-can-probably-augment-or-replace-many-vaccines.html</link><pubDate>Tue, 24 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-can-probably-augment-or-replace-many-vaccines.html</guid><description>&lt;p>&lt;strong>Can We Translate Vitamin D Immunomodulating Effect on Innate and Adaptive Immunity to Vaccine Response?&lt;/strong>&lt;/p>
&lt;p>Nutrients 2015, 7(3), 2044-2060; doi:10.3390/nu7032044&lt;/p>
&lt;p>Pierre Olivier Lang 1,2,* and Richard Aspinall 2&lt;/p>
&lt;p>1 Geriatric medicine and Geriatric rehabilitation division, Department of medicine, University Hospital of Lausanne (CHUV), CH-1011 Lausanne, Switzerland&lt;/p>
&lt;p>2 Health and Wellbeing academy, Anglia Ruskin University, CM1 1SQ Cambridge, UK; E-Mail: &lt;a href="mailto:pierre-olivier.lang@chuv.ch">pierre-olivier.lang@chuv.ch&lt;/a>&lt;/p>
&lt;ul>
&lt;li>Author to whom correspondence should be addressed; E-Mail: &lt;a href="mailto:pierre-olivier.lang@chuv.ch">pierre-olivier.lang@chuv.ch&lt;/a>;&lt;/li>
&lt;/ul>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;a href="https://VitaminDWiki.com/Vaccine+effectiveness+may+drop+to+only+16%25+in+6+months+if+time+between+jabs+was+only+3+weeks+%E2%80%93+July+2021#VitaminDWiki_titles_containing_VACCIN">288 VitaminDWiki pages with VACCIN in title as of Sept 2024&lt;/a>&lt;/p></description></item><item><title>Frequent falls in nursing home more likely due to drug haze than low vitamin D</title><link>/posts/frequent-falls-in-nursing-home-more-likely-due-to-drug-haze-than-low-vitamin-d.html</link><pubDate>Tue, 17 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/frequent-falls-in-nursing-home-more-likely-due-to-drug-haze-than-low-vitamin-d.html</guid><description>&lt;h4 id="persistent-hypovitaminosis-d-and-loss-of-hip-bone-mineral-density-over-time-as-additional-risk-factors-for-recurrent-falls-in-a-population-based-prospective-cohort-of-elderly-persons-living-in-the-community-the-são-paulo-ageing--health-spah-study">Persistent hypovitaminosis D and loss of hip bone mineral density over time as additional risk factors for recurrent falls in a population-based prospective cohort of elderly persons living in the community. The São Paulo Ageing &amp;amp; Health (SPAH) Study.&lt;/h4>
&lt;p>Osteoporos Int. 2015 Jan 20. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:400px">
&lt;p>705 community-dwellers in Brazil&lt;/p>
&lt;p>Of the 16% who had fallen more than twice in previous year&lt;/p>
&lt;p>2.5X more likely if visual impairment&lt;/p></description></item><item><title>Growth Hormone problem (Acromegaly) more likely if vitamin D gene problems</title><link>/posts/growth-hormone-problem-acromegaly-more-likely-if-vitamin-d-gene-problems.html</link><pubDate>Sun, 08 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/growth-hormone-problem-acromegaly-more-likely-if-vitamin-d-gene-problems.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-across-growth-hormone-gh-disorders-from-gh-deficiency-to-gh-excess---april-2017">Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess - April 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#people-with-acromegaly-should-be-tested-for-vitamin-d-deficiency---may-2018">People with acromegaly should be tested for Vitamin D deficiency - May 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-in-children-with-growth-hormone-deficiency-due-to-pituitary-stalk-interruption-syndrome---jan-2018">Vitamin D in children with growth hormone deficiency due to pituitary stalk interruption syndrome - Jan 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#investigation-of-the-vitamin-d-receptor-polymorphisms-in-acromegaly-patients---march-2015-50">Investigation of the Vitamin D Receptor Polymorphisms in Acromegaly Patients - March 2015 (50%)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#igf-1-increases-if-take--1000-iu-of-vitamin-d-daily---meta-analysis-dec-2019">IGF-1 increases if take &amp;gt; 1,000 IU of vitamin D daily - meta-analysis Dec 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-binding-protein-and-free-vitamin-d-concentrations-in-acromegaly---nov-2015">Vitamin D-binding protein and free vitamin D concentrations in acromegaly - Nov 2015&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-across-growth-hormone-gh-disorders-from-gh-deficiency-to-gh-excess---april-2017">Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess - April 2017&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/gh-chart.jpg" alt="image" width="800">
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/gh-spectrum.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Hens fed a form of vitamin D had more hatchable eggs and more immune chicks</title><link>/posts/hens-fed-a-form-of-vitamin-d-had-more-hatchable-eggs-and-more-immune-chicks.html</link><pubDate>Sat, 07 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/hens-fed-a-form-of-vitamin-d-had-more-hatchable-eggs-and-more-immune-chicks.html</guid><description>&lt;h4 id="effect-of-hen-age-and-maternal-vitamin-d-source-on-performance-hatchability-bone-mineral-density-and-progeny-in-vitro-early-innate-immune-function">Effect of hen age and maternal vitamin D source on performance, hatchability, bone mineral density, and progeny in vitro early innate immune function.&lt;/h4>
&lt;p>Poult Sci. 2015 Mar 5. pii: pev002. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Saunders-Blades JL1, Korver DR2.&lt;/p>
&lt;p>1Department of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, Canada T6G 2P5.&lt;/p>
&lt;p>2Department of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, Canada T6G 2P5 &lt;a href="mailto:doug.korver@ualberta.ca">doug.korver@ualberta.ca&lt;/a>&lt;/p>
&lt;p>The metabolite 25-hydroxy vitamin D3 (25-OHD) can complement or replace vitamin D3 in poultry rations, and may influence broiler production and immune function traits. The effect of broiler breeder dietary 25-OHD on egg production, hatchability, and chick early innate immune function was studied. We hypothesized that maternal dietary 25-OHD would support normal broiler breeder production and a more mature innate immune system of young chicks. Twenty-three-week-old Ross 308 hens (n = 98) were placed in 4 floor pens and fed either&lt;/p></description></item><item><title>Overview Sickle Cell and Vitamin D</title><link>/posts/overview-sickle-cell-and-vitamin-d.html</link><pubDate>Tue, 03 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/overview-sickle-cell-and-vitamin-d.html</guid><description>&lt;p> &lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#00F;">Several Sickle Cell trials have found that a loading dose of vitamin D followed by a good sized maintenance dose greatly reduces the number of days of SC pain&lt;/span>&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;strong>The size of the loading and maintence doses should vary by weight and health.&lt;/strong>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;strong>One study used a loading dose 100,000 IU weekly for 6 weeks - ignoring weight&lt;/strong>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;strong>One study used a loading dose of 5,234 IU/kg for 4 days&lt;/strong>&lt;/p></description></item><item><title>Blacks have lower vitamin D levels, but OK active vitamin D levels (VDBP)</title><link>/posts/blacks-have-lower-vitamin-d-levels-but-ok-active-vitamin-d-levels-vdbp.html</link><pubDate>Thu, 26 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/blacks-have-lower-vitamin-d-levels-but-ok-active-vitamin-d-levels-vdbp.html</guid><description>&lt;h2 class="showhide_heading" id="See_also_VitaminDWiki">
&lt;p>See also VitaminDWiki&lt;/h2>&lt;/p>
&lt;ul>&lt;li>
&lt;p>&lt;a class="wiki wiki_page" href="Overview+Dark+Skin+and+Vitamin+D" title="Overview Dark Skin and Vitamin D">Overview Dark Skin and Vitamin D&lt;/a>&lt;/li>&lt;/p>
&lt;li>
&lt;p>&lt;a class="wiki wiki_page" href="Testing+misses+the+Vitamin+D+tied+up+with+VDBP+%E2%80%93+June+2014" title="Testing misses the Vitamin D tied up with VDBP – June 2014">Testing misses the Vitamin D tied up with VDBP – June 2014&lt;/a>&lt;/li>&lt;/p>
&lt;li>
&lt;p>&lt;a class="wiki wiki_page" href="Vitamin+D+can+be+somewhat+blocked+by+Vitamin+D+Binding+Protein+%E2%80%93+May+2014" title="Vitamin D can be somewhat blocked by Vitamin D Binding Protein – May 2014">Vitamin D can be somewhat blocked by Vitamin D Binding Protein – May 2014&lt;/a>&lt;/li>&lt;/p>
&lt;li>
&lt;p>&lt;a class="wiki wiki_page" href="Vitamin+D+tests+assume+constant+Binding+Protein+-+not+correct+across+races+and+clinical+situations+%E2%80%93+July+2014" title="Vitamin D tests assume constant Binding Protein - not correct across races and clinical situations – July 2014">Vitamin D tests assume constant Binding Protein - not correct across races and clinical situations – July 2014&lt;/a>&lt;/li>&lt;/p></description></item><item><title>Poorly functioning livers do not process vitamin D (Calcidiol is needed)</title><link>/posts/poorly-functioning-livers-do-not-process-vitamin-d-calcidiol-is-needed.html</link><pubDate>Tue, 24 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/poorly-functioning-livers-do-not-process-vitamin-d-calcidiol-is-needed.html</guid><description>&lt;p>&lt;strong>Note: The study appears to be unaware of Calcidiol&lt;/strong>&lt;/p>
&lt;h4 id="hepatic-osteodystrophy">Hepatic osteodystrophy.&lt;/h4>
&lt;p>Clin Cases Miner Bone Metab. 2014 Sep;11(3):185-91.&lt;/p>
&lt;p>Gatta A1, Verardo A1, Di Pascoli M1, Giannini S1, Bolognesi M1.&lt;/p>
&lt;p>Metabolic disturbances of bone are frequent in patients with chronic liver disease. The prevalence of osteoporosis among patients with advanced chronic liver disease is reported between 12% and 55%; it is higher in primary biliary cirrhosis. All patients with advanced liver disease should be screened for osteoporosis with a densitometry, especially if the etiology is cholestatic and in the presence of other risk factors. Clinical relevance of hepatic osteodystrophy increases after liver transplantation.&lt;/p></description></item><item><title>Down syndrome children have low vitamin D levels, 400 IU not enough to help</title><link>/posts/down-syndrome-children-have-low-vitamin-d-levels-400-iu-not-enough-to-help.html</link><pubDate>Tue, 17 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/down-syndrome-children-have-low-vitamin-d-levels-400-iu-not-enough-to-help.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#down-syndrome-children-trisomy-21---2-out-of-3-had-less-than-20-ng-of-vitamin-d--aug-2018">Down syndrome children (Trisomy 21) - 2 out of 3 had less than 20 ng of vitamin D – Aug 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#determinants-of-vitamin-d-levels-in-children-and-adolescents-with-down-syndrome--2015">Determinants of vitamin d levels in children and adolescents with down syndrome- 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#down-syndrome-patients-have-smaller-bodies-increased-risk-of-osteoporosis-and-lower-vitamin-d-levels---july-2017">Down syndrome patients have smaller bodies, increased risk of Osteoporosis, and lower Vitamin D levels - July 2017&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="down-syndrome-children-trisomy-21---2-out-of-3-had-less-than-20-ng-of-vitamin-d--aug-2018">Down syndrome children (Trisomy 21) - 2 out of 3 had less than 20 ng of vitamin D – Aug 2018&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/downs-syndrome-and-low-vitamin-d-several-studies" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Down's syndrome and low vitamin D - several studies">Down&amp;rsquo;s syndrome and low vitamin D - several studies&lt;/a>&lt;/p></description></item><item><title>Rare skin diseases (autoimmune bullous ) strongly associated with low vitamin D and is increasing</title><link>/posts/rare-skin-diseases-autoimmune-bullous-strongly-associated-with-low-vitamin-d-and-is-increasing.html</link><pubDate>Wed, 04 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/rare-skin-diseases-autoimmune-bullous-strongly-associated-with-low-vitamin-d-and-is-increasing.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-skeletal-health-in-autoimmune-bullous-skin-diseases-a-case-control-study">Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-and-skeletal-health-in-autoimmune-bullous-skin-diseases-a-case-control-study">Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study&lt;/h4>
&lt;p>Orphanet Journal of Rare Diseases 2015, 10:8 doi:10.1186/s13023-015-0230-0&lt;/p>
&lt;p>Angelo Valerio Marzano1, Valentina Trevisan1, Elisa Cairoli23, Cristina Eller-Vainicher3, Valentina Morelli23, Anna Spada23, Carlo Crosti1 and Iacopo Chiodini 3 Iacopo Chiodini &lt;a href="mailto:iacopo.chiodini@unimi.it">iacopo.chiodini@unimi.it&lt;/a>&lt;/p>
&lt;p>Background The presence of hypovitaminosis D in patients with autoimmune bullous skin diseases, such as pemphigus vulgaris (PV) and bullous pemphigoid (BP), is debated. In a previous study we found an increased prevalence of vertebral fractures (VFx) and hypovitaminosis D in PV and BP patients. The present study extends the sample size of the previous one, for investigating the 25-hydroxyvitamin D (25OHVitD) levels in relation with the skeletal health and disease intensity in these patients.&lt;/p></description></item><item><title>Quarterly vitamin D injections 2 years after burns did not help bones</title><link>/posts/quarterly-vitamin-d-injections-2-years-after-burns-did-not-help-bones.html</link><pubDate>Sun, 01 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/quarterly-vitamin-d-injections-2-years-after-burns-did-not-help-bones.html</guid><description>&lt;h4 id="effects-of-cholecalciferol-supplementation-and-optimized-calcium-intakes-on-vitamin-d-status-muscle-strength-and-bone-health-a-one-year-pilot-randomized-controlled-trial-in-adults-with-severe-burns">Effects of cholecalciferol supplementation and optimized calcium intakes on vitamin D status, muscle strength and bone health: A one-year pilot randomized controlled trial in adults with severe burns&lt;/h4>
&lt;p>Burns, Volume 41, Issue 2, March 2015, Pages 317–325, doi:10.1016/j.burns.2014.07.005&lt;/p>
&lt;p>Anne-Françoise Rousseaua, , , Marguerite Foidart-Desalleb, Didier Ledouxa, Christophe Remya, c, Jean-Louis Croisierc, Pierre Damasa, Etienne Cavalierd&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;ul>
&lt;li>
&lt;p>How long after injection was the vitamin D test made?&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Why so long between injections ?– 1 month is much better&lt;/p></description></item><item><title>Elderly lost extra half pound of leg and arm muscle mass if low vitamin D (6 years)</title><link>/posts/elderly-lost-extra-half-pound-of-leg-and-arm-muscle-mass-if-low-vitamin-d-6-years.html</link><pubDate>Tue, 27 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/elderly-lost-extra-half-pound-of-leg-and-arm-muscle-mass-if-low-vitamin-d-6-years.html</guid><description>&lt;h3 id="poor-vitamin-d-status-is-prospectively-associated-with-greater-muscle-mass-loss-in-middle-aged-and-elderly-chinese-individuals">Poor vitamin D status is prospectively associated with greater muscle mass loss in middle-aged and elderly Chinese individuals.&lt;/h3>
&lt;p>J Acad Nutr Diet. 2014 Oct;114(10):1544-1551.e2. &lt;a href="https://doi.org/10.1016/j.jand.2014.05.012.">doi: 10.1016/j.jand.2014.05.012.&lt;/a> Epub 2014 Jul 16.&lt;/p>
&lt;p>Liu G, Lu L, Sun Q, Ye X, Sun L, Liu X, Zong G, Jin Q, Li H, Lin X. &lt;a href="mailto:xlin@sibs.ac.cn">xlin@sibs.ac.cn&lt;/a>&lt;/p>
&lt;p>BACKGROUND:&lt;/p>
&lt;p>Poor vitamin D status can increase age-related muscle mass loss. However, existing prospective evidence is limited and controversial.&lt;/p>
&lt;p>OBJECTIVE:&lt;/p>
&lt;p>This study aimed to investigate the association of plasma 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> with muscle mass loss in middle-aged and elderly Chinese individuals over 6 years.&lt;/p></description></item><item><title>Vitamin D - new popular pages in VitaminDWiki - 2014</title><link>/posts/vitamin-d-new-popular-pages-in-vitamindwiki-2014.html</link><pubDate>Sat, 17 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-new-popular-pages-in-vitamindwiki-2014.html</guid><description>&lt;h2 id="see-also">See also&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/tiki-wiki_rankings.php?limit=100">Most Read pages in VitaminDWiki&lt;/a> not just one year&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/cat98%2098&amp;amp;sort_mode=created_desc">Top New Pages&lt;/a> - sorted by date created&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="http://orthomolecular.org/resources/omns/v11n03.shtml">Top Vitamin D Research of 2014&lt;/a> by Dr. W.B. Grant&lt;/p>
&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>    Categories: Randomized Control Trials, Observational studies, Pregnancy, Mendelian randomization,&lt;/p>
&lt;/blockquote>
&lt;p>&lt;a href="/posts/serotonin-regulated-by-vitamin-d-part-1-autism">Serotonin regulated by Vitamin D – part 1 autism – Feb 2014&lt;/a>&lt;/p>
&lt;p>&lt;a href="/posts/why-indias-vitamin-d-deficiency-is-grim-40-pages">Why India&amp;rsquo;s vitamin D deficiency is grim - 40 pages Feb 2014&lt;/a>&lt;/p>
&lt;p>&lt;a href="/posts/williams-beuren-syndrome-rare-and-too-much-vitamin-d">Williams-Beuren Syndrome (rare) and too much Vitamin D&lt;/a>&lt;/p></description></item><item><title>Quantifying the vitamin D economy in the body - Heaney</title><link>/posts/quantifying-the-vitamin-d-economy-in-the-body-heaney.html</link><pubDate>Tue, 30 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/quantifying-the-vitamin-d-economy-in-the-body-heaney.html</guid><description>&lt;p>&lt;strong>Figure 1&lt;/strong>&lt;/p>
&lt;img src="/attachments/d3.mock.jpg" alt="image" width="600">
&lt;p>Quantifying the vitamin D economy&lt;/p>
&lt;p>Nutrition Reviews VR Vol. 73(1):51–67, &lt;a href="https://doi.org/10.1093/nutrit/nuu004">doi: 10.1093/nutrit/nuu004&lt;/a> Special Article&lt;/p>
&lt;p>Robert P. Heaney and Laura A.G. Armas&lt;/p>
&lt;p>R.P. Heaney is with Creighton University, Omaha, Nebraska, USA. &lt;a href="mailto:rpheaney@creighton.edu">rpheaney@creighton.edu&lt;/a>&lt;/p>
&lt;p>L.A.G. Armas is with the Department of Medicine, Creighton University, Omaha, Nebraska, USA&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/quantifying-the-vitamin-d-economy.pdf">Download the PDF with all figures from VitaminDWiki.&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>The following is virtually all of the text, most of the equations, and a few of the figures&lt;/strong>&lt;/p></description></item><item><title>Metadichol (Policosanol) supplement appears to improve health in many ways - multiple studies</title><link>/posts/metadichol-policosanol-supplement-appears-to-improve-health-in-many-ways-multiple-studies.html</link><pubDate>Sun, 28 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/metadichol-policosanol-supplement-appears-to-improve-health-in-many-ways-multiple-studies.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#00F;">Is avaiable in capsules and nanoemulsion spray&lt;/span>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#metadichol-a-novel-nanolipid-formulation-that-inhibits-sars-cov-2-and-a-multitude-of-pathological-viruses-in-vitro---jan-2022">Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro - Jan 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a-review-of-the-effects-of-policosanol-on-metabolic-syndrome---sept-2022">A Review of the Effects of Policosanol on Metabolic Syndrome - Sept 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nano-soma-metadichol--sells-product-has-publications-web-site-comments">NANO SOMA (Metadichol) sells product, has publications, web site comments&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#some-amazon-suppliers">Some Amazon suppliers&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ageing-process-and-policosanol-effects---oct-2021">Ageing process and policosanol effects - Oct 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#metadichol-a-novel-vitamin-d-receptor-inverseprotean-agonist-and-a-vitamin-d-substitute---sept-2017">Metadichol: A novel vitamin D receptor inverse/protean agonist and a vitamin D substitute - Sept 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rheumatoid-arthritis-and-osteoporosis-a-case-study---may-2017">Rheumatoid Arthritis and Osteoporosis: A Case Study - May 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#this-generally-recognized-as-safe-supplement-was-brought-to-my-attention-dec-2014">This Generally Recognized as Safe supplement was brought to my attention Dec 2014&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="metadichol-a-novel-nanolipid-formulation-that-inhibits-sars-cov-2-and-a-multitude-of-pathological-viruses-in-vitro---jan-2022">Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro - Jan 2022&lt;/h4>
&lt;p>Biomed Res Int. 2022 Jan 15;2022:1558860. &lt;a href="https://doi.org/10.1155/2022/1558860.">doi: 10.1155/2022/1558860.&lt;/a> eCollection 2022.&lt;/p></description></item><item><title>Response to 150,000 IU vitamin D once vs 5,000 IU daily – RCT</title><link>/posts/response-to-150000-iu-vitamin-d-once-vs-5000-iu-daily-rct.html</link><pubDate>Wed, 24 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/response-to-150000-iu-vitamin-d-once-vs-5000-iu-daily-rct.html</guid><description>&lt;h4 id="pharmacokinetics-of-daily-versus-monthly-vitamin-d3-supplementation-in-non-lactating-women">Pharmacokinetics of daily versus monthly vitamin D3 supplementation in non-lactating women&lt;/h4>
&lt;p>Eur J Clin Nutr. 2014 May ; 68(5): 632-634. doi:10.1038/ejcn.2013.278.&lt;/p>
&lt;p>Michael E MEEKINS, PharmD1, Sara S OBERHELMAN, MD2, Bernard R LEE, PharmD3, Brian M GARDNER, PharmD4, Stephen S CHA, Ph.D5, Ravinder J SINGH, Ph.D6, John M PETTIFOR, M.B.,B.Ch., Ph.D7, Philip R FISCHER, MD8, and Tom D THACHER, MD2&lt;/p>
&lt;p>Mayo, etc - see PDF&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:650px">
&lt;p>&lt;strong>Chart of data by VitaminDWiki&lt;/strong>&lt;/p></description></item><item><title>Burns, ulcers, and wounds healed by Vitamin D - many studies</title><link>/posts/burns-ulcers-and-wounds-healed-by-vitamin-d-many-studies.html</link><pubDate>Sat, 20 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/burns-ulcers-and-wounds-healed-by-vitamin-d-many-studies.html</guid><description>&lt;p>&lt;strong>Note: Vitamin D lotions/oils applied &lt;a href="/posts/topical-vitamin-d">topically&lt;/a> will probably better than oral Vitamin D. Perhaps 100X higher concentration on burn if applied topically&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#asked-ai-are-burns-less-severe-if-the-person-has-higher-level-of-vitamin-d">Asked AI: Are burns less severe if the person has higher level of vitamin d?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#burn-with-low-vitamin-d-1-day-longer-infection-3x-more-likely-when-leave-hospital---feb-2024">Burn with low Vitamin D: 1 day longer, infection 3X more likely when leave hospital - Feb 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#burn-length-of-stay-in-hospital-vs-vitamin-d-level---18-vs-12-days---dec-2023">Burn length of stay in hospital vs. Vitamin D level - 18 vs 12 days - Dec 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#more-intense-burns-associated-with-lower-vitamin-d-might-low-d-cause-more-burn-sept2020">More intense burns associated with lower Vitamin D (might low D cause more burn)– Sept 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#potential-ways-vitamin-d-can-help-burns---april2019">Potential ways Vitamin D can help burns - April 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#burn-centers-typically-still-do-not-test-vitamin-d-levels--survey--march2019">Burn Centers typically still do not test vitamin D levels- survey – March 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#burns-with-higher-vitamin-d-have-fewer-problems---feb2019">Burns with higher vitamin D have fewer problems - Feb 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nearly-all-burn-patients-have-low-vitamin-d-levels---may2018">Nearly all burn patients have low Vitamin D levels - May 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#50-fracture-admissions-occurred-within-7-years-of-burn-admission---sept2017">50% fracture admissions occurred within 7 years of burn admission - Sept 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#burns-with-low-vitamin-d-associated-with-more-days-in-icu-and-hospital--jan2017">Burns with low vitamin D associated with more days in ICU and hospital – Jan 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bone-fractures-after-a-burn---none-if-vitamin-d-6-if-no-vitamin-d--rct-may2015">Bone fractures after a burn - none if vitamin D, 6 if no vitamin D – RCT May 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-after-a-high-dose-of-cholecalciferol-in-healthy-and-burnsubjects">Vitamin D status after a high dose of cholecalciferol in healthy and burn subjects&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#quarterly-vitamin-d-injections-200000-iu-helped-muscles-in-burn-patients---march2015">Quarterly Vitamin D injections (200,000 IU) helped muscles in burn patients - March 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#both-vitamins-d3-and-d2-100-iukg-provided-some-help-to-critically-ill-pediatric-burn-patients---june2015">Both vitamins D3 and D2 (100 IU/kg) provided some help to Critically Ill Pediatric Burn Patients - June 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#97-of-pediatric-burn-patients-had-low-vitamin-d---feb2016">97% of pediatric burn patients had low vitamin D - Feb 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pain-6-months-after-thermal-burn-and-skin-autography-associated-with-low-vitamin-d-and-low-omega-3---march2018">Pain 6 months after thermal burn and skin autography associated with low vitamin D and low Omega-3 - March 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#burned-in-factory-explosion-8x-less-likely-to-get-infected-if-treated-with-magnesium-and-vitamins-such-as-b12---rct-nov2018">Burned in factory explosion: 8X less likely to get infected if treated with Magnesium and Vitamins such as B12 - RCT Nov 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-may-improve-wound-healing-in-burns-patients--nov2017">Vitamin D may improve wound healing in burns patients – Nov 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#diabetic-foot-ulcers-helped-by-50000-iu-weekly--rct-june2016">Diabetic foot ulcers helped by 50,000 IU weekly – RCT June 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-the-vitamin-d-receptor-in-the-epidermal-stem-cell-response-to-wounding---aug-2024">The Role of the Vitamin D Receptor in the Epidermal Stem Cell Response to Wounding - Aug 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#diabetic-foot-ulcers-healed-2x-faster-with-6400-iu-daily---rct-june2021">Diabetic foot ulcers healed 2X faster with 6,400 IU daily - RCT June 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-vitamin-d-deficiency-epidemic-pulsating-wound-jan2018">The Vitamin D Deficiency Epidemic (pulsating wound) Jan 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-for-healing-wounds--nov2014">Vitamin D for Healing Wounds – Nov 2014&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="asked-ai-are-burns-less-severe-if-the-person-has-higher-level-of-vitamin-d">Asked AI: Are burns less severe if the person has higher level of vitamin d?&lt;/h4>
&lt;p>The study mentioned in 1 found that 88.9% of burn patients had a vitamin D deficiency and that wound healing time (WHT) across all three burn types was a common factor associated with vitamin D levels. Particularly, electrical burn patients with vitamin D deficiency showed prolonged wound healing over a post-burn period of 2 months.&lt;/p></description></item><item><title>Anorexia nervosa and Vitamin D - several studies</title><link>/posts/anorexia-nervosa-and-vitamin-d-several-studies.html</link><pubDate>Sat, 06 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/anorexia-nervosa-and-vitamin-d-several-studies.html</guid><description>&lt;p>Anorexia Nervosa appears to be associated with&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Season of birth,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Low vitamin D while pregnant,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>High latitude&lt;/p>
&lt;/li>
&lt;/ul>
&lt;hr>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#anorexia-nervosa---10-year-update---oct-2021">Anorexia Nervosa - 10 year update - Oct 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-in-anorexia-nervosa-a-meta-analysis---2014">Vitamin D status in anorexia nervosa: A meta-analysis - 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#strong-relationship-between-vitamin-d-status-and-bone-mineral-density-in-anorexia-nervosa---may-2015">Strong relationship between vitamin d status and bone mineral density in anorexia nervosa - May 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#an-after-low-seasonal-vitamin-d-during-pregnancy-or-high-latitude---2013">AN after low seasonal vitamin D during pregnancy or high latitude - 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#anorexia-resulted-in-vitamin-d-level-25-ngml--aug-2014">Anorexia resulted in vitamin D level 25 ng/ml – Aug 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#season-of-birth-related-to-an--11-studies-conclude-an-association---2012">Season of birth related to AN – 11 studies conclude an association - 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#season-of-birth-and-anorexia-nervosa-may-2011">Season of birth and anorexia nervosa May 2011&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#speculation-supplementing-with-vitamin-d-while-pregnant-will-reduce-later-anorexia">Speculation: Supplementing with vitamin D while pregnant will reduce later anorexia&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="anorexia-nervosa---10-year-update---oct-2021">Anorexia Nervosa - 10 year update - Oct 2021&lt;/h4>
&lt;p>&lt;strong>Anorexia Nervosa—What Has Changed in the State of Knowledge about Nutritional Rehabilitation for Patients over the Past 10 Years? A Review of Literature&lt;/strong>&lt;/p></description></item><item><title>UK Osteoporosis Society (inadequate) guidelines for vitamin D and bone health</title><link>/posts/uk-osteoporosis-society-inadequate-guidelines-for-vitamin-d-and-bone-health.html</link><pubDate>Sat, 29 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/uk-osteoporosis-society-inadequate-guidelines-for-vitamin-d-and-bone-health.html</guid><description>&lt;h3 id="national-osteoporosis-society-practical-clinical-guideline-on-vitamin-d-and-bone-health">National Osteoporosis Society Practical Clinical Guideline on Vitamin D and Bone Health&lt;/h3>
&lt;p>Maturitas: November 27, 2014, DOI: &lt;a href="http://dx.doi.org/10.1016/j.maturitas.2014.11.018">http://dx.doi.org/10.1016/j.maturitas.2014.11.018&lt;/a>&lt;/p>
&lt;p>R.M. Francisemail, T.J. Aspray, C.E. Bowring, W.D. Fraser, N.J. Gittoes, M.K. Javaid, H.M. Macdonald, S. Patel, P.L. Selby, N. Tanna&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/uk-osteo-society.pdf">Download the PDF from VitaminDWiki.&lt;/a>&lt;/strong>&lt;/p>
&lt;p>There is growing interest in the importance of vitamin D in the maintenance of bone health and the prevention of falls and fractures. Although there is no universal consensus on the criteria for vitamin D deficiency, this is common in the UK, particularly in frail older people &lt;sup>[1]&lt;/sup>. This has resulted in a marked increase in requests for serum 25 hydroxyvitamin D (25OHD) estimation, but there has been confusion about the indications for these measurements, interpretation of the results and the management of vitamin D deficiency.&lt;/p></description></item><item><title>Smoking associated with 9 ng less vitamin D age 40-50</title><link>/posts/smoking-associated-with-9-ng-less-vitamin-d-age-40-50.html</link><pubDate>Tue, 18 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/smoking-associated-with-9-ng-less-vitamin-d-age-40-50.html</guid><description>&lt;h3 id="smoking-is-a-significant-determinant-of-low-serum-vitamin-d-in-young-and-middle-aged-healthy-males">Smoking is a significant determinant of low serum vitamin D in young and middle-aged healthy males.&lt;/h3>
&lt;p>Hormones (Athens). 2014 Nov 5. &lt;a href="https://doi.org/10.14310/horm.2002.1521.">doi: 10.14310/horm.2002.1521.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Eva N. Kassi,1,2 Spiros Stavropoulos,1 &lt;a href="mailto:ekassi@med.uoa.gr">ekassi@med.uoa.gr&lt;/a> Panayiotis Kokkoris,3* Antonis Galanos,1 Paraskevi Moutsatsou,2 Cleanthi Dimas,4 Athanasios Papatheodorou,3 Christos Zafeiris,1 George Lyritis 1&lt;/p>
&lt;p>1Laboratory for Research of Musculoskeletal System “Theodoros Garofalidis”, University of Athens, KAT Hospital, Kifissia;&lt;/p>
&lt;p>2Laboratory of Biological Chemistry, Medical School, University of Athens;&lt;/p>
&lt;p>3Department of Endocrinology, 251 Air Force General Hospital;&lt;/p></description></item><item><title>Eldecalcitol (Vitamin D analog) not change vitamin D levels but does help bone a bit</title><link>/posts/eldecalcitol-vitamin-d-analog-not-change-vitamin-d-levels-but-does-help-bone-a-bit.html</link><pubDate>Fri, 14 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/eldecalcitol-vitamin-d-analog-not-change-vitamin-d-levels-but-does-help-bone-a-bit.html</guid><description>&lt;h3 id="relationship-between-the-effect-of-eldecalcitol-and-serum-25ohd-level">Relationship between the effect of eldecalcitol and serum 25(OH)D level&lt;/h3>
&lt;p>doi:10.1016/j.jsbmb.2013.11.005&lt;/p>
&lt;p>Toshiyuki Takanoa, Satoshi Kondoa, Hitoshi Saitoa, Toshio Matsumotob, , , , The Eldecalcitol Study Group&lt;/p>
&lt;p>In previous studies, we demonstrated that 12-month treatment with 0.75 μg/day eldecalcitol increased bone mineral density in osteoporotic patients regardless of serum 25-hydroxyvitamin D (25(OH)D) level, and in a 3-year randomized double-blind clinical trial, eldecalcitol significantly reduced the incidences of vertebral and wrist fractures compared to alfacalcidol. However, it remains unclear whether the fracture risk reduction by eldecalcitol is affected by serum 25(OH)D. In the fracture prevention trial, patients with low 25(OH)D level at baseline were supplemented with 400 IU/day native vitamin D3. In the current study, patients from that trial were divided according to the tertiles of serum 25(OH)D level at 6 months after treatment initiation. The increases in lumbar and hip BMD by eldecalcitol were significantly higher in all tertiles than those by alfacalcidol. The incidences of vertebral and osteoporotic fractures tended to be lower in each tertile of the eldecalcitol-treated group than in the corresponding tertile of the alfacalcidol-treated group, with the exception of vertebral fractures in the low tertile. We also investigated whether eldecalcitol treatment affected levels of serum 25(OH)D, serum 1,25(OH)2D, and parathyroid hormone in patients without vitamin D supplementation. With eldecalcitol treatment, serum 1,25(OH)2D concentration was reduced by approximately 50%, whereas serum levels of parathyroid hormone and 25(OH)D were not affected. The major findings of the present study were that eldecalcitol did not affect serum 25(OH)D levels, and that it reduced the incidence of osteoporotic fractures and increased BMD in comparison with alfacalcidol regardless of serum 25(OH)D level within the range of serum 25(OH)D concentrations at or higher than 20 ng/mL. Whether eldecalcitol is similarly effective at vitamin D deficient serum 25(OH)D levels remains to be clarified.&lt;/p></description></item><item><title>T1 Diabetes associated with low vitamin D</title><link>/posts/t1-diabetes-associated-with-low-vitamin-d.html</link><pubDate>Sun, 09 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/t1-diabetes-associated-with-low-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-abnormalities-more-common-in-us-children-with-t1d-than-in-healthy-children">Vitamin D Abnormalities: More Common in US Children with T1D than in Healthy Children&lt;/h4>
&lt;p>Journal of Diabetes Mellitus, 2014,4, 324-333&lt;/p>
&lt;p>Craig Sheedy1, Meng Xu2, Ben Saville2, Jill Simmons3&lt;/p>
&lt;p>department of Emergency Medicine, Vanderbilt University School of Medicine, Nashville, USA department of Biostatistics, Vanderbilt University School of Medicine, Nashville, USA department of Pediatrics, Division of Endocrinology and Diabetes, Vanderbilt University School of Medicine, Nashville, USA&lt;/p>
&lt;p>Email: &lt;a href="mailto:iill.h.simmons@vanderbilt.edu">iill.h.simmons@vanderbilt.edu&lt;/a>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/t1-f1.jpg" alt="image" width="500">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/t1-f2.jpg" alt="image" width="500">
&lt;p>Background: Pediatric patients with type 1 diabetes (T1D) have increased risk for low bone mineral density, which may be due in part to low 25-hydroxyvitamin D levels. Vitamin D levels are influenced by sunlight exposure and thus display geographical variation. We hypothesize that the prevalence of 25-hydroxyvitamin D deficiency (&amp;lt;20 ng/mL) and insufficiency (20 - 29 ng/mL) in children with T1D living in the United States is higher than in healthy children and that diabetes duration, HbA1c, and insulin dose/kg are inversely associated with 25-hydroxyvitamin D levels.&lt;/p></description></item><item><title>Low heart rate variability (bad) is associated with low Vitamin D and COVID – many studies</title><link>/posts/low-heart-rate-variability-bad-is-associated-with-low-vitamin-d-and-covid-many-studies.html</link><pubDate>Thu, 23 Oct 2014 00:00:00 +0000</pubDate><guid>/posts/low-heart-rate-variability-bad-is-associated-with-low-vitamin-d-and-covid-many-studies.html</guid><description>&lt;p>Heart Rate Variability (HRV) is the moment to moment variation in Heart Rate&lt;/p>
&lt;p>HRV &amp;lt;40 is a sign of poor heart function and thus a reason to not exercise&lt;/p>
&lt;p>Many devices costing about $100 can constantly display HRV&lt;/p>
&lt;p>Long-COVID, Fibromyalgia, and low Vitamin D are all associated with low HRV&lt;/p>
&lt;p>A few studies have found that Vitamin supplementation improves HRV for some diseases&lt;/p>
&lt;p>    &lt;span style="color:#00F;">Speculation: Vitamin D will also improve low HRV for COVID&lt;/span>&lt;/p></description></item><item><title>Vitamin D levels in Europe</title><link>/posts/vitamin-d-levels-in-europe.html</link><pubDate>Tue, 30 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-levels-in-europe.html</guid><description>&lt;p>&lt;strong>Vitamin D: An overview of vitamin D status and intake in Europe&lt;/strong>&lt;/p>
&lt;p>Nutrition Bulletin. Article first published online: 30 SEP 2014, DOI: 10.1111/nbu.12108&lt;/p>
&lt;p>A. Spiro* and J. L. Buttriss&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/e-t4.jpg" alt="image" width="1000">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/e-t5.jpg" alt="image" width="1000">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/e-t7.jpg" alt="image" width="1000">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/e-t6.jpg" alt="image" width="500">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/policies.jpg" alt="image" width="1000">
&lt;p>In recent years, there have been reports suggesting a high prevalence of low vitamin D intakes and vitamin D deficiency or inadequate vitamin D status in Europe. Coupled with growing concern about the health risks associated with low vitamin D status, this has resulted in increased interest in the topic of vitamin D from healthcare professionals, the media and the public. Adequate vitamin D status has a key role in skeletal health. Prevention of the well-described vitamin D deficiency disorders of rickets and osteomalacia are clearly important, but there may also be an implication of low vitamin D status in bone loss, muscle weakness and falls and fragility fractures in older people, and these are highly significant public health issues in terms of morbidity, quality of life and costs to health services in Europe.&lt;/p></description></item><item><title>84 percent had less than 30 ng of vitamin D (10,000 patients in Saudi Arabia)</title><link>/posts/84-percent-had-less-than-30-ng-of-vitamin-d-10000-patients-in-saudi-arabia.html</link><pubDate>Fri, 26 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/84-percent-had-less-than-30-ng-of-vitamin-d-10000-patients-in-saudi-arabia.html</guid><description>&lt;h4 id="increasing-trends-and-significance-of-hypovitaminosis-d-a-population-based-study-in-the-kingdom-of-saudi-arabia">Increasing trends and significance of hypovitaminosis D: a population-based study in the Kingdom of Saudi Arabia&lt;/h4>
&lt;p>Archives of Osteoporosis, September 2014, 9:190, Date: 12 Sep 2014&lt;/p>
&lt;p>Aneela N. Hussain, Abdullah Hamad Alkhenizan, Mohammad El Shaker, Hussein Raef, Alia Gabr&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:>70%">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-middle-east-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Middle East and vitamin D">Overview Middle East and vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/70-pcnt-of-saudi-women-were-extremely-vitamin-d-deficient-but-only-40-pcnt-of-men" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: 70 pcnt of Saudi women were extremely vitamin D deficient, but only 40 pcnt of men – March 2012">70 pcnt of Saudi women were extremely vitamin D deficient, but only 40 pcnt of men – March 2012&lt;/a>&lt;/p></description></item><item><title>Inflammation, infection, active vitamin D, and Olmesartan</title><link>/posts/inflammation-infection-active-vitamin-d-and-olmesartan.html</link><pubDate>Fri, 26 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/inflammation-infection-active-vitamin-d-and-olmesartan.html</guid><description>&lt;p>Author asked that their paper be removed from VitaminDWiki&lt;/p>
&lt;!-- ~tc~
__Inflammation and vitamin D: the infection connection__
Inflammation Research, October 2014, Volume 63, Issue 10, pp 803-819,
Meg Mangin info@chronicillnessrecovery.org, Rebecca Sinha, Kelly Fincher
Chronic Illness Recovery, Fort Worth, Texas, USA

__Figure 1 Metabolism__
{img fileId=2700}

__Figure 2__
{img attId="4410" width ="400"}

__Figure 3 Hypothesis __
{img attId="4411"}
__~~#00F: {ATTACH(inline="1" id="4409" icon="1")}Download the PDF from VitaminDWiki.{ATTACH}~~__

Introduction
Inflammation is believed to be a contributing factor to many chronic diseases. The influence of vitamin D deficiency on inflammation is being explored but studies have not demonstrated a causative effect.
Methods
Low serum 25(OH)D is also found in healthy persons exposed to adequate sunlight. Despite increased vitamin D supplementation inflammatory diseases are increasing. The current method of determining vitamin D status may be at fault. The level of 25(OH)D does not always reflect the level of 1,25(OH)2D. Assessment of both metabolites often reveals elevated 1,25(OH)2D, indicating abnormal vitamin D endocrine function.
Findings
This article reviews vitamin D's influence on the immune system, examines the myths regarding vitamin D photosynthesis, discusses ways to accurately assess vitamin D status, describes the risks of supplementation, explains the effect of persistent infection on vitamin D metabolism and presents a novel immunotherapy which provides evidence of an infection connection to inflammation.
Conclusion
Some authorities now believe that low 25(OH)D is a consequence of chronic inflammation rather than the cause. Research points to a bacterial etiology pathogenesis for an inflammatory disease process which results in high 1,25(OH)2D and low 25(OH)D. Immunotherapy, directed at eradicating persistent intracellular pathogens, corrects dysregulated vitamin D metabolism and resolves inflammatory symptoms.
{maketoc}
!!!!Introduction
Inflammation is involved in many chronic diseases and concern has been raised about the influence of vitamin D deficiency on inflammatory processes. When studies found an association between inflammatory diseases and low serum 25-hydroxyvitamin D (25(OH)D), further research found evidence of low vitamin D in a large segment of the general population. This led some authorities to declare a world-wide epidemic of vitamin D deficiency and to recommend vitamin D supplementation. Experts are debating the definition of vitamin D deficiency and the appropriate vitamin D doses, while further research is being done to determine if vitamin D supplementation has the intended effect.
According to some current definitions of vitamin D deficiency, even healthy persons, exposed to adequate sunlight, are unable to acquire enough vitamin D without supplementation. Often reiterated causes of vitamin D deficiency can be disputed in the light of more current research. In the absence of definitive studies, authorities are questioning the wisdom of supplementing the general population with vitamin D. The definition of Vitamin D deficiency needs re-evaluation in view of the fact that low 25(OH)D is found in both healthy and sick individuals. Concerns about vitamin D deficiency merit a closer look at the current method of determining vitamin D status because the level of 25(OH)D does not always reflect the level of 1,25-dihydroxyvitamin-D (1,25(OH)2D). Analysis of this active metabolite may reveal elevated 1,25(OH)2D) in the presence of low 25(OH)D and lead to a diagnosis of abnormal vitamin D endocrine system function.
An infectious pathogenesis posits that intracellular bacteria disrupt the vitamin D regulated immune system, resulting in persistent infection and chronic inflammation.
In the clinical setting, a novel immunotherapy is demonstrating the ability to resolve vitamin D metabolism dysfunction, restore immune function, and thus, eliminate infection and reduce inflammation. This review ponders the question, ‘‘Is low 25(OH)D a cause of, or a consequence of inflammation?” The answer is found in the evidence that adds persistent intracellular infection to the equation.
!!!!Vitamin D metabolism
The sequential metabolic processes that convert biologically inactive, parental vitamin D into active metabolites begin when vitamin D3 is photosynthesized in the skin or when vitamin D2 or D3 is ingested. Vitamin D is transported to the liver where it is hydroxylated by an enzyme (CYP2R1, also known as cytochrome P450 2R1) to produce 25(OH)D [1]. 25(OH)D is then transported to the kidneys where it is hydroxylated by another enzyme (CYP27B1, formerly 1a-hydroxylase) to produce 1,25(OH)2D. 1,25(OH)2D (also known as calcitriol), the active metabolite, is the most potent steroid hormone in the human body [2]. Feedback mechanisms regulate production of 1,25(OH)2D in the kidneys via serum levels of parathyroid hormone (PTH), fibroblast-like growth factor- 23 (FGF23) calcium, and phosphate [3]. 1,25(OH)2D is also produced in many other tissues (e.g., skin, macrophages, colon, pancreas, blood vessels, etc.) by enzymatic actions [4]. The vitamin D binding protein (VDBP) transports 1,25(OH)2D to the vitamin D receptor (VDR) in the cell nucleus [5]. The VDR is a member of the nuclear receptor family of ligand-regulated transcription factors. 1,25(OH)2D binds to the VDR and mediates the transcription of DNA, triggered by signaling proteins, like nuclear factor kappa-B (NFk-B) [6] (Fig. 1).
The influence of 1,25(OH)2D on the immune system is one of its most important roles. 1,25(OH)2D regulates the immune system via the VDR which is present in most immune cell types, particularly in antigen-presenting cells (APCs) such as monocytes, macrophages and dendritic cells [7]. 1,25(OH)2D activates the VDR to express antimicrobial peptides (AMPs) such as cathelicidin and beta defensins which attack pathogens [8, 9]. In general, the innate immune system is enhanced and the adaptive immune system is inhibited by 1,25(OH)2D [10, 11]. Thus, an effective immune response is heavily dependent on the vitamin D endocrine system which performs a balancing act of inflammation versus anti-inflammation.
!!!!Vitamin D deficiency
Concerns about vitamin D deficiency arose when studies showed patients with autoimmune diseases have lower levels of serum 25(OH)D and study subjects given vitamin D had lower rates of autoimmune diseases and fewer markers of inflammation [12, 13]. However, authorities have not agreed on the significance of low 25(OH)D and without a consistent normal range for serum 25(OH)D, the definitions of vitamin D insufficiency and deficiency from the Vitamin D Council, the Endocrine Society and the Institute of Medicine vary significantly.
__The Vitamin D Council definition [14]:__
Deficient: 0-40 ng/ml
Sufficient: 40-80 ng/ml
High normal: 80-100 ng/ml
__The Endocrine Society definition [15]:__
Deficiency &lt; 20 ng/ml
Insufficiency = 20-29 ng/ml
__The Institute of Medicine definition [16]:__
Risk/deficiency &lt;12 ng/ml
Risk/insufficiency = 12-20 ng/ml
Sufficient = 20 ng/ml
In 2006, the Merck Manual listed 25-40 ng/ml as the normal 25(OH)D range [17]. Recently, this range has skyrocketed to 30-74 ng/ml [18]. Quest Diagnostics now lists the upper limit of normal 25(OH)D as 100 ng/ml [19]. Laboratory reference ranges for serum 25(OH)D levels have long been based upon average values from populations of healthy individuals but many people are now supplementing with vitamin D. In the US, the leading authority regarding medical research is the prestigious Institute of Medicine (IOM). The 2010 IOM report on vitamin D emphasized that the current measurements, or cut-off points, of sufficiency and deficiency of 25(OH) D in use by laboratories have not been set using rigorous scientific studies. It suggests that since no central authority has determined which cut-off points to use, reports of deficiency and lab ranges may be skewed and numbers overestimated [16]. Therefore, it would be prudent to use the IOM vitamin D deficiency guideline in the clinical setting, for clinical studies and when evaluating research results.
!!!!Purported reasons for vitamin D deficiency
Is low 25(OH)D among the general population an accurate assessment of vitamin D deficiency? Many reasons are cited for the current ‘epidemic’ of vitamin D ‘deficiency’ but closer examination reveals these beliefs are based on outdated or limited studies and can be challenged with more recent research.
Melanin pigmentation is only one factor that determines the amount of vitamin D3 which is photosynthesized [20, 21]. Bogh et al. [22] measured the baseline serum 25(OH)D and total cholesterol levels of 182 fair-skinned and dark-skinned subjects; and studied the effect of UV radiation on their serum 25(OH)D levels. They found the amount of serum 25(OH)D produced was determined by the amount of cholesterol in the skin, not on skin pigmentation. Matsuoka et al. [23] investigated the effect of racial pigmentation on vitamin D3 formation, simulating the process with a fixed dose of UVB radiation and concluded that while racial pigmentation has a photoprotective effect, it does not prevent the generation of normal levels of active vitamin D metabolites. Persons with dark skin also compensate for low 25(OH)D by rapidly converting it to the active 1,25(OH)2D metabolite, thus allowing them to maintain adequate vitamin D status [24]. Skin pigmentation does not appear to negatively affect vitamin D status [25].
Clothing is a barrier to vitamin D photosynthesis but this is an issue only for people who cover themselves from head to toe [26]. It takes relatively little sunlight exposure to acquire adequate stores of vitamin D and few people wear enough clothes to prevent that from happening. Ten to 15 min of sunlight or daylight exposure to a small area of skin (e.g., the forearm or face, etc.) twice a week, without sunscreen, supplies all the vitamin D necessary for health [27]. The belief that sunscreen lotion blocks vitamin D production is based on a 1987 study done by Matsuoka et al. [28] that was funded by the ultraviolet foundation, which is supported by the tanning bed industry. Contradictory information was provided by Diehl and Chiu [29] which concluded that although sunscreens are effective, many may not actually be blocking UV-B because they are improperly or inadequately applied [30]. Thus, sunscreen use may not actually diminish vitamin D synthesis in real world use. However, prolonged unprotected sun exposure should be avoided to reduce the risk of developing skin cancer.
Although pollution can block some ultraviolet radiation, even in urban areas of high pollution 50 % of UV rays reach the ground [31]. A significant amount of UV radiation exposure can be obtained in dense metropolitan areas; tall buildings provide shade but shade gives up to 50 % of UV rays. Indoor workers receive 10-20 % of outdoor workers’ yearly UV exposure [31]; and for many, this may be adequate, especially if sunlight exposure is higher when they are not working. UV radiation is reflected or scattered to varying extents by different surfaces. The scattering and absorption of light by clouds may not significantly reduce natural light exposure because over 90 % of UV rays may penetrate clouds [31]. Environmental factors are rarely an impediment to photosynthesis of adequate vitamin D.
As the skin ages, there is a decline in the cutaneous levels of 7-dehydrocholesterol, resulting in a marked reduction of the skin’s capacity to produce vitamin D3 [32].
However, despite the up to fourfold reduction in vitamin D3 production in a 70-year-old compared to a 20-year-old, the skin has such a high capacity to make vitamin D3 that elders exposed to sunlight will produce an adequate amount of vitamin D3 to satisfy their vitamin D requirement [33, 34].
A 1988 study by Webb et al. [35] is often cited to support the conviction that latitude dramatically influences the amount of solar radiation available to synthesize vitamin D3. However, other researchers who conducted more recent studies refute this hypothesis. Kimlin et al. [36] report, ‘‘It may no longer be correct to assume that vitamin D levels in populations follow latitude gradients’’. And Lubin [37] states, ‘‘Geophysical surveys have shown that UV-B penetration over 24 h, during the summer months at Canadian north latitudes when there are many hours of sunlight, equals or exceeds UV-B penetration at the equator.’’ Ross et al. [16] report that ample opportunities exist to form vitamin D (and store it in the liver and fat for later use) from exposure to sunlight during the spring, summer, and fall months even in the far north latitudes.
Acceptance of these vitamin D myths regarding photosynthesis prevents consideration of the alternate hypothesis—low serum 25(OH)D, despite adequate photosynthesis of vitamin D3, is a result of an inflammatory process.
!!!!Low vitamin D is found in healthy subjects
Many studies of healthy subjects have found levels of 25(OH)D that, by some vitamin D definitions, are declared deficient (hypovitaminosis-D) [38, 39]. Vitamin D levels that are considered deficient have even been found in persons who are exposed to abundant sunlight [40]. Binkley et al. [41] showed a mean 25(OH)D level of 31.6 ng/ml among healthy young adult Hawaiian surfers. It is clear that low levels of 25(OH)D are found in both healthy persons and those with autoimmune or chronic inflammatory diseases. Opposing reasoning can be used to explain this contradiction. One explanation reasons that healthy persons with low 25(OH)D will become sick and sick people will develop lower 25(OH)D levels (Fig. 2); however, studies do not support this hypothesis. The correct explanation may be that, in the absence of disease, low 25(OH)D is normal.
!!!!Low vitamin D in the presence of diseases
Since low 25(OH)D is found in both healthy persons and those with autoimmune or chronic inflammatory diseases, assessing vitamin D status with the measurement of an additional clinical marker may be helpful. It is asserted that D status with measurement of 1,25(OH)2D may be helpful low levels of 25(OH)D accurately reflect vitamin D status; however, measurement of 1,25(OH)2D often demonstrates a positive correlation of elevated 1,25(OH)2D to inflammatory diseases (Fig. 2). This is illustrated by Blaney et al.

Fig. 2 Interpretation of vitamin D deficiency via calcitriol measurement. Since low 25(OH)D is found in both healthy persons and those with autoimmune or chronic inflammatory diseases, assessing vitamin D status with measurement of 1,25(OH)2D may be helpful

in a study of 100 patients with autoimmune and chronic disease which found that 85 % of subjects had levels of 1,25(OH)2D higher than 46.2 pg/ml without hypercalcemia. Although this serum level may be considered normal by some, lab ranges for 1,25(OH)2D may have been skewed high by the presence of patients with unrecognized persistent intracellular infection and thus, dysregulated vitamin D metabolism. The Danish 1,25(OH)2D population data (from a large and reliable study) found the mean value for 1,25(OH)2D in a normal population was 29 pg/ml with a standard deviation of 9.5
. More frequent measurement of both D-metabolites in the clinical and research settings, may shed light on the true meaning of low 25(OH)D.
Rickets is often cited as proof of the need for vitamin D supplementation. However, a review of the metabolic processes involved provides some prospective. Adequate vitamin D is essential to prevent rickets, but adequate calcium is equally important; if either calcium or vitamin D is deficient, bone health suffers. Hypophosphatemia is the common denominator of all rickets; low calcium intake leads to hyperparathyroidism, which leads to high phosphorus excretion and, thus, phosphorus deficiency [44]. Rickets is rare in the developed world; however, children in developing countries, who usually photosynthesize enough vitamin D from sunlight, develop rickets if poverty prevents them from eating enough calcium-rich food [45, 46]. Studies have found that rickets occurs in sunny countries due to poor calcium intake and is cured with increased calcium ingestion [47, 48].
Osteoporosis is another disease which is closely linked with vitamin D. Adequate vitamin D is an important factor in maintaining bone health to avoid osteoporosis but a study by Reid et al. [49] published in The Lancet found little evidence supporting the use of vitamin D supplements by seniors hoping to improve bone density and ward off potential fractures. 1,25(OH)2D maintains calcium homeostasis between blood, cells and bones by stimulating calcium absorption from the intestines, reabsorption in the kidneys, and resorption in bones [50]. 1,25(OH)2D up- regulates the VDR in the small intestine, which then transcribes genes that shuttle calcium and phosphorus through the intestinal epithelium. However, mucosal response and calcium/phosphorus absorption are dependent on a competent VDR and elevated 1,25(OH)2D reduces VDR competence [51]. Thus, calcium and phosphorus absorption may be inhibited if VDR function is impaired by elevated 1,25(OH)2D. This is illustrated by Abreu et al. [52] in a study of Crohn’s patients with elevated 1,25(OH)2D and low bone mineral density which concluded that treatment of the underlying inflammation would improve metabolic bone disease. In fact, there is ample evidence that elevated 1,25(OH)2D leads to bone loss. Brot et al. [53] found that elevated levels of 1,25(OH)2D were strongly associated with decreased bone mineral density and content, and increased bone turnover. When levels are above 42 pg/ml 1,25(OH)2D stimulates bone osteoclasts. This leads to osteoporosis, dental fractures and calcium deposition into the soft tissues [54]. Vanderschueren et al. [55] found that a combination of high 1,25(OH)2D and low 25(OH)D is associated with the poorest bone health.
!!!!Vitamin D supplementation
It is reasoned that if low 25(OH)D indicates a current or potential disease state, then increasing 25(OH)D by supplementing with vitamin D should provide some symptom relief and/or protection. So far, there is scant evidence for this hypothesis [56, 57]. According to Ross et al. [16] in the 2010 IOM report, ‘‘Outcomes related to autoimmune disorders, cancer, cardiovascular disease and hypertension, diabetes and metabolic syndrome, falls and physical performance, immune functioning, infections, neuropsychological functioning, and preeclampsia could not be linked reliably with calcium or vitamin D intake and were often conflicting.’’ Despite the recent increase in vitamin D supplementation, chronic diseases have increased and are expected to continue increasing [58, 59].
Consequently, more vitamin D experts are beginning to reconsider vitamin D supplementation among the general population [60]. Recommending higher vitamin D intake to large populations carries the potential risk of overdosing certain individuals [61]. It is difficult to ingest too much vitamin D from food, and natural mechanisms regulate the amount of vitamin D3 photosynthesized from sunlight [62].
However, elevated 25(OH)D and hypervitaminosis-D can occur due to vitamin D supplementation [63]. A study by Noordam et al. [65] cast doubt on the causal nature of previously reported associations between low levels of vitamin D and age-related diseases and mortality. A comprehensive review by Autier et al. [65] concluded that low concentrations of 25(OH)D are most likely an effect of health disorders and not a cause of illness. Commenting on the findings in a press statement, Autier et al. [64] advised against vitamin D supplementation and explained the observed discrepancy between observational and randomized trials:
Decreases in vitamin D levels are a marker of deteriorating health. Ageing and inflammatory processes involved in disease occurrence and clinical course reduce vitamin D concentrations, which would explain why vitamin D deficiency is reported in a wide range of disorders. We postulate that inflammation is the common factor between most nonskeletal health disorders and low 25(OH)D concentrations. Inflammatory processes involved in disease occurrence and clinical course would reduce 25(OH)D, which would explain why low vitamin D status is reported in a wide range of disorders. However, increases in 25(OH)D have no effect on inflammatory processes or on disorders at the origin of these processes.
A 2014 meta-analysis by Bolland et al. [66] on the effects of vitamin D supplementation on skeletal, vascular, or cancer outcomes concludes that vitamin D supplementation with or without calcium does not reduce skeletal or non-skeletal outcomes in unselected community-dwelling individuals by more than 15 %. The authors further state that future trials with similar designs are unlikely to alter these conclusions. Because of emerging concerns about elevated 25(OH)D, the IOM has shifted the paradigm from thinking about ‘more is better’ to a more risk-averse approach [67]. It has also challenged the notion that harm should be viewed in terms of vitamin D toxicity such as hypercalcemia, hypercalciuria, or metastatic calcification and has advanced the concept of ‘harm’ in terms of chronic disease outcomes and mortality [16]. Because adverse effects of vitamin D supplementation may take decades to be realized, clinicians (mindful of the medical ethics precept ‘‘First, do no harm’’) should err on the side of caution; follow the IOM guideline and wait for the results of longterm vitamin D studies.
!!!!Bacterial pathogenesis of low vitamin D hypothesis
If evidence indicates that most people get adequate vitamin D from sunlight exposure but healthy persons are found to be ‘deficient’ by recent standards, what is the explanation for this phenomenon? Vitamin D proponents use a disease deficiency model to explain low levels of 25(OH)D. Their hypothesis states low 25(OH)D causes chronic diseases; however, a pathogenesis has not been elucidated [68]. Low serum 25(OH)D in the presence of disease can also be explained with a dysregulated vitamin D metabolism model [69]. This hypothesis proposes that low vitamin D is the consequence of a chronic inflammatory process caused by persistent infection. The bacterial pathogenesis theorizes that intracellular (cell wall deficient) bacteria invade nucleated cells, use strategies to avoid destruction and cause abnormal vitamin D endocrine function, resulting in low vitamin D. Excess 1,25(OH)2D is produced in an effort to up-regulate the VDR to transcribe AMPs; and 25(OH)D is rapidly metabolized in the process, resulting in a low serum level. The resulting elevated 1,25(OH)2D causes chronic, systemic inflammation and its accompanying symptoms (Fig. 3).
The existence of bacteria which are capable of invading human cells has been known for over a century and are described by many authors [70, 71]. The lack of a cell wall enables them to enter human cells and proliferate because they fail to elicit an appropriate response when the immune system is compromised. In particular, they enter the macrophages—the very immune cells deployed to kill invading pathogens. The inability of most research labs to culture cell wall deficient (CWD) bacteria has been an obstacle to their acceptance, and reliance on Koch’s postulates has made it difficult to correlate CWD bacteria to specific diseases [72]. But some researchers believe Koch’s postulates may have to be redefined in terms of molecular data when dormant and non-culturable bacteria are implicated as causative agents of mysterious diseases [73]. OConnor et al. [74] (in their article entitled Emerging Infectious Determinants of Chronic Diseases) report, ‘‘microbes can now be irrefutably linked to pathology without meeting Koch’s postulates” and “...powerful tools of molecular biology have exposed new causal links by detecting diffi- cult-to-culture and novel agents in chronic illness settings.’’ Domingue [75] commented, ‘‘This might translate into an etiology for chronic inflammatory diseases, when the stressed bacteria increase in numbers and overwhelm the normal biological functions of the host.’’ Nunez [76] was quoted in the University of Michigan Health System newsletter, ‘‘In our study, the presence of bacterial microbes inside the cell is what triggers the immune response.’’ Rolhion and Darfeuille-Michaud [77] observed that the presence of pathogenic invasive bacteria could be the link between an innate immune response to invasive bacteria and the development of inflammation. A number of studies suggest disease associations with CWD bacteria [78-83]. Verway et al. [79] report ‘‘.data suggest that at least a subset of the genetic predisposition to Crohn’s disease results from defects in the detection and/or processing of intracellular pathogens by the innate immune system.’’ O’Connor et al. [74] state, ‘‘The epidemiologic, clinical, and pathologic features of many chronic inflammatory diseases are consistent with a microbial cause. Infectious agents likely determine more cancers, immune-mediated syndromes, neurodevelopmental disorders, and other chronic conditions than currently appreciated.”
CWD bacteria are considered communicable but not contagious; protective immunity depends on an effective cell-mediated immune response [80]. It is now well appreciated that pathologic processes caused by infectious agents may only emerge clinically after an incubation of decades [81]. Among the speculated causes of the increase in chronic infections are overuse of beta-lactam antibiotics [82, 83] and immunosuppression via excess 25(OH)D production [84] or immunosuppressive medications [85]. Many microbiologists now believe at least some, if not all, of the inflammation which drives the chronic disease process is caused by the presence of these stealthy intracellular pathogens [86]. A considerable body of experimental and clinical evidence supports the concept that difficult-to- culture and dormant bacteria are involved in latency of infection and that these persistent bacteria may be pathogenic [73, 87, 88]. McDougal [89] states, ‘‘Evidence now confirms that non-communicable chronic diseases can stem from infectious agents.’’
!!!!Effects of intracellular pathogens on the immune system
Pathogens gain many advantages by parasitizing immune cells and altering nuclear receptor activity. Tissue invasion provides a privileged niche with access to host protein and iron, sequestration from immune response, and a means for persistence [90]. In the arms race of host-microbe coevolution, successful microbial pathogens have evolved innovative strategies to evade host immune responses. For example, ‘crosstalk manipulation’ undermines host defenses and contributes to microbial adaptive fitness [91, 92]. Pathogenic microbes also induce stress responses which protect the cell from lethal factors, express proteases that degrade AMPs, use biofilms as a shield and modulate host cell motility to facilitate establishment of an infection [93, 94]. Genetic foreign and host protein interactions alter gene transcription and translation mechanisms, and many species survive by horizontal gene transfer [95, 96].
It is theorized that bacteria have developed some of these strategies in order to invade host cells and remain undetected within cellular cytoplasm. Many bacterial pathogens form antibiotic-tolerant persister cells which can replicate within macrophages. In this form they can cause subclinical infection and have been associated with chronic diseases [95, 97, 98]. Intracellular bacteria can modulate cytokine production [99]; and in monocytes and macrophages, cytokine activation markedly inhibits 1,25(OH)2D/ VDR gene transcription [100].
Macrophage microbicidal mechanisms are responsible for the control and elimination of pathogens. 1,25(OH)2D production and action in macrophages activates toll-like receptors to increase expression of the AMP cathelicidin which kills infectious invaders [101, 102]. When the immune system is fighting a persistent microbe, inflammatory molecules are continuously released in an effort to kill the pathogen [103]. Immune defenses stimulate Th17 cells and contribute to the development of chronic inflammatory conditions [104,	105]. An ineffective immunological response causes low-grade inflammation and hagocyte-inflicted tissue damage plays an important role in many chronic diseases [106]; autoimmune patients acquire a distinct pathogenic microbiota and multi-morbidity often results [107, 108]. Therefore, it is reasonable to infer that bacteria have evolved strategies which allow them to persist within host cells. The exact mechanisms are unknown and warrant further study.
!!!!The compromised immune system, infection and vitamin D
In an essay on the renin-angiotensin system (RAS) and immune response, Smith [109] postulated that unresolved cellular stress may be caused by infectious agents to avoid adaptive immune responses. The host immune response has developed many mechanisms to neutralize and remove pathogenic bacteria. In turn, pathogenic bacteria have developed mechanisms to alter and evade the host immune response [110, 111]. Regulation of the VDR is a common mechanism used in the host defense against pathogens but certain microbes have been shown to slow innate immune defenses by down-regulating the VDR:
*Mycobacterium tuberculosis down-regulates VDR activity [112].
*Mycobacterium leprae inhibits VDR activity through down-regulation of CYP27B1 in monocytes [113].
*Aspergillus fumigatus secretes a toxin capable of down-regulating the VDR in macrophages [114].
*Epstein-Barr virus lowers VDR activity [115].
*HIV completely shuts down VDR activity [116].
*In VDR knockout mice, a circumstance that closely mimics extreme VDR dysregulation, 1,25(OH)2D levels increase by a factor of ten [117].
Studies also point to immune system depression and elevated 1,25(OH)2D in chronic diseases [118]:
*Sarcoidosis patients are deficient in cathelicidin despite healthy vitamin D3 levels [119].
*1,25(OH)2D is high (>60 pg/ml) in 42 % of Crohn’s patients and the source of the active vitamin D may be the inflamed intestine [52].
*1,25(OH)2D is elevated in the synovial fluid of patients with RA (rheumatoid arthritis) [120].
*Crohn’s disease decreases expression of cathelicidin [121].
High levels of 1,25(OH)2D may result when down- regulation of the VDR by bacterial ligands prevents the receptor from expressing enzymes necessary to keep 1,25(OH)2D in a normal range [42]. Elevated 1,25(OH)2D further reduces VDR competence, suppresses macrophage function, and blocks the nuclear factor kappa-B pathway; thus inhibiting immune system function [116, 122, 123]. Reducing the ability of the VDR to express elements of innate immune function allows intracellular bacteria to persist in the cytoplasm of nucleated cells and may account for the increased susceptibility to non-bacterial co-infections that are commonly found in patients with chronic illnesses [124, 125]. Theoretically, immune system suppression allows parasitic microbes to persist and proliferate in host phagocytes, successfully compete for nutritional resources, and displace commensal organisms from their niche [126]. Elevated 1,25(OH)2D appears to be evidence of a disabled immune system’s attempt to activate the VDR to combat infection.
!!!!Autoimmune disease
Numerous examples can be found in which pathogens express antigens that cross-react with host antigens or induce local inflammatory responses that can lead to autoimmune responses through a very complex set of circumstances [127]. The prevailing theory regarding the etiology of autoimmune disease states that an overactive immune system produces auto-antibodies against self, but infection as an environmental factor in autoimmunity has long been recognized. An alternate hypothesis posits a bacterial etiology in which a persistent intracellular infection causes a cytokine release that induces signals to T cells and B cells, and the antibodies they produce (to the intracellular invader) include some that attack human proteins, as well as target the pathogens [128, 129]. Christen et al. [130] explored this hypothesis, ‘‘In theory, a structural similarity or identity between the host and an invading pathogen might cause the immune system of the host to react not only to the pathogen but also to self-components.’’ Infections can act as environmental triggers inducing or promoting autoimmune disease in genetically predisposed individuals [131]; researchers have shown how antinuclear antibodies (ANA) are created in response to infectious agents [132, 133].
Vitamin D appears to have a positive effect on autoimmune disease due to immune system suppression [122, 134, 135] and immune suppression is considered therapeutically beneficial for autoimmune diseases [136, 137]. However, vitamin D proponents have failed to recognize that positive effects are due to the immunosuppressive effect of elevated 25(OH)D or to understand that immunosuppression is contraindicated because of the probable presence of intracellular infection. When the immune system is suppressed clinical disease markers and symptoms are reduced but immunosuppression does not address an underlying cause of persistent bacteria, thus relapse is common [138]. Verway et al. [79] wonder, ‘‘Is a specific pathogen responsible for disease or rather is a dysregulated immune response generated against a complex microbial population? Why would immune-suppressive drugs be efficacious if the primary defect is an immune deficiency?” Much of current research focuses on finding drugs to suppress inflammation but, according to Collins [139], 95 % of these studies have failed It seems clear a better direction is needed. Immunotherapy which restores VDR competence corrects dysregulated vitamin D metabolism and eliminates intracellular bacteria could be the answer (as discussed in the section titled Restoring VDR Competence).
!!!!Dysregulated vitamin D metabolism
In a healthy individual, the complex interplay between innate and adaptive immunity cooperates to mount an appropriate response to infection through regulation of the vitamin D endocrine system [140]. The immune system detects and responds to the presence of intracellular bacteria by producing more 1,25(OH)2D to activate the VDR and express the crucial endogenous AMPs which enable the innate immune system to target intracellular pathogens [141]. Renal production of 1,25(OH)2D is tightly selfregulated, with the end product down-regulating its own further production. In contrast, extra-renal tissues (e.g., uterine decidua and placenta, colon, breast, prostate, spleen, bone, keratinocytes, melanoma and synovial cells, pulmonary monocytes and macrophages, etc.) which produce 1,25(OH)2D are regulated by cytokines (e.g., interferon-gamma), lipopolysaccharide, nitric oxide and intracellular VDBP, which activate the enzyme CYP27B1 to stimulate conversion of 25(OH)D to 1,25(OH)2D [142]. This extra-renal production of 1,25(OH)2D in tissues infected with intracellular bacteria can result in an excess in production of 1,25(OH)2D which may contribute to depletion and low levels of 25(OH)D [143] (Fig. 4).
Because extra-renal production of 1,25(OH)2D is primarily dependent on the availability of 25(OH)D [144], supplementation with vitamin D to increase 25(OH)D may promote the production of 1,25(OH)2D in non-renal tissues that are sites of intracellular infection and result in hypervitaminosis-D

{img attId="4412"}
Fig. 4 Proposed hypothesis for excess 1,25(OH)2D production in bacterially-stimulated extrarenal tissues. Extra-renal tissues, which produce 1,25(OH)2D, are regulated by cytokines, lipopolysaccharide, nitric oxide and intracellular VDBP, which activate the enzyme CYP27B1 to stimulate conversion of 25(OH)D to 1,25(OH)2D, resulting in low 25(OH)D

{img attId="4413"}
Fig. 5 Proposed hypothesis for dysregulated vitamin D metabolism caused by intracellular pathogens. Theoretically, when nucleated cells are parasitized by intracellular bacteria, extra-renal production of 1,25(OH)2D increases, the kidneys lose control of 1,25(OH)2D production, and pro-hormone 25(OH)D decreases due to rapid conversion to 1,25(OH)2D

Sunlight appears to play a part in this process and many patients with autoimmune disease report sun sensitivity. The skin (dermal fibroblasts and keratinocytes possess VDR) has the capacity to synthesize 1,25(OH)2D, and represents an important target tissue for 1,25(OH)2D [145]. If keratinocytes in the skin are infected, natural regulation of photosynthesis may be thwarted and solar energy may overstimulate cellular activity, resulting in an increase in cutaneous production of vitamin D3, 25(OH)D and 1,25(OH)2D following sun exposure.
We hypothesize that when nucleated cells are parasitized by intracellular bacteria, extra-renal production of 1,25(OH)2D increases, the kidneys lose control of 1,25(OH)2D production, and pro-hormone 25(OH)D decreases due to rapid conversion to 1,25(OH)2D. 
The following mechanisms are thought to be responsible (Fig. 5):
*Inflammatory cytokines activate CYP27B1, an enzyme that causes more 25(OH)D to be converted to 1,25(OH)2D [146].
*The microbial-repressed VDR cannot transcribe CYP24A1 (formerly 24-hydroxylase), an enzyme that breaks down excess 1,25(OH)2D [147].
*Excess 1,25(OH)2D binds the PXR (pregnane X receptor), to inhibit conversion of vitamin D3 to 25(OH)D so 25(OH)D is down-regulated [148].
*1,25(OH)2D inhibits the hepatic synthesis of 25(OH)D [149].
Thus, low 25(OH)D may be a consequence of the inflammatory process. More studies are concluding that suboptimal circulating levels of vitamin D appear to be caused by the disease process. Waldronn et al. [150] found serum 25(OH)D was decreased following an acute inflammatory insult (i.e., orthopedic surgery) and concluded that hypovitaminosis-D may be the consequence rather than cause of chronic inflammatory diseases. Ferder et al. [151] state, there may be a relationship between inflammatory processes induced by chronic overstimulation of the renin angiotensin system (RAS) and the worldwide vitamin D deficiency. In fact, the pandemic of vitamin D deficiency could be the other face of increased RAS activity, which could potentially cause a lower activity or lower levels of Vitamin D.’’
!!!!Diagnosis of dysregulated vitamin D metabolism
Assessing dysregulated vitamin D metabolism has the potential to guide clinical practice [152, 153]. Vitamin D status is currently determined by measuring the level of serum 25(OH)D which, presumably, reflects the serum levels of other vitamin D metabolites (e.g., vitamin D3, vitamin D2 and 1,25(OH)2D, etc.). This measurement may not, however, provide enough information to assess vitamin D endocrine function. The clinical utility of measuring 1,25(OH)D is not fully understood, but it is clear that associations are being made between this active metabolite of vitamin D and disease states [154]. 1,25(OH)2D is not being used as a measure associated with vitamin D nutritional status or as an intermediate marker related to health outcomes, or even routinely assessed in vitamin D research. In the context of solving the puzzle of low 25(OH)D, the reasons cited for this lapse fail to consider the possibility of abnormal levels in the presence of chronic inflammation:
*1,25(OH)2D has a short half-life (hours) and fluctuates rapidly.
+However, a high result may be discovered even at trough level.
*1,25(OH)2D levels are regulated by PTH, calcium, phosphate.
+This is not true if extra-renal production is prevalent [143].
*1,25(OH)2D does not decrease until 25(OH)D is very low.
+A low 25(OH)D may be a sign that 1,25(OH)2D is abnormally high [55].
*1,25(OH)2D is only over-produced in hypercalcemic disease states such as sarcoidosis.
+Studies show this is not true [42].
*1,25(OH)2D may be elevated as a result of up- regulation of the CYP27B1 enzyme.
+This begs the question, Why is this enzyme elevated [146]?
Measuring both 25(OH)D and 1,25(OH)2D (and PTH, calcium, phosphate when indicated) as clinical markers in
Table 1 D-metabolites tests
Serum 25(OH)D [157]
CPT code: 82306 [157]
Lowest mortality reported at 20 ng/ml [158] Immunosuppression reported when higher than 30 ng/ml [122] Serum 1,25(OH)2D [157]
CPT code: 82652 [157]
ICD-9 code:
275.40 Disorder of calcium metabolism, unspecified [157] Maximum normal = 45 pg/ml [17]
chronic disease is more likely to provide a true picture of vitamin D status, than measuring 25(OH)D alone [155, 156] (Table 1). Measuring 1,25(OH)2D should be considered in patients with low 25(OH)D, abnormal laboratory results (especially inflammatory markers), a diagnosis of autoimmune disease or other chronic inflammatory illness, or signs of chronic systemic inflammation. For example, elevated 1,25(OH)2D may serve as a marker of Crohn’s disease [52]. The 1,25(OH)2D test is a delicate assay which is only done in specialized laboratories. False low results have been observed due to apparent sample mishandling; freezing for transport is advised to prevent sample degradation due to agitation. A high result is always accurate.
!!!!Restoration of VDR competence
The ability to mount an appropriate immune system response to intracellular infection is highly dependent on a competent VDR [159]. When it appears that 1,25(OH)2D is unable to up-regulate the VDR due to microbial activity, VDR competence may be restored with another VDR ligand which acts as an agonist; an agonist increases the signal transduction activity of a cell when bound to a receptor on that cell. Over 3000 synthetic VDR ligands have been identified, but most of these 1,25(OH)2D analogues have no clinical use because of their undue disruption to calcium regulation [160]. A number of nonvitamin D VDR ligands have also been identified: curcu- min, omega-6 fatty acids (e.g., arachidonic acid, linoleic acid), and lithocolic acid (LCA) but are not being used for this purpose [161, 162].
Angiotensin receptor blockers (ARBs) have been shown, via in silico molecular modeling, to modulate VDR activation [163]. The most promising ARB, __olmesartan__ medoxomil (brand name Benicar®) was estimated to have a Ki value in the low nanomolar range, similar to the Ki values of the natural VDR ligands [163].

{img attId="4414"}
Fig. 6 Proposed hypothesis for restoring renal control of 1,25(OH)2D with __olmesartan__. __olmesartan__ is believed to decrease elevated 1,25(OH)2D by several mechanisms

__Olmesartan__ has been noted to cause a significant reduction in elevated 1,25(OH)2D within weeks of initiation, which provides
further evidence of its ability to up-regulate the VDR [164]. __olmesartan__ is believed to decrease elevated 1,25(OH)2D by several VDR-mediated effects (Fig. 6). The up-regulated VDR:
*transcribes CYP24A1 and CYP3A4 (enzymes which reduce 1,25(OH)2D production) [147].
*represses CYP27B1 (the enzyme that hydroxylates 25(OH)D to 1,25(OH)2D) so less 1,25(OH)2D is produced [146].
Consequently, renal control of 1,25(OH)2D production is restored and extra-renal production of 1,25(OH)2D is reduced. A decrease in elevated 1,25(OH)2D means less systemic inflammation, as these studies of __olmesartan__ indicate:
*Improvement of glycemic control and insulin resistance was only observed in the __olmesartan__ group and these effects of __olmesartan__ might be mediated by an antiinflammatory action [165].
*__Olmesartan__ treatment significantly reduced serum levels of inflammatory markers; h-CRP, h-TNFa, IL-6, MCP-1 after 6 weeks of therapy [166].
*Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity [167].
*Blocking angiotensin II receptor increases bone mass [168, 169].
__Olmesartan__ acts in a manner similar to 1,25(OH)2D to reduce inflammation and, by inference, improve immune system function. VDR and RAS receptors are distributed in almost the same tissues. The endogenous VDR ligand 1,25(OH)2D down-regulates the RAS by repressing renin gene expression to reduce inflammation via the nuclear factor-kappa B pathway [170]. __olmesartan__ has a similar effect in that it reduces angiotensin II (a peptide that is implicated in the inflammatory process) [171]. Inappropriate stimulation of the RAS has been associated with the pathogenesis of hypertension, heart attack and stroke [151]. Ferder et al. [151] state, ‘‘Changes in RAS activity and activation of the VDR seem to be inversely related, making it possible to speculate that both systems could have a feedback relationship. The combination of RAS blockade and VDR stimulation appears to be more effective than each one used individually.” Blocking angiotensin II and stimulating the VDR is what __olmesartan__ appears to accomplish and this function is consistent with a theory of VDR incompetence (Fig. 7).
In patients with autoimmune disorders and inflammatory symptoms, __olmesartan__ is noted to provoke an increase in inflammatory symptoms indicative of a Jarisch-Herxheimer reaction (JHR). JHR is a cascade of reactions including inflammation, cytokine release, and endotoxin release as part of the immune response to the disintegration of infected cells [172]. This immunopathology suggests transcription of AMPs by an activated VDR, points to the presence of occult infection and provides additional evidence that __olmesartan__ is a VDR agonist [167, 173, 174]. Theoretically, __olmesartan__ restores VDR competence and, thus, phagocytosis leads to bacterial death; consequently, inflammation is temporarily increased by cytokine reaction to microbial endotoxins and cellular debris from dead host cells and bacteria [175].
Hajishengallis and Lambris [92] conclude that a blockade of hijacked receptors of the innate immune system may offer promising options to control infection and associated immunopathology. Although this use of __olmesartan__ is off- label, its safety profile is well established [176]. The multiple, documented beneficial effects of __olmesartan__, including the ability to reduce cardiovascular and kidney disease, prevent migraines, and reduce oxidative stress, also suggest it could play a key role in the resolution of chronic systemic inflammation [177, 178].
!!!!Clinical use of __olmesartan__
__Olmesartan__ is being used as a novel VDR ligand in the clinical setting [179]. Immunotherapy with __olmesartan__ may also include pulsed administration of select MIC (minimum inhibitory concentration) oral antibiotics to weaken and help eradicate the intracellular pathogens. With each antibiotic dose, inflammatory symptoms (JHR) wax and wane, providing further evidence of persistent infection [180]. Changes in laboratory findings (e.g., BUN, creatinine, CRP, blood counts, liver enzymes) often point to areas of occult inflammation. A correlating treatment strategy is the avoidance of excessive sunlight exposure, foods high in vitamin D and vitamin D supplements to maintain serum 25(OH)D at a level (20-30 ng/ml) that is not likely to suppress the immune system and inhibit bacterial elimination [122, 135, 137].
Accumulating case reports now support the observation that a number of complex, chronic conditions can be improved by restoring VDR function using this type of immunotherapy [179, 181, 182]. It is becoming increasingly clear that microbes slow down immune reactivity by dysregulating the VDR, ultimately to increase their chance of survival. Immune modulatory therapies that enhance VDR expression and activity should, therefore, be considered in the clinical setting [183].
!!!!Discussion
Vitamin D is essential for many important biological processes and most people get an adequate supply from exposure to sunlight (Table 2). Long-term studies are needed to determine if low 25(OH)D in healthy individuals leads to disease. Evidence that vitamin D supplementation cures or prevents chronic disease is inconsistent. Despite increased supplementation chronic inflammatory diseases are on the rise. Attention to the alternate hypothesis—low 25(OH)D is a consequence of the chronic disease process, provoked by persistent intracellular infection—may be crucial to reversing this trend and needs further research.

!!!!Table 2 Key points
*Vitamin D is a steroid hormone which regulates immune system function
*Photosynthesis of vitamin D3 provides adequate vitamin D stores for most individuals
*Low levels of 25(OH)D are seen in healthy individuals, as well as those with chronic inflammatory conditions
*Studies are inconsistent regarding the health benefits of increasing vitamin D stores; vitamin D supplementation may have negative effects
*25(OH)D may not always reflect the level of 1,25(OH)D; accurate assessment of vitamin D status depends on measuring both metabolites
*Intracellular, cell wall deficient bacteria may cause dysregulated vitamin D metabolism and impaired immune system function
*A novel, non-vitamin D VDR ligand (an angiotensin receptor blocker) appears to 
+reactivate the immune system, 
+restore VDR competence, 
+correct dysregulated vitamin D metabolism and 
+reduce inflammatory symptoms
The prevailing dogma that the level of serum 25(OH)D provides an accurate assessment of vitamin D status needs closer examination. Circulating levels of 25(OH)D may not be an accurate reflection of vitamin D status. In those with an autoimmune disease or chronic inflammatory symptoms, 1,25(OH)2D may be elevated. This can lead to osteoporosis and cause inhibition of innate immunity, which is contraindicated in the presence of infection. The resulting immunosuppression may promote persistentinfection which has been implicated in chronic inflammatory diseases.
Human cells live in harmony with many types of microbes but some microbes may become pathogenic under commonly experienced conditions. The innate immune system is designed to kill pathogens via 1,25(OH)2D- mediated VDR transcription of anti-microbial peptides but microbes may use strategies which down-regulate the VDR in order to live and reproduce within nucleated host cells. Studies using more advanced cell culture and molecular techniques are confirming the presence of previously undetected intracellular bacteria. Defense mechanisms that intracellular bacteria use to persist and proliferate need to be investigated. Pathogen-induced VDR dysfunction which causes the release of pro-inflammatory cytokines appears to be at the root of chronic disease and low 25(OH)D. Improving VDR activation may be the key to reducing inflammatory diseases. Treatments that up-regulate the VDR to restore normal immune function, reduce inflammation and eradicate persistent bacterial infections require further research. An immunotherapy which has demonstrated efficacy in reversing vitamin D metabolism dysfunction and reducing inflammatory symptoms is currently being used by clinicians and warrants formal study.
In summary, elevated 1,25(OH)2D, often accompanied by reduced 25(OH)D, is a clinical sign of dysregulated vitamin D metabolism and evidence that the immune system is competing with parasitic microbes for VDR dominance. Failure of the immune system to mount an effective anti-microbial response results in persistent intracellular infection. This induces relentless inflammation (immunopathology) which causes tissue damage and disease symptoms.

Acknowledgments The authors wish to gratefully acknowledge the reviewers who commented on the original manuscript and provided helpful, expert advice. We thank the editor of Inflammation Research, Dr. Mauro Teixeira, for his kind consideration of our work. Special thanks to Tapen Sinha for sharing with us his expertise regarding manuscript formatting and submission. We thank Tom Mangin, Belinda Fenter, Terry Fenter, Debbie Yeager and John Yeager for their support. And we acknowledge with gratitude the generous donors to Chronic Illness Recovery who have enabled us to continue our research.

Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
!!!!References
#Cheng T, Chimeh C, Lu Z, et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Bio Biophs. 2007;460(2):213-7.
#Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88(2):582-6.
#Holick M, Schnoes H, Deluca H, Suda T, Cousins R. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochem. 1971; 10(14):2799-804.
#Adams J, Hewison M. Extrarenal expression of the 25-hydrox- yvitamin D-1-hydroxylase. Arch Biochem Biophys. 2012; 523(1):95-102.
#Haddad J, Vitamin D. Binding protein (Gc-globulin): multiple tasks. J Steroid Biochem Mol Biol. 1996;53(1-6):579-82.
#Sutton A, MacDonald P. Vitamin D: more than a ‘‘bone-a-fide’’ hormone. Mol Endocrinol. 2003;17(5):777-91.
#White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008;76(9):3837-43.
#Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009;30(3):131-41.
#Wang T, Nestel F, Bourdeau V, et al. Cutting edge: 1,25-di- hydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173(5):2909-12.
#Hayes C, Nashold F, Spach K, Pedersen L. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003;49(2):277-300.
#Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol. 2004;34(4):1068-76.
#Maxmen A. Nutrition advice: the vitamin D-lemma. Nature. 2011;475(7354):23-5.
#Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167(16):1730-7.
#For health professionals: position statement on supplementation, blood levels and sun exposure Vitamin D Council. Vitamin D Council. Jan 12, 2010. Available at http://www.vitamindcouncil. org/further-topics/for-health-professionals-position-statement-on- supplementation-blood-levels-and-sun-exposure/. Accessed 28 Apr 2013.
#Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012;97(4):1153-8.
#Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Dietary reference intakes for calcium and vitamin D. Washington: National Academy of Sciences; 2010. 0-309-16394-3.
#Beers M. Vitamin D Deficiency and Dependency. Merck (Document). Oct 15, 2006. Available at http://web.archive.org/ web/20061015162329/www.merck.com/mrkshared/mmanual/ section1/chapter3/3d.jsp. Accessed 21 Apr 2013.
#Topiwala S. 25-hydroxy vitamin D test. MedlinePlus. Oct 7,
#Available at http://www.nlm.nih.gov/medlineplus/ency/ article/003569.htm. Accessed 21 Apr 2013.
#Vitamin D, 25-Hydroxy, LC/MS/MS. Quest diagnostics. 2013. Available at http://www.questdiagnostics.com/home/physicians/ testing-services/by-test-name/vitamind.html. Accessed 28 Apr 2013.
#Snellman G, Melhus H, Gedeborg R, et al. Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One. 2009;4(11):e7747.
#Bogh MK, Schmedes AV, Philipsen PA, Thieden E, Wulf HC. Vitamin D production depends on ultraviolet-B dose but not on dose rate: a randomized controlled trial. Exp Dermatol. 2011; 20(1):14-8.
#Bogh MK, Schmedes AV, Philipsen PA, Theiden E, Wulf HC. Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation. J Invest Dermatol. 2010;130(2):546-53.
#Matsuoka LY, Worstman J, Haddad JG, Kolm P, Hollis BW. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol. 1991;127(4):536-8.
#Matsuoka LY, Wortsman J, Chen TC, Holick MF. Compensation for the interracial variance in the cutaneous synthesis of vitamin D. J Lab Clin Med. 1995;126(5):452-7.
#Villa M, Kelsey J, Chen J, Marcus R. Skin Pigmentation does not affect vitamin D status in community-dwelling Mexican- American women. J Bone Miner Res. 1994;9(Suppl 1):S418.
#Matsuoka LY, Wortsman J, Dannenberg MJ, Holis BW, Lu Z, Holick MF. Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab. 1992;75(4):1099-103.
#Dietary supplement fact sheet: vitamin D. National Institutes of Health. Jan 24, 2011. Available at http://ods.od.nih.gov/ factsheets/VitaminD-HealthProfessional/?print=1. Accessed 10 Mar 2013.
#Matsuoka LY, Ide L, MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987;64(6):1165-8.
#Diehl JW, Chiu MW. Effects of ambient sunlight and photoprotection on vitamin D status. Dermatol Ther. 2010;23(1): 48-60.
#Youl PH, Janda M, Kimlin M. Vitamin D and sun protection: the impact of mixed public health messages in Australia. Int J Cancer. 2009;124(8):1963-70.
#Global Solar UV Index: A Practical Guide. Geneva, Switzerland: World Health Organization; 2002. ISBN 9241590076.
#MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76(4): 1536-8.
#Chuck A, Todd J, Diffey B. Subliminal ultraviolet-B irradiation for the prevention of vitamin D deficiency in the elderly: a feasibility study. Photodermatol Photoimmunol Photomed. 2001;17(4):168-71.
#Chel VG, Ooms ME, Popp-Snijders C, et al. Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res. 1998;13(8):1238-42.
#Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. Clin Endocrinol Metab. 1988;67(2): 373-8.
#Kimlin MG, Olds WJ, Moore MR. Location and vitamin D synthesis: is the hypothesis validated by geophysical data? J Photochem Photobiol B. 2007;86(3):234-9.
#Lubin D, Jensen EH, Gies HP. Global surface ultraviolet radiation climatology from TOMS and ERBE data. J Geo Res. 1998;103(D20):26061-91.
#Schoenmakers I, Goldberg GR, Prentice A. Abundant sunshine and vitamin D deficiency. Br J Nutr. 2008;99(6):1171-3.
#Al-Othman A, Al-Musharaf S, Al-Daghri NM, et al. Tea and coffee consumption in relation to vitamin D and calcium levels in Saudi adolescents. Nutr J. 2012;11:56.
#Willis KS, Smith DT, Broughton KS, Larson-Meyer DE. Vitamin D status and biomarkers of inflammation in runners. Open Access J Sports Med. 2012;2012(3):35-42.
#Binkley N, Novotny R, Krueger D, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007;92(6):2130-5.
#Blaney GP, Albert PJ, Proal AD. Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann NY Acad Sci. 2009;1173:384-90.
#Brot C, Jorgensen NR, Sorensen OH. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr. 1999;53(12):920-6.
#Tiosano D, Hochberg Z. Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab. 2009;27(4): 392-401.
#Rickets. MedlinePlus. Aug 1, 2012. Available at http://www. nlm.nih.gov/medlineplus/ency/article/000344.htm. Accessed 6 May 2013.
#Lerch C, Meissner T. Interventions for the prevention of nutritional rickets in term born children. Cochrane Database Syst Rev. 2007;4:CD006164.
#Pettifor JM, Ross P, Wang J, Moodley G, Couper-Smith J. Rickets in children of rural origin in South Africa: is low dietary calcium a factor? J Pediatr. 1978;92(2):320-4.
#Pettifor JM. Nutritional rickets: deficiency of vitamin D, calcium, or both? Am J Clin Nutr. 2004;80(6 Suppl):1725S-9S.
#Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet. 2013;383:146-55.
#Boden SD, Kaplan FS. Calcium homeostasis. Orthop Clin North Am. 1990;21(1):31-42.
#Sun J. Vitamin D and mucosal immune function. Curr Opin Gastroenterol. 2010;26(6):591-5.
#Abreu MT, Kantorovich V, Vasiliauskas EA, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25- dihydroxyvitamin D and low bone mineral density. Gut. 2004;53(8):1129-36.
#Brot C, J0rgensen N, Madsen OR, Jensen LB, S0rensen OH. Relationships between bone mineral density, serum vitamin D metabolites and calcium:phosphorus intake in healthy peri- menopausal women. J Intern Med. 1999;245(5):509-16.
#Ishizuka S, Kurihara N, Miura D, et al. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25- dihydroxyvitamin D3 from pagetic bone marrow cells. J Steroid Biochem Mol Biol. 2004;89-90(1-5):331-4.
#Vanderschueren D, Pye SR, O’Neill TW, et al. Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS). J Clin Endocrinol Metab. 2013;98(3):995-1005.
#Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the US. Preventive Services Task Force. Ann Intern Med. 2011;155(12): 827-38.
#Whayne TF Jr. Vitamin D: popular cardiovascular supplement but benefit must be evaluated. Int J Angiol. 2011;20(2):63-72.
#Shelby J. Needs great, evidence lacking for people with multiple chronic conditions. Scribd. Apr 2013. Accessed 7 May 2013.
#Mattke S, Klautzer L, Mengistu T, Hu J, Wu H. Health and wellbeing in the home: a global analysis of needs, expectations, and priorities for home health care technology. Rand Corporation. 2010. http://www.rand.org/pubs/occasional_papers/OP323.html. Accessed 7 May 2013.
#Tseng L. Controversies in vitamin D supplementation. eScholar- ship. 2003. http://www.escholarship.org/uc/item/4m84d4fn# page-1. Accessed 7 May 2013.
#Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011;(7):CD007470.
#Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. 1995;61(3 Sup- pl):638S-45S.
#Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69(5):842-56.
#Noordam R, de Craen AJ, Pedram P, et al. Levels of 25-hy- droxyvitamin D in familial longevity: the Leiden Longevity Study. CMAJ. 2012;184(18):E963-8.
#Autier P, Boniol M, Pizot C, Mullie P. Vitamin D: chasing a myth? Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2013.
#Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014;4(2):307-20.
#Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-8.
#Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87:1080S-6S.
#Albert PJ, Proal AD, Marshall TG. Vitamin D the alternative hypothesis. Autoimmun Rev. 2009;8(8):639-44.
#Madoff S, editor. The Bacterial L-forms. 1st ed. USA: Marcel Dekker Inc; 1986.
#Allan EJ, Hoischen C, Gumpert J. Bacterial L-forms. Adv Appl Microbiol. 2009;68:1-39.
#Boya P. Lysosomal function and dysfunction: mechanism and disease. Antioxid Redox Signal. 2010;17(5):766-74.
#Domingue GJ, Woody HB. Bacterial persistence and expression of disease. Clin Microbiol Rev. 1997;10(2):320-44.
#O’Connor SM, Taylor CE, Hughes JM. Emerging infectious determinants of chronic diseases. Emerg Infect Dis. 2006;12(7): 1051-7.
#Domingue GJ. Demystifying pleomorphic forms in persistence and expression of disease: are they bacteria, and is peptidogly- can the solution? Discov Med. 2010;10(52):234-46.
#Rueter A. Microbes start immune response by sneaking inside cells. University of Michigan Health System. Apr 16, 2007. http://www2.med.umich.edu/prmc/media/newsroom/details.cfm? ID=577. Accessed 8 May 2013.
#Rolhion N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(10):1277-83.
#Onwuamaegbu ME, Belcher RA, Soare C. Cell wall-deficient bacteria as a cause of infections: a review of the clinical significance. J Int Med Res. 2005;33(1):1-20.
#Verway M, Behr MA, White JH. VitaminD NOD2, autophay and Crohn’s disease. Expert Rev Clin Immunol. 2010;6(4): 505-8.
#Pirofski L, Casadevall A. Q and A what is a pathogen? A question that begs the point. BMC Biol. 2012;12:6.
#Hof H. Opportunistic intracellular bacteria and immunity. Antibiotic treatment of infections with intracellular bacteria. USA: Springer; 2002.
#Fuller E, Elmer C, Nattress F, Horne G, Cook P, Fawcett T. Beta-lactam resistance in Staphylococcus aureus cells that do not require a cell wall for integrity. Antimicrob Agents Che- mother. 2005;49(12):5075-80.
#Wroblewska J, Janicka G, Gospodarek E, Szymankiewicz M. L-forms of Staphylococcus epidermidis induced by penicillin. Pol J Microbiol. 2006;55(3):243-4.
#Garssen J, Vandebriel RJ, De Gruijl FR, et al. UVB exposure- induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology. 1999;97(3):506-14.
#Riminton DS, Hartung HP, Reddel SW. Managing the risks of immunosuppression. Curr Opin Neurol. 2011;24(3):217-23.
#Wall S, Kunze ZM, Saboor S, et al. Identification of spheroplast- like agents isolated from tissues of patients with Crohn’s disease and control tissues by polymerase chain reaction. J Clin Microbiol. 1993;31(5):1241-5.
#Negi M, Takemura T, Guzman J, et al. Localization of propi- onibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod Pathol. 2012;25(9):1284-97.
#Astrauskiene D, Bernotiene E. New insights into bacterial persistence in reactive arthritis. Clin Exp Rheumatol. 2007;25(3): 470-9.
#McDougal JS. Emerging infectious diseases. Centers for Disease Control and Prevention. Mar 2006. http://wwwnc.cdc.gov/eid/ article/12/3/05-1409_article.htm#suggestedcitation. Accessed 8 May 2013.
#Kozarov E. Bacterial invasion of vascular cell types: vascular infectology and atherogenesis. Future Cardiol. 2012;8(1): 123-38.
#Khan N, Gowthaman U, Pahari S, Agrewala JN. Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici! PLoS Pathog. 2012;8(6):e1002676.
#Hajishengallis G, Lambris JD. Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol. 2011;11(33):187-200.
#Dorr T, Vulic M, Lewis K. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 2010;8(2):e1000317.
#Fuks JM, Arrighi RB, Weidner JM, et al. GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii. PLoS Pathog. 2012;8(12): e1003051.
#Smillie CS, Smith MB, Friedman J, Cordero OX, David LA, Alm EJ. Ecology drives a global network of gene exchange connecting the human microbiome. Nature. 2011;480(7376): 241-4.
#Riley DR, Sieber KB, Robinson KM, et al. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLOS Comput Biol. 2013;9(6):e1003107.
#Helaine S, Cheverton AM, Watson KG, Faure LM, Matthews SA, Holden DW. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science. 2014;343(6167):204-208. Available at http://www.sciencemag. org. Accessed 21 Jan 2014.
#Eishi Y. Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes. Biomed Res Int. 2013;2013:935289.
#Wang KX, Chen L. Helicobacter pylori L-form and patients with chronic gastritis. World J Gastroenterol. 2004;10(9): 1306-9.
#Chen Y, Liu W, Sun T, et al. 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting MicroRNA-155-SOCS1 in macrophages. J Immunol. 2013; 190(7):3687-95.
#Nauciel C. Immune defenses against intracellular bacterial infection. In: Paradise LJ, Friedman H, Bendinelli M, editors. Opportunistic intracellular bacteria and immunity. New York: Kluwer Academic; 2002.
#Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770-3.
#Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res. 2001;7(3):167-202.
#McGeachy MJ, McSorley SJ. Microbial-induced Th17: superhero or supervillain? J Immunol. 2012;189(7):3285-91.
#Oswald-Richter KA, Beachboard DC, Seeley EH, et al. Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. J Clin Immunol. 2012;32(5):1129-40.
#Labro M. Interference of antibacterial agents with phagocyte functions: immunomodulation or ‘‘immuno-fairy tales’’? Clin Microbiol Rev. 2000;13(4):615-50.
#Giongo A, Gano KA, Crabb DB, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011; 5(1):82—91.
#Anderson G, Horvath J. The growing burden of chronic disease in America. Public Health Rep. 2004;119(3):263-70.
#Smith G. Angiotensin and systems thinking: wrapping your mind around the big picture. Ochsner J Spring. 2013;13(1): 11-25.
#Woolard MD, Frelinger JA. Outsmarting the host: bacteria modulating the immune response. Immunol Res. 2008;41(3): 188-202.
#Dermine JF, Desjardins M. Survival of intracellular pathogens within macrophages. Protoplasma. 1999;210(1-2):11-24.
#Xu Y, Xie J, Li Y, et al. Using a cDNA microarray to study cellular gene expression altered by Mycobacterium tuberculosis. Chin Med J (Engl). 2003;116(7):1070-3.
#Liu PT, Wheelwright M, Teles R, et al. MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med. 2012;18(2):267-73.
#Coughlan CA, Chotirmall SH, Renwick J, et al. The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis. Am J Respir Crit Care Med. 2012; 186(10):999-1007.
#Yenamandra SP, Lundin A, Arulampalam V, et al. Expression profile of nuclear receptors upon Epstein—Barr virus induced B cell transformation. Exp Oncol. 2009;31(2):92-6.
#Haug CJ, Aukrust P, Haug E, M0rkrid L, Muller F, Fr0land SS. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab. 1998;83(11):3832-8.
#Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997;16(4):391-6.
#Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down- regulates monocyte TLR expression and triggers. Eur J Immunol. 2006;36(2):361-70.
#Barna BP, Culver DA, Kanchwala A, et al. Alveolar macrophage cathelicidin deficiency in severe sarcoidosis. J Innate Immun. 2012;4(5-6):569-78.
#Mawer EB, Hayes ME, Still PE, et al. Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. J Bone Miner Res. 1991;6(7):733-9.
#Wang TT, Dabbas B, Laperriere EG, et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15- defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem. 2010;285(4):2227-31.
#Lemire J. 1,25-Dihydroxyvitamin D3—a hormone with immunomodulatory properties. Z Rheumatol. 2000;59(Suppl 1): 24-7.
#Deb DK, Chen Y, Zhang Z, et al. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway. 296(5): F1212-8.
#Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr. 1989;114(1):555-60.
#Wu S, Sun J. Vitamin D receptor, and macroautophagy in inflammation and infection. Discov Med. 2011;11(59):325-35.
#Domingue G, Turner B, Schlegel JU. Cell-wall deficient bacterial variants in kidney tissue. Detection by immunofluorescence. Urology. 1974;3(3):288-92.
#Pleister A, Eckels DD. Cryptic infection and autoimmunity. Autoimmun Rev. 2003;2(3):126-32.
#Chan TD, Wood K, Hermes JR, et al. Elimination of germinal- center-derived self-reactive B cells is governed by the location and concentration of self-antigen. Immunity. 2012;37(5): 893-904.
#Blander JM, Torchinsky MB, Campisi L. Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells. Immunol Res. 2012;54(1-3):50-68.
#Christen U, Hintermann E, Holdener M, von Herrath MG. Viral triggers for autoimmunity: is the ‘glass of molecular mimicry’ half full or half empty? J Autoimmun. 2010;34(1):38-44.
#Proal AD, Albert PJ, Marshall TG. Autoimmune disease and the human metagenome. In: Nelson KE, editor. Metagenomics of the human body. 1st ed. USA: Springer; 2011.
#Berlin T, Zandman-Goddard G, Blank M, et al. Autoantibodies in nonautoimmune individuals during infections. Ann NY Acad Sci. 2007;1108:584-93.
#Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity. 2005;38(3): 235-45.
#Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003;23:117-45.
#Zhang Y, Leung DY, Richers BN, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188(5): 2127-35.
#Bohm M, Luger TA, Schneider M, Schwarz T, Kuhn A. New insight into immunosuppression and treatment of autoimmune diseases. Clin Exp Rheumatol. 2006;24(1 Suppl 40):S67-71.
#Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007;66(9):1137-42.
#Kim HM, Chung MJ, Chung JB. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment. Pancreas. 2010;39(5):555-60.
#Collins FS. Reengineering translational science: the time is right. Sci Transl Med. 2011;3(90):9017.
#Norman A. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88(2):491S-9S.
#Rasmussen SB, Reinert LS, Paludan SR. Innate recognition of intracellular pathogens: detection and activation of the first line of defense. APMIS. 2009;117(5-6):323-37.
#Dusso AS, Kamimura S, Gallieni M, et al. gamma-Interferon- induced resistance to 1,25-(OH)2D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab. 1997;82(7): 2222-32.
#Edfeldt K, Liu PT, Chun R, et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci USA. 2010; 107(52):22593-8.
#Lambert PW, Stern PH, Avioli RC, et al. Evidence for extrarenal production of 1 alpha,25-dihydroxyvitamin D in man. J Clin Invest. 1982;69(3):722-5.
#Reichrath J. Vitamin D and the skin: an ancient friend, revisited. Exp Dermatol. 2007;16(7):618-25.
#Bikle DD. Vitamin D and immune function: understanding common pathways. Curr Osteoporos Rep. 2009;7(2):58-63.
#Jones G, Prosser DE, Kaufman M. 25-Hydroxyvitamin D-24- hydroxylase (CYP24A1): Its important role in the degradation of vitamin D. Arch Biochem Biophys. 2012;523(1):9-18.
#Xu Y, Hashizume T, Shuhart MC, et al. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin
#D(3): implications for drug-induced osteomalacia. Mol Pharmacol. 2006;69(1):56-65.
#Bell NH, Shaw S, Turner RT. Evidence that 1,25-dihydroxyvi- tamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest. 1984;74(4):1540-4.
#Waldron JL, Ashby HL, Cornes MP, et al. Vitamin D: a negative acute phase reactant. J Clin Pathol. 2013 (Epub ahead of print).
#Ferder M, Inserra F, Manucha W, Ferder L. The world pandemic of Vitamin D deficit could possibly be explained by cellular inflammatory response activity induced by the renin angiotensin system. Am J Physiol Cell Physiol. 2013 (Epub ahead of print).
#Akbaraly TN, Hamer M, Ferrie JE, et al. Chronic inflammation as a determinant of future aging phenotypes. CMAJ. 2013 (Epub ahead of print).
#Phillips CM, Perry IJ. Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab. 2013;98(10):E1610-9.
#Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1a,25 dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Clin Chem. 2011;57(9):1279-85.
#Hollis B. Detection of vitamin D and its major metabolites. In: Feldman D, Pike JW, Glorieux F, editors. vitamin D. San Diego: Elsevier Academic; 2005.
#Perez T. Bacteria induced vitamin D receptor dysfunction in autoimmune disease; theoretical and practical implication for interpretation of serum vitamin D metabolite levels. Paper presented at: 6th International Congress on Autoimmunity, 2006; Porto, Portugal.
#Vitamin D Assay Testing. Medicare Limited Coverage Tests— Covered Diagnosis Codes. Nov 14, 2011. Available at http:// www.sonoraquest.com/uploads/docs/Vitamin_D_Assay_ Testing.pdf?AspxAutoDetectCookieSupport=1. Accessed 31 Jan 2014.
#Durup DJHCJSPHALB. A reverse J-shaped association of allcause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab. 2012;97(8): 2644-52.
#Liu PT, Schenk M, Walker VP, et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One. 2009;4(6):e5810.
#Carlberg C, Molnar F. Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands. Curr Top Med Chem. 2006;6(12):1243-53.
#Haussler M, Haussler C, Bartik L, et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev. 2008;66(10 Suppl 2):98-112.
#Ishizawa M, Matsunawa M, Adachi R, et al. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia. J Lipid Res. 2008;49(4): 763-72.
#Marshall TG, Lee RE, Marshall FE. Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b. Theor Biol Med Model. 2006;3:1.
#Waterhouse JC, Marshall TG, Fenter B, Mangin M, Blaney G. High levels of active 1,25-dihydroxyvitamin D despite low levels of the 25-hydroxyvitamin D precursor-implications of dysregulated vitamin D for diagnosis and treatment of chronic disease. In: Stolzt VD, editor. Vitamin D: New Research. New York: Nova Science Publishers; 2006.
#Arao T, Okada Y, Mori H, Nishida K, Tanaka Y. Antihypertensive and metabolic effects of high-dose __olmesartan__ and telmisartan in type 2 diabetes patients with hypertension. Endocr J. 2013; (Epub ahead of print).
#Fliser D, Buchholz K, Haller H. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation. 2004;110(9): 1103-7.
#Platten M, Youssef S, Hur EM, et al. Blocking angiotensinconverting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci USA. 2009;106(35):14948-53.
#Izu Y, Mizoguchi F, Kawamata A, et al. Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem. 2009;284(8):4857-64.
#Shimuru H, Nakagami H, Osako MK, et al. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J. 2008;22(7):2465-75.
#Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Di- hydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229-38.
#Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003;35(6):881-900.
#Herxheimer K, Martin H. So-called Herxheimer reaction. Arch Derm Syphilol. 1926;13(1):115-7.
#Sonawane A, Santos JC, Mishra BB, et al. Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages. Cell Microbiol. 2011;13(10):1601-17.
#Nickel D, Busch M, Mayer D, Hagemann B, Knoll V, Stenger S. Hypoxia triggers the expression of human beta defensin 2 and antimicrobial activity against Mycobacterium tuberculosis in human macrophages. J Immunol. 2012;188(8):4001-7.
#Hurley JC. Antibiotic-induced release of endotoxin. A therapeutic paradox. Drug Saf. Mar 1995;12(3):183-95.
#Schwocho LR, Masonson HN. Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects. J Clin Pharmacol. 2001;41(5):515-27.
#Ferrario C. Effect of angiotensin receptor blockade on endothelial function: focus on __olmesartan__ medoxomil. Vasc Health Risk Manag. 2009;5(1):301-14.
#Takizawa S, Dan T, Uesugi T, et al. A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage. J Cereb Blood Flow Metab. 2009;29(10): 1665-72.
#Proal AD, Albert PJ, Marshall TG, Blaney GP, Lindseth LA. Immunostimulation in the treatment for chronic fatigue syn- drome/myalgic encephalomyelitis. Immunol Res. 2013;56: 398-412.
#Hof H. Antibiotic treatment of infections with intracellular bacteria. In: Paradise LJ, Friedman H, Bendinelli M, editors. Opportunistic intracellular bacteria and immunity. New York: Kluwer Academic; 2002.
#Waterhouse JC, Perez TH, Albert PJ. Reversing bacteria- induced vitamin D receptor dysfunction is key to autoimmune disease. Ann NY Acad Sci. 2009;1173:757-65.
#Mangin M. Monitoring recovery from autoimmune disease with an interactive, internet-based clinical trial based on a molecular model of chronic disease. Paper presented at: 6th International Congress on Autoimmunity, 2008; Porto, Portugal.
#Kongsbak M, Levring TB, Geisler C, von Essen MR. The vitamin D receptor and T cell function. Front Immunol. 2013; 4:148.</description></item><item><title>Osteoporosis Society UK: 20 ng vitamin D is sufficient, loading dose 300,000 IU</title><link>/posts/osteoporosis-society-uk-20-ng-vitamin-d-is-sufficient-loading-dose-300000-iu.html</link><pubDate>Wed, 17 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-society-uk-20-ng-vitamin-d-is-sufficient-loading-dose-300000-iu.html</guid><description>&lt;h3 id="national-osteoporosis-society-vitamin-d-guideline-summary">National Osteoporosis Society Vitamin D Guideline Summary&lt;/h3>
&lt;p>Age Ageing. 2014;43(5):592-595. © 2014 Oxford University Press&lt;/p>
&lt;p>&lt;a href="http://www.medscape.com/viewarticle/831094_1%20">Medscape&lt;/a>&lt;/p>
&lt;p>Terry J. Aspray, Claire Bowring, William Fraser, Neil Gittoes, M. Kassim Javaid, Helen Macdonald, Sanjeev Patel, Peter Selby, Nuttan Tanna, Roger M. Francis&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:>80%">
&lt;ul>
&lt;li>They appear to have increased the level from their previous publication&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>&lt;a href="/posts/national-osteoporosis-society-of-uk-declares-that-12-ng-of-vitamin-d-is-enough">National Osteoporosis Society of UK declares that 12 ng of vitamin D is enough – June 2013&lt;/a>&lt;/p>
&lt;/blockquote>
&lt;ul>
&lt;li>
&lt;p>They recommend the lowest vitamin D levels in the world (20 ng vs 30-50 ng)&lt;/p></description></item><item><title>Vitamin K-2 – bone biomarkers indicate at least 600 ug of MK-4 are needed daily</title><link>/posts/vitamin-k-2-bone-biomarkers-indicate-at-least-600-ug-of-mk-4-are-needed-daily.html</link><pubDate>Mon, 15 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-k-2-bone-biomarkers-indicate-at-least-600-ug-of-mk-4-are-needed-daily.html</guid><description>&lt;h4 id="low-dose-menaquinone-4-improves-γ-carboxylation-of-osteocalcin-in-young-males-a-non-placebo-controlled-doseresponse-study">Low-dose menaquinone-4 improves γ-carboxylation of osteocalcin in young males: a non-placebo-controlled dose–response study&lt;/h4>
&lt;p>Nutrition Journal 2014, 13:85 doi:10.1186/1475-2891-13-85&lt;/p>
&lt;p>Eriko Nakamura, Mami Aoki, Fumiko Watanabe and Ayako Kamimura &lt;a href="mailto:ayako.kamimura@kyowa-kirin.co.jp">ayako.kamimura@kyowa-kirin.co.jp&lt;/a>&lt;/p>
&lt;p>Healthcare Products Development Center, KYOWA HAKKO BIO CO., LTD, 2 Miyukigaoka, Tsukuba, Ibaraki 305-0841, Japan&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:>60%">
&lt;p>Increased daily doses of MK-4 each week for 13 Japanese males – age 25&lt;/p>
&lt;p>0 ug/day, 300 ug/day, 600 ug/day, 900, ug/day. 1500 ug/day&lt;/p>
&lt;p>Found that 600 ug was enough to show improved bone biomarker&lt;/p></description></item><item><title>Little variation in vitamin D levels with skin color in Brazil</title><link>/posts/little-variation-in-vitamin-d-levels-with-skin-color-in-brazil.html</link><pubDate>Sat, 23 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/little-variation-in-vitamin-d-levels-with-skin-color-in-brazil.html</guid><description>&lt;h3 id="ethnic-aspects-of-vitamin-d-deficiency">Ethnic aspects of vitamin D deficiency&lt;/h3>
&lt;h4 id="aspectos-étnicos-da-deficiência-de-vitamina-d">Aspectos étnicos da deficiência de vitamina D&lt;/h4>
&lt;p>Arq Bras Endocrinol Metab vol.58 no.5 São Paulo July 2014, &lt;a href="http://dx.doi.org/10.1590/0004-2730000003320">http://dx.doi.org/10.1590/0004-2730000003320&lt;/a>&lt;/p>
&lt;p>Arquivos Brasileiros de Endocrinologia &amp;amp; Metabologia&lt;/p>
&lt;p>Aline Correia 1 , Maria do Socorro Azevedo 1 , Fernando Gondim 1 , Francisco Bandeira 1&lt;/p>
&lt;p>1Division of Endocrinology, Diabetes and Bone Diseases, Agamenon Magalhaes Hospital, Brazilian Ministry of Health, University of Pernambuco Medical School, Recife, PE, Brazil&lt;/p>
&lt;p>Received: February 28, , 2014; Accepted: May 26, , 2014&lt;/p></description></item><item><title>Vitamin D levels vs age: compares references by IOM and Endocine Society – MENA study 2014</title><link>/posts/vitamin-d-levels-vs-age-compares-references-by-iom-and-endocine-society-mena-study-2014.html</link><pubDate>Sat, 16 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-levels-vs-age-compares-references-by-iom-and-endocine-society-mena-study-2014.html</guid><description>&lt;h4 id="effects-of-different-doses-of-vitamin-d-replacement-in-middle-eastern-and-north-african-population-a-systematic-review-and-meta-analysis">Effects of Different Doses of Vitamin D Replacement in Middle Eastern and North African Population: a Systematic Review and Meta-analysis.&lt;/h4>
&lt;p>Chakhtoura M, Akl EA, Arabi A, El Ghandour S, Shawwa K, El Hajj Fuleihan G.&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mena1.jpg" alt="image" width="800">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mena2.jpg" alt="image" width="800">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mena3.jpg" alt="image" width="800">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mena4.jpg" alt="image" width="800">
&lt;p>Background:&lt;/p>
&lt;p>Countries in the Middle East and North Africa (MENA) register some of lowest vitamin D levels worldwide. Yet, the optimal dose of vitamin D required to reach desirable serum 25- hydroxyvitamin D (25(OH)D) levels in populations from this region is unknown.&lt;/p></description></item><item><title>Vitamin K2 (as MK-7) is needed for bone quality – Review</title><link>/posts/vitamin-k2-as-mk-7-is-needed-for-bone-quality-review.html</link><pubDate>Sat, 16 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-k2-as-mk-7-is-needed-for-bone-quality-review.html</guid><description>&lt;h4 id="vitamin-k2-and-bone-quality">Vitamin K2 and Bone Quality&lt;/h4>
&lt;p>Toshiro Sato &lt;a href="mailto:oshiro.sato@j-oil.com">oshiro.sato@j-oil.com&lt;/a>&lt;/p>
&lt;p>Fine Chemical Laboratory, Nakashinden, Fukuroi-city, Shizuoka, Japan&lt;/p>
&lt;h3 id="introduction">Introduction&lt;/h3>
&lt;p>Vitamin K acts as a cofactor for the endoplasmic enzyme y-glutamyl carboxylase, during post-translational conversion of glutamic acid residues to y-carboxyglutamic acid (Gla) in specific proteins. These proteins are referred to as vitamin K-dependent proteins, and include several blood coagulation factors and anti-coagulation factors, which are synthesized in the liver; Osteocalcin(OC), a bone-specific protein synthesized by osteoblasts; and Matrix Gla Protein (MGP), which is synthesized in several organs. Recently, considerable attention has been directed towards these vitamin K-dependent Gla proteins; their role in bone metabolism; and their inhibitory effect on artery calcification. The current average intake of vitamin K from a normal diet in healthy adults is greater than that required for normal blood coagulation, but is insufficient for extra hepatic tissue requirements &lt;sup>[1,2]&lt;/sup>.&lt;/p></description></item><item><title>Vitamin D levels lower during darker skin pregnancy, but bone density is OK</title><link>/posts/vitamin-d-levels-lower-during-darker-skin-pregnancy-but-bone-density-is-ok.html</link><pubDate>Tue, 12 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-levels-lower-during-darker-skin-pregnancy-but-bone-density-is-ok.html</guid><description>&lt;h4 id="vitamin-d-status-and-bone-health-in-immigrant-versus-swedish-women-during-pregnancy-and-the-post-partum-period">Vitamin D status and bone health in immigrant versus Swedish women during pregnancy and the post-partum period.&lt;/h4>
&lt;p>J Musculoskelet Neuronal Interact. 2013 Dec;13(4):464-9.&lt;/p>
&lt;p>Dahlman I1, Gerdhem P, Bergström I.&lt;/p>
&lt;p>1Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.&lt;/p>
&lt;p>OBJECTIVE:&lt;/p>
&lt;p>We evaluated the association between vitamin D status and bone health in pregnant and post-partum immigrant versus Swedish women.&lt;/p>
&lt;p>METHODS:&lt;/p>
&lt;p>We consecutively recruited 41 immigrant and 19 age-matched healthy native Swedish women. Serum 25-hydroxy vitamin D(3) &lt;span>[25(OH)D]&lt;/span> and parathyroid hormone (PTH) were analyzed at pregnancy week 12 and 6-12 months postpartum. Dual X-ray absorptiometry (DXA) of the hip and lumbar spine, and peripheral quantitative computed tomography (pQCT) of the radius and tibia were analyzed 6-12 months postpartum.&lt;/p></description></item><item><title>Inflammatory bowel diseases treated with vitamin D – Review</title><link>/posts/inflammatory-bowel-diseases-treated-with-vitamin-d-review.html</link><pubDate>Sun, 10 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/inflammatory-bowel-diseases-treated-with-vitamin-d-review.html</guid><description>&lt;p>&lt;strong>Vitamin D improves inflammatory bowel disease outcomes: Basic science and clinical review&lt;/strong>&lt;/p>
&lt;p>World J Gastroenterol 2014 May 7; 20(17): 4934-4947&lt;/p>
&lt;p>Krista M Reich, Richard N Fedorak, Karen Madsen, Karen I Kroeker&lt;/p>
&lt;p>Krista M Reich, Richard N Fedorak, Karen Madsen, Karen I Kroeker, Division of Gastroenterology, University of Alberta, Edmonton, Alberta T6G 2X8, Canada&lt;/p>
&lt;p>Author contributions: Reich KM developed and wrote the manuscript; Fedorak RN, Madsen K and Kroeker KI contributed to the design and editing of the paper; all authors approve the final version for submission.&lt;/p></description></item><item><title>Understanding vitamin D deficiency - Editorial in Age and Ageing</title><link>/posts/understanding-vitamin-d-deficiency-editorial-in-age-and-ageing.html</link><pubDate>Sat, 02 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/understanding-vitamin-d-deficiency-editorial-in-age-and-ageing.html</guid><description>&lt;p>Opinder Sahota*&lt;/p>
&lt;p>Department of Healthcare of Older People, QMC, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK Tel: (+44) 1159249924; Fax (+44) 1159709947;&lt;/p>
&lt;p>Email: &lt;a href="mailto:opinder.sahota@nuh.nhs.uk">opinder.sahota@nuh.nhs.uk&lt;/a> *To whom correspondence should be addressed.&lt;/p>
&lt;p>Age and Ageing Advance Access published July 28, 2014&lt;/p>
&lt;p>© The Author 2014. Published by Oxford University Press on behalf of the British Geriatrics Society. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-CommercialLicense (&lt;a href="http://creativecommons.org/licenses/by-nc/4.0/)">http://creativecommons.org/licenses/by-nc/4.0/)&lt;/a>, which permits non-commercial re-use, distribution, and reproduction in any medium, provided the originalwork is properly cited.&lt;/p></description></item><item><title>Hypothesis: increased bone mineral density needs protein, Ca, Mg, Vitamin D and K</title><link>/posts/hypothesis-increased-bone-mineral-density-needs-protein-ca-mg-vitamin-d-and-k.html</link><pubDate>Sat, 26 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/hypothesis-increased-bone-mineral-density-needs-protein-ca-mg-vitamin-d-and-k.html</guid><description>&lt;h3 id="the-paradox-of-osteoporosis-irreversibilityhttpblogscreightoneduheaney20140725the-paradox-of-osteoporosis-irreversibility-2comment-34702-dr-heaney-july-2014">&lt;a href="http://blogs.creighton.edu/heaney/2014/07/25/the-paradox-of-osteoporosis-irreversibility-2/#comment-34702">The Paradox of Osteoporosis Irreversibility&lt;/a> Dr. Heaney July 2014&lt;/h3>
&lt;p>He makes a good case for protein being needed to increase Bone Mineral Density (BMD) and has the following chart&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/bmd-vs-protein.jpg" alt="image">
&lt;p>&lt;strong>Question posted by VitaminDWiki&lt;/strong>&lt;/p>
&lt;p>Is there any evidence that bone structure (spongy latticework ) is rebuilt, rather than just BMD increased with increased protein, Calcium and Vitamin D?&lt;/p>
&lt;p>Also - Magnesium and Vitamin K2 are vital for building bones&lt;/p>
&lt;hr>
&lt;h4 id="a-calcium-collagen-chelate-dietary-supplement-attenuates-bone-loss-in-postmenopausal-women-with-osteopenia-a-randomized-controlled-trial---2014">A Calcium-Collagen Chelate Dietary Supplement Attenuates Bone Loss in Postmenopausal Women with Osteopenia: A Randomized Controlled Trial - 2014&lt;/h4>
&lt;p>J Med Food. 2014 Oct&lt;/p></description></item><item><title>5,000 IU of vitamin D (in bread) was great – should have continued forever</title><link>/posts/5000-iu-of-vitamin-d-in-bread-was-great-should-have-continued-forever.html</link><pubDate>Wed, 23 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/5000-iu-of-vitamin-d-in-bread-was-great-should-have-continued-forever.html</guid><description>&lt;h4 id="three-year-follow-up-of-serum-25-hydroxyvitamin-d-parathyroid-hormone-and-bone-mineral-density-in-nursing-home-residents-who-had-received-12-months-of-daily-bread-fortification-with-125-μg-of-vitamin-d">Three-year follow-up of serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in nursing home residents who had received 12 months of daily bread fortification with 125 μg of vitamin D₃.&lt;/h4>
&lt;p>Nutr J. 2013 Oct 11;12:137. &lt;a href="https://doi.org/10.1186/1475-2891-12-137.">doi: 10.1186/1475-2891-12-137.&lt;/a>&lt;/p>
&lt;p>Mocanu V1, Vieth R. 1Department of Pathophysiology, Grigore T, Popa University of Medicine and Pharmacy, 16 Universitatii str, Iasi 700115, Romania. &lt;a href="mailto:vmocanu@iasi.mednet.ro">vmocanu@iasi.mednet.ro&lt;/a>.&lt;/p>
&lt;p>BACKGROUND:&lt;/p>
&lt;p>We conducted a single-arm clinical trial in institutionalized seniors, on the effects of high-dose vitamin D3-fortified bread daily intake (clinicaltrials.gov registration NCT00789503).&lt;/p></description></item><item><title>Vitamin D can quickly deal with Osteoporosis in the very old – Europe working group review</title><link>/posts/vitamin-d-can-quickly-deal-with-osteoporosis-in-the-very-old-europe-working-group-review.html</link><pubDate>Wed, 16 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-can-quickly-deal-with-osteoporosis-in-the-very-old-europe-working-group-review.html</guid><description>&lt;h2 id="management-of-osteoporosis-of-the-oldest-old">Management of osteoporosis of the oldest old.&lt;/h2>
&lt;p>Osteoporos Int. 2014 Jul 15. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Rizzoli R1, Branco J, Brandi ML, Boonen S, Bruyère O, Cacoub P, Cooper C, Diez-Perez A, Duder J, Fielding RA, Harvey NC, Hiligsmann M, Kanis JA, Petermans J, Ringe JD, Tsouderos Y, Weinman J, Reginster JY.&lt;/p>
&lt;p>1Service of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland, &lt;a href="mailto:Rene.Rizzoli@unige.ch">Rene.Rizzoli@unige.ch&lt;/a>.&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#management-of-osteoporosis-of-the-oldest-old">Management of osteoporosis of the oldest old.&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>This consensus article reviews the diagnosis and treatment of osteoporosis in geriatric populations. Specifically, it reviews the risk assessment and intervention thresholds, the impact of nutritional deficiencies, fall prevention strategies, pharmacological treatments and their safety considerations, the risks of sub-optimal treatment adherence and strategies for its improvement.&lt;/p></description></item><item><title>A doctor becomes aware of vitamin D deficiency in Brazil, a sunny country</title><link>/posts/a-doctor-becomes-aware-of-vitamin-d-deficiency-in-brazil-a-sunny-country.html</link><pubDate>Wed, 09 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/a-doctor-becomes-aware-of-vitamin-d-deficiency-in-brazil-a-sunny-country.html</guid><description>&lt;h3 id="shed-some-sunlight-on-vitamin-d-deficiency">Shed some (sun)light on vitamin D deficiency&lt;/h3>
&lt;p>Revista Brasileira de Hematologia e Hemoterapia, Print version ISSN 1516-8484&lt;/p>
&lt;p>Rev. Bras. Hematol. Hemoter. vol.36 no.3 São José do Rio Preto May/June 2014&lt;/p>
&lt;p>Adriana Seber *, Hospital Samaritano, São Paulo, SP, Brazil&lt;/p>
&lt;p>&lt;strong>We do not read an article that can make us change practice very often.&lt;/strong>&lt;/p>
&lt;p>&amp;ldquo;Vitamin D deficiency in children and adolescents submitted to hematopoietic stem cell transplantation&amp;rdquo;&lt;/p>
&lt;p>by Campos DJ from the Curitiba Pediatric Transplantation group&lt;/p></description></item><item><title>Osteocalcin and Vitamin D - both are hormones</title><link>/posts/osteocalcin-and-vitamin-d-both-are-hormones.html</link><pubDate>Thu, 03 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/osteocalcin-and-vitamin-d-both-are-hormones.html</guid><description>&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=Osteocalcin&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com">Search VitaminDWiki for OSTEOCALCIN&lt;/a> 201 items as of July 2014&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/obesity-related-to-osteocalcin-but-not-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Obesity related to osteocalcin but not vitamin D – Feb 2012">Obesity related to osteocalcin but not vitamin D – Feb 2012&lt;/a>&lt;/p>
&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>    &lt;strong>There is a strong relationship between vitamin K2 and osteocalcin&lt;/strong>&lt;/p>
&lt;/blockquote>
&lt;h2 id="see-also-web">See also web&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed?term=osteocalcin%5BTitle%5D">Search PubMed for OSTEOCALCIN in TITLE&lt;/a> 1570 as of July 2014&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/24847664">Reduced serum total osteocalcin is associated with central obesity in Korean children&lt;/a> May 2014&lt;/p></description></item><item><title>Back pain extremely associated with low level of vitamin D</title><link>/posts/back-pain-extremely-associated-with-low-level-of-vitamin-d.html</link><pubDate>Thu, 29 May 2014 00:00:00 +0000</pubDate><guid>/posts/back-pain-extremely-associated-with-low-level-of-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#assessment-of-vitamin-d-status-in-patients-of-chronic-low-back-pain-of-unknown-etiology">Assessment of Vitamin D status In Patients of Chronic Low Back Pain of Unknown Etiology&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#prevalence-of-vitamin-d-deficiency-in-patients-with-lumbar-spinal-stenosis-and-its-relationship-with-pain">Prevalence of vitamin D deficiency in patients with lumbar spinal stenosis and its relationship with pain.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#women-were-24-x-more-lifely-to-have--nonspecific-low-back-pain-if-low-vitamin-d">Women Were 2.4 X more lifely to have nonspecific low back pain if low vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="assessment-of-vitamin-d-status-in-patients-of-chronic-low-back-pain-of-unknown-etiology">Assessment of Vitamin D status In Patients of Chronic Low Back Pain of Unknown Etiology&lt;/h4>
&lt;p>Indian Journal of Clinical Biochemistry, May 2014&lt;/p></description></item><item><title>Vitamin D-binding protein and vitamin D status of black Americans and white Americans</title><link>/posts/vitamin-d-binding-protein-and-vitamin-d-status-of-black-americans-and-white-americans.html</link><pubDate>Thu, 29 May 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-binding-protein-and-vitamin-d-status-of-black-americans-and-white-americans.html</guid><description>&lt;p>N Engl J Med. 2013 Nov 21;369(21):1991-2000. &lt;a href="https://doi.org/10.1056/NEJMoa1306357.">doi: 10.1056/NEJMoa1306357.&lt;/a>&lt;/p>
&lt;p>Powe CE1, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R.&lt;/p>
&lt;p>1From the Department of Medicine, Brigham and Women&amp;rsquo;s Hospital (C.E.P.), Division of Nephrology, Massachusetts General Hospital (J.W., H.T., I.B., R.T.), Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School (A.H.B.), Division of Nephrology, Beth Israel Deaconess Medical Center (D.Z., S.A.K.), and Howard Hughes Medical Institute (D.Z., S.A.K.) - all in Boston; the Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Baltimore (M.K.E., A.B.Z.); the Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD (M.N.); and the Department of Medicine, San Francisco General Hospital and University of California, San Francisco, San Francisco (N.R.P.).&lt;/p></description></item><item><title>Rickets in half of premature births – 200 IU of vitamin D is enough – RCT</title><link>/posts/rickets-in-half-of-premature-births-200-iu-of-vitamin-d-is-enough-rct.html</link><pubDate>Sat, 24 May 2014 00:00:00 +0000</pubDate><guid>/posts/rickets-in-half-of-premature-births-200-iu-of-vitamin-d-is-enough-rct.html</guid><description>&lt;h4 id="prophylactic-effect-of-low-dose-vitamin-d-in-osteopenia-of-prematurity-a-clinical-trial-study">Prophylactic Effect of Low Dose Vitamin D in Osteopenia of Prematurity: A Clinical Trial Study&lt;/h4>
&lt;p>Paymaneh Alizadeh 1, Negar Sajjadian1 &lt;a href="mailto:nsajjadian@yahoo.com">nsajjadian@yahoo.com&lt;/a>, Bahram Beyrami 1, Mamak Shariat 2&lt;/p>
&lt;p>1 Department of Pediatrics, Bahrami Children Hospital, Tehran University of Medical Sciences, Tehran, Iran&lt;/p>
&lt;p>2 Research Maternofetal Center, Vali Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran&lt;/p>
&lt;p>Received: 10 Jul 2013; Accepted: 2 Nov. 2013&lt;/p>
&lt;p>Osteopenia of prematurity (OOP) is a preventable disease. Improved survival of newborns with OOP is associated with an increased incidence of OOP. The purpose of this study was to compare the prophylactic effects of two low doses of vitamin D (200 and 400 IU/Day) on the clinical, biochemical and radiological indices of the rickets of prematurity. In a randomized clinical trial, 60 preterm newborns with birth weight &amp;lt; 2000 g &amp;amp; gestational age &amp;lt; 37 weeks were randomly divided in two groups. Thirty newborns received 200 IU/d of vitamin D in group one and 30 ones received 400 IU/day of vitamin D in group two. On the 6th and 8th weeks of life, serum calcium, phosphate, alkaline phosphates, and 25 - hydroxy vitamin D concentrations were measured and x- ray of left wrist and physical examination were performed. Both groups had no difference in biochemical, radiological or clinical presentation of rickets. Current study indicated that low dose vitamin D (200 IU/Day) is enough for prevention of OOP.&lt;/p></description></item><item><title>Parkinson’s disease 2X more likely if low Vitamin D – meta-analysis</title><link>/posts/parkinsons-disease-2x-more-likely-if-low-vitamin-d-meta-analysis.html</link><pubDate>Thu, 22 May 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-2x-more-likely-if-low-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="vitamin-d-status-and-parkinsons-disease-a-systematic-review-and-meta-analysis">Vitamin D status and Parkinson’s disease: a systematic review and meta-analysis&lt;/h4>
&lt;p>Neurological Sciences, May 2014&lt;/p>
&lt;p>Zheng Lv, Huiping Qi, Le Wang, Xiaoxue Fan, Fei Han, Hong Wang, Sheng Bi &lt;a href="mailto:13224510036@163.com">13224510036@163.com&lt;/a>&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Department of Rehabilitation, the First Affiliated Hospital, Harbin Medical University, Harbin, 150001, China&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Neurology, the Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, China&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Neurology, the First Affiliated Hospital, Harbin Medical University, Harbin, 150001, China&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>To estimate the associations between vitamin D status and Parkinson’s disease (PD). We searched electronic databases of the human literature in PubMed, EMBASE and the Cochrane Library up to February, 2014 using the following keywords: ‘vitamin D’ or ‘25(OH)D’ and ‘status’ or ‘deficiency’ or ‘insufficiency’ and ‘Parkinson’s disease’. A systematic review and meta-analysis were conducted on observational studies that reported the association between blood vitamin D levels and PD. Seven studies met the inclusion criteria. 1,008 patients and 4,536 controls were included.&lt;/p></description></item><item><title>Vitamin D and bone health: Epidemiologic studies</title><link>/posts/vitamin-d-and-bone-health-epidemiologic-studies.html</link><pubDate>Wed, 14 May 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-bone-health-epidemiologic-studies.html</guid><description>&lt;p>BoneKEy Reports (2014) 3, Article number: 511 (2014) doi:10.1038/bonekey.2014.6&lt;/p>
&lt;p>Received 04 September 2013 Accepted 11 November 2013 Published online 05 March 2014&lt;/p>
&lt;p>Peter R Ebeling&lt;/p>
&lt;p>Department of Endocrinology, NorthWest Academic Centre, The University of Melbourne, Western Health, St. Albans, Victoria, Australia&lt;/p>
&lt;img src="/attachments/d3.mock.jpg" alt="image">
&lt;p>Allelic variation in the vitamin D receptor was the first non-structural gene to be associated with osteoporosis, and together with the effects of the vitamin D system on bone homeostasis, suggested that this vitamin might have a strong role in bone health. However, controversy exists regarding what level of serum 25-hydroxyvitamin D (25(OH)D) is optimal. Current data from biochemical, observational and randomized controlled trials (RCTs), indicate serum 25(OH)D levels of at least 50 nmol l−1 are required for normalization of parathyroid hormone (PTH) levels, to minimize the risk of osteomalacia and for optimal bone cell function. The skeletal consequences of 25(OH)D insufficiency include secondary hyperparathyroidism, increased bone turnover and bone loss and an increased risk of minimal trauma fractures. In large scale epidemiological studies, serum 25(OH)D levels are associated with bone mineral density in both men and women. However, there is mixed evidence on the effectiveness of optimizing serum 25(OH)D levels for the prevention of bone loss and minimal trauma fractures in postmenopausal women and older men. There may be some benefit on primary fracture prevention for those who have inadequate serum levels of 25(OH)D, particularly in institutionalised elderly patients, but only when combined with calcium supplements. For optimal bone health, evidence from RCTs suggests vitamin D may be considered a threshold nutrient with few further bone benefits observed at levels of 25(OH)D above which PTH is normalized. An adequate calcium intake is also imperative to gain optimum benefit from an improved vitamin D status in those with insufficient 25(OH)D levels, with an increased calcium intake being associated with suppression of PTH levels.&lt;/p></description></item><item><title>Liver problems in children associated with 9 ng lower levels of vitamin D</title><link>/posts/liver-problems-in-children-associated-with-9-ng-lower-levels-of-vitamin-d.html</link><pubDate>Tue, 13 May 2014 00:00:00 +0000</pubDate><guid>/posts/liver-problems-in-children-associated-with-9-ng-lower-levels-of-vitamin-d.html</guid><description>&lt;h3 id="vitamin-d-levels-and-liver-histological-alterations-in-children-with-nonalcoholic-fatty-liver-disease">Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease.&lt;/h3>
&lt;p>Eur J Endocrinol. 2014 Mar 8;170(4):547-53. &lt;a href="https://doi.org/10.1530/EJE-13-0609.">doi: 10.1530/EJE-13-0609.&lt;/a> Print 2014 Apr.&lt;/p>
&lt;p>Nobili V1, Giorgio V, Liccardo D, Bedogni G, Morino G, Alisi A, Cianfarani S.&lt;/p>
&lt;p>1Hepato-Metabolic Disease Unit, Bambino Gesù Children&amp;rsquo;s Hospital - IRCCS, Rome, Italy.&lt;/p>
&lt;p>OBJECTIVE:&lt;/p>
&lt;p>To investigate the association between plasma vitamin D (VD) levels and histological liver damage in children with nonalcoholic fatty liver disease (NAFLD).&lt;/p></description></item><item><title>Bone density does not decrease with lower vitamin D levels in blacks as it does in whites</title><link>/posts/bone-density-does-not-decrease-with-lower-vitamin-d-levels-in-blacks-as-it-does-in-whites.html</link><pubDate>Sun, 11 May 2014 00:00:00 +0000</pubDate><guid>/posts/bone-density-does-not-decrease-with-lower-vitamin-d-levels-in-blacks-as-it-does-in-whites.html</guid><description>&lt;h3 id="vitamin-d-status-does-not-influence-bone-density-in-africans-abstract-p168">Vitamin D Status does not influence Bone Density in Africans Abstract P168:&lt;/h3>
&lt;p>Circulation. 2014; 129: AP168&lt;/p>
&lt;p>Caroline K Thoreson; Michelle Y O&amp;rsquo;Connor; Madia Ricks; Stephanie T Chung; James C Reynolds; Anne E Sumner&lt;/p>
&lt;p>National Institutes of Health, Bethesda, MD&lt;/p>
&lt;p>Without regard to race, the Institute of Medicine states that to protect bone health vitamin D, measured as 25(OH)D, should be &amp;gt;20 ng/mL while levels of 12-19 ng/mL are inadequate and levels of &amp;lt;12 ng/mL are deficient. However, even when 25(OH)D levels are low, bone mineral density (BMD) is not compromised in African-Americans. The relationship of 25(OH)D levels to BMD in Africans is unknown. Therefore 78 African immigrants to the United States (77% male, median age 35y, age range 22-63y (95% CI: 36, 40)) had 25(OH)D levels and dual-energy X-ray absorptiometry (DXA) scans. Distribution of 25(OH)D levels by quartile was determined (Fig. 1). The distribution of whole body BMD across quartiles of 25(OH)D was assessed (Fig. 2). Median 25(0H)D levels was 21 ng/mL (95% CI: 20, 23) with 47% having 25(OH)D&amp;lt;20 ng/mL and 8% having 25(OH)D &amp;lt;12 ng/mL. BMD did not change across quartiles of 25(OH)D (Fig. 2). Spearman correlation between BMD and 25(OH)D was r =0.1, P=0.5. As there was no relationship between vitamin D levels and BMD, low 25(OH)D levels are not a predictor of low bone density in Africans.&lt;/p></description></item><item><title>The role of vitamin D in prevention and treatment of infection</title><link>/posts/the-role-of-vitamin-d-in-prevention-and-treatment-of-infection.html</link><pubDate>Sat, 03 May 2014 00:00:00 +0000</pubDate><guid>/posts/the-role-of-vitamin-d-in-prevention-and-treatment-of-infection.html</guid><description>&lt;p>Inflamm Allergy Drug Targets. 2013 Aug;12(4):239-45.&lt;/p>
&lt;p>Gunville CF1, Mourani PM, Ginde AA.&lt;/p>
&lt;p>1Section of Critical Care, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. &lt;a href="mailto:cameron.gunville@childrenscolorado.org">cameron.gunville@childrenscolorado.org&lt;/a>&lt;/p>
&lt;p>Vitamin D is well known for its classic role in the maintenance of bone mineral density. However, vitamin D also has an important &amp;ldquo;non-classic&amp;rdquo; influence on the body&amp;rsquo;s immune system by modulating the innate and adaptive immune system, influencing the production of important endogenous antimicrobial peptides such as cathelicidin, and regulating the inflammatory cascade. Multiple epidemiological studies in adults and children have demonstrated that vitamin D deficiency is associated with increased risk and greater severity of infection, particularly of the respiratory tract. Although the exact mechanisms by which vitamin D may improve immune responses to infection continue to be evaluated, vitamin D supplementation trials of prevention and adjunct therapy for infection are underway. Given its influence on the immune system and inflammatory cascade, vitamin D may have an important future role in the prevention and treatment of infection.&lt;/p></description></item><item><title>MRI of elderly skeletal muscle lacking vitamin D</title><link>/posts/mri-of-elderly-skeletal-muscle-lacking-vitamin-d.html</link><pubDate>Wed, 30 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/mri-of-elderly-skeletal-muscle-lacking-vitamin-d.html</guid><description>&lt;h2 id="imaging-of-skeletal-muscle-in-vitamin-d-deficiency">Imaging of skeletal muscle in vitamin D deficiency&lt;/h2>
&lt;p>World J Radiol 2014 April 28; 6(4): 119-124 ISSN 1949-8470 (online)&lt;/p>
&lt;p>Bianca Bignotti, Angela Cadoni, Carlo Martinoli, Alberto Tagliafico,&lt;/p>
&lt;p>Bianca Bignotti, Carlo Martinoli, Radiology Department, University of Genoa, 16138 Genoa, Italy&lt;/p>
&lt;p>Angela Cadoni, Alberto Tagliafico, Institute of Anatomy, Department of Experimental Medicine, University of Genoa, 16138 Genoa, Italy&lt;/p>
&lt;p>Correspondence to: Alberto Tagliafico, MD, Institute of Anatomy, Department of Experimental Medicine, University of Genoa, Via de Toni 14, 16138 Genoa, Italy. &lt;a href="mailto:albertotagliafico@gmail.com">albertotagliafico@gmail.com&lt;/a> Telephone: +39-347-9745122 Fax: +39-347-9745122 Received: December 27, 2013 Revised: February 28, 2014&lt;/p></description></item><item><title>Increased Bone strength during military training – with just 800 IU of vitamin D and Calcium – RCT</title><link>/posts/increased-bone-strength-during-military-training-with-just-800-iu-of-vitamin-d-and-calcium-rct.html</link><pubDate>Tue, 29 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/increased-bone-strength-during-military-training-with-just-800-iu-of-vitamin-d-and-calcium-rct.html</guid><description>&lt;h4 id="a-calcium-and-vitamin-d-fortified-food-product-improves-bone-adaptation-during-military-training">A calcium and vitamin D fortified food product improves bone adaptation during military training&lt;/h4>
&lt;p>The FASEB Journal, vol. 28 no. 1 Supplement 634.3 April 2014&lt;/p>
&lt;p>Erin Gaffney-Stomberg 2, Laura Lutz 2, Julie Hughes 2, Nancy Murphy 2, Louis Marchitelli 2, Sonya Cable1, Andrew Young2 and James McClung2&lt;/p>
&lt;p>1 Initital Military Training Center of Excellence Fort Eustis VA United States&lt;/p>
&lt;p>2 US Army Research Institute of Environmental Medicine Natick MA United States&lt;/p></description></item><item><title>Vitamin D Conference papers and poster abstracts – London</title><link>/posts/vitamin-d-conference-papers-and-poster-abstracts-london.html</link><pubDate>Thu, 24 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-conference-papers-and-poster-abstracts-london.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#F00;">188 abstracts&lt;/span>&lt;/strong>&lt;/p>
&lt;p>Browser (cntrl F usually) can FIND words, phrases, authors, etc.&lt;/p>
&lt;p>Note: due to extraction and formatting problems all &lt;span>[ became ( &lt;del>hs&lt;/del> &lt;del>hs&lt;/del> and all ]&lt;/span> became )&lt;/p>
&lt;p>Conference is described at: &lt;a href="/posts/vitamin-d-conference-in-england-april-23-25-2014">Vitamin D conference in England - April 23-25 2014&lt;/a>&lt;/p>
&lt;p>These absracts of presentations and posters were published in the &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/25054551?dopt=Abstract">Journal Nutrients&lt;/a> July 2014&lt;/p>
&lt;p>    Note: Clicking on Hide Health Problems above will make it easier to read the Table of Contents&lt;/p></description></item><item><title>Hypothesis: Vitamin D is the link between Osteoporosis, Obesity, and Diabetes</title><link>/posts/hypothesis-vitamin-d-is-the-link-between-osteoporosis-obesity-and-diabetes.html</link><pubDate>Thu, 17 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/hypothesis-vitamin-d-is-the-link-between-osteoporosis-obesity-and-diabetes.html</guid><description>&lt;h3 id="vitamin-d-link-between-osteoporosis-obesity-and-diabetes">Vitamin D: Link between Osteoporosis, Obesity, and Diabetes?&lt;/h3>
&lt;p>Int. J. Mol. Sci. 2014, 15(4), 6569-6591; doi:10.3390/ijms15046569 (doi registration under processing)&lt;/p>
&lt;p>Flávia Galvão Cândido &lt;a href="mailto:flaviagcandido@hotmail.com">flaviagcandido@hotmail.com&lt;/a> and Josefina Bressan&lt;/p>
&lt;p>Laboratory of Body Composition and Energy Metabolism, Departamento de Nutrição e Saúde-CCB II, Universidade Federal de Viçosa, Avenida PH Rolfs, s/n, Viçosa, MG 36570-900, Brazil&lt;/p>
&lt;p>(This article belongs to the Section Bioactives and Nutraceuticals)&lt;/p>
&lt;p>Vitamin D (1,25(OH)2D3) is a steroid hormone that has a range of physiological functions in skeletal and nonskeletal tissues, and can contribute to prevent and/or treat osteoporosis, obesity, and Type 2 diabetes mellitus (T2DM). In bone metabolism, vitamin D increases the plasma levels of calcium and phosphorus, regulates osteoblast and osteoclast the activity, and combats PTH hypersecretion, promoting bone formation and preventing/treating osteoporosis. This evidence is supported by most clinical studies, especially those that have included calcium and assessed the effects of vitamin D doses (≥800 IU/day) on bone mineral density. However, annual megadoses should be avoided as they impair bone health.&lt;/p></description></item><item><title>Fractures reduced with any amount of vitamin D and some Calcium - Cochraine</title><link>/posts/fractures-reduced-with-any-amount-of-vitamin-d-and-some-calcium-cochraine.html</link><pubDate>Mon, 14 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/fractures-reduced-with-any-amount-of-vitamin-d-and-some-calcium-cochraine.html</guid><description>&lt;h4 id="cochraine-like-many-other-meta-groups-ignores-dose-size-so-the-majority-of-studies-which-use-400-iu-cancel-out-the-benefits-from-studies-using-10x-as-much">Cochraine, like many other meta-groups, ignores dose size, so the majority of studies which use 400 IU cancel out the benefits from studies using 10X as much&lt;/h4>
&lt;p>&lt;strong>They also ignore the importance of Magnesium, Boron, and Silicone in building strong bones.&lt;/strong>&lt;/p>
&lt;h4 id="they-probably-also-wrongly-assume-that-the-increase-bone-mineral-density-bmd-results-in-increase-in-bone-strength">They probably also (wrongly) assume that the increase Bone Mineral Density (BMD) results in increase in Bone Strength.&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/osteo-hip-joint.jpg" alt="image">
&lt;hr>
&lt;h4 id="vitamin-d-and-related-vitamin-d-compounds-for-preventing-fractures-resulting-from-osteoporosis-in-older-people-updated">Vitamin D and related vitamin D compounds for preventing fractures resulting from osteoporosis in older people Updated&lt;/h4>
&lt;p>Avenell A, Mak JCS, O&amp;rsquo;Connell D&lt;/p></description></item><item><title>Parkinson's disease and vitamin D – review finds promising indications</title><link>/posts/parkinsons-disease-and-vitamin-d-review-finds-promising-indications.html</link><pubDate>Wed, 02 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-and-vitamin-d-review-finds-promising-indications.html</guid><description>&lt;h2 id="a-review-of-vitamin-d-and-parkinsons-disease">A review of vitamin D and Parkinson&amp;rsquo;s disease.&lt;/h2>
&lt;p>Maturitas. 2014 Mar 5. pii: S0378-5122(14)00063-2. &lt;a href="https://doi.org/10.1016/j.maturitas.2014.02.012.">doi: 10.1016/j.maturitas.2014.02.012.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Peterson AL.&lt;/p>
&lt;p>The role of vitamin D in bone health has been known for over a century. More recent research has suggested that vitamin D may play a role in the muscular, immune, endocrine, and central nervous systems. Animal research suggests that vitamin D may have some protective effects against toxic insults that are known to damage dopamine cells, the primary cells to degenerate in PD. Persons with PD tend to have lower vitamin D levels than persons of similar ages without PD. Vitamin D levels are generally associated with bone mineral density (BMD) in persons with PD, but simply giving vitamin D does not appear to improve BMD. Results of genetic studies examining polymorphism of the vitamin D receptor and PD risk, severity, or age at onset have shown variable results, with FokI CC seeming to possibly carry some increased risk of PD. Amount of sun exposure and vitamin D levels in earlier life may influence the risk of developing PD. Cross-sectional research suggests a relationship between vitamin D levels and severity of PD symptoms. A single intervention study did show some improvement in PD with vitamin D supplementation. Vitamin D may have effects on PD symptoms and perhaps even on the risk of disease development or disease progression. More well designed intervention studies are needed to confirm the effect of vitamin D on PD symptoms. Human neuroprotection studies are needed, but probably not feasible until better biomarkers are established.&lt;/p></description></item><item><title>137 health problems associated with low vitamin D – meta-meta-analysis</title><link>/posts/137-health-problems-associated-with-low-vitamin-d-meta-meta-analysis.html</link><pubDate>Tue, 01 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/137-health-problems-associated-with-low-vitamin-d-meta-meta-analysis.html</guid><description>&lt;p>Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials&lt;/p>
&lt;img src="/attachments/d3.mock.jpg" alt="image">
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#evidence-category-from-the-study">Evidence category (from the study)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#forest-plots-from-the-study">Forest plots (from the study)&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#methods">Methods&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#structure-of-umbrella-review">Structure of umbrella review&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#search-strategy">Search strategy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#eligibility-criteria-and-appraisal-of-included-studies">Eligibility criteria and appraisal of included studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#data-extraction">Data extraction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#data-analysis">Data analysis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#results">Results&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-concentrations-and-health-outcomes-systematic-reviews-of-observational-studies">Vitamin D concentrations and health outcomes: systematic reviews of observational studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-concentrations-and-health-outcomes-meta-analyses-of-observational-studies">Vitamin D concentrations and health outcomes: meta-analyses of observational studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#summary-effects-heterogeneity-and-bias-tests-for-meta-analyses-of-observational-associations">Summary effects, heterogeneity, and bias tests for meta-analyses of observational associations&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#significant-observational-associations-without-hints-of-bias">Significant observational associations without hints of bias&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#meta-analyses-of-randomised-controlled-trials-of-vitamin-d-supplementation">Meta-analyses of randomised controlled trials of vitamin D supplementation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#comparison-of-findings-from-observational-studies-and-clinical-trials">Comparison of findings from observational studies and clinical trials&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#strengths-and-weaknesses-of-study-and-in-relation-to-other-studies">Strengths and weaknesses of study and in relation to other studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#possible-explanations-and-implications-for-clinicians-and-policy-makers">Possible explanations and implications for clinicians and policy makers&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#conclusions-unanswered-questions-and-future-research">Conclusions, unanswered questions, and future research&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#what-is-already-known-on-this-topic">What is already known on this topic&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-this-study-adds">What this study adds&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#editorial-on-the-study-vitamin-d-and-chronic-disease-prevention">Editorial on the study: Vitamin D and chronic disease prevention&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references-1">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>BMJ2014;348:g2035 &lt;a href="https://doi.org/10.1136/bmj.g2035">doi: 10.1136/bmj.g2035&lt;/a> (Published 1 April 2014)&lt;/p></description></item><item><title>Vitamin D update – 40-60 ng ideal, 50K biweekly maintenance</title><link>/posts/vitamin-d-update-40-60-ng-ideal-50k-biweekly-maintenance.html</link><pubDate>Mon, 24 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-update-40-60-ng-ideal-50k-biweekly-maintenance.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-update-2013-from-rickets-prophylaxis-to-general-preventive-healthcare">Vitamin D: Update 2013 From rickets prophylaxis to general preventive healthcare&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#from-sunshine-vitamin-to-sunshine-hormone">From Sunshine Vitamin to Sunshine Hormone&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-barometer-of-vitamin-d-health-25-hydroxyvitamin-d">The Barometer of Vitamin D Health: 25-hydroxyvitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#health-risk-vitamin-d-deficiency">Health Risk: Vitamin D Deficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bone-muscle-metabolism-and-dental-health-risk-of-fractures-falling-and-caries">Bone, Muscle Metabolism, and Dental Health: Risk of Fractures, Falling and Caries&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ecological-association-studies">Ecological Association Studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#gene-expression-link-between-vitamin-d-and-prevention">Gene Expression: Link Between Vitamin D and Prevention&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cardiovascular-system-hypertension-and-cardiac-insufficiency">Cardiovascular System: Hypertension and Cardiac Insufficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#diabetology">Diabetology&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#type-1-diabetes">Type 1 diabetes.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#type-2-diabetes-and-metabolic-syndrome">Type 2 diabetes and metabolic syndrome.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#respiratory-tract-diseases-rti">Respiratory tract diseases (RTI)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#atopic-dermatitis-psoriasis-other-dermatides">Atopic dermatitis, psoriasis other dermatides.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#autoimmune-disease-rheumatoid-arthritis-ibd-and-multiple-sclerosis">Autoimmune disease: rheumatoid arthritis, IBD and multiple sclerosis.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#degenerative-brain-disease-and-traumatic-injury">Degenerative Brain Disease and Traumatic Injury&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cancers">Cancers&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#medical-drugs-and-vitamin-d">Medical Drugs and Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#treatment-strategies">Treatment Strategies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#concluding-remarks">Concluding Remarks&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references-in-pdf">References in PDF&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="vitamin-d-update-2013-from-rickets-prophylaxis-to-general-preventive-healthcare">Vitamin D: Update 2013 From rickets prophylaxis to general preventive healthcare&lt;/h2>
&lt;p>Dermato-Endocrinology 5:3, e2; September-December 2013; © 2013 Landes Bioscience&lt;/p></description></item><item><title>MS and vitamin D consensus from Brazil - 40-100 ng, not monotherapy</title><link>/posts/ms-and-vitamin-d-consensus-from-brazil-40-100-ng-not-monotherapy.html</link><pubDate>Wed, 12 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/ms-and-vitamin-d-consensus-from-brazil-40-100-ng-not-monotherapy.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#dr-cicero-galli-coimbra-brazil-is-not-mentioned-as-an-author-contributor-nor-as-a-reference">Dr. Cicero Galli Coimbra (Brazil) is not mentioned as an author, contributor, nor as a reference&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#supplementation-and-therapeutic-use-of-vitamin-d-in-patients-with-multiple-sclerosis">Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-ms-and-eae">VITAMIN D, MS, AND EAE&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#randomized-and-controlled-clinical-trials-with-vitamin-d-in-the-treatment-of-ms">RANDOMIZED AND CONTROLLED CLINICAL TRIALS WITH VITAMIN D IN THE TREATMENT OF MS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-other-issues">VITAMIN D AND OTHER ISSUES&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#safety-profile">SAFETY PROFILE&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d--side-effects">VITAMIN D – SIDE EFFECTS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#final-considerations">FINAL CONSIDERATIONS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#acknowledgements">ACKNOWLEDGEMENTS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">REFERENCES&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="dr-cicero-galli-coimbra-brazil-is-not-mentioned-as-an-author-contributor-nor-as-a-reference">Dr. Cicero Galli Coimbra (Brazil) is not mentioned as an author, contributor, nor as a reference&lt;/h3>
&lt;p>&lt;strong>Suspect it is because Dr. Coimbra:&lt;/strong>&lt;/p></description></item><item><title>Military and Vitamin D - many studies</title><link>/posts/military-and-vitamin-d-many-studies.html</link><pubDate>Tue, 11 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/military-and-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#overview">Overview&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-in-the-military-its-time-to-act---oct2021">Vitamin D Deficiency in the Military: It’s Time to Act! - Oct 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#86-of-us-military-no-longer-have-enough-vitamin-d-30-ng--dec2020">86% of US military no longer have enough Vitamin D (30 ng) – Dec 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#soldiers-vitamin-d-levels-dropped-by-half-over-18-years--march2014">Soldiers&amp;rsquo; vitamin D levels dropped by half over 18 years – March 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chart-vitamin-d-levels-of-everyone-dropped-by-half-over-18years">Chart: Vitamin D levels of everyone dropped by half over 18 years&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#need-for-routine-vitamin-d-screening-in-military-personnel---letter-to-editor2016">Need for Routine Vitamin D Screening in Military Personnel - letter to Editor 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#related-items-on-theweb">Related items on the web&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="overview">Overview&lt;/h4>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;ul>
&lt;li>
&lt;p>Vitamin D is essential for soldiers, to enhance physical and mental performance, and to combat stress and fatigue&lt;/p></description></item><item><title>Fewer pre-infants were vitamin D deficient when they got 800 IU – RCT</title><link>/posts/fewer-pre-infants-were-vitamin-d-deficient-when-they-got-800-iu-rct.html</link><pubDate>Sun, 23 Feb 2014 00:00:00 +0000</pubDate><guid>/posts/fewer-pre-infants-were-vitamin-d-deficient-when-they-got-800-iu-rct.html</guid><description>&lt;h4 id="trial-of-daily-vitamin-d-supplementation-in-preterm-infants">Trial of Daily Vitamin D Supplementation in Preterm Infants.&lt;/h4>
&lt;p>Pediatrics. 2014 Feb 10.&lt;/p>
&lt;p>Natarajan CK1, Sankar MJ, Agarwal R, Pratap OT, Jain V, Gupta N, Gupta AK, Deorari AK, Paul VK, Sreenivas V.&lt;/p>
&lt;p>OBJECTIVE:&lt;/p>
&lt;p>To compare the effect of 800 vs 400 IU of daily oral vitamin D3 on the prevalence of vitamin D deficiency (VDD) at 40 weeks&amp;rsquo; postmenstrual age (PMA) in preterm infants of 28 to 34 weeks&amp;rsquo; gestation.&lt;/p></description></item><item><title>Roles of Vitamin D in 11 diseases</title><link>/posts/roles-of-vitamin-d-in-11-diseases.html</link><pubDate>Mon, 03 Feb 2014 00:00:00 +0000</pubDate><guid>/posts/roles-of-vitamin-d-in-11-diseases.html</guid><description>&lt;h3 id="summary-of-studies-of-vitamin-d-and-the-following-concerns">Summary of studies of Vitamin D and the following concerns&lt;/h3>
&lt;p>Sorry that we do not have hyperlinks (yet). You will have to scroll down or FIND table #&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Table 1 Diabetes Mellitus&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 2 Tuberculosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 3 Hypertension&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 4 Cardiovascular Diseases&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 5 Osteoporosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 6 Multiple Sclerosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 7 Cognition&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 8 Chronic Pain&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 9 Colon Cancer&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 10 Breast cancer&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 11 Prostate cancer&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 12 Vitamin D levels recommended&lt;/p></description></item><item><title>Osteoporosis quality of life better if more than 20 ng of vitamin D</title><link>/posts/osteoporosis-quality-of-life-better-if-more-than-20-ng-of-vitamin-d.html</link><pubDate>Tue, 28 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-quality-of-life-better-if-more-than-20-ng-of-vitamin-d.html</guid><description>&lt;h4 id="serum-25-hydroxyvitamin-d-level-as-an-independent-determinant-of-quality-of-life-in-osteoporosis-with-a-high-risk-for-fracture">Serum 25-Hydroxyvitamin D Level as an Independent Determinant of Quality of Life in Osteoporosis With a High Risk for Fracture☆&lt;/h4>
&lt;p>Hiroaki Ohta, MD, PhD, Yukari Uemura, PhD, Toshitaka Nakamura, MD, PhD, Masao Fukunaga, MD, PhD, Yasuo Ohashi, PhD, Takayuki Hosoi, MD, PhD, Satoshi Mori, MD, PhD, Toshitsugu Sugimoto, MD, PhD, Eiji Itoi, MD, PhD, Hajime Orimo, MD, PhD, Masataka Shiraki, MD, PhDemail address, for the Adequate Treatment of Osteoporosis (A-TOP) Research Group&lt;/p></description></item><item><title>Vitamin D Deficiency: Time for Inaction (question mark)</title><link>/posts/vitamin-d-deficiency-time-for-inaction-question-mark.html</link><pubDate>Mon, 20 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-deficiency-time-for-inaction-question-mark.html</guid><description>&lt;h2 id="vitamin-d-deficiency-time-for-inaction">Vitamin D Deficiency: Time for Inaction?&lt;/h2>
&lt;p>GLOBAL ADVANCES IN HEALTH AND MEDICINE January 2013 • Volume 2, Number 1&lt;/p>
&lt;p>Gregory Plotnikoff, MD, MTS, FACP, United States&lt;/p>
&lt;p>Penny George Institute for Health and Healing, Center for Health Care Innovation, Allina Health Care, Minneapolis, Minnesota.&lt;/p>
&lt;p>Dr Plotnikoff is an editor of Global Advances in Health and Medicine. &lt;a href="mailto:Gregory.Plotnikoff@allina.com">Gregory.Plotnikoff@allina.com&lt;/a>&lt;/p>
&lt;p>In 1998, the British Medical Journal boldly stated in an editorial headline, &amp;quot; &lt;strong>Vitamin D Deficiency: Time for Action.&lt;/strong> &amp;ldquo;1 The urgency was clear: vitamin D deficiency was going undiagnosed and untreated in large numbers of people. Patients were at risk and suffering needlessly. A simple, extremely low-cost, low-toxicity intervention was readily available. All that was required was vitamin D advocacy.&lt;/p></description></item><item><title>2800 IU of vitamin D before and after parathyroid surgery helped a lot – RCT</title><link>/posts/2800-iu-of-vitamin-d-before-and-after-parathyroid-surgery-helped-a-lot-rct.html</link><pubDate>Thu, 16 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/2800-iu-of-vitamin-d-before-and-after-parathyroid-surgery-helped-a-lot-rct.html</guid><description>&lt;h3 id="vitamin-d-treatment-in-primary-hyperparathyroidism-a-randomized-placebo-controlled-trial">Vitamin D Treatment in Primary Hyperparathyroidism: a Randomized Placebo Controlled Trial.&lt;/h3>
&lt;p>J Clin Endocrinol Metab. 2014 Jan 13:jc20133978.&lt;/p>
&lt;p>Rolighed L, Rejnmark L, Sikjaer T, Heickendorff L, Vestergaard P, Mosekilde L, Christiansen P.&lt;/p>
&lt;p>Department of Surgery P, Breast and Endocrine Section, THG, Aarhus University Hospital, Denmark&lt;/p>
&lt;p>Context: Low 25-hydroxy vitamin D (25OHD) levels are common in patients with primary hyperparathyroidism (PHPT) and associated with higher PTH levels and hungry bone syndrome following parathyroidectomy (PTX). However, concerns have been raised on safety of vitamin D supplementation in PHPT.&lt;/p></description></item><item><title>Need at least 800 IU of vitamin D for 6-12 months – meta-regression analysis of RCT</title><link>/posts/need-at-least-800-iu-of-vitamin-d-for-6-12-months-meta-regression-analysis-of-rct.html</link><pubDate>Tue, 14 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/need-at-least-800-iu-of-vitamin-d-for-6-12-months-meta-regression-analysis-of-rct.html</guid><description>&lt;h3 id="serum-25ohd-response-to-vitamin-d3-supplementation-a-meta-regression-analysis">Serum 25(OH)D response to vitamin D3 supplementation: A meta-regression analysis&lt;/h3>
&lt;p>Nutrition Jan 2014&lt;/p>
&lt;p>Sakineh Shab-Bidar, M.S &lt;a href="mailto:s.shabbidar@yahoo.com">s.shabbidar@yahoo.com&lt;/a>, Sandrine Bours, MD , Piet P.M.M. Geusens, MD. Ph.D , Alfons G.H. Kessels, MD. Ph.D , Joop P.W. van den Bergh, MD. Ph.D&lt;/p>
&lt;p>Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran&lt;/p>
&lt;p>Objective: The aim of this study was to review factors that influence serum 25(OH)D when giving vitamin D3 supplements.&lt;/p></description></item><item><title>Bone density correlates better with free D (calculated) rather than measured vitamin D</title><link>/posts/bone-density-correlates-better-with-free-d-calculated-rather-than-measured-vitamin-d.html</link><pubDate>Sun, 05 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/bone-density-correlates-better-with-free-d-calculated-rather-than-measured-vitamin-d.html</guid><description>&lt;h3 id="serum-free-and-bio-available-25-hydroxyvitamin-d-correlate-better-with-bone-density-than-serum-total-25-hydroxyvitamin-d">Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D.&lt;/h3>
&lt;p>Scand J Clin Lab Invest. 2014 Jan 2.&lt;/p>
&lt;p>Martin S. Johnsen 1, Guri Grimnes 1,2, Yngve Figenschau 3, Peter A. Torjesen 4, Bjørg Almås 5 &amp;amp; Rolf Jorde 1,2&lt;/p>
&lt;p>1 Tromsø Endocrine Research Group, Department of Clinical Medicine, University of Tromsø,&lt;/p>
&lt;p>Tromsø&lt;/p>
&lt;p>2 Division of Internal Medicine, University Hospital of North Norway, Tromsø&lt;/p>
&lt;p>3 Institute of Medical Biochemistry, University of Tromsø and Department of Laboratory Medicine, University Hospital of North Norway, Tromsø&lt;/p></description></item><item><title>Handbook of Vitamin D – 700 pages – 2013</title><link>/posts/handbook-of-vitamin-d-700-pages-2013.html</link><pubDate>Fri, 20 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/handbook-of-vitamin-d-700-pages-2013.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#handbook-of-vitamin-d-in-human-health-vitamin-d-in-human-health-prevention-treatment-and-toxicity">Handbook of vitamin D in human health: vitamin D in human health, Prevention, treatment and toxicity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#overview-of-key-vitamin-d-modified-conditions">Overview of key vitamin D modified conditions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-musculoskeletal-health">Vitamin D and musculoskeletal health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-chronic-disease">Vitamin D and chronic disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-infectious-disease">Vitamin D and infectious disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-cancer">Vitamin D and cancer&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#women-and-children">Women and children&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#index">Index&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="handbook-of-vitamin-d-in-human-health-vitamin-d-in-human-health-prevention-treatment-and-toxicity">Handbook of vitamin D in human health: vitamin D in human health, Prevention, treatment and toxicity&lt;/h3>
&lt;p>Edited by: Ronald Ross Watson&lt;/p></description></item><item><title>Anemia 1.9X more likely in white children having lowish vitamin D</title><link>/posts/anemia-19x-more-likely-in-white-children-having-lowish-vitamin-d.html</link><pubDate>Thu, 19 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/anemia-19x-more-likely-in-white-children-having-lowish-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-race-and-risk-for-anemia-in-children">Vitamin D, Race, and Risk for Anemia in Children&lt;/h4>
&lt;p>The Journal of Pediatrics. Volume 164, Issue 1 , Pages 153-158.e1, January 2014&lt;/p>
&lt;p>Portions of this study were presented as a poster at the Pediatric Academic Societies&amp;rsquo; Meeting, Denver, CO, April 30 - May 3, 2011.&lt;/p>
&lt;p>Meredith A. Atkinson, MD, MHS &lt;a href="mailto:matkins3@jhmi.edu">matkins3@jhmi.edu&lt;/a> , Michal L. Melamed, MD, MHS, Juhi Kumar, MD, MPH, Cindy N. Roy, PhD, Edgar R. Miller III, PhD, MD, Susan L. Furth, MD, PhD , Jeffrey J. Fadrowski, MD, MHS&lt;/p></description></item><item><title>Fibromyalgia patients with low vitamin D have more pain</title><link>/posts/fibromyalgia-patients-with-low-vitamin-d-have-more-pain.html</link><pubDate>Wed, 18 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/fibromyalgia-patients-with-low-vitamin-d-have-more-pain.html</guid><description>&lt;h3 id="fibromyalgia-syndrome-is-it-related-to-vitamin-d-deficiency-in-premenopausal-female-patients">Fibromyalgia syndrome: is it related to vitamin d deficiency in premenopausal female patients?&lt;/h3>
&lt;p>Pain Manag Nurs. 2013 Dec;14(4):e156-63. &lt;a href="https://doi.org/10.1016/j.pmn.2011.09.006.">doi: 10.1016/j.pmn.2011.09.006.&lt;/a> Epub 2011 Dec 20.&lt;/p>
&lt;p>Okumus M, Koybası M, Tuncay F, Ceceli E, Ayhan F, Yorgancioglu R, Borman P.&lt;/p>
&lt;p>There are a number of studies that have evaluated the relationship between fibromyalgia (FM) and vitamin D deficiency with conflicting results. The aim of this study was to assess vitamin D deficiency in patients with FM and to evaluate the relationship with the common symptoms of FM and levels of serum vitamin D. Forty premenopausal female fibromyalgia patients and 40 age- and sex-matched control subjects were included in the study. The demographic characteristics of all subjects, including age, sex, and body mass index, were recorded. The number of tender points was recorded, and the intensity of the widespread pain of the subjects was measured by the visual analog scale. The activities of daily living component of the Fibromyalgia Impact Questionnaire (FIQ-ADL), was used to assess physical functional capacity. Serum vitamin D was measured in both groups, and vitamin D levels &amp;lt;37.5 nmol/L were accepted as vitamin D deficiency. The vitamin D levels and clinical and laboratory characteristics of the patient and control groups were comparatively analyzed. The relationship between vitamin D levels and clinical findings of the FM patients were also determined. The mean age was 41.23 ± 4.8 and 39.48 ± 4.08 years for the patient and control groups, respectively.&lt;/p></description></item><item><title>Hip fractures reduced 2X to 6X with just 10 minutes of sunlight daily – RCT 2003-2010</title><link>/posts/hip-fractures-reduced-2x-to-6x-with-just-10-minutes-of-sunlight-daily-rct-2003-2010.html</link><pubDate>Tue, 03 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/hip-fractures-reduced-2x-to-6x-with-just-10-minutes-of-sunlight-daily-rct-2003-2010.html</guid><description>&lt;p>&lt;strong>Three trials on shut-ins (in this case, shut in hospital) by the same authors in Japan&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#6x-reduction-in-hip-fracture-of-stroke-patients-who-got-sun-exposture---rct-2003">6X reduction in hip fracture of stroke patients who got sun exposture - RCT 2003&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#amelioration-of-osteoporosis-and-hypovitaminosis-d-by-sunlight-exposure-in-stroke-patients">Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#10-minutes-of-daily-sun-reduced-fracture-rate-by-37-for-alzheimers-patients---rct-2005">10 minutes of daily sun reduced fracture rate by 3.7 for Alzheimer’s patients - RCT 2005&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#amelioration-of-osteoporosis-and-hypovitaminosis-d-by-sunlight-exposure-in-hospitalized-elderly-women-with-alzheimers-disease-a-randomized-controlled-trial">Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer&amp;rsquo;s disease: a randomized controlled trial.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#9-minutes-of-daily-sunlight-reduced-hip-fractures-by-24x-in-parkinsons-disease-patients---rct-2011">9 minutes of daily sunlight reduced hip fractures by 2.4X in Parkinson’s Disease patients - RCT 2011&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#amelioration-of-osteoporosis-and-hypovitaminosis-d-by-sunlight-exposure-in-parkinsons-disease">Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in Parkinson&amp;rsquo;s disease.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#just-imagine-how-much-more-reduction-would-have-resulted-if-they-had---">Just imagine how much more reduction would have resulted if they had . . .&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="6x-reduction-in-hip-fracture-of-stroke-patients-who-got-sun-exposture---rct-2003">6X reduction in hip fracture of stroke patients who got sun exposture - RCT 2003&lt;/h2>
&lt;h3 id="amelioration-of-osteoporosis-and-hypovitaminosis-d-by-sunlight-exposure-in-stroke-patients">Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients.&lt;/h3>
&lt;p>Neurology. 2003 Aug 12;61(3):338-42.&lt;/p></description></item><item><title>Vitamin D and Bone Disease – Review 2012</title><link>/posts/vitamin-d-and-bone-disease-review-2012.html</link><pubDate>Fri, 29 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-bone-disease-review-2012.html</guid><description>&lt;p>BioMed Research International. Volume 2013 (2013), Article ID 396541, 6 pages, &lt;a href="http://dx.doi.org/10.1155/2013/396541">http://dx.doi.org/10.1155/2013/396541&lt;/a>&lt;/p>
&lt;p>S. Christodoulou, T. Goula, A. Ververidis, and G. Drosos&lt;/p>
&lt;p>Department of Orthopaedic Surgery, School of Medicine, Democritus University of Thrace, University General Hospital of Alexandroupolis, Dragana, 68100 Alexandroupolis, Greece&lt;/p>
&lt;p>Received 6 July 2012; Accepted 29 August 2012&lt;/p>
&lt;p>Vitamin D is important for normal development and maintenance of the skeleton. Hypovitaminosis D adversely affects calcium metabolism, osteoblastic activity, matrix ossification, bone remodeling and bone density. It is well known that Vit. D deficiency in the developing skeleton is related to rickets, while in adults is related to osteomalacia. The causes of rickets include conditions that lead to hypocalcemia and/or hypophosphatemia, either isolated or secondary to vitamin D deficiency. In osteomalacia, Vit. D deficiency leads to impairment of the mineralisation phase of bone remodeling and thus an increasing amount of the skeleton being replaced by unmineralized osteoid. The relationship between Vit. D and bone mineral density and osteoporosis are still controversial while new evidence suggests that Vit. D may play a role in other bone conditions such as osteoarthritis and stress fractures. In order to maintain a “good bone health” guidelines concerning the recommended dietary intakes should be followed and screening for Vit. D deficiency in individuals at risk for deficiency is required, followed by the appropriate action.&lt;/p></description></item><item><title>Vitamin D needed after most spinal surgeries (and before as well) – 2013</title><link>/posts/vitamin-d-needed-after-most-spinal-surgeries-and-before-as-well-2013.html</link><pubDate>Fri, 29 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-needed-after-most-spinal-surgeries-and-before-as-well-2013.html</guid><description>&lt;h3 id="vitamin-d-status-and-spine-surgery-outcomes">Vitamin D Status and Spine Surgery Outcomes&lt;/h3>
&lt;p>Orthopedics. Volume 2013, Article ID 471695,12 pages &lt;a href="http://dx.doi.org/10.1155/2013/471695">http://dx.doi.org/10.1155/2013/471695&lt;/a>&lt;/p>
&lt;p>William J. Rodriguez and Jason Gromelski&lt;/p>
&lt;p>Nola Physical Therapy, 2 West 45th Street, Suite 208, New York, NY 10036, USA Correspondence should be addressed to William J. Rodriguez; &lt;a href="mailto:rodrig.bill@gmail.com">rodrig.bill@gmail.com&lt;/a> Received 20 February 2013; Accepted 19 March 2013&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;ol>
&lt;li>
&lt;p>Yes, need to normalize vitamin D levels after spinal surgery&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Need to also normalize vitamin D levels BEFORE spinal surgery – and thus perhaps eliminate the surgery&lt;/p></description></item><item><title>Bones grow better with high level of magnesium: rat study</title><link>/posts/bones-grow-better-with-high-level-of-magnesium-rat-study.html</link><pubDate>Thu, 28 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/bones-grow-better-with-high-level-of-magnesium-rat-study.html</guid><description>&lt;h4 id="the-effects-of-magnesium-supplementation-in-diets-with-different-calcium-levels-on-the-bone-status-and-bone-metabolism-in-growing-female-rats">The effects of magnesium supplementation in diets with different calcium levels on the bone status and bone metabolism in growing female rats.&lt;/h4>
&lt;p>Biol Trace Elem Res. 2013 Dec;155(3):431-8. &lt;a href="https://doi.org/10.1007/s12011-013-9798-1.">doi: 10.1007/s12011-013-9798-1.&lt;/a>&lt;/p>
&lt;p>Bae YJ, Kim MH. &lt;a href="mailto:mhkim1129@kangwon.ac.kr">mhkim1129@kangwon.ac.kr&lt;/a>&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Department of Food and Nutritional Sciences, Hanbuk University, Dongducheon, 483-120, South Korea&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Food and Nutrition, Kangwon National University, Samcheok, 245-749, South Korea&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>Previous studies have revealed that magnesium (Mg) plays a significant role in bone health; however, few studies have investigated the effects of Mg supplementation in diets with different calcium (Ca) levels on the bone status and bone metabolism in a growing stage. In this present study, we tested the effects of Mg supplementation on bone status in growing female rats, relative to Ca intake levels. A total of 40 Sprague-Dawley female rats aged 6 weeks were divided into the following four groups and fed for 12 weeks as indicated:&lt;/p></description></item><item><title>Vitamin D for older people (VDOP) trial, with 48,000 IU per month – RCT started Fall 2012</title><link>/posts/vitamin-d-for-older-people-vdop-trial-with-48000-iu-per-month-rct-started-fall-2012.html</link><pubDate>Sun, 24 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-for-older-people-vdop-trial-with-48000-iu-per-month-rct-started-fall-2012.html</guid><description>&lt;h4 id="vitamin-d-supplementation-in-older-people-vdop-study-protocol-for-a-randomised-controlled-intervention-trial-with-monthly-oral-dosing-with-12000-iu-24000-iu-or-48000-iu-of-vitamin-d3">Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D3&lt;/h4>
&lt;p>Inez Schoenmakers,&lt;/p>
&lt;p>Roger M Francis,&lt;/p>
&lt;p>Elaine McColl,&lt;/p>
&lt;p>Thomas Chadwick,&lt;/p>
&lt;p>Gail R Goldberg,&lt;/p>
&lt;p>Christine Harle,&lt;/p>
&lt;p>Alison Yarnall,&lt;/p>
&lt;p>Jennifer Wilkinson,&lt;/p>
&lt;p>Jennie Parker,&lt;/p>
&lt;p>Ann Prentice,&lt;/p>
&lt;p>… show all 11&lt;/p>
&lt;p>The randomised, double blind intervention trial ‘Optimising Vitamin D Status in Older People’ (VDOP) will test the effect of three oral dosages of vitamin D given for one year on bone mineral density (BMD) and biochemical markers of vitamin D metabolism, bone turnover and safety in older people. VDOP is funded by Arthritis Research UK, supported through Newcastle University and MRC Human Nutrition Research and sponsored by the Newcastle upon Tyne Hospitals NHS Foundation Trust.a&lt;/p></description></item><item><title>Low vitamin D during pregnancy resulted in 2.7 percent less bone content at age 20</title><link>/posts/low-vitamin-d-during-pregnancy-resulted-in-27-percent-less-bone-content-at-age-20.html</link><pubDate>Mon, 11 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-during-pregnancy-resulted-in-27-percent-less-bone-content-at-age-20.html</guid><description>&lt;h4 id="maternal-vitamin-d-status-during-pregnancy-and-bone-mass-in-offspring-at-20-years-of-age-a-prospective-cohort-study">Maternal Vitamin D Status During Pregnancy and Bone Mass in Offspring at 20 Years of Age: A Prospective Cohort Study†&lt;/h4>
&lt;p>Journal of Bone and Mineral Research; DOI: 10.1002/jbmr.2138&lt;/p>
&lt;p>Kun Zhu PhD1,2,*,&lt;/p>
&lt;p>Andrew J. O. Whitehouse PhD3,‡,&lt;/p>
&lt;p>Prue Hart PhD3,‡,&lt;/p>
&lt;p>Merci Kusel MBBS3,‡,&lt;/p>
&lt;p>Jenny Mountain MBA3,&lt;/p>
&lt;p>Stephen Lye PhD4,&lt;/p>
&lt;p>Craig Pennell PhD5,&lt;/p>
&lt;p>John P Walsh PhD1,2&lt;/p>
&lt;p>1 Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Australia&lt;/p>
&lt;p>2 School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia&lt;/p></description></item><item><title>Obese diabetics had low vitamin D and spine fractures</title><link>/posts/obese-diabetics-had-low-vitamin-d-and-spine-fractures.html</link><pubDate>Mon, 11 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/obese-diabetics-had-low-vitamin-d-and-spine-fractures.html</guid><description>&lt;h2 id="spinal-deformity-index-in-patients-with-type-2-diabetes">Spinal deformity index in patients with type 2 diabetes.&lt;/h2>
&lt;p>Endocrine. 2013 Jun;43(3):651-8. &lt;a href="https://doi.org/10.1007/s12020-012-9848-z.">doi: 10.1007/s12020-012-9848-z.&lt;/a> Epub 2012 Dec 11.&lt;/p>
&lt;p>Di Somma C, Rubino M, Faggiano A, Vuolo L, Contaldi P, Tafuri N, Andretti M, Savastano S, Colao A.&lt;/p>
&lt;p>SDN Foundation Naples, Naples, Italy. &lt;a href="mailto:cdisomma@unina.it">cdisomma@unina.it&lt;/a>&lt;/p>
&lt;p>The objective of this study is to investigate bone metabolism, density, and quality in patients with diabetes type 2 using DEXA and &lt;strong>spinal deformity index (SDI)&lt;/strong> , a surrogate index of bone quality. &lt;strong>Fifty-six patients&lt;/strong> with type 2 diabetes were studied; exclusion criteria were diseases and medications that affect bone and mineral metabolism.&lt;/p></description></item><item><title>Chronic Kidney Disease clinical trials of UV in Germany</title><link>/posts/chronic-kidney-disease-clinical-trials-of-uv-in-germany.html</link><pubDate>Sun, 10 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/chronic-kidney-disease-clinical-trials-of-uv-in-germany.html</guid><description>&lt;h2 id="vitamin-d-and-uv-exposure-in-chronic-kidney-disease">Vitamin D and UV exposure in chronic kidney disease&lt;/h2>
&lt;p>Rolfdieter Krause&lt;/p>
&lt;p>Dermato-Endocrinology Vol 5 #1&lt;/p>
&lt;p>With loss of renal function and decreasing glomerula filtration rate the serum levels of 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> as well as 1,25-dihydroxyvitamin D &lt;span>[1,25 (OH)2 D]&lt;/span> often decrease simultaneously. In representative groups of German patients on renal replacement therapy (hemodialysis, peritoneal dialysis, kidney transplantation) our group retrospectively analyzed the vitamin D status over a period of 12 y (1995‒2006).&lt;/p></description></item><item><title>Vitamin D update – Holick</title><link>/posts/vitamin-d-update-holick.html</link><pubDate>Sat, 09 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-update-holick.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-update-2013">Vitamin D: Update 2013&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#from-sunshine-vitamin-to-sunshine-hormone">From Sunshine Vitamin to Sunshine Hormone&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-barometer-of-vitamin-d-health-25-hydroxyvitamin-d">The Barometer of Vitamin D Health: 25-hydroxyvitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#health-risk-vitamin-d-deficiency">Health Risk: Vitamin D Deficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bone-muscle-metabolism-and-dental-health-risk-of-fractures-falling-and-caries">Bone, Muscle Metabolism, and Dental Health: Risk of Fractures, Falling and Caries&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ecological-association-studies">Ecological Association Studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#gene-expression-link-between-vitamin-d-and-prevention">Gene Expression: Link Between Vitamin D and Prevention&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cardiovascular-system-hypertension-and-cardiac-insufficiency">Cardiovascular System: Hypertension and Cardiac Insufficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#diabetology">Diabetology&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#immune-system">Immune system.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#respiratory-tract-diseases-rti">Respiratory tract diseases (RTI).&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#atopic-dermatitis-psoriasis-other-dermatides">Atopic dermatitis, psoriasis other dermatides.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#autoimmune-disease-rheumatoid-arthritis-ibd-and-multiple-sclerosis">Autoimmune disease: rheumatoid arthritis, IBD and multiple sclerosis.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#degenerative-brain-disease-and-traumatic-injury">Degenerative Brain Disease and Traumatic Injury&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cancers">Cancers&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#medical-drugs-and-vitamin-d">Medical Drugs and Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#treatment-strategies">Treatment Strategies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#concluding-remarks">Concluding Remarks&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolor00fpdf-is-attached-at-the-bottom-of-this-pagespan">&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="vitamin-d-update-2013">Vitamin D: Update 2013&lt;/h2>
&lt;p>&lt;strong>From rickets prophylaxis to general preventive healthcare&lt;/strong>&lt;/p></description></item><item><title>Osteoporosis due to antiepileptic drugs: placebo including Vitamin D helped 69 percent, placebo with risedronate helped 70%</title><link>/posts/osteoporosis-due-to-antiepileptic-drugs-placebo-including-vitamin-d-helped-69-pe-lped-70-percent.html</link><pubDate>Fri, 08 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-due-to-antiepileptic-drugs-placebo-including-vitamin-d-helped-69-pe-lped-70-percent.html</guid><description>&lt;h4 id="prevention-of-bone-loss-and-vertebral-fractures-in-patients-with-chronic-epilepsy-antiepileptic-drug-and-osteoporosis-prevention-trial">Prevention of bone loss and vertebral fractures in patients with chronic epilepsy-Antiepileptic drug and osteoporosis prevention trial.&lt;/h4>
&lt;p>Epilepsia. 2013 Sep 6. &lt;a href="https://doi.org/10.1111/epi.12351.">doi: 10.1111/epi.12351.&lt;/a>&lt;/p>
&lt;p>Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM.&lt;/p>
&lt;p>Primary Care Service, Boston VA Healthcare System, Boston, Massachusetts, U.S.A; Osteoporosis Clinic, Boston VA Healthcare System, Boston, Massachusetts, U.S.A; Rheumatology Section, Boston VA Healthcare System, Boston, Massachusetts, U.S.A; Department of Medicine, Boston VA Healthcare System, Boston, Massachusetts, U.S.A; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, U.S.A; Department of Medicine, Harvard Medical School, Boston, Massachusetts, U.S.A.&lt;/p></description></item><item><title>Low vitamin D, not low BMD, associated with both breaking hip and upper body bone in a fall</title><link>/posts/low-vitamin-d-not-low-bmd-associated-with-both-breaking-hip-and-upper-body-bone-in-a-fall.html</link><pubDate>Mon, 04 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-not-low-bmd-associated-with-both-breaking-hip-and-upper-body-bone-in-a-fall.html</guid><description>&lt;h4 id="vitamin-d-depletion-in-hip-fracture-women-is-associated-with-the-occurrence-of-simultaneous-upper-limb-fractures-independently-of-bone-mineral-density">Vitamin D depletion in hip fracture women is associated with the occurrence of simultaneous upper limb fractures independently of bone mineral density&lt;/h4>
&lt;p>European Geriatric Medicine, Available online 31 October 2013&lt;/p>
&lt;p>M. Di Monaco a, &lt;a href="mailto:marco.di.monaco@alice.it">marco.di.monaco@alice.it&lt;/a>; C. Castiglioni a; F. Vallero a; R. Di Monaco b; R. Tappero a&lt;/p>
&lt;p>a Osteoporosis Research Center, and Division of Physical Medicine and Rehabilitation, Presidio Sanitario San Camillo, Strada Santa Margherita 136, 10131 Torino, Italy&lt;/p>
&lt;p>b Department of Social Science, University Torino, via Sant’Ottavio 50, 10124 Torino, Italy&lt;/p></description></item><item><title>60,000 IU vitamin D weekly with daily Calcium was safe but not enough in the winter – 2012</title><link>/posts/60000-iu-vitamin-d-weekly-with-daily-calcium-was-safe-but-not-enough-in-the-winter-2012.html</link><pubDate>Sat, 02 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/60000-iu-vitamin-d-weekly-with-daily-calcium-was-safe-but-not-enough-in-the-winter-2012.html</guid><description>&lt;p>&lt;strong>Efficacy and Safety of Cholecalciferol Supplementation in Vitamin D Deficient Subjects Based on Endocrine Society Clinical Practice Guidelines&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#materials-andmethods">Materials and Methods&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#follow-up-compliance-and-subjectsanalyzed">Follow-up, compliance, and subjects analyzed&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#biochemical-estimations">Biochemical estimations&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#statistical-analysis">Statistical analysis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#results">Results&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>Endocrinol Metabol Syndrome 2012, S:4 &lt;a href="http://dx.doi.org/10.4172/2161-1017.S4-004">http://dx.doi.org/10.4172/2161-1017.S4-004&lt;/a>&lt;/p>
&lt;p>Chittari Venkata Harinarayan1*, Leena Appicatlaa2, Bangalore Arunachalam Nalini3 and Shalini Joshi3&lt;/p>
&lt;p>1Chief Consultant Endocrinologist, Fortis Hospitals (opp IIM-B), Bannerughatta Road, Bangalore - 560 076, India 2Chief Biochemistry Services, Fortis Hospitals (opp IIM-B), Bannerughatta Road, Bangalore - 560 076, India &amp;lsquo;Consultant Internal Medicine, Fortis Hospitals (opp IIM-B), Bannerughatta Road, Bangalore - 560 076, India&lt;/p></description></item><item><title>Inflammation and Vitamin D in Chronic Kidney Disease</title><link>/posts/inflammation-and-vitamin-d-in-chronic-kidney-disease.html</link><pubDate>Sat, 02 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/inflammation-and-vitamin-d-in-chronic-kidney-disease.html</guid><description>&lt;h3 id="infection-inflammation-and-vitamin-d">Infection Inflammation and Vitamin D&lt;/h3>
&lt;p>Clin Microbial 2013, 2:4 &lt;a href="http://dx.doi.org/10.4172/2327-5073.1000116">http://dx.doi.org/10.4172/2327-5073.1000116&lt;/a>&lt;/p>
&lt;p>Yildirim I, Magden K and Hur E &lt;a href="mailto:hurender@hotmail.com">hurender@hotmail.com&lt;/a>&lt;/p>
&lt;p>Bulent Ecevit University Medical School, Division of Nephrology, Department of Internal Medicine, Zonguldak, Turkey&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>See also &lt;a href="/posts/kidney-inflammation-not-reduced-by-30-ng-vitamin-d-many-health-problems-need-50-ng" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Kidney Inflammation not reduced by 30 ng Vitamin D (many health problems need 50 ng) – Nov 2022">Kidney Inflammation not reduced by 30 ng Vitamin D (many health problems need 50 ng) – Nov 2022&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Higher vitamin D during pregnancy associated with stronger hand grip at age 4</title><link>/posts/higher-vitamin-d-during-pregnancy-associated-with-stronger-hand-grip-at-age-4.html</link><pubDate>Fri, 01 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/higher-vitamin-d-during-pregnancy-associated-with-stronger-hand-grip-at-age-4.html</guid><description>&lt;h4 id="maternal-antenatal-vitamin-d-status-and-offspring-muscle-development-findings-from-the-southampton-womens-survey">Maternal antenatal vitamin D status and offspring muscle development: findings from the Southampton Women’s Survey&lt;/h4>
&lt;p>The Journal of Clinical Endocrinology &amp;amp; Metabolism October 31, 2013 jc.2013-3241&lt;/p>
&lt;p>Nicholas C. Harvey1,2,&lt;em>, Rebecca J. Moon1,3,&lt;/em>, Avan Aihie Sayer1, Georgia Ntani1, Justin H. Davies3, M Kassim Javaid4, Sian M. Robinson1, Keith M. Godfrey1,2, Hazel M. Inskip1, Cyrus Cooper1,2,4,&lt;/p>
&lt;p>The Southampton Women&amp;rsquo;s Survey Study Group&lt;/p>
&lt;p>1 MRC Lifecourse Epidemiology Unit, University of Southampton, Tremona Rd, Southampton, SO16 6YD, UK;&lt;/p></description></item><item><title>Vitamin D and Bone Health – UK National Osteoporosis Society</title><link>/posts/vitamin-d-and-bone-health-uk-national-osteoporosis-society.html</link><pubDate>Sat, 19 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-bone-health-uk-national-osteoporosis-society.html</guid><description>&lt;h4 id="vitamin-d-and-bone-health-a-practical-clinical-guideline-for-patient-management">Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management&lt;/h4>
&lt;p>There is growing interest in the importance of vitamin D, not only in the maintenance of bone health but also in terms of its potential role in the prevention of nonskeletal disorders such as auto-immune disease, cancer, mental health problems and cardiovascular disease. Although there is no universal consensus on the criteria for vitamin D deficiency, it is common in the UK, particularly in older people. The awareness that vitamin D deficiency may contribute to the development of osteoporosis and to falls and fractures has resulted in a dramatic increase in requests for serum 25 hydroxyvitamin D (25OHD) measurements. The lack of national guidance on the indications for 25OHD measurements, on the interpretation of the results and on the correction of vitamin D deficiency has resulted in confusion among patients and health-care professionals and in the proliferation of conflicting guidelines and inconsistent practice across the UK. As a result, the National Osteoporosis Society has developed this practical clinical guideline on the management of vitamin D deficiency in adult patients with, or at risk of developing, bone disease. This guideline does not address the management of vitamin D deficiency in childhood, in pregnancy or in patients with severe or end-stage chronic kidney disease (CKD Stages 4-5).&lt;/p></description></item><item><title>First episode psychosis associated with a 33 percent lower vitamin D in 3 races</title><link>/posts/first-episode-psychosis-associated-with-a-33-percent-lower-vitamin-d-in-3-races.html</link><pubDate>Tue, 15 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/first-episode-psychosis-associated-with-a-33-percent-lower-vitamin-d-in-3-races.html</guid><description>&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/phychosis.jpg" alt="image" width="600">
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-deficiency-in-first-episode-psychosis-a-case-control-study">Vitamin D deficiency in first episode psychosis: A case-control study.&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="vitamin-d-deficiency-in-first-episode-psychosis-a-case-control-study">Vitamin D deficiency in first episode psychosis: A case-control study.&lt;/h2>
&lt;p>Schizophr Res. 2013 Sep 20. pii: S0920-9964(13)00472-6. &lt;a href="https://doi.org/10.1016/j.schres.2013.08.036.">doi: 10.1016/j.schres.2013.08.036.&lt;/a>&lt;/p>
&lt;p>Crews M, Lally J, Gardner-Sood P, Howes O, Bonaccorso S, Smith S, Murray RM, Di Forti M, Gaughran F.&lt;/p>
&lt;p>Bromley Assertive Outreach and Rehabilitation Team, Oxleas NHS Foundation Trust, London, United Kingdom; Institute of Psychiatry, King&amp;rsquo;s College London, London, United Kingdom.&lt;/p></description></item><item><title>Acute Multiple Sclerosis relapse associated with low bone mineral density (low vitamin D)</title><link>/posts/acute-multiple-sclerosis-relapse-associated-with-low-bone-mineral-density-low-vitamin-d.html</link><pubDate>Sat, 12 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/acute-multiple-sclerosis-relapse-associated-with-low-bone-mineral-density-low-vitamin-d.html</guid><description>&lt;h3 id="patients-with-an-acute-multiple-sclerosis-relapse-a-high-risk-group-for-osteopenia-and-osteoporosis">PATIENTS WITH AN ACUTE MULTIPLE SCLEROSIS RELAPSE: A HIGH RISK GROUP FOR OSTEOPENIA AND OSTEOPOROSIS&lt;/h3>
&lt;p>J Neurol Neurosurg Psychiatry 2013;84:e2 doi:10.1136/jnnp-2013-306573.194&lt;/p>
&lt;p>Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23–24 October 2013&lt;/p>
&lt;p>Olwen Murphy⇓, Michael S Zandi, Nitzan Lindenberg, Elaine Murphy, Jeremy Chataway&lt;/p>
&lt;p>National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London.&lt;/p>
&lt;p>Objective To evaluate the bone health of a cohort of patients with an acute Multiple Sclerosis (MS) relapse and to develop an algorithm for the management of bone health in this patient group.&lt;/p></description></item><item><title>Yet again, 800 IU of vitamin D was found to be barely enough to help bones – Lancet</title><link>/posts/yet-again-800-iu-of-vitamin-d-was-found-to-be-barely-enough-to-help-bones-lancet.html</link><pubDate>Fri, 11 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/yet-again-800-iu-of-vitamin-d-was-found-to-be-barely-enough-to-help-bones-lancet.html</guid><description>&lt;h2 id="the-study">The study:&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>Ignored how much vitamin D was given - most of the studies used &amp;lt; 800 IU.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Ignored if vitamin D2 vs Vitamin &lt;strong>&lt;span style="color:#00F;">D3&lt;/span>&lt;/strong> was used - Vitamin D2 has far less benefit, and sometimes decreases the D3 levels&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Ignored how often the vitamin D dose was given - they included studies which used annual doses&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Ignored if Calcium or other cofactors were given&lt;/p>
&lt;ul>
&lt;li>&lt;strong>Only 5 of the 23 studies used &amp;gt;800 IU of vitamin D3 with Calcium&lt;/strong>&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>&lt;strong>6 studies actually found a benefit&lt;/strong>&lt;/p></description></item><item><title>Vitamin K and bone health – need more research</title><link>/posts/vitamin-k-and-bone-health-need-more-research.html</link><pubDate>Sun, 06 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-k-and-bone-health-need-more-research.html</guid><description>&lt;h4 id="vitamin-k-and-bone-health">Vitamin K and bone health&lt;/h4>
&lt;p>Journal of Clinical Densitometry&lt;/p>
&lt;p>Maryam S. Hamidi1,&lt;/p>
&lt;p>Olga Gajic-Veljanoski1,&lt;/p>
&lt;p>Angela M. Cheung1, 2, &lt;a href="mailto:angela.m.cheung@gmail.com">angela.m.cheung@gmail.com&lt;/a>&lt;/p>
&lt;p>1 Osteoporosis and Women&amp;rsquo;s Health Programs at University Health Network, Toronto, ON, Canada&lt;/p>
&lt;p>2 Department of Medicine at University of Toronto, Toronto, ON, Canada&lt;/p>
&lt;p>Vitamin K has been purported to play an important role in bone health. It is required for the gamma-carboxylation of osteocalcin (the most abundant noncollagenous protein in bone), making osteocalcin functional.&lt;/p></description></item><item><title>20 ng is enough vitamin D for healthy Nordic Caucasians: 5th Nordic meta-analysis</title><link>/posts/20-ng-is-enough-vitamin-d-for-healthy-nordic-caucasians-5th-nordic-meta-analysis.html</link><pubDate>Thu, 03 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/20-ng-is-enough-vitamin-d-for-healthy-nordic-caucasians-5th-nordic-meta-analysis.html</guid><description>&lt;h2 id="nordic-nutrition-recommendations---the-nnr5-project">Nordic Nutrition Recommendations - the NNR5 project&lt;/h2>
&lt;p>Department of Food and Environmental Sciences, University of Helsinki, Helsinki, Finland;&lt;/p>
&lt;p>2UIT-The Arctic University of Norway, Troms0, Norway; 3Department of Community Medicine, Institute of Health and Society, University of Oslo, Oslo, Norway; 4Norwegian Institute of Public Health, Oslo, Norway; 5Unit for Nutrition Research, LandspitaliUniversity Hospital&amp;amp; University of Iceland, Reykjavik, Iceland&lt;/p>
&lt;hr>
&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#00F;">Appendicies are attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p></description></item><item><title>3 to 55 X more likely to have these health problems if low Vitamin D</title><link>/posts/3-to-55-x-more-likely-to-have-these-health-problems-if-low-vitamin-d.html</link><pubDate>Tue, 24 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/3-to-55-x-more-likely-to-have-these-health-problems-if-low-vitamin-d.html</guid><description>&lt;!-- ~tc~ start ~/tc~ -->
&lt;ul>
&lt;li>
&lt;p>&lt;strong>Many health problems associated with low vitamin D&lt;br>
        click to read the studies&lt;/strong>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/bone-fractures-in-children-requiring-surgery-were-55x-more-likely-with-low-vitamin-d">&lt;strong>55 X&lt;/strong> more likely to have &lt;strong>&lt;del>#00F:bone fracture requiring surgery&lt;/del>&lt;/strong>&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/copd-becoming-suddenly-worse-is-30x-more-likely-if-low-vitamin-d">&lt;strong>30 X&lt;/strong> more likely for &lt;strong>&lt;del>#00F:COPD becoming suddenly worse&lt;/del>&lt;/strong>&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/25-x-more-likely-to-have-span-stylecolor00fsenior-momentspan" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 2415"> &lt;strong>25 X&lt;/strong> more likely to have &lt;strong>&lt;span style="color:#00F;">senior moment&lt;/span>&lt;/strong> &lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/23-x-more-likely-to-have-span-stylecolor00fvertigospan" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 3460"> &lt;strong>23 X&lt;/strong> more likely to have &lt;strong>&lt;span style="color:#00F;">vertigo&lt;/span>&lt;/strong> &lt;/a>&lt;/p></description></item><item><title>Need 40 to 80 ng of vitamin D to lose weight – Colgan</title><link>/posts/need-40-to-80-ng-of-vitamin-d-to-lose-weight-colgan.html</link><pubDate>Sat, 21 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/need-40-to-80-ng-of-vitamin-d-to-lose-weight-colgan.html</guid><description>&lt;h3 id="vitamin-d-against-overweight-dr-michael-colganhttpswwwfacebookcomcortexhypnosisposts70402531627773820-facebook-sept-2013">&lt;a href="https://www.facebook.com/cortexhypnosis/posts/704025316277738%20">Vitamin D against Overweight, Dr Michael Colgan&lt;/a> Facebook Sept 2013&lt;/h3>
&lt;p>When I write about different nutrients and lifestyle factors that regulate body fat, I get a few folk writing back saying that overeating or processed carbs, or couch surfing, are the main causes. Of course they are. If you follow Miss Piggy’s advice to, “Never eat anything bigger than your head”, you’re going to be fat as a porker.&lt;/p>
&lt;p>But we have hundreds of folk through the Colgan Institute who are trying their best to lose fat, sticking to good nutrition and exercise that would lean most of us down to a rail. &lt;strong>Yet the fat, especially belly fat, just hangs on&lt;/strong> . In these articles, I give you the factors backed by the most robust science, that we use to get them over the hump. I like to keep articles short, down to 5 or 6 main studies, but this time, just for once, I will cite a bit more of the latest evidence than usual, just to let folk know that we know what we are doing. It’s certainly the case with vitamin D.&lt;/p></description></item><item><title>Vitamin D provides many benefits and is cost-effective (need 32-40 ng) – Summer 2013</title><link>/posts/vitamin-d-provides-many-benefits-and-is-cost-effective-need-32-40-ng-summer-2013.html</link><pubDate>Sun, 15 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-provides-many-benefits-and-is-cost-effective-need-32-40-ng-summer-2013.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#effect-of-vitamin-d-status-on-pharmacological-treatment-efficacy">Effect of Vitamin D Status on Pharmacological Treatment Efficacy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-and-infectious-diseases">Vitamin D supplementation and infectious diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-as-adjunctive-therapy-in-autoimmune-diseases">Vitamin D supplementation as adjunctive therapy in autoimmune diseases&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#table-2-2000-iu-of-vitamin-d-reduced-atopic-dermatitus-by-2x">Table 2: 2000 IU of vitamin D reduced atopic dermatitus by 2X&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-as-adjunctive-therapy-in-ckd">Vitamin D supplementation as adjunctive therapy in CKD&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-as-adjunctive-therapy-in-osteoporosis">Vitamin D supplementation as adjunctive therapy in osteoporosis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-as-adjunctive-therapy-in-neurological-disorders">Vitamin D supplementation as adjunctive therapy in neurological disorders&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusions">Conclusions&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h1 id="effect-of-vitamin-d-status-on-pharmacological-treatment-efficiency-impact-on-cost-effective-management-in-medicine">Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine&lt;/h1>
&lt;p>Dermato-Endocrinology • Volume 5 • Issue 2&lt;/p></description></item><item><title>Review of Vitamin D (including free, frequency, injection, how much.)</title><link>/posts/review-of-vitamin-d-including-free-frequency-injection-how-much.html</link><pubDate>Fri, 13 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/review-of-vitamin-d-including-free-frequency-injection-how-much.html</guid><description>&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/bone-density-correlates-better-with-free-d-calculated-rather-than-measured-vitamin-d">Bone density correlates better with free D (calculated) rather than measured vitamin D – Jan 2014&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-supplementation-protocols-loading-injection-etc-rct">Vitamin D supplementation protocols: loading, injection, etc – RCT June 2014&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/600000-vitamin-d-loading-doses-good-response-to-both-oral-and-muscular">600,000 vitamin D loading doses – good response to both oral and muscular – Oct 2015&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=injection&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com">Search VitaminDWiki for INJECTION&lt;/a> 629 items as of Jan 2015&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/endocine-disease.pdf">Download the PDF from VitaminDWiki.&lt;/a>&lt;/strong>&lt;/p>
&lt;/div>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#value-and-limitations-of-assessing-vitamin-d-nutritional-status-and-advised-levels-of-vitamin-d-supplementation">Value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#measurement-of-25ohd">Measurement of 25(OH)D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-binding-protein">Vitamin D binding protein&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-search-for-a-threshold">Vitamin D and the search for a threshold&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-supplementation-general-considerations">Vitamin D and supplementation: general considerations&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-supplementation-the-discussion">Vitamin D and the supplementation: the discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#achieving-and-maintaining-vitamin-d-sufficiency">Achieving and maintaining vitamin D sufficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-which-type">Vitamin D supplementation: which type?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-im-or-oral-route-of-administration">Vitamin D supplementation: i.m. or oral route of administration?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-and-safety">Vitamin D supplementation and safety&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-and-the-real-world">Vitamin D supplementation and the real world&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusions-and-perspectives">Conclusions and perspectives&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="value-and-limitations-of-assessing-vitamin-d-nutritional-status-and-advised-levels-of-vitamin-d-supplementation">Value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation&lt;/h2>
&lt;p>European Journal of Endocrinology (2013) 169 R59-R69&lt;/p></description></item><item><title>No rise in vitamin D levels of fibromyalgia patients in the summer</title><link>/posts/no-rise-in-vitamin-d-levels-of-fibromyalgia-patients-in-the-summer.html</link><pubDate>Sun, 08 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/no-rise-in-vitamin-d-levels-of-fibromyalgia-patients-in-the-summer.html</guid><description>&lt;h3 id="bone-mass-and-vitamin-d-levels-in-women-with-a-diagnosis-of-fibromyalgia">Bone mass and vitamin D levels in women with a diagnosis of fibromyalgia.&lt;/h3>
&lt;p>Osteoporos Int. 2013 Sep 6.&lt;/p>
&lt;p>Mateos F, Valero C, Olmos JM, Casanueva B, Castillo J, Martínez J, Hernández JL, González Macías J.&lt;/p>
&lt;p>Department of Internal Medicine, University Hospital Marqués de Valdecilla. University of Cantabria. RETICEF. IFIMAV, 39005, Santander, Spain, &lt;a href="mailto:e639@humv.es">e639@humv.es&lt;/a>.&lt;/p>
&lt;p>No differences in either bone mineral density or serum 25OHD levels have been found between 205 women with fibromyalgia (both pre- and postmenopausal) and their controls.&lt;/p></description></item><item><title>Rheumatoid Arthritis associated heart problems reduced in those having more vitamin D</title><link>/posts/rheumatoid-arthritis-associated-heart-problems-reduced-in-those-having-more-vitamin-d.html</link><pubDate>Mon, 02 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/rheumatoid-arthritis-associated-heart-problems-reduced-in-those-having-more-vitamin-d.html</guid><description>&lt;p>&lt;strong>This editorial is followed by the abstract of the article&lt;/strong>&lt;/p>
&lt;h3 id="vitamin-d-replacement-therapy">Vitamin D Replacement Therapy:&lt;/h3>
&lt;p>A Promising Adjunct in Cardiovascular Risk Management Among Patients with Rheumatoid Arthritis?&lt;/p>
&lt;p>The Journal of Rheumatology vol. 40 no. 9 1463-1465&lt;/p>
&lt;p>PATRICK H. DESSEIN, MD, FCP(SA), FRCP(UK), PhD⇑&lt;/p>
&lt;p>Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.&lt;/p>
&lt;p>Address correspondence to Professor Patrick H. Dessein, P.O. Box 1012, Melville 2109, Johannesburg, South Africa. E-mail: &lt;a href="mailto:Dessein@telkomsa.net">Dessein@telkomsa.net&lt;/a>&lt;/p></description></item><item><title>Large seasonal variation in vitamin D levels associated with poor bone health</title><link>/posts/large-seasonal-variation-in-vitamin-d-levels-associated-with-poor-bone-health.html</link><pubDate>Thu, 29 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/large-seasonal-variation-in-vitamin-d-levels-associated-with-poor-bone-health.html</guid><description>&lt;h4 id="greater-seasonal-cycling-of-25-hydroxyvitamin-d-is-associated-with-increased-parathyroid-hormone-and-bone-resorption">Greater seasonal cycling of 25-hydroxyvitamin D is associated with increased parathyroid hormone and bone resorption.&lt;/h4>
&lt;p>Osteoporos Int. 2013 Aug 28. DOI: 10.1007/s00198-013-2493-4&lt;/p>
&lt;p>Darling AL, Hart KH, Gibbs MA, Gossiel F, Kantermann T, Horton K, Johnsen S, Berry JL, Skene DJ, Eastell R, Vieth R, Lanham-New SA.&lt;/p>
&lt;p>Department of Nutritional Sciences, School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK, &lt;a href="mailto:a.darling@surrey.ac.uk">a.darling@surrey.ac.uk&lt;/a>.&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/seasonal-d-and-pth.pdf">Download the PDF from Sci-Hub via VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>HIV increases Calcium in soft tissues and reduces Calcium in bones</title><link>/posts/hiv-increases-calcium-in-soft-tissues-and-reduces-calcium-in-bones.html</link><pubDate>Wed, 28 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/hiv-increases-calcium-in-soft-tissues-and-reduces-calcium-in-bones.html</guid><description>&lt;h3 id="inverse-correlation-between-vascular-calcification-and-bone-mineral-density-in-human-immunodeficiency-virus-infected-patients">Inverse Correlation Between Vascular Calcification and Bone Mineral Density in Human Immunodeficiency Virus-Infected Patients&lt;/h3>
&lt;p>Calcified Tissue International, August 2013&lt;/p>
&lt;p>Antonio Bellasi,&lt;/p>
&lt;p>Stefano Zona,&lt;/p>
&lt;p>Gabriella Orlando,&lt;/p>
&lt;p>Federica Carli,&lt;/p>
&lt;p>Guido Ligabue,&lt;/p>
&lt;p>Vincenzo Rochira,&lt;/p>
&lt;p>Antonella Santoro,&lt;/p>
&lt;p>Cristina Mussini,&lt;/p>
&lt;p>Giovanni Guaraldi, &lt;a href="mailto:giovanni.guaraldi@unimore.it">giovanni.guaraldi@unimore.it&lt;/a>&lt;/p>
&lt;p>Paolo Raggi&lt;/p>
&lt;p>HIV-infected individuals suffer from accelerated aging, which manifests as premature cardiovascular and bone disease. However, little is known of the association of these two disorders in the HIV population. Our objective was to investigate the association between a marker of atherosclerosis (coronary artery calcium &lt;span>[CAC]&lt;/span>) and low bone mineral density (BMD) in a cross-sectional cohort of HIV-infected patients. The study was conducted at the University of Modena and Reggio Emilia, Italy. A total of 636 consecutive middle-aged, HIV-infected subjects were recruited between January 2006 and December 2010. All patients underwent CAC and BMD assessment. Patients were categorized according to a CAC score &amp;lt;100 or &amp;gt;100 units based on previous literature that identified this cut-point as a marker of increased risk.&lt;/p></description></item><item><title>Osteoporosis 2.8 X more likely if Vitamin D receptor (VDR) genes altered</title><link>/posts/osteoporosis-28-x-more-likely-if-vitamin-d-receptor-vdr-genes-altered.html</link><pubDate>Tue, 27 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/osteoporosis-28-x-more-likely-if-vitamin-d-receptor-vdr-genes-altered.html</guid><description>&lt;h4 id="vitamin-d-receptor-vdr-gene-polymorphism-influences-the-risk-of-osteoporosis-in-postmenopausal-women-of-northwest-india">Vitamin D receptor (VDR) gene polymorphism influences the risk of osteoporosis in postmenopausal women of Northwest India.&lt;/h4>
&lt;p>Arch Osteoporos. 2013 Dec;8(1-2):147. &lt;a href="https://doi.org/10.1007/s11657-013-0147-y.">doi: 10.1007/s11657-013-0147-y.&lt;/a> Epub 2013 Aug 22.&lt;/p>
&lt;p>Singh M, Singh P, Singh S, Juneja PK, Kaur T.&lt;/p>
&lt;p>Molecular Genetics Laboratory, Department of Human Genetics, Punjabi University, Patiala, Punjab, India.&lt;/p>
&lt;p>Abstract: The influence of VDR gene for the risk of osteoporosis has remained inconclusive.&lt;/p>
&lt;p>VDR gene polymorphism in relation to BMD in postmenopausal women of Northwest India revealed a susceptibility haplotype AGT.&lt;/p></description></item><item><title>Working other than dayshift reduces vitamin D levels and Bone Mineral Density and increases bone pain</title><link>/posts/working-other-than-dayshift-reduces-vitamin-d-levels-and-bone-mineral-density-an-eases-bone-pain.html</link><pubDate>Thu, 22 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/working-other-than-dayshift-reduces-vitamin-d-levels-and-bone-mineral-density-an-eases-bone-pain.html</guid><description>&lt;h4 id="other-than-daytime-working-is-associated-with-lower-bone-mineral-density">Other than Daytime Working Is Associated with Lower Bone Mineral Density:&lt;/h4>
&lt;p>The Korea National Health and Nutrition Examination Survey 2009.&lt;/p>
&lt;p>Calcif Tissue Int. 2013 Aug 21.&lt;/p>
&lt;p>Kim BK, Choi YJ, Chung YS.&lt;/p>
&lt;p>Department of Endocrinology and Metabolism, Ajou University School of Medicine, San 5 Wonchon-dong, Yeongtong-gu, Suwon, 443-721, South Korea.&lt;/p>
&lt;p>Occupation affects bone mineral density (BMD); however, only few studies have been published. This study evaluated the effect of working time during a day on BMD. The cross-sectional study involved 18- to 50-year-old people who reported their working time and were measured for BMD using dual-energy X-ray absorptiometry in the Fourth Korea National Health and Nutrition Examination Survey 2009. The time period of work was divided into &amp;ldquo;daytime&amp;rdquo; and &amp;ldquo;other than daytime.&amp;rdquo; The other-than-daytime group included evening time, nighttime, regular shift time, and irregular shift time.&lt;/p></description></item><item><title>Low vitamin D associated with 5.5X increased risk of low bone mineral density</title><link>/posts/low-vitamin-d-associated-with-55x-increased-risk-of-low-bone-mineral-density.html</link><pubDate>Wed, 21 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-associated-with-55x-increased-risk-of-low-bone-mineral-density.html</guid><description>&lt;h4 id="relationships-between-serum-25-hydroxyvitamin-d-and-quantitative-ultrasound-bone-mineral-density-in-0-6-year-old-children">Relationships between serum 25-hydroxyvitamin D and quantitative ultrasound bone mineral density in 0-6 year old children.&lt;/h4>
&lt;p>Bone. 2013 Mar;53(1):306-10. &lt;a href="https://doi.org/10.1016/j.bone.2012.12.012.">doi: 10.1016/j.bone.2012.12.012.&lt;/a> Epub 2012 Dec 24.&lt;/p>
&lt;p>Yu X, Zhang J, Yan C, Shen X.&lt;/p>
&lt;p>MOE-Shanghai Key Lab of Children&amp;rsquo;s Environmental Health, XinHua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China. &lt;a href="mailto:shahd1230@yahoo.com.cn">shahd1230@yahoo.com.cn&lt;/a>&lt;/p>
&lt;p>The relationship between serum 25-hydroxyvitamin D and quantitative ultrasound bone mineral density in young children remains unclear. In addition, consensus has not been reached with regard to the concentration of 25(OH)D to define vitamin D deficiency for infants and children. In the present study, 203 children 0-6 years old were recruited in Shanghai, China. The concentrations of serum 25(OH)D, weight, length, and quantitative ultrasound bone mineral density (BMD) of left mid-tibia were determined. Low BMD was defined as &amp;lt;20th percentile of given age and sex. Low 25(OH)D was defined as 25(OH)D&amp;lt;20 ng/ml. The results showed that median serum 25(OH)D level was 19.0 ng/ml, and 58.6% had a serum 25(OH)D below 20 ng/ml. After adjusting for potential confounders, a linear relationship between serum 25(OH)D and BMD was observed. Serum 25(OH)D was positively associated with BMD (ß=323.3, 95% CI=201.0-445.7, p&amp;lt;0.001), and &lt;strong>low 25(OH)D (&amp;lt;20 ng/ml) had a high risk for low BMD (OR=5.5, 95% CI=2.5-12)&lt;/strong> . In addition, there is a nonlinear relationship between 25(OH)D and low BMD, and a threshold for 25(OH)D of 20 ng/ml existed for low BMD. The prevalence of low BMD was 47.1% in the group of 25(OH)D&amp;lt;20 ng/ml, much higher than 16.7% in the group of 25(OH)D ≥ 20 ng/ml (p&amp;lt;0.05). The results suggested that quantitative ultrasound BMD could be an indicator for vitamin D status in young children, and also provided further evidence to define vitamin D deficiency for infants and children.&lt;/p></description></item><item><title>800 IU and 20 ng is enough vitamin D, need RCT</title><link>/posts/800-iu-and-20-ng-is-enough-vitamin-d-need-rct.html</link><pubDate>Tue, 06 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/800-iu-and-20-ng-is-enough-vitamin-d-need-rct.html</guid><description>&lt;h3 id="optimal-vitamin-d-status-a-critical-analysis-on-the-basis-of-evidence-based-medicine">Optimal Vitamin D Status: A Critical Analysis on the Basis of Evidence-Based Medicine&lt;/h3>
&lt;p>The Journal of Clinical Endocrinology &amp;amp; Metabolism August 1, 2013 vol. 98 no. 8 E1283-E1304&lt;/p>
&lt;p>Roger Bouillon, &lt;a href="mailto:roger.bouillon@med.kuleuven.be">roger.bouillon@med.kuleuven.be&lt;/a>&lt;/p>
&lt;p>Natasja M. Van Schoor,&lt;/p>
&lt;p>Evelien Gielen,&lt;/p>
&lt;p>Steven Boonen Deceased May 20, 2013&lt;/p>
&lt;p>Chantal Mathieu,&lt;/p>
&lt;p>Dirk Vanderschueren and&lt;/p>
&lt;p>Paul Lips&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Clinical and Experimental Endocrinology (R.B., C.M., D.V.), KU Leuven, Departments of Endocrinology and Laboratory Medicine, UZ Leuven, 3000 Leuven, Belgium; Department of Internal Medicine, Endocrine Section, and&lt;/p></description></item><item><title>Bones can activate vitamin D</title><link>/posts/bones-can-activate-vitamin-d.html</link><pubDate>Mon, 05 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/bones-can-activate-vitamin-d.html</guid><description>&lt;h2 id="vitamin-d-activities-and-metabolic-bone-disease">Vitamin D activities and metabolic bone disease&lt;/h2>
&lt;p>Clinica Chimica Acta. Available online 30 July 2013&lt;/p>
&lt;p>Jackson W. Ryan, Paul H. Anderson, Andrew G. Turner, Howard A. Morris &lt;a href="mailto:Howard.Morris@health.sa.gov.au">Howard.Morris@health.sa.gov.au&lt;/a>&lt;/p>
&lt;p>School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia&lt;/p>
&lt;p>Chemical Pathology Directorate and Hanson Institute, SA Pathology, Adelaide South Australia 5000, Australia&lt;/p>
&lt;h3 id="highlights">Highlights&lt;/h3>
&lt;p>Bone mineral status depends on plasma calcium and phosphate homeostasis.&lt;/p>
&lt;p>Vitamin D regulates bone remodelling via endocrine and intracrine activities.&lt;/p></description></item><item><title>Hypothesis: An intestinal calcistat regulates Calcium level in body</title><link>/posts/hypothesis-an-intestinal-calcistat-regulates-calcium-level-in-body.html</link><pubDate>Wed, 31 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/hypothesis-an-intestinal-calcistat-regulates-calcium-level-in-body.html</guid><description>&lt;h3 id="calcium-homeostasis-and-clinical-or-subclinical-vitamin-d-deficiency">Calcium homeostasis, and clinical or subclinical vitamin D deficiency&lt;/h3>
&lt;p>– Can a hypothesis of “intestinal calcistat” explain it all?&lt;/p>
&lt;p>Medical Hypotheses, Volume 81, Issue 2, August 2013, Pages 253–258&lt;/p>
&lt;p>M.K. Garg a, &lt;a href="mailto:mkgargs@gmail.com">mkgargs@gmail.com&lt;/a>&lt;/p>
&lt;p>Namita Mahalle b&lt;/p>
&lt;p>a Department of Endocrinology, Command Hospital (Southern Command), Pune 411040, Maharashtra, India&lt;/p>
&lt;p>b Biochemistry Division, Department of Pathology, Deenanath Mangeshkar Hospital and Research Center, Erandawane, Pune, India&lt;/p>
&lt;p>The main physiological function of vitamin D is maintenance of calcium homeostasis by its effect on calcium absorption, and bone health in association with parathyroid gland. Vitamin D deficiency (VDD) is defined as serum 25-hydroxy vitamin D (25OHD) levels &amp;lt;20 ng/ml. Vitamin D insufficiency is called when serum 25OHD levels are between 20–29 ng/ml, though existence of this entity has been questioned.&lt;/p></description></item><item><title>Overview Alcohol and Vitamin D</title><link>/posts/overview-alcohol-and-vitamin-d.html</link><pubDate>Wed, 31 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/overview-alcohol-and-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamindwiki-references">VitaminDWiki references&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#alcohol-increases-the-risk-of-some-cancers">Alcohol increases the risk of some Cancers&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#overview-of-3-recent-reports-on-alcohol-and-health-nothing-about-vitamin-d---dr-topol-april-2025">Overview of 3 recent reports on Alcohol and Health (nothing about Vitamin D - Dr. Topol April 2025&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chronic-alcohol-consumption-reduces-vitamins-such-as-vitamin-d---march-2022">Chronic Alcohol Consumption reduces Vitamins, such as Vitamin D - March 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#low-calcium-associated-with-alcohol-craving---nov-2016-note-low-ca-may-be-due-to-low-vitamin-d">Low Calcium associated with alcohol craving - Nov 2016 (note: low Ca may be due to low Vitamin D)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-alcohol-a-review-of-the-current-literature---feb-2017">Vitamin D and alcohol: A review of the current literature - Feb 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#study-on-vitamin-d-and-alcohol-related-psychiatric-disorders---may-2024">STUDY ON VITAMIN D AND ALCOHOL RELATED PSYCHIATRIC DISORDERS - May 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#putative-role-of-vitamin-d-in-the-mechanism-of-alcoholism-and-other-addictions---a-hypothesis-nov-2020">Putative role of vitamin D in the mechanism of alcoholism and other addictions - a hypothesis Nov 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#drinkers-of-alcohol-2x-more-likely-to-have-pain-if-low-vitamin-d--nov-2020">Drinkers of alcohol 2X more likely to have pain if low vitamin D – Nov 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#google-scholar-allintitlealcohol-vitamin-d--alcoholic-91-entries-as-of-feb-2025">Google Scholar allintitle:(alcohol &amp;ldquo;vitamin d&amp;rdquo;) -alcoholic 91 entries as of Feb 2025&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nutrient-deficiencies-due-to-alcohol---sept-2021">Nutrient deficiencies due to Alcohol - Sept 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#alcohol-use-disorder-massively-upsets-the-gut-microbiome---feb-2024">Alcohol Use Disorder massively upsets the gut microbiome - Feb 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#foetal-alcohol-spectrum-disorders-in-11-of-infants-in-south-africas-western-capehttpswwwtelegraphcoukglobal-healthscience-and-diseasefoetal-alcohol-spectrum-disorder-pregnancy-south-africawtmc_ide_dm293785wttsrcemailetypeedi_ghs_new_friutmsourceemailutm_mediumedi_ghs_new_fri20240315utm_campaigndm293785---march-2024">Foetal alcohol spectrum disorders in &lt;a href="https://www.telegraph.co.uk/global-health/science-and-disease/foetal-alcohol-spectrum-disorder-pregnancy-south-africa/?WT.mc_id=e_DM293785&amp;amp;WT.tsrc=email&amp;amp;etype=Edi_GHS_New_Fri&amp;amp;utmsource=email&amp;amp;utm_medium=Edi_GHS_New_Fri20240315&amp;amp;utm_campaign=DM293785">11% of infants in South Africa’s Western Cape&lt;/a> - March 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#web">Web&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#asked-ai--how-might-alcoholics-anonymous-be-helped-by-vitamin-d---feb-2024">Asked AI : How might Alcoholics Anonymous be helped by Vitamin D - Feb 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamindwiki-references">VitaminDWiki references&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/addictions-to-smoking-alcohol-opiates-etc-may-be-reduced-by-vitamin-d-dopamine-etc-28-studies" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Addictions to smoking, alcohol, opiates, etc. may be reduced by Vitamin D (dopamine etc. 28 studies) – Nov 2024">Addictions to smoking, alcohol, opiates, etc. may be reduced by Vitamin D (dopamine etc. 28 studies) – Nov 2024&lt;/a>&lt;/p></description></item><item><title>Following a stroke, a hip fracture is 6X more likely if low vitamin D</title><link>/posts/following-a-stroke-a-hip-fracture-is-6x-more-likely-if-low-vitamin-d.html</link><pubDate>Sun, 28 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/following-a-stroke-a-hip-fracture-is-6x-more-likely-if-low-vitamin-d.html</guid><description>&lt;h3 id="vitamin-d-deficiency-and-risk-of-hip-fractures-among-disabled-elderly-stroke-patients">Vitamin D deficiency and risk of hip fractures among disabled elderly stroke patients.&lt;/h3>
&lt;p>Stroke. 2001 Jul;32(7):1673-7.&lt;/p>
&lt;p>Sato Y, Asoh T, Kondo I, Satoh K.&lt;/p>
&lt;p>Department of Neurology, Kurume University Medical Center, Japan. &lt;a href="mailto:noukenrs@cc.hirosaki-u.ac.jp">noukenrs@cc.hirosaki-u.ac.jp&lt;/a>&lt;/p>
&lt;p>BACKGROUND AND PURPOSE: Risk of hip fracture after stroke is 2 to 4 times that in a reference population. Osteomalacia is present in some patients with hip fractures in the absence of stroke, while disabled elderly stroke patients occasionally have severe deficiency in serum concentrations of 25-hydroxyvitamin D (25-OHD) (&amp;lt;/=5 ng/mL). To determine the effects of vitamin D status on hip fracture risk, we prospectively studied a cohort of patients with hemiplegia after stroke who were aged at least 65 years.&lt;/p></description></item><item><title>Global Map of vitamin D deficiency</title><link>/posts/global-map-of-vitamin-d-deficiency.html</link><pubDate>Thu, 25 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/global-map-of-vitamin-d-deficiency.html</guid><description>&lt;h2 id="a-global-representation-of-vitamin-d-status-in-healthy-populations">A global representation of vitamin D status in healthy populations.&lt;/h2>
&lt;p>Arch Osteoporos. 2012 Dec;7(1-2):155-72. &lt;a href="https://doi.org/10.1007/s11657-012-0093-0.">doi: 10.1007/s11657-012-0093-0.&lt;/a> Epub 2012 Aug 29.&lt;/p>
&lt;p>D. A. Wahl (2); C. Cooper (3); P. R. Ebeling (4); M. Eggersdorfer (5); J. Hilger (6); K. Hoffmann (6)&lt;/p>
&lt;p>R. Josse (7); J. A. Kanis (9); A. Mithal (8); D. D. Pierroz (2); J. Stenmark (2); E. Stöcklin (5); B. Dawson-Hughes &lt;a href="mailto:bess.dawson-hughes@tufts.edu">bess.dawson-hughes@tufts.edu&lt;/a> (1)&lt;/p>
&lt;ol>
&lt;li>
&lt;p>U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, 711 Washington Street, Boston, MA, 02111, USA&lt;/p></description></item><item><title>Chinese have very low vitamin D</title><link>/posts/chinese-have-very-low-vitamin-d.html</link><pubDate>Mon, 22 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/chinese-have-very-low-vitamin-d.html</guid><description>&lt;h4 id="updatea-hrefpostsvitamin-d-levels-are-correlated-with-6-environmental-variables-in-china-stylecolor-red-text-decoration-underline-titlethis-postcategory-does-not-exist-yet-vitamin-d-levels-are-correlated-with-6-environmental-variables-in-china--july-2022vitamin-d-levels-are-correlated-with-6-environmental-variables-in-china--july-2022a">Update: &lt;a href="/posts/vitamin-d-levels-are-correlated-with-6-environmental-variables-in-china" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vitamin D levels are correlated with 6 environmental variables in China – July 2022">Vitamin D levels are correlated with 6 environmental variables in China – July 2022&lt;/a>&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/map.jpg" alt="image" width="700">
&lt;h4 id="a-glimpse-of-vitamin-d-status-in-mainland-china">A glimpse of vitamin D status in Mainland China&lt;/h4>
&lt;p>&lt;a href="http://www.sciencedirect.com/science/journal/08999007">Nutrition&lt;/a>&lt;a href="http://www.sciencedirect.com/science/journal/08999007/29/7">Volume 29, Issues 7–8&lt;/a>, July–August 2013, Pages 953–957&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="http://www.sciencedirect.com/science/article/pii/S089990071300052X#">Weiguo Zhang&lt;/a>, M.D., Ph.D.{ANAME()}bcor1|&lt;img src="http://cdn.els-cdn.com/sd/entities/REcor.gif" alt="image">{ANAME}&lt;sup>, &lt;/sup>,weiguo.zhang@dsm.com&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="http://www.sciencedirect.com/science/article/pii/S089990071300052X#">Elisabeth Stoecklin&lt;/a>, M.D.,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="http://www.sciencedirect.com/science/article/pii/S089990071300052X#">Manfred Eggersdorfer&lt;/a>, Ph.D.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>DSM Nutritional Products, Human Nutrition and Health, Beijing, China and Kaiseraugst, Switzerland&lt;/p></description></item><item><title>Chronic Pancreatitis associated with painful bones (vitamin D) – meta-analysis</title><link>/posts/chronic-pancreatitis-associated-with-painful-bones-vitamin-d-meta-analysis.html</link><pubDate>Mon, 15 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/chronic-pancreatitis-associated-with-painful-bones-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="high-prevalence-of-osteoporosis-in-patients-with-chronic-pancreatitis-a-systematic-review-and-meta-analysis">High Prevalence of Osteoporosis in Patients with Chronic Pancreatitis: a Systematic Review and Meta-Analysis&lt;/h4>
&lt;p>Clinical Gastroenterology and Hepatology&lt;/p>
&lt;p>Sinead N. Duggan &lt;a href="mailto:siduggan@tcd.ie">siduggan@tcd.ie&lt;/a>, Niamh D. Smyth. Anne Murphy. David MacNaughton , Stephen JD. O’Keefe , Kevin C. Conlon&lt;/p>
&lt;p>Received 21 March 2013; received in revised form 19 June 2013; accepted 19 June 2013. published online 15 July 2013.&lt;/p>
&lt;p>Background &amp;amp; Aims: Patients with chronic pancreatitis may be at high risk for osteoporosis and osteopenia. We performed a systematic review and meta-analysis to determine the prevalence of osteoporosis and osteopenia in patients with chronic pancreatitis.&lt;/p></description></item><item><title>Beyond the bone: conference summary</title><link>/posts/beyond-the-bone-conference-summary.html</link><pubDate>Sun, 14 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/beyond-the-bone-conference-summary.html</guid><description>&lt;h1 id="vitamin-d-beyond-bone">Vitamin D: beyond bone&lt;/h1>
&lt;p>ANNALS OF THE NEW YORK ACADEMY OF SCIENCES&lt;/p>
&lt;p>Sylvia Christakos,1 Martin Hewison,2 David G. Gardner,3 Carol L. Wagner,4 Igor N. Sergeev,5 Erica Rutten,6 Anastassios G. Pittas,7 Ricardo Boland,8 Luigi Ferrucci,9 and Daniel D. Bikle10&lt;/p>
&lt;p>1 Department of Biochemistry and Molecular Biology, UMDNJ-New Jersey Medical School, Newark, New Jersey. 2Department of Orthopedic Surgery, The David Geffen School of Medicine at the University of California, Los Angeles, California.3Diabetes Center and Department of Medicine, University of California, San Francisco, California.4Division of Neonatology, Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina. 5Department of Health and Nutritional Sciences, South Dakota State University, Brookings, South Dakota. 6Ciro, Center of Expertise for Chronic Organ Failure, Horn, the Netherlands. 7Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, Massachusetts. 8Departamento de Biologla, Bioqulmica, y Farmacia, Universidad Nacional del Sur, Bahia Blanca, Argentina. 9Longitudinal Studies Section, National Institute on Aging, National Institutes of Health, Baltimore, Maryland. 10Departments of Medicine and Dermatology, University of California San Francisco, and VA Medical Center, San Francisco, California&lt;/p></description></item><item><title>Overview of vitamin D issues: IoM, Endocrine Society etc.</title><link>/posts/overview-of-vitamin-d-issues-iom-endocrine-society-etc.html</link><pubDate>Fri, 12 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/overview-of-vitamin-d-issues-iom-endocrine-society-etc.html</guid><description>&lt;p>&lt;strong>Value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementations&lt;/strong>&lt;/p>
&lt;p>Eur J Endocrinol July 11, 2013 EJE-13-0435&lt;/p>
&lt;p>Elisabetta Romagnoli, Jessica Pepe, Sara Piemonte, Cristiana Cipriani, Salvatore Minisola &lt;a href="mailto:salvatore.minisola@fastwebnet.it">salvatore.minisola@fastwebnet.it&lt;/a> ; &lt;a href="mailto:salvatore.minisola@uniroma1.it">salvatore.minisola@uniroma1.it&lt;/a>&lt;/p>
&lt;p>Department of Internal Medicine and Medical Disciplines, University of Rome &amp;ldquo;Sapienza&amp;rdquo;, Rome, Italy&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#abstract">Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#figure-1">Figure 1&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#figure-2">Figure 2&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#measurement-of-25ohd">Measurement of 25(OH)D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-binding-protein">Vitamin D binding protein&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-vitamin-d-and-the-search-for-a-threshold">The vitamin D and the search for a threshold&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-vitamin-d-and-the-supplementation-general-considerations">The vitamin D and the supplementation: general considerations&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-vitamin-d-and-the-supplementation-the-discussion">The vitamin D and the supplementation: the discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#achieving-and-maintaining-vitamin-d-sufficiency">Achieving and maintaining vitamin D sufficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-which-type">Vitamin D supplementation: which type?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-intramuscular-or-oral-route-of-administration">Vitamin D supplementation: intramuscular or oral route of administration?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-and-the-safety">Vitamin D supplementation and the safety&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-and-real-world">Vitamin D supplementation and real world&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusions-and-perspectives">Conclusions and perspectives&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references-are-in-pdf">References are in PDF&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="abstract">Abstract&lt;/h3>
&lt;p>The growing attention to the role of vitamin D in skeletal and extra-skeletal diseases over the last decade, induced an increased demand for Vitamin D determination as well as a dramatic rise of sales of vitamin D supplement. However, several critical points in this field remain to be clarified. We lack a clear consensus about the definition of vitamin D deficiency, insufficiency and sufficiency. The identification of different thresholds defining vitamin D status have relevant implications in clinical practice. In fact, the worldwide prevalence of low vitamin D status is highly varying according to the level of 25(OH)D utilized to define sufficiency. Therefore, the assessment of 25-hydroxyvitamin D levels may have a critical role, but a number of different technical problems associated with its determination may interfere in interpreting the results. The hydrophobic nature of the vitamin D and the tight binding to its carrier (vitamin D binding protein, DBP), the different forms circulating in blood and the issue of standardisation are among the most important factors influencing the measurement of this metabolite. Another controversial point relies on the conflicting guidance on prevention and treatment of vitamin D deficiency endorsed by different medical and scientific communities. In particular, uncertainty exists about how to replete vitamin D stores, how to maintain normal 25(OH)D levels after repletion, which form of vitamin D is preferable for supplementation, which route of administration and dosing regimens are advisable. Finally, concerns have been raised regarding vitamin D toxicity and its adverse effects.&lt;/p></description></item><item><title>22 percent more bone cracking found with low vitamin D</title><link>/posts/22-percent-more-bone-cracking-found-with-low-vitamin-d.html</link><pubDate>Thu, 11 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/22-percent-more-bone-cracking-found-with-low-vitamin-d.html</guid><description>&lt;h3 id="vitamin-d-deficiency-induces-early-signs-of-aging-in-human-bone-increasing-the-risk-of-fracture">Vitamin D Deficiency Induces Early Signs of Aging in Human Bone, Increasing the Risk of Fracture&lt;/h3>
&lt;p>Sci Transl Med 10 July 2013: Vol. 5, Issue 193, p. 193ra88&lt;/p>
&lt;p>Björn Busse 1,2, &lt;a href="mailto:b.busse@uke.uni-hamburg.de">b.busse@uke.uni-hamburg.de&lt;/a>&lt;/p>
&lt;p>Hrishikesh A. Bale 2,&lt;/p>
&lt;p>Elizabeth A. Zimmermann 1,2,3,&lt;/p>
&lt;p>Brian Panganiban 2,&lt;/p>
&lt;p>Holly D. Barth 2,3,&lt;/p>
&lt;p>Alessandra Carriero 2,&lt;/p>
&lt;p>Eik Vettorazzi 4,&lt;/p>
&lt;p>Josef Zustin 5,&lt;/p>
&lt;p>Michael Hahn 1,&lt;/p>
&lt;p>Joel W. Ager III 2,&lt;/p>
&lt;p>Klaus Püschel 6,&lt;/p>
&lt;p>Michael Amling 1 and&lt;/p></description></item><item><title>Children with epilepsy advised to take vitamin D</title><link>/posts/children-with-epilepsy-advised-to-take-vitamin-d.html</link><pubDate>Thu, 11 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/children-with-epilepsy-advised-to-take-vitamin-d.html</guid><description>&lt;h4 id="children-with-epilepsy-advised-to-take-vitamin-dhttpwwwepilepsyorguknewsnewschildren-epilepsy-advised-take-vitamin-d-6323420-epilepsy-org-in-uk--july-2013">&lt;a href="http://www.epilepsy.org.uk/news/news/children-epilepsy-advised-take-vitamin-d-63234%20">Children with epilepsy advised to take vitamin D&lt;/a> Epilepsy Org in UK July 2013&lt;/h4>
&lt;p>Talks about the study listed below&lt;/p>
&lt;hr>
&lt;h3 id="vitamin-d-deficiency-in-children-with-epilepsy-do-we-need-to-detect-and-treat-it">Vitamin D deficiency in children with epilepsy: Do we need to detect and treat it?&lt;/h3>
&lt;p>The Journal of Paediatric Neurosciences 2013 | Volume : 8 | Issue : 1 | Page : 5-10&lt;/p>
&lt;p>Pooja Harijan, Arif Khan, Nahin Hussain&lt;/p>
&lt;p>Department of Paediatric Neurology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester LE1 5WW, United Kingdom&lt;/p></description></item><item><title>Full-on Multiple Sclerosis was 3.3X more likely in patients with the lowest vitamin D levels</title><link>/posts/full-on-multiple-sclerosis-was-33x-more-likely-in-patients-with-the-lowest-vitamin-d-levels.html</link><pubDate>Wed, 10 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/full-on-multiple-sclerosis-was-33x-more-likely-in-patients-with-the-lowest-vitamin-d-levels.html</guid><description>&lt;h3 id="vitamin-d-levels-and-risk-of-multiple-sclerosis-in-patients-with-clinically-isolated-syndromes">Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.&lt;/h3>
&lt;p>Mult Scler. 2013 Jul 8.&lt;/p>
&lt;p>Martinelli V, Dalla Costa G, Colombo B, Dalla Libera D, Rubinacci A, Filippi M, Furlan R, Comi G.&lt;/p>
&lt;p>Department of Neurology, San Raffaele Hospital, Milan, Italy.&lt;/p>
&lt;p>BACKGROUND: Growing evidence suggests that vitamin D deficiency may be one of the most important environmental factors for the development of multiple sclerosis (MS).&lt;/p>
&lt;p>OBJECTIVES: The objectives of this paper are to evaluate serum 25-hydroxyvitamin D (25(OH)D) levels in patients with clinically isolated syndromes (CIS) and to examine whether they are related to MS risk.&lt;/p></description></item><item><title>Sunny vacations are one of the ways to raise vitamin D levels</title><link>/posts/sunny-vacations-are-one-of-the-ways-to-raise-vitamin-d-levels.html</link><pubDate>Wed, 03 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/sunny-vacations-are-one-of-the-ways-to-raise-vitamin-d-levels.html</guid><description>&lt;h4 id="seasonal-variation-in-25ohd-at-aberdeen-57n-and-bone-health-indicators--could-holidays-in-the-sun-and-cod-liver-oil-supplements-alleviate-deficiency">Seasonal variation in 25(OH)D at Aberdeen (57°N) and bone health indicators -could holidays in the sun and cod liver oil supplements alleviate deficiency?&lt;/h4>
&lt;p>PLoS One. 2013;8(1):e53381. &lt;a href="https://doi.org/10.1371/journal.pone.0053381.">doi: 10.1371/journal.pone.0053381.&lt;/a> Epub 2013 Jan 8.&lt;/p>
&lt;p>Mavroeidi A, Aucott L, Black AJ, Fraser WD, Reid DM, Macdonald HM.&lt;/p>
&lt;p>Musculoskeletal Research Programme, University of Aberdeen, Aberdeen, United Kingdom.&lt;/p>
&lt;p>Vitamin D has been linked with many health outcomes. The aim of this longitudinal study, was to assess predictors of seasonal variation of 25-hydroxy-vitamin D ( 25(OH)D) (including use of supplements and holidays in sunny destinations) at a northerly latitude in the UK (57°N) in relation to bone health indicators. 365 healthy postmenopausal women (mean age 62.0 y (SD 1.4)) had 25(OH)D measurements by immunoassay, serum C-telopeptide (CTX), estimates of sunlight exposure (badges of polysulphone film), information regarding holidays in sunny destinations, and diet (from food diaries, including use of supplements such as cod liver oil (CLO)) at fixed 3-monthly intervals over 15 months (subject retention 88%) with an additional 25(OH)D assessment in spring 2008. Bone mineral density (BMD) at the lumbar spine (LS) and dual hip was measured in autumn 2006 and spring2007 (Lunar I-DXA). Deficiency prevalence (25(OH)D&amp;lt;25 nmol/L) was reduced in women who went on holiday to sunny destinations 3 months prior to their visit, compared to women who did not go on holidays &lt;span>[5.4% vs. 24.6% in Spring (p&amp;lt;0.001) and 3.8% vs. 25.6% in Winter (p = 0.001), respectively]&lt;/span>. Similarly deficiency was lower amongst those who took CLO supplements compared to women that did not consume these supplements &lt;span>[2.0% vs. 23.7% in Spring (p = 0.001) and 4.5% vs. 24.8% in winter (p = 0.005), respectively]&lt;/span>. There was no seasonal variation in CTX; 25(OH)D predicted a small proportion (1.8% variation) of LS BMD in spring 2007 &lt;span>[unstandardized β (SE): 0.039 (0.016), p = 0.017]&lt;/span>. Seasonal variation of 25(OH)D had little effect on BMD and no effect on CTX. It appears that small increments in vitamin D (e.g. those that can be achieved by cod liver oil supplements of 5 µg/day) are sufficient to ensure that 25(OH)D is above 25 nmol/L for most people throughout the year. Similarly, holidays in sunny destinations show benefit.&lt;/p></description></item><item><title>Saudi have very little vitamin D fortification of food</title><link>/posts/saudi-have-very-little-vitamin-d-fortification-of-food.html</link><pubDate>Tue, 02 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/saudi-have-very-little-vitamin-d-fortification-of-food.html</guid><description>&lt;p>
&lt;p>&lt;span class="citation-abbreviation">J Family Community Med. &lt;/span>&lt;span class="citation-publication-date">2013 Jan-Apr; &lt;/span>&lt;span class="citation-volume">20&lt;/span>&lt;span class="citation-issue">(1)&lt;/span>&lt;span class="citation-flpages">: 49–52. &lt;/span>&lt;/p>&lt;/p>
&lt;div>
&lt;p>&lt;span class="doi">doi:  &lt;a href="http://dx.doi.org/10.4103%2F2230-8229.108186">10.4103/2230-8229.108186&lt;/a>&lt;/span>&lt;/div>&lt;/p>
&lt;div class="inline_block three_col va_top show-overflow align_right">
&lt;div class="fm-citation-ids">
&lt;div class="fm-citation-pmcid">
&lt;p>&lt;span class="fm-citation-ids-label">PMCID: &lt;/span>&lt;span>PMC3663164&lt;/span>&lt;/div>&lt;/p>
&lt;/div>
&lt;/div>
&lt;h1 class="content-title">
&lt;p>Fortification with vitamin D: Comparative study in the Saudi Arabian and US markets&lt;/h1>&lt;/p>
&lt;div class="half_rhythm">
&lt;div class="contrib-group fm-author">
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Sadat-Ali%20M%5Bauth%5D">Mir Sadat-Ali&lt;/a>, &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Al%20Elq%20A%5Bauth%5D">Abdulmohsen Al Elq&lt;/a>,&lt;sup>1&lt;/sup>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Al-Farhan%20M%5Bauth%5D">Mohammed Al-Farhan&lt;/a>,&lt;sup>2&lt;/sup> and &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Sadat%20NA%5Bauth%5D">Nazia A. Sadat&lt;/a>&lt;sup>3&lt;/sup>&lt;/div>&lt;/p>
&lt;/div>
&lt;div class="fm-panel small half_rhythm">
&lt;div class="fm-authors-info fm-panel half_rhythm">
&lt;div class="fm-affl">
&lt;p>&lt;em>Departments of Orthopaedic Surgery, College of Medicine, University of Dammam, Dammam, Saudi Arabia&lt;/em>&lt;/div>&lt;/p>
&lt;div class="fm-affl">
&lt;p>&lt;sup>1&lt;/sup>&lt;em>Department of Internal Medicine, College of Medicine, University of Dammam, Dammam, Saudi Arabia&lt;/em>&lt;/div>&lt;/p>
&lt;div class="fm-affl">
&lt;p>&lt;sup>2&lt;/sup>&lt;em>Department of Orthopaedic Surgery, College of Medicine, King Faisal University, AlHassa, Saudi Arabia&lt;/em>&lt;/div>&lt;/p></description></item><item><title>Vitamin D Global Perspective - Holick</title><link>/posts/vitamin-d-global-perspective-holick.html</link><pubDate>Tue, 02 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-global-perspective-holick.html</guid><description>&lt;p>It is now generally accepted that vitamin D deficiency is a worldwide health problem that affects not only musculoskeletal health but also a wide range of acute and chronic diseases. However, there remains cynicism about the lack of randomized controlled trials to support the association studies regarding the nonskeletal health benefits of vitamin D. This review was obtained by searching English-language studies published up to April 1, 2013, in PubMed, MEDLINE, and the Cochrane Central Register of Controlled Trials (search terms: vitamin D and supplementation) and focuses on recent challenges regarding the definition of vitamin D deficiency and how to achieve optimal serum 25-hydroxyvitamin D concentrations from dietary sources, supplements, and sun exposure. The effect of vitamin D on fetal programming epigenetics and gene regulation could potentially explain why vitamin D has been reported to have such wide-ranging health benefits throughout life. There is potentially a great upside to increasing the vitamin D status of children and adults worldwide for improving musculoskeletal health and reducing the risk of chronic illnesses, including some cancers, autoimmune diseases, infectious diseases, type 2 diabetes mellitus, neurocognitive disorders, and mortality.&lt;/p></description></item><item><title>Child bone conference: many vitamin D and ricket abstracts</title><link>/posts/child-bone-conference-many-vitamin-d-and-ricket-abstracts.html</link><pubDate>Mon, 01 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/child-bone-conference-many-vitamin-d-and-ricket-abstracts.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#F00;">6th International Conference on Children&amp;rsquo;s bone Health&lt;/span>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>June 22-25, 2013, Rotterdam Netherlands&lt;/strong>&lt;/p>
&lt;hr>
&lt;p>&lt;strong>The following are a few of the many presentations and posters on vitamin D and/or rickets&lt;/strong>&lt;/p>
&lt;p>Several are incomplete due to problems of the text being in footnotes. See PDF for actual details&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#is11-other-therapeutic-options-nutrition-vitamin-d-and-physical-activity">IS11 Other Therapeutic Options: Nutrition, Vitamin D, and Physical Activity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#oc4-maternal-antenatal-25oh-vitamin-d-status-is-associated-with-offspring-muscle-strength-at-4-years-of-age">OC4 Maternal antenatal 25(OH)-vitamin D status is associated with offspring muscle strength at 4 years of age&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p111-vitamin-d-status-and-association-to-bone-health-in-781-healthy-8-11-year-old-danish-school-children--preliminary-results-from-the-opus-school-meal-study">P111 Vitamin D status and association to bone health in 781 healthy 8-11 year old Danish school children -preliminary results from the OPUS School Meal Study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p116-vitamin-d-dependent-rickets-type-1-vddr-1-two-years-after-discontinuation-of-treatment">P116 Vitamin D dependent rickets type 1 (VDDR-1): two years after discontinuation of treatment&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p118-variation-in-response-to-vitamin-d-therapy-in-a-series-of-consecutive-children-referred-to-a-paediatric-bone-disease-service">P118 Variation in response to vitamin D therapy in a series of consecutive children referred to a paediatric bone disease service&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p164-vitamin-d-deficiency-in-moscow-children-and-adolescents">P164 Vitamin D deficiency in Moscow children and adolescents&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p184-high-fgf23-measurements-in-a-child-with-vitamin-d-dependent-rickets-type-i-cause-or-consequence">P184 High FGF23 measurements in a child with Vitamin D dependent rickets type I. Cause or consequence?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p192-the-assessement-of-the-vitamin-d-supply-in-the-population-of-polish-children-at-the-age-of-9-12-years--multicentre-research--preliminary-report">P192 The assessement of the vitamin D supply in the population of Polish children at the age of 9-12 years -multicentre research- preliminary report&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p199-levels-of-25ohvitamin-d-in-children-and-adolescents-with-type-1-diabetes-mellitus-and-in-healthy-controls-in-bulgarian-population">P199 Levels of 25(OH)vitamin D in Children and Adolescents with Type 1 Diabetes Mellitus and in Healthy Controls in Bulgarian Population&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p200-low-25-hydroxyvitamin-d-levels-in-scheuermanns-disease-a-preliminary-study-of-nineteen-patients">P200 Low 25-hydroxyvitamin D levels in Scheuermann&amp;rsquo;s disease: a preliminary study of nineteen patients&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p189-clinical-features-of-temporary-brittle-bone-disease">P189 Clinical features of temporary brittle bone disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p17-the-optimal-dose-of-vitamin-d-in-growing-girls-during-academic-years-a-randomized-trial">P17 The optimal dose of vitamin D in growing girls during academic years: a randomized trial&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p20-assessment-of-vitamin-d-nutrition-status-and-dietary-calcium-intake-in-children-2-5-years-of-age">P20 Assessment of vitamin D nutrition status and dietary calcium intake in children 2-5 years of age&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p25-maternal-bone-density-and-rickets-in-nigerian-children">P25 Maternal bone density and rickets in Nigerian children&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p39-prevalence-of-vitamin-d-deficiency-in-adolescent-muslim-girls-attending-a-school-in-the-uk-which-adheres-to-a-conservative-dress-code">P39 Prevalence of Vitamin D deficiency in adolescent Muslim girls attending a school in the UK which adheres to a conservative dress code&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p44-a-homozygous-mutation-in-the-dna-binding-domain-of-human-vitamin-d-receptor-causes-vitamin-d-resistant-rickets">P44 A homozygous mutation in the DNA binding domain of human vitamin D receptor causes vitamin D resistant rickets&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p47-vitamin-d-deficiency-and-structural-and-functional-state-of-bone-tissue-in-schoolchildren-of-ukraine">P47 Vitamin D deficiency and structural and functional state of bone tissue in schoolchildren of Ukraine&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p60-failure-of-free-public-vitamin-d-supplementation-program-for-quebec-infants---temporal-trends-and-significant-predictors">P60 Failure of free, public vitamin D supplementation program for Quebec infants - temporal trends and significant predictors&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p64-the-level-of-vitamin-d-and-calcium-in-urban-pregnant-women-in-russian-federation">P64 The level of vitamin D and calcium in urban pregnant women in Russian Federation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p91-hypovitaminosis-d-in-chronically-ill-children-in-greece-and-its-management">P91 Hypovitaminosis D in chronically ill children in Greece and its Management&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p99-potential-association-between-vitamin-d-deficiency-and-hypertension-in-adolescents-a-pilot-study">P99 Potential association between vitamin D deficiency and hypertension in adolescents: A pilot study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p129-radiographic-evidence-of-rapid-healing-of-vitamin-d-deficient-rickets-after-2-weeks-of-therapy">P129 Radiographic Evidence of Rapid Healing of Vitamin D Deficient Rickets after 2 weeks of Therapy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p173-vitamin-d-prescription-a-review-of-british-national-formulary-for-children-recommendations-and-a-proposal">P173 Vitamin D Prescription: A review of British National Formulary for Children recommendations, and a proposal&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#p190-vitamin-d-deficiency-rickets-in-neonates">P190 Vitamin D deficiency rickets in neonates&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="is11-other-therapeutic-options-nutrition-vitamin-d-and-physical-activity">IS11 Other Therapeutic Options: Nutrition, Vitamin D, and Physical Activity&lt;/h3>
&lt;p>Catherine Gordon&lt;/p></description></item><item><title>Hypovitaminosis D in the Middle East and North Africa</title><link>/posts/hypovitaminosis-d-in-the-middle-east-and-north-africa.html</link><pubDate>Mon, 01 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/hypovitaminosis-d-in-the-middle-east-and-north-africa.html</guid><description>&lt;h3 class="showhide_heading" id="Hypovitaminosis_D_in_the_Middle_East_and_North_Africa:_Prevalence_risk_factors_and_impact_on_outcomes">
&lt;p>Hypovitaminosis D in the Middle East and North Africa: Prevalence, risk factors and impact on outcomes&lt;/h3>&lt;/p>
&lt;p>
&lt;p>Dermato Endocrinology&lt;br />&lt;/p>
&lt;p>Darina Bassil, Maya Rahme, Maha Hoteit, * Ghada El-Hajj Fuleihan&lt;br />&lt;/p>
&lt;p>Submitted January 15, 2013; Revised May 10, 2013; Accepted May 21, 2013; Published Online April 1, 2013&lt;/p>&lt;/p>
&lt;p>
&lt;p>Background: The Middle East and North Africa (MENA) region registers some of the highest rates of hypovitaminosis D worldwide.&lt;/p>&lt;/p>
&lt;p>
&lt;p>Aim: We systematically reviewed the prevalence of hypovitaminosis D, rickets and osteomalacia, their predictors and impact on major outcomes, in the region.&lt;/p></description></item><item><title>Rickets: Calcium, Genes, etc</title><link>/posts/rickets-calcium-genes-etc.html</link><pubDate>Mon, 01 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/rickets-calcium-genes-etc.html</guid><description>&lt;p>
&lt;p>&lt;strong>&lt;span class="citation-abbreviation">Indian J Endocrinol Metab. &lt;/span>&lt;span class="citation-publication-date">2013 Jan-Feb; &lt;/span>&lt;span class="citation-volume">17&lt;/span>&lt;span class="citation-issue">(1)&lt;/span>&lt;span class="citation-flpages">: 1–4. &lt;/span>&lt;/strong>&lt;/p>&lt;/p>
&lt;div class="fm-citation-pmcid">
&lt;p>&lt;span class="doi">doi:  &lt;a href="http://dx.doi.org/10.4103%2F2230-8210.107789">10.4103/2230-8210.107789&lt;/a>&lt;/span>&lt;span class="fm-citation-ids-label">PMCID: &lt;/span>&lt;span>PMC3659873&lt;/span>&lt;/div>&lt;/p>
&lt;h1 class="content-title">
&lt;p>Rickets: Twists and turns in the Gordian knot&lt;/h1>&lt;/p>
&lt;div class="half_rhythm">
&lt;div class="contrib-group fm-author">
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Garg%20MK%5Bauth%5D">M. K. Garg&lt;/a> and &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kalra%20S%5Bauth%5D">Sanjay Kalra&lt;/a>&lt;sup>1&lt;/sup>&lt;/div>&lt;/p>
&lt;/div>
&lt;div class="fm-panel small half_rhythm">
&lt;div class="fm-authors-info fm-panel half_rhythm">
&lt;div class="fm-affl">
&lt;p>&lt;em>Department of Endocrinology, Command Hospital, Southern Command, Pune, Maharashtra, India&lt;/em>&lt;/div>&lt;/p>
&lt;div class="fm-affl">
&lt;p>&lt;sup>1&lt;/sup>&lt;em>Department of Endocrinology, Bharti Hospital and B.R.I.D.E., Karnal, Haryana, India&lt;/em>&lt;/div>&lt;/p>
&lt;div id="cor1">
&lt;p>&lt;strong>Corresponding Author:&lt;/strong> Col. M. K. Garg, Department of Endocrinology, Command Hospital, Southern Command, Pune, Maharashtra, India. E-mail: &lt;span class="e_id352731">&lt;a href="mailto:mkgargs@gmail.com">&lt;a href="mailto:mkgargs@gmail.com">mkgargs@gmail.com&lt;/a>&lt;/a>&lt;/span>&lt;/div>&lt;/p>
&lt;/div>
&lt;div class="fm-cpl-info fm-panel half_rhythm">
&lt;div class="fm-copyright half_rhythm">
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html">Copyright&lt;/a> : © Indian Journal of Endocrinology and Metabolism&lt;/div>&lt;/p></description></item><item><title>Vitamin D deficiency in Middle East and North Africa</title><link>/posts/vitamin-d-deficiency-in-middle-east-and-north-africa.html</link><pubDate>Fri, 21 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-deficiency-in-middle-east-and-north-africa.html</guid><description>&lt;h4 id="hypovitaminosis-d-in-the-middle-east-and-north-africa-prevalence-risk-factors-and-impact-on-outcomes">Hypovitaminosis D in the Middle East and North Africa: Prevalence, risk factors and impact on outcomes&lt;/h4>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/hypovitaminosis-d-in-the-middle-east-and-north-africa.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;h4 id="xml-file">XML File&lt;/h4>
&lt;ul>
&lt;li>&lt;a href="http://www.landesbioscience.com/article/25111/full_text_xml/">&lt;img src="http://www.landesbioscience.com/new_landes_images/icon_xml.png" alt="image">&lt;/a> &lt;a href="http://www.landesbioscience.com/article/25111/full_text_xml/">Full Text XML&lt;/a>&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>387.24 KB XML Document&lt;/p>
&lt;/blockquote>
&lt;p>&lt;img src="http://www.landesbioscience.com/images/OA-icon.gif" alt="image"> This is an open access article.&lt;/p>
&lt;p>&lt;a href="%7Bimg%20src=%22http://www.landesbioscience.com/icons/crystal_project/24x24/apps/printer.png%22%7D%20Print%20this%20page%20">&lt;img src="http://www.landesbioscience.com/icons/crystal_project/24x24/apps/printer.png" alt="image"> Print this page &lt;/a>&lt;a href="%7Bimg%20src=%22http://www.landesbioscience.com/icons/crystal_project/24x24/actions/mail_forward.png%22%7D%20Email%20this%20page%20">&lt;img src="http://www.landesbioscience.com/icons/crystal_project/24x24/actions/mail_forward.png" alt="image"> Email this page &lt;/a>&lt;/p>
&lt;p>&amp;mdash;Article Citation&lt;/p>
&lt;p>&lt;a href="http://www.landesbioscience.com/api/articles/citation_ris/25111/">&lt;img src="http://www.landesbioscience.com/icons/table_go.png" alt="image"> RIS&lt;/a>&lt;/p>
&lt;p>&lt;a href="http://www.landesbioscience.com/marc/article/25111/">&lt;img src="http://www.landesbioscience.com/icons/table_go.png" alt="image"> MARC (XML)&lt;/a>&lt;/p>
&lt;p>{ANAME()}show_full_citation&lt;img src="http://www.landesbioscience.com/icons/table_go.png" alt="image"> FULL CITATION{ANAME}&lt;/p>
&lt;p>&amp;mdash;&lt;a href="http://www.facebook.com/sharer.php?u=http://www.landesbioscience.com/journals/dermatoendocrinology/article/25111/?show_full_text=true&amp;amp;">&lt;img src="http://www.landesbioscience.com/icons/facebook_24.png" alt="image"> Share on Facebook&lt;/a>&lt;/p>
&lt;p>&lt;a href="http://www.linkedin.com/shareArticle?mini=true&amp;amp;ur">&lt;img src="http://www.landesbioscience.com/icons/linkedin.png" alt="image">&lt;/a>&lt;/p>
&lt;p>&lt;a href="https://twitter.com/share?ur">&lt;img src="http://www.landesbioscience.com/icons/tweet_button.png" alt="image">&lt;/a>&lt;a href="http://www.landesbioscience.com/journals/dermatoendocrinology/toc/volume/5/issue/2/">Volume 5, Issue 2&lt;/a>   April/May/June 2013   &lt;strong>Dermato-Endocrinology&lt;/strong>&lt;/p>
&lt;p>&lt;a href="http://dx.doi.org/10.4161/derm.25111"> &lt;strong>http://dx.doi.org/10.4161/derm.25111&lt;/strong> &lt;/a>&lt;/p></description></item><item><title>Might Vitamin D be the fountain of youth</title><link>/posts/might-vitamin-d-be-the-fountain-of-youth.html</link><pubDate>Tue, 04 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/might-vitamin-d-be-the-fountain-of-youth.html</guid><description>&lt;h1 id="scientific-overview-of-hormone-treatment-used-for-rejuvenation">Scientific overview of hormone treatment used for rejuvenation&lt;/h1>
&lt;p>Fertility and Sterility. Volume 99, Issue 7 , Pages 1807-1813, June 2013&lt;/p>
&lt;p>John E. Morley, M.B., B.Ch. &lt;a href="mailto:morley@slu.edu">morley@slu.edu&lt;/a>&lt;/p>
&lt;p>Division of Geriatric Medicine, Saint Louis University School of Medicine, St. Louis, Missouri&lt;/p>
&lt;p>A search for a hormonal fountain of youth has been hotly pursued over the last century, predominately by those who wish to market hormones to a gullible public. &lt;strong>There is little or no benefit of hormone replacement in persons who do not have a hormone deficiency&lt;/strong> . Overall, the present state of the art suggests that the findings have been disappointing.&lt;/p></description></item><item><title>Hypothesis: Not vitamin D deficient if have normal PTH and BMD</title><link>/posts/hypothesis-not-vitamin-d-deficient-if-have-normal-pth-and-bmd.html</link><pubDate>Fri, 31 May 2013 00:00:00 +0000</pubDate><guid>/posts/hypothesis-not-vitamin-d-deficient-if-have-normal-pth-and-bmd.html</guid><description>&lt;h3 id="calcium-homeostasis-and-clinical-or-subclinical-vitamin-d-deficiency---can-a-hypothesis-of-intestinal-calcistat-explain-it-all">Calcium homeostasis, and clinical or subclinical vitamin D deficiency ‰%- Can a hypothesis of &amp;ldquo;intestinal calcistat&amp;rdquo; explain it all?&lt;/h3>
&lt;p>Med Hypotheses. 2013 May 13. pii: S0306-9877(13)00205-3. &lt;a href="https://doi.org/10.1016/j.mehy.2013.04.035.">doi: 10.1016/j.mehy.2013.04.035.&lt;/a>&lt;/p>
&lt;p>Garg MK, Mahalle N.&lt;/p>
&lt;p>Department of Endocrinology, Command Hospital (Southern Command), Pune 411040, Maharashtra, India. Electronic address: &lt;a href="mailto:mkgargs@gmail.com">mkgargs@gmail.com&lt;/a>.&lt;/p>
&lt;p>The main physiological function of vitamin D is maintenance of calcium homeostasis by its effect on calcium absorption, and bone health in association with parathyroid gland. Vitamin D deficiency (VDD) is defined as serum 25-hydroxy vitamin D (25OHD) levels &amp;lt;20ng/ml. Vitamin D insufficiency is called when serum 25OHD levels are between 20-29ng/ml, though existence of this entity has been questioned. Do all subjects with VDD have clinical disease according to this definition? Analysis of published studies suggests that calcium absorption in inversely correlated with serum 25OHD levels and calcium intake. We hypothesize that there exist an intestinal calcistat, which controls the calcium absorption independent of PTH levels. It consists of calcium sensing receptor (CaSR) on intestinal brush border, which senses calcium in intestinal cells and vitamin D system in intestinal cells. CaSR dampens the generation of active vitamin D metabolite in intestinal cells and decrease active transcellular calcium transport. It also facilitates passive paracellular diffusion of calcium in intestine. This local adaptation adjusts the fractional calcium absorption according the body requirement. Failure of local adaptation due to decreased calcium intake, decreased supply of 25OHD, mutation in CaSR or vitamin D system decreases systemic calcium levels and systemic adaptations comes into the play. Systemic adaptations consist of rise in PTH and increase in active vitamin D metabolites. These adaptations lead to bone resorption and maintenance of calcium homeostasis. Not all subjects with varying levels of VDD manifest with secondary hyperparathyroidism and decreased in bone mineral density. We suggest that rise in PTH is first indicator of VDD is rise in PTH along with decrease in BMD depending on duration of VDD. Hence, subjects with any degree of VDD with normal PTH and BMD should not be labeled as vitamin D deficient. These subjects can be called subclinical VDD, and further studies are required to assess beneficial effect of vitamin D supplementation in this subset of population. This hypothesis further highlights pitfalls in treatment of hypoparathyroidism.&lt;/p></description></item><item><title>Japanese women 20X more likely to be vitamin D deficient than men, etc. – Many 2013</title><link>/posts/japanese-women-20x-more-likely-to-be-vitamin-d-deficient-than-men-etc-many-2013.html</link><pubDate>Fri, 31 May 2013 00:00:00 +0000</pubDate><guid>/posts/japanese-women-20x-more-likely-to-be-vitamin-d-deficient-than-men-etc-many-2013.html</guid><description>&lt;h3 id="profiles-of-vitamin-d-insufficiency-and-deficiency-in-japanese-men-and-women-association-with-biological-environmental-and-nutritional-factors-and-coexisting-disorders-the-road-study">Profiles of vitamin D insufficiency and deficiency in Japanese men and women: association with biological, environmental, and nutritional factors and coexisting disorders: the ROAD study.&lt;/h3>
&lt;p>Osteoporos Int. 2013 May 15.&lt;/p>
&lt;p>Yoshimura N, Muraki S, Oka H, Morita M, Yamada H, Tanaka S, Kawaguchi H, Nakamura K, Akune T.&lt;/p>
&lt;p>Department of Joint Disease Research, 22nd Century Medical and Research Center, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan, &lt;a href="mailto:YOSHIMURAN-ORT@h.u-tokyo.ac.jp">YOSHIMURAN-ORT@h.u-tokyo.ac.jp&lt;/a>.&lt;/p></description></item><item><title>Hypothesis: Soy isoflavones synergistically aid vitamin D in building bones</title><link>/posts/hypothesis-soy-isoflavones-synergistically-aid-vitamin-d-in-building-bones.html</link><pubDate>Wed, 29 May 2013 00:00:00 +0000</pubDate><guid>/posts/hypothesis-soy-isoflavones-synergistically-aid-vitamin-d-in-building-bones.html</guid><description>&lt;h4 id="vitamin-d-interactions-with-soy-isoflavones-on-bone-after-menopause-a-review">Vitamin D interactions with soy isoflavones on bone after menopause: a review.&lt;/h4>
&lt;p>Park CY, Weaver CM.&lt;/p>
&lt;p>Department of Nutrition Science, Purdue University, 700 W State St, West Lafayette, IN 47907, USA. &lt;a href="mailto:cypark@purdue.edu">cypark@purdue.edu&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>There might also be BAD Soy= with Glysophate&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/gmo-soybeans-have-high-levels-of-glyphosate">GMO soybeans have high levels of glyphosate – June 2014&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/20-x-more-parkinsons-and-100x-more-autism-with-gmo-soy-in-china">20 X more Parkinson&amp;rsquo;s and 100X more Autism with GMO soy in China&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/huge-increases-in-health-problems-risk-factors-include-vitamin-d-antibiotics-and-roundup">Huge increases in health problems – risk factors include Vitamin D, Antibiotics, and Roundup&lt;/a>&lt;/p></description></item><item><title>Alzheimer’s and Parkinson’s diseases associated with low vitamin D – meta-analysis</title><link>/posts/alzheimers-and-parkinsons-diseases-associated-with-low-vitamin-d-meta-analysis.html</link><pubDate>Wed, 22 May 2013 00:00:00 +0000</pubDate><guid>/posts/alzheimers-and-parkinsons-diseases-associated-with-low-vitamin-d-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-levels-in-alzheimers-and-parkinsons-diseases-a-meta-analysis">Vitamin D levels in Alzheimer’s and Parkinson’s diseases: A meta-analysis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="vitamin-d-levels-in-alzheimers-and-parkinsons-diseases-a-meta-analysis">Vitamin D levels in Alzheimer’s and Parkinson’s diseases: A meta-analysis&lt;/h2>
&lt;p>Nutrition, Volume 29, Issue 6 , Pages 828-832, June 2013&lt;/p>
&lt;p>Yan Zhao, B.Sc., Yan Sun, B.Sc., Hong-Fang Ji, Ph.D. &lt;a href="mailto:jhf@sdut.edu.cn">jhf@sdut.edu.cn&lt;/a>, Liang Shen, Ph.D.email address&lt;/p>
&lt;p>Shandong Provincial Research Center for Bioinformatic Engineering and Technique, Shandong University of Technology, Zibo, P. R. China&lt;/p>
&lt;p>Received 6 July 2012; accepted 25 November 2012. published online 15 February 2013.&lt;/p></description></item><item><title>HIV interactions with low Vitamin D</title><link>/posts/hiv-interactions-with-low-vitamin-d.html</link><pubDate>Sat, 18 May 2013 00:00:00 +0000</pubDate><guid>/posts/hiv-interactions-with-low-vitamin-d.html</guid><description>&lt;h3 id="vitamin-d-deficiency-in-hiv-infection-an-underestimated-and-undertreated-epidemic">Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic&lt;/h3>
&lt;p>European Review for Medical and Pharmacological Sciences&lt;/p>
&lt;p>M.R. P\NZONE, M. D\ ROSA, M. MAIAGUARNERA, G. MADEDDU, E. FOCA, G. CECCARELL, G. D&amp;rsquo;ETTORRE, V. VULLO, R. F\S\CHELLA, B. CACOPARDO, G. NUNNAR\1,7&lt;/p>
&lt;p>Corresponding Author: Giuseppe Nunnari, MD; e-mail: &lt;a href="mailto:gnunnari@hotmail.com">gnunnari@hotmail.com&lt;/a>&lt;/p>
&lt;p>Hypovitaminosis D is a very common disorder, regarding both Western and developing countries. A growing amount of data over the last years have shown vitamin D deficiency to be high prevalent among HIV-positive subjects. In addition to &amp;ldquo;classic&amp;rdquo; risk factors, such as female sex, low dietary intake, dark skin pigmentation and low sun exposure, HlV-related factors, including immune activation and anti-retroviral adverse effects, may affect vitamin D status. Even if both protease inhibitors and non-nucleoside reverse transcriptase inhibitors have been associated with low vitamin D levels, available evidences have failed to univocally associate hypovitaminosis D with specific antiretroviral class effects.&lt;/p></description></item><item><title>Review of Vitamin D and Physical Performance</title><link>/posts/review-of-vitamin-d-and-physical-performance.html</link><pubDate>Fri, 17 May 2013 00:00:00 +0000</pubDate><guid>/posts/review-of-vitamin-d-and-physical-performance.html</guid><description>&lt;h2 id="vitamin-d-and-physical-performance">Vitamin D and Physical Performance&lt;/h2>
&lt;p>Sports Medicine, May 2013&lt;/p>
&lt;p>Daniel S. Moran &lt;a href="mailto:dmoran@sheba.health.gov.il">dmoran@sheba.health.gov.il&lt;/a> (1) (2) (3)&lt;/p>
&lt;p>James P. McClung (4)&lt;/p>
&lt;p>Tal Kohen (2)&lt;/p>
&lt;p>Harris R. Lieberman (4)&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Oak Ridge Institute for Science and Education Program, United States Army Research Institute of Environmental Medicine, Natick, MA, 01760, USA&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Heller Institute of Medical Research, Sheba Medical Center, Tel Hashomer, 52621, Israel&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Ariel University, Ariel, Israel&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Military Nutrition Division, United States Army Research Institute of Environmental Medicine, Natick, MA, 01760, USA&lt;/p></description></item><item><title>No longer debating vitamin D supplementation, now debating need for testing first</title><link>/posts/no-longer-debating-vitamin-d-supplementation-now-debating-need-for-testing-first.html</link><pubDate>Thu, 16 May 2013 00:00:00 +0000</pubDate><guid>/posts/no-longer-debating-vitamin-d-supplementation-now-debating-need-for-testing-first.html</guid><description>&lt;p>&lt;strong>Am Fam Physician. 2013 Apr 15;87(8)&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#F00;">Should Family Physicians Screen for Vitamin D Deficiency?&lt;/span>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#yes-targeted-screening-in-at-risk-populations-is-prudent">Yes: Targeted Screening in At-Risk Populations Is Prudent&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#no-screening-is-unnecessary-and-routine-supplementation-makes-more-sense">No: Screening Is Unnecessary, and Routine Supplementation Makes More Sense&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="yes-targeted-screening-in-at-risk-populations-is-prudent">Yes: Targeted Screening in At-Risk Populations Is Prudent&lt;/h2>
&lt;p>LEIGH M. ECK, MD, University of Kansas Medical Center, Kansas City, Kansas&lt;/p>
&lt;p>Vitamin D is critical for bone mineralization.1 Over the previous decade, vitamin D deficiency has received significant media attention for its association with many adverse health outcomes beyond bone health, including cancer, autoimmune diseases, infections, diabetes mellitus, and cardiovascular health.2 Because of this attention, there has been a notable increase in screening for vitamin D deficiency.3&lt;/p></description></item><item><title>Japanese recommendations without RDA: Vitamin D about 200 IU, Vitamin K about 60 ug</title><link>/posts/japanese-recommendations-without-rda-vitamin-d-about-200-iu-vitamin-k-about-60-ug.html</link><pubDate>Wed, 08 May 2013 00:00:00 +0000</pubDate><guid>/posts/japanese-recommendations-without-rda-vitamin-d-about-200-iu-vitamin-k-about-60-ug.html</guid><description>&lt;h2 id="dietary-reference-intakes-for-japanese-2010-fat-soluble-vitamins">Dietary Reference Intakes for Japanese 2010: Fat-Soluble Vitamins&lt;/h2>
&lt;p>/Nutr Sci Vitaminol, 59, S57-S66, 2013&lt;/p>
&lt;p>Kiyoshi Tanaka1, Junji TfeRAO2, Yoshihiro Shidoji3, Hiroshi Tamai4, Eri Imai5 and Toshio Okano6&lt;/p>
&lt;p>1 Department of Food and Nutrition, Kyoto Women&amp;rsquo;s University, Kyoto 605-8501, Japan &lt;a href="mailto:tanakak@kyoto-wu.ac.jp">tanakak@kyoto-wu.ac.jp&lt;/a>&lt;/p>
&lt;p>2 Department of Food Science, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8503, Japan&lt;/p>
&lt;p>3 Department of Nutrition and Health Science, Graduate School of Human Health Science, University of Nagasaki, Nagasaki 851-2195, Japan 4Department of Pediatrics, Osaka Medical College, Osaka 569-8686, Japan 5 Section of the Dietary Reference Intakes, Department of Nutritional Epidemiology, National Institute of Health and Nutrition, Tokyo 162-8636, Japan 6Department of Hygienic Sciences, Kobe Pharmaceutical University, Kobe, 658-8558, Japan&lt;/p></description></item><item><title>Many preemies need at least 800 IU of vitamin D – RCT</title><link>/posts/many-preemies-need-at-least-800-iu-of-vitamin-d-rct.html</link><pubDate>Sun, 05 May 2013 00:00:00 +0000</pubDate><guid>/posts/many-preemies-need-at-least-800-iu-of-vitamin-d-rct.html</guid><description>&lt;h2 class="showhide_heading" id="Preterm_infants_may_need_800_IU_of_vitamin_D3_per_day">
&lt;p>Preterm infants may need 800 IU of vitamin D3 per day&lt;/h2>&lt;/p>
&lt;p>
&lt;br />
&lt;p>The American Academy of Pediatrics PAS MEETING UPDATE:&lt;/p>&lt;/p>
&lt;p>
&lt;p>Carla Kemp, Senior Editor&lt;/p>&lt;/p>
&lt;p>
&lt;p>Preterm infants may need to be given 800 international units (IU) of vitamin D a day to ensure they develop strong bones, according to a study to be presented Sunday, May 5, at the Pediatric Academic Societies (PAS) annual meeting in Washington, D.C.&lt;/p>&lt;/p>
&lt;p>
&lt;p>Preemies are known to be at risk for vitamin D insufficiency. If levels of vitamin D are too low, infants and children can get rickets, which leads to softening and weakening of the bones.&lt;/p></description></item><item><title>COPD and Osteoporosis are related – vitamin D is one possible connection – 2013</title><link>/posts/copd-and-osteoporosis-are-related-vitamin-d-is-one-possible-connection-2013.html</link><pubDate>Wed, 01 May 2013 00:00:00 +0000</pubDate><guid>/posts/copd-and-osteoporosis-are-related-vitamin-d-is-one-possible-connection-2013.html</guid><description>&lt;h3 id="european-respiratory-monograph-59-copd-and-comorbidityhttpbooksgooglecombookshlenlrlang_enidt_tnga_8pnqcoifndpgpa26dq22vitamind22otszgr8mu7zgjsigkkcq8an4c0_bizpa5uhscgnbj30vonepageq22vitamin20d22ffalse">&lt;a href="http://books.google.com/books?hl=en&amp;amp;lr=lang_en&amp;amp;id=T_tNgA_8pnQC&amp;amp;oi=fnd&amp;amp;pg=PA26&amp;amp;dq=%22vitamin+d%22&amp;amp;ots=zgr8mu7ZGj&amp;amp;sig=KKCq8aN4C0_BizPA5UHscgNBj30#v=onepage&amp;amp;q=%22vitamin%20d%22&amp;amp;f=false">European Respiratory Monograph 59: COPD and Comorbidity&lt;/a>&lt;/h3>
&lt;p>By Klaus F. Rabe, Jadwiga A. Wedzicha and Emiel F.M. Wouters&lt;/p>
&lt;p>can per read via Google – 87 references&lt;/p>
&lt;h3 id="chapter-7-osteoporosis-in-copd---4-pages">Chapter 7. Osteoporosis in COPD – 4 pages?&lt;/h3>
&lt;p>Elisabeth A.P.M. Romme*,&lt;/p>
&lt;p>Frank W.J.M. Smeenk*,&lt;/p>
&lt;p>Emiel F.M. Wouters# and&lt;/p>
&lt;p>Erica P.A. Rutten&lt;/p>
&lt;ul>
&lt;li>Dept of Respiratory Medicine, Catharina Hospital, Eindhoven, #Dept of Respiratory Medicine, Maastricht University Medical Centre, Maastricht University, Maastricht, and&lt;/li>
&lt;/ul>
&lt;p>Program Development Centre, Centre of Expertise for Chronic Organ failure (CIRO+), Horn, The Netherlands.&lt;/p></description></item><item><title>Summary of Vitamin D portion of Bone and Mineral Research Meeting</title><link>/posts/summary-of-vitamin-d-portion-of-bone-and-mineral-research-meeting.html</link><pubDate>Thu, 25 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/summary-of-vitamin-d-portion-of-bone-and-mineral-research-meeting.html</guid><description>&lt;h2 id="meeting-report-from-the-34th-annual-meeting-of-the-american-society-for-bone-and-mineral-research">Meeting report from the 34th Annual Meeting of the American Society for Bone and Mineral Research,&lt;/h2>
&lt;p>Minneapolis, MN, USA, 12–15 October 2012&lt;/p>
&lt;p>&lt;strong>Report on recent vitamin D research (ASBMR 2012)&lt;/strong>&lt;/p>
&lt;p>IBMS BoneKEy, (2013), 10, Article number: 329; doi:10.1038/bonekey.2013.63; Published online, 10 April 2013&lt;/p>
&lt;p>Roger Bouillon&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#meeting-report-from-the-34th-annual-meeting-of-the-american-society-for-bone-and-mineral-research">Meeting report from the 34th Annual Meeting of the American Society for Bone and Mineral Research,&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#125-dihydroxyvitamin-d-and-bone">1,25-Dihydroxyvitamin D and bone&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2425-dihydroxyvitamin-d">24,25-Dihydroxyvitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-intestine">Vitamin D and the intestine&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#extra-renal-cyp27b1-expression-and-production-of-125-dihydroxyvitamin-d">Extra renal cyp27b1 expression and production of 1,25-dihydroxyvitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#fgf23-and-production-of-125-dihydroxyvitamin-d">FGF23 and production of 1,25-dihydroxyvitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#skin-synthesis-of-vitamin-d">Skin synthesis of vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-worldwide">Vitamin D status worldwide&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-and-vitamin-d-status">Vitamin D supplementation and vitamin D status&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#intermittent-high-dose-vitamin-d-supplementation-and-vitamin-d-status">Intermittent high-dose vitamin D supplementation and vitamin D status&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pregnancy-and-second-generation-effects">Pregnancy and second-generation effects&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-muscle-and-falls">Vitamin D supplementation: muscle and falls&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-metabolic-syndrome">Vitamin D and the metabolic syndrome&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#assay-methodology-for-vitamin-d-metabolites">Assay methodology for vitamin D metabolites&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#references-numbers-are-approximate">References (numbers are approximate)&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#ion-line-index-to-abstracts">IOn-line index to abstracts&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="125-dihydroxyvitamin-d-and-bone">1,25-Dihydroxyvitamin D and bone&lt;/h3>
&lt;p>Vitamin D is well known for its effects on promoting bone mineralization as the primary characteristic of rickets, and osteomalacia refers to decreased mineralization of the bone matrix. However, the direct effects of the vitamin D endocrine system on bone cells need further clarification. Earlier studies revealed that overexpression of VDR in osteoblasts (driven by osteocalcin promoter) increased bone mass and strength.1 Deletion of VDR in osteocytes (using a dmp1 cre system) did not influence bone mass or other parameters of bone metabolism.2 Deletion of VDR in osteoblasts using an osteocalcin cre system, however, increased (&amp;gt;20%) bone mass (total and trabecular femoral bone, mainly by increase in the number of trabeculae) as reported by Anderson et al.3 and by S Kato (presented at the 2012 Endocrine Society Meeting as summarized in Bouillon4). However, the mechanisms involved are not clear, as preliminary data suggested increase bone formation (as reported by Anderson et al.3) and decreased bone resorption in the Japanese osteoblast-selective VDR mice. These observations imply that VDR activation can have beneficial effects (prevent rickets and osteomalacia) but can also impair bone formation or mineralization in case of exposure to very high serum concentrations of 1,25(OH)2D.2, 5 Such negative effects of vitamin D on mineral deposition were also observed by studying the gene expression profile after exposure to 1,25(OH)2D (Pike’s group, as reported in the previous BoneKey Report4) and now in a series of in vitro experiments using osteoblasts from different regions (calvaria and femur). Exposure to 1,25(OH)2D could inhibit mineral deposition in early-stage calvaria-derived osteoblasts, whereas it enhanced mineral deposition in more mature cortical-bone-derived osteoblasts, at least in the presence of high extracellular calcium concentration.6 The direct effects of the vitamin D endocrine system on bone cells were also explored by analyzing mice with transgenic overexpression of cyp27b1 in osteoblasts using an osteocalcin promoter region. At 20 weeks of age, such mice displayed a 10% increase in bone volume as well in the lumbar vertebrae as in the femoral metaphysis.7 This beneficial effect was due to increased bone formation with unaltered bone resorption, indicating a direct bone anabolic effect of locally produced 1,25(OH)2D in osteoblasts. All these new observations indicate that the vitamin D endocrine system has a yin/yang effect on bone: in most circumstances it enhances mineral deposition but in the presence of low calcium supply the vitamin D endocrine system tries to maintain serum calcium homeostasis at the expense of bone (increased resorption and decreased mineralization).&lt;/p></description></item><item><title>Crohn’s helped by 5000 IU vitamin D</title><link>/posts/crohns-helped-by-5000-iu-vitamin-d.html</link><pubDate>Mon, 22 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/crohns-helped-by-5000-iu-vitamin-d.html</guid><description>&lt;h3 id="therapeutic-effect-of-vitamin-d-supplementation-in-a-pilot-study-of-crohns-patients">Therapeutic Effect of Vitamin D Supplementation in a Pilot Study of Crohn’s Patients&lt;/h3>
&lt;p>Clinical and Translational Gastroenterology (2013) 4, e33; doi:10.1038/ctg.2013.1, Published online 18 April 2013&lt;/p>
&lt;p>Linlin Yang PhD1, Veronika Weaver1, Jill P Smith MD2, Sandra Bingaman RN2, Terryl J Hartman MPH/PhD3 and Margherita T Cantorna PhD1&lt;/p>
&lt;p>1 Department of Veterinary and Biomedical Science, Center for Molecular Immunology and Infectious Disease, University Park, Pennsylvania, USA&lt;/p>
&lt;p>2 Department of Medicine, Hershey, Pennsylvania, USA&lt;/p></description></item><item><title>Vitamin K-2 (180 ug MK-7) helped both bone density and strength – RCT</title><link>/posts/vitamin-k-2-180-ug-mk-7-helped-both-bone-density-and-strength-rct.html</link><pubDate>Thu, 18 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-k-2-180-ug-mk-7-helped-both-bone-density-and-strength-rct.html</guid><description>&lt;h4 id="three-year-low-dose-menaquinone-7-supplementation-helps-decrease-bone-loss-in-healthy-postmenopausal-women">Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women&lt;/h4>
&lt;p>Osteoporosis International March 2013&lt;/p>
&lt;p>M. H. J. Knapen, N. E. Drummen, E. Smit, C. Vermeer, E. Theuwissen&lt;/p>
&lt;p>We have investigated whether low-dose vitamin K2 supplements (menaquinone-7, MK-7) could beneficially affect bone health. Next to an improved vitamin K status, MK-7 supplementation significantly decreased the age-related decline in bone mineral density and bone strength. Low-dose MK-7 supplements may therefore help postmenopausal women prevent bone loss.&lt;/p></description></item><item><title>Common Vitamin D gene variants and resulting diseases</title><link>/posts/common-vitamin-d-gene-variants-and-resulting-diseases.html</link><pubDate>Sat, 13 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/common-vitamin-d-gene-variants-and-resulting-diseases.html</guid><description>&lt;p>&lt;strong>Abstract&lt;/strong>&lt;/p>
&lt;p>The vitamin D binding protein (DBP) is the major plasma carrier for vitamin D and its metabolites, but it is also an actin scavenger, and is the precursor to the immunomodulatory protein, Gc-MAF. Two missense variants of the DBP gene - rs7041 encoding Asp432Glu and rs4588 encoding Thr436Lys - change the amino acid sequence and alter the protein function.&lt;/p>
&lt;p>They are common enough to generate population-wide constitutive differences in vitamin D status, based on assay of the serum metabolite, 25-hydroxyvitamin D (25OHD).&lt;/p></description></item><item><title>Hip bone loss stopped with 1000 IU of vitamin D, while 400 IU similar to placebo – RCT</title><link>/posts/hip-bone-loss-stopped-with-1000-iu-of-vitamin-d-while-400-iu-similar-to-placebo-rct.html</link><pubDate>Sat, 13 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/hip-bone-loss-stopped-with-1000-iu-of-vitamin-d-while-400-iu-similar-to-placebo-rct.html</guid><description>&lt;h3 id="hip-bone-loss-is-attenuated-with-1000-iu-but-not-400-iu-daily-vitamin-d3-a-1-year-double-blind-rct-in-postmenopausal-women">Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1 year double-blind RCT in postmenopausal women&lt;/h3>
&lt;p>Journal of Bone and Mineral Research, Vol. 28 Issue 4, DOI: 10.1002/jbmr.1959&lt;/p>
&lt;p>Helen M Macdonald1,‖, &lt;a href="mailto:h.macdonald@abdn.ac.uk">h.macdonald@abdn.ac.uk&lt;/a>&lt;/p>
&lt;p>Adrian D Wood1,‖,&lt;/p>
&lt;p>Lorna S Aucott1,&lt;/p>
&lt;p>Alison J Black3,&lt;/p>
&lt;p>William D Fraser4,&lt;/p>
&lt;p>Alexandra Mavroeidi2,&lt;/p>
&lt;p>David M Reid1,&lt;/p>
&lt;p>Karen R Secombes1,&lt;/p>
&lt;p>William G Simpson5,&lt;/p>
&lt;p>Frank Thies1&lt;/p>
&lt;p>1 School of Medicine and Dentistry, University of Aberdeen, Foresterhill, Aberdeen&lt;/p></description></item><item><title>Factors (including skin temperature) Influencing Vitamin D Status – 2011</title><link>/posts/factors-including-skin-temperature-influencing-vitamin-d-status-2011.html</link><pubDate>Thu, 04 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/factors-including-skin-temperature-influencing-vitamin-d-status-2011.html</guid><description>&lt;h1 id="factors-influencing-vitamin-d-status">Factors Influencing Vitamin D Status&lt;/h1>
&lt;p>Acta Derm Venereol 2011; 91: 115–124. (Accepted June 27, 2010)&lt;/p>
&lt;p>William G. Tsiaras and Martin A. Weinstock&lt;/p>
&lt;p>Dermatoepidemiology Unit, VA Medical Center, the Department of Dermatology, Rhode Island Hospital, and the Departments of Dermatology and Community Health, Brown University, Providence, Rhode Island&lt;/p>
&lt;p>Martin A. Weinstock, MD, PhD, Dermatoepidemiology Unit, VA Medical Center-111D, 830 Chalkstone Ave, Providence, RI 02908, USA. E-mail: &lt;a href="mailto:maw@brown.edu">maw@brown.edu&lt;/a>&lt;/p>
&lt;p>{&lt;a href="http://www.medicaljournals.se/acta/content/?doi=10.2340/00015555-0980&amp;amp;html=1">&lt;span style="color:#00F;">CLICK HERE for on-line version&lt;/span>&lt;/a>}&lt;/p></description></item><item><title>Lumbar spinal stenosis pain strongly associated with low vitamin D</title><link>/posts/lumbar-spinal-stenosis-pain-strongly-associated-with-low-vitamin-d.html</link><pubDate>Thu, 21 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/lumbar-spinal-stenosis-pain-strongly-associated-with-low-vitamin-d.html</guid><description>&lt;h4 id="prevalence-of-vitamin-d-deficiency-in-patients-with-lumbar-spinal-stenosis-and-its-relationship-with-pain">Prevalence of vitamin d deficiency in patients with lumbar spinal stenosis and its relationship with pain.&lt;/h4>
&lt;p>Pain Physician. 2013 Mar;16(2):165-76.&lt;/p>
&lt;p>Kim TH, Lee BH, Lee HM, Lee SH, Park JO, Kim HS, Kim SW, Moon SH.&lt;/p>
&lt;p>Spine Center, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea; Department of Orthopedic Surgery, Yonsei University College of Medicine, Seoul, Korea.&lt;/p>
&lt;p>BACKGROUND: Patients with lumbar spinal stenosis (LSS) are at a great risk of a fall and fracture, which vitamin D protects against. Vitamin D deficiency is expected to be highly prevalent in LSS patient, and pain is thought to have a profound effect on vitamin D status by limiting activity and sunlight exposure.&lt;/p></description></item><item><title>A vitamin D analog is developed (Eldecalcitol) but is not compared to vitamin D</title><link>/posts/a-vitamin-d-analog-is-developed-eldecalcitol-but-is-not-compared-to-vitamin-d.html</link><pubDate>Wed, 13 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/a-vitamin-d-analog-is-developed-eldecalcitol-but-is-not-compared-to-vitamin-d.html</guid><description>&lt;h1 id="eldecalcitol--newly-developed-active-vitamin-d3-analog-for-the-treatment-of-osteoporosis">Eldecalcitol : newly developed active vitamin D3 analog for the treatment of osteoporosis.&lt;/h1>
&lt;p>Expert Opin Pharmacother. 2013 Mar 11;&lt;/p>
&lt;p>Hagino H&lt;/p>
&lt;p>Introduction: Eldecalcitol is an active vitamin D3 analog, characterized by high stability in the circulation and also in the peripheral tissues, and by strong activity in increasing bone mass in osteoporotic patients. The objective of the present review was to evaluate the effect of eldecalcitol on bone compared with active vitamin D or placebo in preclinical and clinical studies. Areas covered: Eldecalcitol increased bone mineral density and reduced bone turnover markers greater than alfacalcidol and placebo. Interestingly, in a 3-year clinical trial, bone resorption marker remained suppressed during the eldecalcitol treatment, whereas bone formation markers gradually recovered after initial suppression.&lt;/p></description></item><item><title>Collegiate Swimmers getting 4000 IU of vitamin D had fewer injuries</title><link>/posts/collegiate-swimmers-getting-4000-iu-of-vitamin-d-had-fewer-injuries.html</link><pubDate>Tue, 12 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/collegiate-swimmers-getting-4000-iu-of-vitamin-d-had-fewer-injuries.html</guid><description>&lt;h3 id="the-effects-of-season-long-vitamin-d-supplementation-on-collegiate-swimmers-and-divers">The Effects of Season-Long Vitamin D Supplementation on Collegiate Swimmers and Divers.&lt;/h3>
&lt;p>Int J Sport Nutr Exerc Metab. 2013 Mar 8.&lt;/p>
&lt;p>Lewis RM, Redzic M, Thomas DT.&lt;/p>
&lt;p>Division of Clinical Nutrition, University of Kentucky, Lexington, KY.&lt;/p>
&lt;p>The purpose of this 6-month randomized placebo controlled trial was to determine the effect of season-long (September-March) vitamin D supplementation on changes in vitamin D status (measured as 25(OH)D), body composition, inflammation, frequency of illness and injury. Forty-five male and female athletes were randomized to 4000IU vitamin D (n=23) or placebo (n=22). 25(OH)D, bone turnover markers (NTx and BSAP), and inflammatory cytokines (TNF-alpha, IL-6, and IL1-β) were measured at baseline, midpoint, and endpoint. Body composition was assessed by DXA and injury and illness data were collected.&lt;/p></description></item><item><title>A look at inner workings of committee looking at vitamin D for UK</title><link>/posts/a-look-at-inner-workings-of-committee-looking-at-vitamin-d-for-uk.html</link><pubDate>Sun, 24 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/a-look-at-inner-workings-of-committee-looking-at-vitamin-d-for-uk.html</guid><description>&lt;h2 id="context-by-vitamindwiki">Context by VitaminDWiki&lt;/h2>
&lt;p>A &lt;a href="http://www.sacn.gov.uk/">committee&lt;/a> meets several times a year in the period 2011-2014 to establish new recommendations for vitamin D for the UK&lt;/p>
&lt;p>Their past and future meetings: 04/12/2013, 24/04/2013, 19/02/2013, 07/12/2012, 18/09/2012, 28/06/2012, 28/03/2012, 07/12/2011, 08/09/2011, 26/05/2011&lt;/p>
&lt;p>The draft of their meeting minutes for Dec 2012 is below&lt;/p>
&lt;h3 id="observation-by-vitamindwiki-it-is-amazing">Observation by VitaminDWiki: It is amazing:&lt;/h3>
&lt;ol>
&lt;li>
&lt;p>how long it takes,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>how little of the literature they consider,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>how they seem to allow no rebuttal&lt;/p></description></item><item><title>8X higher Osteoporosis risk if high level of vitamin A, vitamin D important too</title><link>/posts/8x-higher-osteoporosis-risk-if-high-level-of-vitamin-a-vitamin-d-important-too.html</link><pubDate>Tue, 19 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/8x-higher-osteoporosis-risk-if-high-level-of-vitamin-a-vitamin-d-important-too.html</guid><description>&lt;h2 id="vitamin-d-insufficiency-together-with-high-serum-levels-of-vitamin-a-increases-the-risk-for-osteoporosis-in-postmenopausal-women">Vitamin D insufficiency together with high serum levels of vitamin A increases the risk for osteoporosis in postmenopausal women.&lt;/h2>
&lt;p>Arch Osteoporos. 2013 Dec;8(1-2):124. Epub 2013 Feb 16.&lt;/p>
&lt;p>Mata-Granados JM, Cuenca-Acevedo JR, Luque de Castro MD, Holick MF, Quesada-Gómez JM.&lt;/p>
&lt;p>Department of I+D+I, Sanyres Group, Córdoba, Spain.&lt;/p>
&lt;p>Postmenopausal women who were vitamin D deficient and had high serum levels of retinol had an eight times higher risk of having osteoporosis.&lt;/p>
&lt;p>A high retinol level together with vitamin D deficiency/insufficiency is an additional risk factor for osteoporosis.&lt;/p></description></item><item><title>Fracture reduction vs vitamin D - trial history</title><link>/posts/fracture-reduction-vs-vitamin-d-trial-history.html</link><pubDate>Sat, 16 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/fracture-reduction-vs-vitamin-d-trial-history.html</guid><description>&lt;h2 id="why-the-optimal-requirement-for-vitamin-d3-is-probably-much-higher-than-what-is-officially-recommended-for-adults">Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults&lt;/h2>
&lt;p>The Journal of Steroid Biochemistry and Molecular Biology, Volumes 89–90, May 2004, Pages 575–579&lt;/p>
&lt;p>Proceedings of the 12th Workshop on Vitamin D&lt;/p>
&lt;p>Reinhold ViethCorresponding author contact information, E-mail the corresponding author&lt;/p>
&lt;p>Department of Laboratory Medicine and Pathobiology, University of Toronto, and Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada M5G 1X5&lt;/p>
&lt;p>The physiologic range for circulating 25-hydroxyvitamin D3 &lt;span>[25(OH)D; the measure of Vitamin D nutrient status]&lt;/span> concentration in humans and other primates extends to beyond 200 nmol/L (&amp;gt;80 ng/mL). This biologic “normal” value is greater than current population norms for 25(OH)D. Concentrations of 25(OH)D that correlate with desirable effects extend to at least 70 nmol/L, with no obvious threshold. Randomized clinical trials using 20 mcg (800 IU) per day of Vitamin D show that this suppresses parathyroid hormone, preserves bone mineral density, prevents fractures, lowers blood pressure and improves balance. Calcium absorption from diet correlates with 25(OH)D in the normal range. Health effects of Vitamin D beyond osteoporosis are mostly supported by the circumstantial evidence of epidemiologic studies and laboratory research. These include prevention of cancer and the autoimmune diseases, insulin-dependent diabetes and multiple sclerosis. One mcg per day of Vitamin D3 (cholecalciferol) increases circulating 25(OH)D by about 1 nmol/L (0.4 ng/mL). A recommended dietary allowance (RDA) is the long-term daily intake level that meets the total requirements for the nutrient by nearly all healthy individuals (it would presume no sunshine). If 70 nmol/L is regarded as a minimum desirable target 25(OH)D concentration, then current recommendations of 15 mcg per day do not meet the criterion of an RDA.&lt;/p></description></item><item><title>Expert Review by Dermatologists: get more vitamin D but avoid the sun</title><link>/posts/expert-review-by-dermatologists-get-more-vitamin-d-but-avoid-the-sun.html</link><pubDate>Thu, 14 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/expert-review-by-dermatologists-get-more-vitamin-d-but-avoid-the-sun.html</guid><description>&lt;h1 id="vitamin-d-and-sun-exposure-to-bare-all-or-cover-up">Vitamin D and sun exposure: to bare all or cover up?&lt;/h1>
&lt;p>Editorial, Expert Review of Dermatology, December 2012, Vol. 7, No. 6, Pages 495-497 , DOI 10.1586/edm.12.60&lt;/p>
&lt;p>Aaron Hughes*, Jeremy Hoffman and Adiele Hoffman&lt;/p>
&lt;ul>
&lt;li>Author for correspondence&lt;/li>
&lt;/ul>
&lt;hr>
&lt;p>&lt;strong>PDF is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;h1 id="they-do-not-want-to-say-that-they-have-been-wrong-for-50-years">They do not want to say that they have been wrong for 50 years&lt;/h1>
&lt;p>&lt;strong>Quote from the PDF&lt;/strong>&lt;/p>
&lt;p>Advice that encourages the public to increase sun exposure has the potential to undermine the work done by health agencies over the past 50 years.&lt;/p></description></item><item><title>Ankylosing spondylitis and low vitamin D – many studies</title><link>/posts/ankylosing-spondylitis-and-low-vitamin-d-many-studies.html</link><pubDate>Sat, 09 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/ankylosing-spondylitis-and-low-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#ankylosing-spondylitis--patients-should-increase-vitamin-d-levels---meta-analysis-nov-2022">Ankylosing Spondylitis patients should increase Vitamin D levels - meta-analysis Nov 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ankylosing-spondylitis-is-still-associated-with-low-vitamin-d---meta-analysis-sept-2022">Ankylosing Spondylitis is still associated with low Vitamin D - meta-analysis Sept 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#considering-testing-all-as-patients-for-low-vitamin-d----jan-2017">Considering testing all AS patients for low Vitamin D - Jan 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#patients-with-ankylosing-spondylitis-continue-to-have-low-vitamin-d---march-2021">Patients with Ankylosing Spondylitis continue to have low Vitamin D - March 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#males-with-ankylosing-spondylitis-having-10ng-of-vitamin-d-had-a-22-x-higher-risk-of-dying---may-2020">Males with Ankylosing Spondylitis having &amp;lt;10ng of vitamin D had a 2.2 X higher risk of dying - May 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#as-related-to-low-vitamin-d---sept-2018">AS related to low Vitamin D - Sept 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#higher-vitamin-d-associated-with-less-risk-of-as---span-stylecolorf00review--meta-analysisspan-sept-2014">Higher Vitamin D associated with less risk of AS - &lt;span style="color:#F00;">review &amp;amp; meta-analysis&lt;/span> Sept 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#sponsdyloarthritis-is-21-x-more-likely-if-vitamin-d-deficiency---nov-2017">Sponsdyloarthritis is 2.1 X more likely if Vitamin D Deficiency - Nov 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#decreased-plasma-vitamin-d-levels-in-patients-with-undifferentiated-spondyloarthritis-and-ankylosing-spondylitis---2013">Decreased plasma vitamin d levels in patients with undifferentiated spondyloarthritis and ankylosing spondylitis - 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#systematic-review-of-association-between-vitamin-d-levels-and-susceptibility-and-disease-activity-of-ankylosing-spondylitis---2014">Systematic review of association between vitamin D levels and susceptibility and disease activity of ankylosing spondylitis - 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#4-out-of-7-studies-found-as-associated-with-low-vitamin-d---july-2014">4 out of 7 studies found AS associated with low vitamin D - July 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="ankylosing-spondylitis--patients-should-increase-vitamin-d-levels---meta-analysis-nov-2022">Ankylosing Spondylitis patients should increase Vitamin D levels - meta-analysis Nov 2022&lt;/h4>
&lt;p>&lt;strong>Ankylosing spondylitis disease activity and serum vitamin D levels: A systematic review and meta-analysis&lt;/strong>&lt;/p></description></item><item><title>Vitamin D: Is It the Best Thing Under the Sun - Medscape</title><link>/posts/vitamin-d-is-it-the-best-thing-under-the-sun-medscape.html</link><pubDate>Fri, 08 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-it-the-best-thing-under-the-sun-medscape.html</guid><description>&lt;p>Robert Finn; Deborah Flapan; Darbe Rotach&lt;/p>
&lt;h3 id="the-following-is-the-first-of-25-images">The following is the first of 25 images&lt;/h3>
&lt;img src="/attachments/d3.mock.jpg" alt="image"> 
&lt;p>The number of research studies on vitamin D has soared in recent years.&lt;/p>
&lt;p>Citations of studies involving vitamin D increased from 1142 in the year 2000 to 3877 in 2012.&lt;/p>
&lt;p>In comparison, citations for research on vitamin A and vitamin C have remained more or less level.&lt;/p>
&lt;p>You have to register with &lt;a href="http://www.medscape.com/features/slideshow/vitamin-d#20">Medscape&lt;/a> to see the other images, with text&lt;/p></description></item><item><title>Vitamin D: one sided debate is published in Multiple Sclerosis Journal</title><link>/posts/vitamin-d-one-sided-debate-is-published-in-multiple-sclerosis-journal.html</link><pubDate>Thu, 07 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-one-sided-debate-is-published-in-multiple-sclerosis-journal.html</guid><description>&lt;h2 id="if-i-had-a-clinically-isolated-syndrome-with-mri-diagnostic-of-ms-i-would-take-vitamin-d-10000-iu-daily-no">If I had a clinically isolated syndrome with MRI diagnostic of MS, I would take vitamin D 10,000 IU daily: No&lt;/h2>
&lt;p>Mult Scler February 2013 vol. 19 no. 2 140-142&lt;/p>
&lt;p>Caroline Papeix, Catherine Lubetzki&lt;/p>
&lt;p>Université Pierre et Marie Curie AP-HP, France&lt;/p>
&lt;p>Catherine Lubetzki, Department of Neurology, Pitié-Salpêtrière Hospital, 75013 Paris, France. Email: &lt;a href="mailto:catherine.lubetzki@psl.aphp.fr">catherine.lubetzki@psl.aphp.fr&lt;/a>&lt;/p>
&lt;hr>
&lt;h3 id="observation-by-vitamindwiki">Observation by VitaminDWiki&lt;/h3>
&lt;p>We see MS professionals, with a lot a stake to keep the status quo (note the conflict of interest section) valiently state why vitamin D has not yet been absolutely proven, and can never be absolutely proven to help MS (people in the placebo group can get vitamin D from food and sun).&lt;/p></description></item><item><title>Vitamin D DRI for children lowered to 200 IU in Korea</title><link>/posts/vitamin-d-dri-for-children-lowered-to-200-iu-in-korea.html</link><pubDate>Sun, 03 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-dri-for-children-lowered-to-200-iu-in-korea.html</guid><description>&lt;h3 id="adequate-vitamin-d-status-and-adiposity-contribute-to-bone-health-in-peripubertal-nonobese-children">Adequate vitamin D status and adiposity contribute to bone health in peripubertal nonobese children.&lt;/h3>
&lt;p>J Bone Miner Metab. 2013 Jan 31.&lt;/p>
&lt;p>Lee YA, Kim JY, Kang MJ, Chung SJ, Shin CH, Yang SW.&lt;/p>
&lt;p>Division of Endocrinology and Metabolism, Department of Pediatrics, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 110-769, Korea.&lt;/p>
&lt;p>The dietary reference intake (DRI) of vitamin D for Korean children was &lt;strong>reduced from 400 IU/day in 2005 to 200 IU/day in 2010.&lt;/strong>&lt;/p></description></item><item><title>Autoimmunity and vitamin D – review</title><link>/posts/autoimmunity-and-vitamin-d-review.html</link><pubDate>Wed, 30 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/autoimmunity-and-vitamin-d-review.html</guid><description>&lt;h3 id="the-implication-of-vitamin-d-and-autoimmunity-a-comprehensive-review">The Implication of Vitamin D and Autoimmunity: a Comprehensive Review.&lt;/h3>
&lt;p>Clin Rev Allergy Immunol. 2013 Jan 29.&lt;/p>
&lt;p>Yang CY, Leung PS, Adamopoulos IE, Gershwin ME.&lt;/p>
&lt;p>Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, 451 Health Sciences Drive, Suite 6510, Davis, CA, 95616, USA.&lt;/p>
&lt;p>Historically, vitamin D has been associated with the regulation of bone metabolism. However, increasing evidence demonstrates a strong association between vitamin D signaling and many biological processes that regulate immune responses. The discovery of the vitamin D receptor in multiple immune cell lineages, such as monocytes, dendritic cells, and activated T cells credits vitamin D with a novel role in modulating immunological functions and its subsequent role in the development or prevention of autoimmune diseases. In this review we, discuss five major areas in vitamin D biology of high immunological significance:&lt;/p></description></item><item><title>Bone changes during and after pregnancy</title><link>/posts/bone-changes-during-and-after-pregnancy.html</link><pubDate>Tue, 29 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/bone-changes-during-and-after-pregnancy.html</guid><description>&lt;h1 id="changes-in-bone-mineral-density-and-body-composition-during-pregnancy-and-postpartum-a-controlled-cohort-study">Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study.&lt;/h1>
&lt;p>Osteoporos Int. 2012 Apr;23(4):1213-23. &lt;a href="https://doi.org/10.1007/s00198-011-1654-6.">doi: 10.1007/s00198-011-1654-6.&lt;/a> Epub 2011 May 25.&lt;/p>
&lt;p>Møller UK, Við Streym S, Mosekilde L, Rejnmark L.&lt;/p>
&lt;p>Department of Endocrinology and Internal Medicine, MEA, Aarhus Sygehus, Aarhus University Hospital, Tage Hansens Gade 2, DK-8000, Aarhus C, Denmark. &lt;a href="mailto:kristine.moller@ki.au.dk">kristine.moller@ki.au.dk&lt;/a>&lt;/p>
&lt;p>In a controlled cohort study, bone mineral density (BMD) was measured in 153 women pre-pregnancy; during pregnancy; and 0.5, 4, 9, and 19 months postpartum. Seventy-five age-matched controls, without pregnancy plans, were followed in parallel. Pregnancy and breastfeeding cause a reversible bone loss, which, initially, is most pronounced at trabecular sites but also involves cortical sites during prolonged breastfeeding.&lt;/p></description></item><item><title>Bone health not correlated with Vitamin D level in multiple sclerosis – review</title><link>/posts/bone-health-not-correlated-with-vitamin-d-level-in-multiple-sclerosis-review.html</link><pubDate>Tue, 29 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/bone-health-not-correlated-with-vitamin-d-level-in-multiple-sclerosis-review.html</guid><description>&lt;h1 id="bone-health-in-multiple-sclerosis">Bone health in multiple sclerosis&lt;/h1>
&lt;p>Osteoporos Int. 2011 Dec;22(12):2935-49. &lt;a href="https://doi.org/10.1007/s00198-011-1644-8.">doi: 10.1007/s00198-011-1644-8.&lt;/a> Epub 2011 May 21.&lt;/p>
&lt;p>Gibson JC, Summers GD.&lt;/p>
&lt;p>Level 2, Department of Rehabilitation Medicine, Royal Derby Hospital, Uttoxeter Road, Derby, DE22 3NE, UK. &lt;a href="mailto:jeremy.gibson@nhs.net">jeremy.gibson@nhs.net&lt;/a>&lt;/p>
&lt;p>People who are disabled with multiple sclerosis (MS) may be at increased risk of osteoporosis. This review discusses issues relevant to bone health in MS and makes practical recommendations regarding prevention and screening for osteoporosis and fracture risk in MS. A search of the literature up until 5 April 2011 was performed using key search terms, and articles pertinent to bone health in MS were analysed. Bone mineral density (BMD) is reduced at the lumbar spine, hip and total body in MS, with the degree of reduction being greatest at the hip. A strong relationship exists between the disability level, measured by the Expanded Disability Status Score, and BMD at the lumbar spine and femoral neck, particularly the latter. The rate of loss of BMD also correlates with the level of disability. Pulsed corticosteroids for acute episodes of MS, even with a high cumulative steroid dose, do not significantly affect BMD, but an effect on fracture risk is yet to be elucidated.&lt;/p></description></item><item><title>Calcium and vitamin D receptors are important to many health conditions</title><link>/posts/calcium-and-vitamin-d-receptors-are-important-to-many-health-conditions.html</link><pubDate>Thu, 24 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/calcium-and-vitamin-d-receptors-are-important-to-many-health-conditions.html</guid><description>&lt;h4 id="calcium-nutrition-and-extracellular-calcium-sensing-relevance-for-the-pathogenesis-of-osteoporosis-cancer-and-cardiovascular-diseases">Calcium Nutrition and Extracellular Calcium Sensing: Relevance for the Pathogenesis of Osteoporosis, Cancer and Cardiovascular Diseases&lt;/h4>
&lt;p>Nutrients 2013, 5, 302-327; doi:10.3390/nu5010302&lt;/p>
&lt;p>Meinrad Peterlik &lt;a href="mailto:meinrad.peterlik@meduniwien.ac.at">meinrad.peterlik@meduniwien.ac.at&lt;/a>, Enikoe Kallay and Heide S. Cross&lt;/p>
&lt;p>Department of Pathophysiology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria; E-Mails: &lt;a href="mailto:enikoe.kallay@meduniwien.ac.at">enikoe.kallay@meduniwien.ac.at&lt;/a> (E.K.); &lt;a href="mailto:heide.cross@meduniwien.ac.at">heide.cross@meduniwien.ac.at&lt;/a> (H.S.C.)&lt;/p>
&lt;p>Received: 30 October 2012; in revised form: 10 January 2013 / Accepted: 11 January 2013 / Published: 22 January 2013&lt;/p>
&lt;p>&lt;strong>PDF, including all figures and tables, is attached at the bottom of this page&lt;/strong>&lt;/p></description></item><item><title>3D images of bone plus position statements on Osteo and vitamin D – 2012</title><link>/posts/3d-images-of-bone-plus-position-statements-on-osteo-and-vitamin-d-2012.html</link><pubDate>Thu, 17 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/3d-images-of-bone-plus-position-statements-on-osteo-and-vitamin-d-2012.html</guid><description>&lt;p>The following is a fraction of &lt;strong>The fragile beauty of bone architecture&lt;/strong> published in Medicographia&lt;/p>
&lt;p>Louis-Georges STE-MARIE,MD&lt;/p>
&lt;p>Natalie DION PhD&lt;/p>
&lt;p>Centre Hospitalier de l’Université de Montréal&lt;/p>
&lt;p>Université de Montréal – Montréal, CANADA&lt;/p>
&lt;hr>
&lt;p>&lt;strong>The full issue of Medicographia, which includes the article: CONTROVERSIAL QUESTION, Is systematic supplementation with calcium/vitamin D necessary to treat postmenopausal osteoporosis? Is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;hr>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/3d-bone.jpg" alt="image">
&lt;h2 id="figure-2-structural-impairment-in-bone-disease">Figure 2. Structural impairment in bone disease.&lt;/h2>
&lt;p>Undecalcified bone biopsies (3D microcomputed tomography or 2D microscopic histology &lt;span>[Goldner’s stain]&lt;/span>).&lt;/p></description></item><item><title>Vitamin D review – Holick</title><link>/posts/vitamin-d-review-holick.html</link><pubDate>Thu, 10 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-review-holick.html</guid><description>&lt;h3 id="vitamin-deffects-on-skeletal-and-extraskeletal-health-and-the-need-for-supplementation">Vitamin D—Effects on Skeletal and Extraskeletal Health and the Need for Supplementation&lt;/h3>
&lt;p>Nutrients 2013, 5(1), 111-148; doi:10.3390/nu5010111 (doi registration under processing)&lt;/p>
&lt;p>Received: 15 October 2012; in revised form: 21 November 2012 / Accepted: 13 December 2012 / Published: 10 January 2013&lt;/p>
&lt;p>Matthias Wacker and Michael F. Holick* email&lt;/p>
&lt;p>Nutrition, and Diabetes, Vitamin D, Skin and Bone Research Laboratory, Section of Endocrinology, Department of Medicine, Boston University Medical Center, 85 East Newton Street, M-1013, Boston, MA 02118, USA&lt;/p></description></item><item><title>Vitamin D different relationship between whites and blacks for bone and plaque</title><link>/posts/vitamin-d-different-relationship-between-whites-and-blacks-for-bone-and-plaque.html</link><pubDate>Wed, 09 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-different-relationship-between-whites-and-blacks-for-bone-and-plaque.html</guid><description>&lt;h1 id="effect-of-race-and-genetics-on-vitamin-d-metabolism-bone-and-vascular-health">Effect of race and genetics on vitamin D metabolism, bone and vascular health.&lt;/h1>
&lt;p>Nat Rev Nephrol. 2012 Jun 12;8(8):459-66. &lt;a href="https://doi.org/10.1038/nrneph.2012.112.">doi: 10.1038/nrneph.2012.112.&lt;/a>&lt;/p>
&lt;p>Freedman BI, Register TC.&lt;/p>
&lt;p>Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC 27157-1053, USA. &lt;a href="mailto:bfreedma@wakehealth.edu">bfreedma@wakehealth.edu&lt;/a>&lt;/p>
&lt;p>The pathophysiology of chronic kidney disease-mineral and bone disorder accounts for an inverse relationship between bone mineralization and vascular calcification in progressive nephropathy. Inverse associations between bone mineral density (BMD) and calcified atherosclerotic plaque are also observed in individuals of European and African ancestry without nephropathy, suggesting a mechanistic link between these processes that is independent of kidney disease.&lt;/p></description></item><item><title>More than Calcium and Vitamin D can improve bones</title><link>/posts/more-than-calcium-and-vitamin-d-can-improve-bones.html</link><pubDate>Fri, 28 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/more-than-calcium-and-vitamin-d-can-improve-bones.html</guid><description>&lt;p>Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D.&lt;/p>
&lt;p>Osteoporos Int. 2012 Nov 14.&lt;/p>
&lt;p>Nieves JW.&lt;/p>
&lt;p>Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY, 10032, USA, &lt;a href="mailto:nievesj@helenhayeshosp.org">nievesj@helenhayeshosp.org&lt;/a>.&lt;/p>
&lt;p>There is a need to understand the role of nutrition, beyond calcium and vitamin D, in the treatment and prevention of osteoporosis in adults. Results regarding soy compounds on bone density and bone turnover are inconclusive perhaps due to differences in dose and composition or in study population characteristics. The skeletal benefit of black cohosh and red clover are unknown. Dehydroepiandrosterone (DHEA) use may benefit elderly individuals with low serum dehydroepiandrosterone-sulfate levels, but even in this group, there are inconsistent benefits to bone density (BMD). Higher fruit and vegetable intakes may relate to higher BMD.&lt;/p></description></item><item><title>Is High Dose Vitamin D Harmful</title><link>/posts/is-high-dose-vitamin-d-harmful.html</link><pubDate>Thu, 20 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/is-high-dose-vitamin-d-harmful.html</guid><description>&lt;h4 id="is-high-dose-vitamin-d-harmful">Is High Dose Vitamin D Harmful?&lt;/h4>
&lt;p>Calcif Tissue Int Dec 2012 DOI 10.1007/s00223-012-9679-1&lt;/p>
&lt;p>Kerrie M. Sanders • Geoffrey C. Nicholson • Peter R. Ebeling&lt;/p>
&lt;p>K. M. Sanders (&amp;amp;) • G. C. Nicholson • P. R. Ebeling Department of Medicine, Western Health, NorthWest Academic Centre, University of Melbourne, PO Box 294, St Albans, VIC 3021, Australia e-mail: &lt;a href="mailto:ksanders@unimelb.edu.au">ksanders@unimelb.edu.au&lt;/a>&lt;/p>
&lt;p>G. C. Nicholson&lt;/p>
&lt;p>Rural Clinical School, School of Medicine, University of Queensland, Toowoomba, QLD, Australia&lt;/p></description></item><item><title>Sickle cell and low vitamin D – 3 presentations</title><link>/posts/sickle-cell-and-low-vitamin-d-3-presentations.html</link><pubDate>Sat, 08 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/sickle-cell-and-low-vitamin-d-3-presentations.html</guid><description>&lt;p>&lt;strong>All presented at 2012 American Society of Hematology December 8-11, 2012 Atlanta, GA&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-zinc-deficiency-associated-with-increased-pain-episodes-in-children-with-sickle-cell-disease-poster-abstract-3237">Vitamin D and Zinc Deficiency Associated with Increased Pain Episodes in Children with Sickle Cell Disease: poster, Abstract 3237&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#relationship-between-vitamin-d-deficiency-and-bone-fragility-in-sickle-cell-disease">Relationship Between vitamin D Deficiency and Bone Fragility in Sickle Cell Disease:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-deficiency-cd40l-and-vegf-in-a-young-population-with-sickle-cell-disease-abstract-4768">Vitamin Deficiency, CD40L and VEGF in a Young Population with Sickle Cell Disease, Abstract 4768&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="vitamin-d-and-zinc-deficiency-associated-with-increased-pain-episodes-in-children-with-sickle-cell-disease-poster-abstract-3237">Vitamin D and Zinc Deficiency Associated with Increased Pain Episodes in Children with Sickle Cell Disease: poster, Abstract 3237&lt;/h3>
&lt;p>Abi Vijenthira, BHSc*,1, Christine G Chretien, BSCN*,2, Sydney Harris-Janz, RD*,2 and Robert J Klaassen, MD2&lt;/p></description></item><item><title>The problems of vitamin d insufficiency in older people</title><link>/posts/the-problems-of-vitamin-d-insufficiency-in-older-people.html</link><pubDate>Tue, 04 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/the-problems-of-vitamin-d-insufficiency-in-older-people.html</guid><description>&lt;h3 id="the-problems-of-vitamin-d-insufficiency-in-older-people">The problems of vitamin d insufficiency in older people.&lt;/h3>
&lt;p>Aging Dis. 2012 Aug;3(4):313-29. Epub 2012 Jun 6.&lt;/p>
&lt;p>Boucher BJ. Queen Mary University of London, Centre for Diabetes, Blizard Institute, London, E12AT, UK.&lt;/p>
&lt;p>&lt;strong>(PDF is attached at the bottom of this page)&lt;/strong>&lt;/p>
&lt;p>This report reviews evidence on disorders related to inadequate vitamin D repletion in older people. Vitamin D is as essential for bone health in adults as in children, preventing osteomalacia and muscle weakness and protecting against falls and low-impact fractures. Vitamin D is provided by skin synthesis by UVB-irradiation from summer sunshine and to a small extent by absorption from food. However, these processes become less efficient with age. Loss of mobility or residential care restricts solar exposure. Reduced appetite and financial problems often add to these problems. Thus, hypovitaminosis D is common world-wide, but is more common and more severe in older people.&lt;/p></description></item><item><title>Vitamin D Receptor genes bb and BB and Osteoporosis, esp. for blacks – meta-analysis</title><link>/posts/vitamin-d-receptor-genes-bb-and-bb-and-osteoporosis-esp-for-blacks-meta-analysis.html</link><pubDate>Fri, 30 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-receptor-genes-bb-and-bb-and-osteoporosis-esp-for-blacks-meta-analysis.html</guid><description>&lt;h4 id="vitamin-d-receptor-bsmi-polymorphism-and-osteoporosis-risk-a-meta-analysis-from-26-studies">Vitamin D Receptor BsmI Polymorphism and Osteoporosis Risk: A Meta-Analysis from 26 Studies&lt;/h4>
&lt;p>Genetic Testing and Molecular Biomarkers – Nov 2012&lt;/p>
&lt;p>Rui-Fen Sun,2,* Qun-Hui Li,1 Da-Xing Wang,1 Feng Zhao,1 Jun-Min Li,1 Qi Pu,1 Zhong-Zi Zhang,1 Yan Jin,1 Bai-Lian Liu,1 and Ying Xiong1&lt;/p>
&lt;p>1 Department of Orthopedics, Kunming Medical University, National Clinical Key Specialty, Yanan Hospital, Kunming, People&amp;rsquo;s Republic of China.&lt;/p>
&lt;p>2 Central Laboratory, Yunnan University of Chinese Traditional Medicine, Kunming, People&amp;rsquo;s Republic of China.&lt;/p></description></item><item><title>Hip fractures greatly reduced by sunshine, vitamin D, and vitamin K – meta-analysis</title><link>/posts/hip-fractures-greatly-reduced-by-sunshine-vitamin-d-and-vitamin-k-meta-analysis.html</link><pubDate>Fri, 23 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/hip-fractures-greatly-reduced-by-sunshine-vitamin-d-and-vitamin-k-meta-analysis.html</guid><description>&lt;h4 id="strategy-for-prevention-of-hip-fractures-in-patients-with-parkinsons-disease">Strategy for prevention of hip fractures in patients with Parkinson&amp;rsquo;s disease.&lt;/h4>
&lt;p>World J Orthop. 2012 Sep 18;3(9):137-41. &lt;a href="https://doi.org/10.5312/wjo.v3.i9.137.">doi: 10.5312/wjo.v3.i9.137.&lt;/a>&lt;/p>
&lt;p>Iwamoto J, Sato Y, Takeda T, Matsumoto H.&lt;/p>
&lt;p>Jun Iwamoto, Tsuyoshi Takeda, Hideo Matsumoto, Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.&lt;/p>
&lt;p>Hypovitaminosis D and K due to malnutrition or sunlight deprivation, increased bone resorption due to immobilization, low bone mineral density (BMD) and an increased risk of falls may contribute to an increased risk of hip fractures in patients with Parkinson&amp;rsquo;s disease. The purpose of the present study was to clarify the efficacy of interventions intended to prevent hip fractures in elderly patients with Parkinson&amp;rsquo;s disease. PubMed was used to search the literature for randomized controlled trials (RCTs) regarding Parkinson&amp;rsquo;s disease and hip fractures. The inclusion criteria were 50 or more subjects per group and a study period of 1 year or longer.&lt;/p></description></item><item><title>Vertigo treated by Vitamin D - many studies</title><link>/posts/vertigo-treated-by-vitamin-d-many-studies.html</link><pubDate>Fri, 23 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/vertigo-treated-by-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vertigo-bppv-greatly-reduced-by-vitamin-d---meta-analysis-april-2025">Vertigo (BPPV) greatly reduced by Vitamin D - meta-analysis April 2025&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#87-reduction-in-recurrence-of-bppv-with-13-weeks-of-vitamin-d-2000-iu-daily---rct-aug-2024">87% reduction in recurrence of BPPV with 13 weeks of Vitamin D (2,000 IU daily) - RCT Aug 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-greatly-reduced-by-vitamin-d-in-those-who-were-deficient--aug-2024">BPPV greatly reduced by Vitamin D in those who were deficient – Aug 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-recurrences-decreased-with-vitamin-d-supplements--4-out-of-5-studies--feb-2024">BPPV recurrences decreased with Vitamin D supplements (4 out of 5 studies) – Feb 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-associated-with-low-vitamin-d---dr-berg-video-april2023">BPPV associated with low vitamin D - Dr. Berg Video April 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#those-still-dizzy-after-bppv-treatment-were-55-x-more-likely-to-have-low-vitamin-d--june2022">Those still dizzy after BPPV treatment were 5.5 X more likely to have low vitamin D – June 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-substantially-reduced-if-raise-vitamin-d-levels--aug2021">BPPV substantially reduced if raise Vitamin D levels – Aug 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vertigo-associated-with-low-vitamin-d-supplementation-reduced-relapse-pdf-costs-36---nov2021">Vertigo associated with low vitamin D, supplementation reduced relapse (PDF costs $36) - Nov 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-has-many-risk-factors-low-vitamin-d-is-one-of-them--meta-analysis-aug2020">BPPV has many risk factors, low Vitamin D is one of them – Meta-analysis Aug 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-risk-reduced-3x-with-vitamin-d---meta-analysis-aug--2020">BPPV risk reduced 3X with Vitamin D - meta-analysis Aug 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-2x-more-likely-if-low-vitamin-d---meta-analysis-of-18-studies-jan2020">BPPV 2X more likely if low Vitamin D - meta-analysis of 18 studies Jan 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-is-associated-with-bppv---meta-analysis-oct2019">Vitamin D is associated with BPPV - meta-analysis Oct 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-eliminated-by-vitamin-d--april2019">BPPV eliminated by Vitamin D – April 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-meta-analysis-found-no-association-with-low-vitamin-d-in-the-blood--oct2018">BPPV Meta-analysis found no association with low vitamin D in the blood- Oct 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#calcium-carbonate-crystals-in-ear-decrease-in-elderly-with-low-vit-d---april2018">Calcium Carbonate crystals in ear decrease in elderly with low Vit D - April 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-23x-more-likely-if-vitamin-d-deficient---oct2012">BPPV 23X more likely if vitamin D deficient - Oct 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-reduced-5-x-by-50000-iu-of-vitamin-d-every-2-weeks--2016-the-effect-of-serum-vitamin-d-normalization-in-preventing-recurrences-of-benign-paroxysmal-positional-vertigo-a-case-control-study-caspian-j-intern-med-2016-summer73173-177">BPPV reduced 5 X by 50,000 IU of vitamin D every 2 weeks - 2016** The effect of serum vitamin D normalization in preventing recurrences of benign paroxysmal positional vertigo: A case-control study. **Caspian J Intern Med. 2016 Summer;7(3):173-177.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-21-x-more-likely-if-low-vitamin-d---dec2017">BPPV 2.1 X more likely if low vitamin D - Dec 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bppv-much-more-common-with-low-vitamin-d---oct2016-serum-vitamin-d-and-recurrent-benign-paroxysmal-positional-vertigo-laryngoscope-investig-otolaryngol-2016-oct-2016150-153-doi-101002lio235httpsdoiorg101002lio235-ecollection-2016-dec">BPPV much more common with low vitamin D - Oct 2016** Serum vitamin D and recurrent benign paroxysmal positional vertigo. **Laryngoscope Investig Otolaryngol. 2016 Oct 20;1(6):150-153. &lt;a href="https://doi.org/10.1002/lio2.35.">doi: 10.1002/lio2.35.&lt;/a> eCollection 2016 Dec.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vertigo-bppv-greatly-reduced-by-vitamin-d---meta-analysis-april-2025">Vertigo (BPPV) greatly reduced by Vitamin D - meta-analysis April 2025&lt;/h4>
&lt;p>&lt;strong>Association between vitamin D, vitamin D supplementation and benign paroxysmal positional vertigo: a systematic review and meta-analysis&lt;/strong>&lt;/p></description></item><item><title>Infant-Child</title><link>/posts/infant-child.html</link><pubDate>Fri, 16 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/infant-child.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#overview">Overview&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#search-terms-for-children-and-vitamin-d---may-2021">Search terms for Children and Vitamin D - May 2021&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="overview">Overview&lt;/h4>
&lt;!-- ~tc~ start ~/tc~ -->
&lt;ul>
&lt;li>
&lt;p>No consensus on MINIMUM International Units (IU) for healthy infant of normal weight&lt;/p>
&lt;/li>
&lt;li>
&lt;p>400 IU Vitamin D is no longer enough&lt;/p>
&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>Was OK in the past century, but D levels have been dropping for a great many reasons.&lt;/p>
&lt;/blockquote>
&lt;blockquote>
&lt;p>&lt;a href="/posts/fda-doubles-the-amount-of-vitamin-d-permitted-in-milk">FDA doubles the amount of vitamin D permitted in milk – July 2016&lt;/a>&lt;/p>
&lt;/blockquote>
&lt;ul>
&lt;li>
&lt;p>No consensus: range is 600 to 1600 IU – based on many randomized controlled trials&lt;/p></description></item><item><title>Vitamin D enabled a woman with MS to walk long distances again</title><link>/posts/vitamin-d-enabled-a-woman-with-ms-to-walk-long-distances-again.html</link><pubDate>Thu, 01 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-enabled-a-woman-with-ms-to-walk-long-distances-again.html</guid><description>&lt;h1 id="effect-of-high-dose-vitamin-d3-intake-on-ambulation-muscular-pain-and-bone-mineral-density">Effect of High-Dose Vitamin D3 Intake on Ambulation, Muscular Pain and Bone Mineral Density&lt;/h1>
&lt;h2 id="in-a-woman-with-multiple-sclerosis-a-10-year-longitudinal-case-report">in a Woman with Multiple Sclerosis: A 10-Year Longitudinal Case Report&lt;/h2>
&lt;p>Int. J. Mol. Sci. 2012, 13(10), 13461-13483; doi:10.3390/ijms131013461&lt;/p>
&lt;p>Barbara M. van Amerongen 1,2, &lt;a href="mailto:b.m.van.amerongen@inter.nl.net">b.m.van.amerongen@inter.nl.net&lt;/a> and François Feron 3&lt;/p>
&lt;p>1 Department of Molecular Cell Biology and Immunology, VU University Medical Center,1017 MB Amsterdam, The Netherlands&lt;/p>
&lt;p>2 Department of Cariology Endodontology Pedodontology, Academic Centre for Dentistry, 1081 LA Amsterdam, Amsterdam, The Netherlands&lt;/p></description></item><item><title>Vitamin D: what clinicians need to know</title><link>/posts/vitamin-d-what-clinicians-need-to-know.html</link><pubDate>Sat, 27 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-what-clinicians-need-to-know.html</guid><description>&lt;h1 id="vitamin-d-what-clinicians-need-to-know">Vitamin D: what clinicians need to know&lt;/h1>
&lt;p>Sunil J Wimalawansa&lt;/p>
&lt;p>Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2012; 2: 73-88&lt;/p>
&lt;hr>
&lt;h2 id="note-by-vitamindwiki">Note by VitaminDWiki&lt;/h2>
&lt;p>The following paper appears to be a very small condensation of the excellent book which he published in 2012 &lt;a href="/posts/vitamin-d-everything-you-need-to-know" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 2397"> &lt;strong>Vitamin D: Everything You Need to Know&lt;/strong> &lt;/a>&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#00F;">The figures are in the PDF of the paper is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p></description></item><item><title>Vertebral fracture 3X more likely with aortic calcification – Vitamins D3 and K2</title><link>/posts/vertebral-fracture-3x-more-likely-with-aortic-calcification-vitamins-d3-and-k2.html</link><pubDate>Wed, 17 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/vertebral-fracture-3x-more-likely-with-aortic-calcification-vitamins-d3-and-k2.html</guid><description>&lt;h1 id="aortic-calcification-and-bone-metabolism">Aortic Calcification and Bone Metabolism:&lt;/h1>
&lt;h2 id="the-relationship-between-aortic-calcification-bmd-vertebral-fracture-25-hydroxyvitamin-d-and-osteocalcin">The Relationship between Aortic Calcification, BMD, Vertebral Fracture, 25-Hydroxyvitamin D, and Osteocalcin.&lt;/h2>
&lt;p>Calcif Tissue Int. 2012 Sep 29.&lt;/p>
&lt;p>Kim KJ, Kim KM, Park KH, Choi HS, Rhee Y, Lee YH, Cha BS, Kim MJ, Oh SM, Brown JK, Lim SK.&lt;/p>
&lt;p>Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul, 120-752, South Korea.&lt;/p>
&lt;p>The aim of this study was to investigate the relationship between aortic calcification (AC) and low bone mineral density (BMD), 25(OH)D, C-terminal telopeptide (CTx), and osteocalcin levels in Asian women. We also tried to find the association between AC and the risk of vertebral fracture. We included 769 patients in this study. All patients underwent QCT. Aortic calcium score (ACS) was quantified by the Agatston scoring method. Spinal fracture was defined by lumbar spine radiography.&lt;/p></description></item><item><title>Is the Iranian Revolution to Blame for the Increasing Incidence of Multiple Sclerosis in Iran</title><link>/posts/is-the-iranian-revolution-to-blame-for-the-increasing-incidence-of-multiple-sclerosis-in-iran.html</link><pubDate>Mon, 15 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/is-the-iranian-revolution-to-blame-for-the-increasing-incidence-of-multiple-sclerosis-in-iran.html</guid><description>&lt;p>There are two items on this page&lt;/p>
&lt;hr>
&lt;h3 id="multiple-sclerosis-and-the-iranian-revolution">MULTIPLE SCLEROSIS AND THE IRANIAN REVOLUTION&lt;/h3>
&lt;p>J Neurol Neurosurg Psychiatry 2013;84:e2 doi:10.1136/jnnp-2013-306573.185&lt;/p>
&lt;p>Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23–24 October 2013&lt;/p>
&lt;p>Julia Pakpoor⇓,&lt;/p>
&lt;p>Sreeram Ramagopalan&lt;/p>
&lt;p>University of Oxford; Barts and the London School of Medicine and Dentistry&lt;/p>
&lt;p>Multiple Sclerosis (MS) is a complex neurological disorder most likely caused by gene–environment interactions. There is a latitudinal gradient of MS prevalence and vitamin D deficiency has been strongly implicated in MS aetiology. Iran is a country of high levels of sunshine which has previously been considered a low–risk MS region. However, Iran has recently observed an &lt;strong>&lt;span style="color:#F00;">8.3–fold rise in the incidence of MS between 1989–2006&lt;/span>.&lt;/strong> 1 Previous studies have indicated a genetic predisposition to MS in the Iranian population but genetic changes are unlikely to account for the substantial rise in MS over the last few decades. Thus, we aimed to develop a novel hypothesis to explain the identification of Iran as a high–risk MS region. We believe that the influence of decreased sunshine exposure and vitamin D levels on MS risk needs to be strongly considered in the context of Iran&amp;rsquo;s history. In 1979 the Iranian Revolution took place and a country previously under great Western influences became an Islamic republic. It became a government requirement for women to wear loose–fitting clothing and the veil in public; it has previously been shown that veiled women have lower vitamin D levels compared to unveiled women. This significant cultural shift would not only potentially explain the observed increase in MS but notably, it would account for the increasing female preponderance of MS in Iran. Given that the average age of MS onset is 30 years old and that MS incidence in Iran just over 30 years following the revolution is the highest so far recorded, an association with the Iranian revolution and reduced subsequent vitamin D levels in particularly pregnant women is likely. Lifestyle changes such as urbanization and use of sunscreen may to some extent have contributed to increased vitamin D deficiency, but these are unlikely to contribute to the particularly high increase in MS observed in Iran as these changes occurred across the developed world and there is no evidence to suggest that they were particularly great in Iran. &lt;strong>A similar high incidence of MS has been observed among Iranian immigrants in countries at high latitude such as Sweden&lt;/strong> where Iranian immigrants have a reported greater prevalence of MS compared to the general population, &lt;strong>despite wearing a veil not being a requirement.&lt;/strong> Instead it is well–known that UVB exposure is lower in countries at high latitude and thus, a similar effect of increased MS incidence due to vitamin D deficiency may be observed among those in Iran wearing the veil and those resident in countries at high latitude, even if they are not wearing the veil. Therefore, vitamin D repletion is a critical public health issue for Iranians both within and outside Iran, and could help prevent an emerging MS epidemic in this population. More generally, this region is highly interesting for MS research and highlights that regions of exception to the latitudinal gradient of MS prevalence are an under–appreciated and very useful resource in evaluating MS aetiology.&lt;/p></description></item><item><title>Sept 2012 Vitamin D News email</title><link>/posts/sept-2012-vitamin-d-news-email.html</link><pubDate>Sun, 30 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/sept-2012-vitamin-d-news-email.html</guid><description>&lt;h3 id="the-a-hrefpostsweb-version-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-3246web-versiona-of-this-page-has-graphics-and-provides-translation-to-64-other-languages-with-1-click">The &lt;a href="/posts/web-version" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 3246">web version&lt;/a> of this page has graphics and provides translation to 64 other languages with 1 click&lt;/h3>
&lt;h2 id="top-vitamin-d-news-at-vitamindwiki">Top Vitamin D News at VitaminDWiki&lt;/h2>
&lt;p>&lt;a href="/posts/far-more-vitamin-d-publications-than-other-vitamins">Far more vitamin D publications than other vitamins - Sept 2012&lt;/a>&lt;/p>
&lt;img src="/attachments/d3.mock.jpg" alt="image">
&lt;p>&lt;a href="/posts/more-vitamin-invervention-trials-for-d-than-for-the-total-of-vitamins-a-c-e-and-k" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 1336">More Vitamin Invervention trials for &lt;strong>D&lt;/strong> than for the total of Vitamins A, C, E, and K&lt;/a>&lt;/p>
&lt;p>Vitamin D 915 vs 798 = &amp;ldquo;Vitamin A&amp;rdquo; 188 + &amp;ldquo;Vitamin C&amp;rdquo; 269 + &amp;ldquo;Vitamin E&amp;rdquo; 236 + &amp;ldquo;Vitamin K&amp;rdquo; 105&lt;/p></description></item><item><title>Hip fracture and vitamin D – Health ABC study</title><link>/posts/hip-fracture-and-vitamin-d-health-abc-study.html</link><pubDate>Fri, 28 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/hip-fracture-and-vitamin-d-health-abc-study.html</guid><description>&lt;h1 id="calciotropic-hormones-and-the-risk-of-hip-and-nonspine-fractures-in-older-adults">Calciotropic hormones and the risk of hip and nonspine fractures in older adults:&lt;/h1>
&lt;h2 id="the-health-abc-study">the Health ABC Study.&lt;/h2>
&lt;p>J Bone Miner Res. 2012 May;27(5):1177-85. &lt;a href="https://doi.org/10.1002/jbmr.1545.">doi: 10.1002/jbmr.1545.&lt;/a>&lt;/p>
&lt;p>Barbour KE, Houston DK, Cummings SR, Boudreau R, Prasad T, Sheu Y, Bauer DC, Tooze JA, Kritchevsky SB, Tylavsky FA, Harris TB, Cauley JA; Health ABC Study.&lt;/p>
&lt;p>Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, USA. &lt;a href="mailto:barbourk@edc.pitt.edu">barbourk@edc.pitt.edu&lt;/a>&lt;/p>
&lt;p>The effects of vitamin D and parathyroid hormone (PTH) levels on incident fracture remain uncertain.&lt;/p></description></item><item><title>Increasing bone mineral density increases breast cancer by at least 2X</title><link>/posts/increasing-bone-mineral-density-increases-breast-cancer-by-at-least-2x.html</link><pubDate>Mon, 17 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/increasing-bone-mineral-density-increases-breast-cancer-by-at-least-2x.html</guid><description>&lt;h3 id="osteoporosis-myth-the-dangers-of-high-bone-mineral-densityhttpwwwgreenmedinfocomblogosteoporosis-myth-dangers-high-bone-mineral-densityutm_sourcewwwgreenmedinfocomutm_campaignb739c633e3-greenmedinfoutm_mediumemail-green-med-info">&lt;a href="http://www.greenmedinfo.com/blog/osteoporosis-myth-dangers-high-bone-mineral-density?utm_source=www.GreenMedInfo.com&amp;amp;utm_campaign=b739c633e3-Greenmedinfo&amp;amp;utm_medium=email">Osteoporosis Myth: The Dangers of High Bone Mineral Density&lt;/a> Green Med Info&lt;/h3>
&lt;h3 id="the-following-was-clipped-from-the-above-item">The following was clipped from the above item&lt;/h3>
&lt;p>One of the most important facts about bone mineral density, conspicuously absent from discussion, is that having higher-than-normal bone density in middle-aged and older women actually &lt;strong>&lt;span style="color:#F00;">INCREASES their risk of breast cancer by 200-300%&lt;/span>&lt;/strong> , and this is according to research published in some of the world&amp;rsquo;s most well-respected and authoritative journals, e.g. Lancet, JAMA, NCI. (see citations below).&lt;/p></description></item><item><title>Forearm fracture 3.5X more often in black children with low levels of vitamin D</title><link>/posts/forearm-fracture-35x-more-often-in-black-children-with-low-levels-of-vitamin-d.html</link><pubDate>Fri, 07 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/forearm-fracture-35x-more-often-in-black-children-with-low-levels-of-vitamin-d.html</guid><description>&lt;h4 id="bone-mineral-density-and-vitamin-d-status-among-african-american-children-with-forearm-fractures">Bone mineral density and vitamin d status among african american children with forearm fractures.&lt;/h4>
&lt;p>Pediatrics. 2012 Sep;130(3):e553-60. Epub 2012 Aug 27.&lt;/p>
&lt;p>Ryan LM, Teach SJ, Singer SA, Wood R, Freishtat R, Wright JL, McCarter R, Tosi L, Chamberlain JM.&lt;/p>
&lt;p>Children&amp;rsquo;s National Medical Center, Division of Emergency Medicine, 111 Michigan Ave NW, Washington, DC 20010. &lt;a href="mailto:lryan@childrensnational.org">lryan@childrensnational.org&lt;/a>.&lt;/p>
&lt;p>OBJECTIVE:&lt;/p>
&lt;p>To determine whether African American children with forearm fractures have decreased bone mineral density and an increased prevalence of vitamin D deficiency (serum 25-hydroxyvitamin D level ?20 ng/mL) compared with fracture-free control patients.&lt;/p></description></item><item><title>Vitamin D levels in healthy populations around the globe</title><link>/posts/vitamin-d-levels-in-healthy-populations-around-the-globe.html</link><pubDate>Fri, 31 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-levels-in-healthy-populations-around-the-globe.html</guid><description>&lt;h2 id="a-global-representation-of-vitamin-d-status-in-healthy-populations">A global representation of vitamin D status in healthy populations&lt;/h2>
&lt;p>ARCHIVES OF OSTEOPOROSIS, 2012, DOI: 10.1007/s11657-012-0093-0&lt;/p>
&lt;p>D. A. Wahl, C. Cooper, P. R. Ebeling, M. Eggersdorfer, J. Hilger, K. Hoffmann, R. Josse, J. A. Kanis, A. Mithal and D. D. Pierroz, et al.&lt;/p>
&lt;hr>
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-deficiency-of-vitamin-d" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 889">Overview Deficiency of vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-deficiency-is-a-major-global-public-health-problem-maps">Vitamin D deficiency is a major global public health problem – Maps Nov 2013&lt;/a>&lt;/p></description></item><item><title>Vitamin D intervention stopped bone loss in those mice getting too much alcohol</title><link>/posts/vitamin-d-intervention-stopped-bone-loss-in-those-mice-getting-too-much-alcohol.html</link><pubDate>Wed, 15 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-intervention-stopped-bone-loss-in-those-mice-getting-too-much-alcohol.html</guid><description>&lt;h1 id="vitamin-d-supplementation-protects-against-bone-loss-associated-with-chronic-alcohol-administration-in-female-mice">Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice&lt;/h1>
&lt;p>10.1124/jpet.112.197038&lt;/p>
&lt;p>Journal of Pharocology and Experimentgal Therapeutics August 14, 2012&lt;/p>
&lt;p>Kelly E Mercer1, Rebecca A Wynne2, Oxana P Lazarenko2, Charles K. Lumpkin1, William R Hogue1, Larry J. Suva1, Jin-Ran Chen1, Andrew Z Mason3, Thomas M Badger1 and Martin J.J. Ronis1, &lt;a href="mailto:ronismartinj@uams.edu">ronismartinj@uams.edu&lt;/a>&lt;/p>
&lt;p>1 University of Arkansas for Medical Sciences;&lt;/p>
&lt;p>2 Arkansas Children&amp;rsquo;s Nutrition Center;&lt;/p>
&lt;p>3 California State University&lt;/p></description></item><item><title>Echocardiograms confirm problems with low vitamin D</title><link>/posts/echocardiograms-confirm-problems-with-low-vitamin-d.html</link><pubDate>Tue, 14 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/echocardiograms-confirm-problems-with-low-vitamin-d.html</guid><description>&lt;h1 id="relationship-of-vitamin-d-deficiency-to-echocardiography-findings-in-veterans">Relationship of Vitamin D Deficiency to Echocardiography Findings in Veterans&lt;/h1>
&lt;p>Joshi et al., J Clin Exp Cardiolog 2012, S:3 &lt;a href="http://dx.doi.org/10.4172/2155-9880.S3-005">http://dx.doi.org/10.4172/2155-9880.S3-005&lt;/a>&lt;/p>
&lt;p>Hetvi Joshi 1, Pablo Lopez 1, Beth Bailey 2, Costy Mattar 3, Todd Manning 4 and Alan Peiris 5 &lt;a href="mailto:peiris@etsu.edu">peiris@etsu.edu&lt;/a>&lt;/p>
&lt;p>&amp;lsquo;East Tennessee State University, Department of Internal Medicine, USA 2East Tennessee State University, Department of Family Medicine, USA &amp;lsquo;Division of Cardiology, Mountain Home Veterans Affairs Medical Center, USA&lt;/p>
&lt;p>Received April &amp;lsquo;2, 2012; Accepted May 2&amp;rsquo;, 2012; Published May 23, 2012&lt;/p></description></item><item><title>Calcium and bone disorders in pregnancy</title><link>/posts/calcium-and-bone-disorders-in-pregnancy.html</link><pubDate>Sun, 12 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/calcium-and-bone-disorders-in-pregnancy.html</guid><description>&lt;p>Indian J Endocrinol Metab. 2012 May-Jun; 16(3): 358–363, &lt;a href="https://doi.org/10.4103/2230-8210.95665">doi: 10.4103/2230-8210.95665&lt;/a>, PMCID: PMC3354840&lt;/p>
&lt;p>Shriraam Mahadevan, V. Kumaravel,1 and R. Bharath2&lt;/p>
&lt;p>Department of Clinical Endocrinology, Dr. E. V. Kalyani Medical Centre, Chennai, India&lt;/p>
&lt;p>1 Department of Clinical Endocrinology, Alpha Hospital and Research Centre, Madurai, India&lt;/p>
&lt;p>2 Department of Endocrinology, Chettinad Medical College and Research Institute, Chennai, India&lt;/p>
&lt;p>Corresponding Author: Dr. Shriraam Mahadevan, Department of Clinical Endocrinology, Dr. E. V. Kalyani Medical Centre, 4, Radhakrishnan Salai, Mylapore, Chennai 600004, India. E-mail: &lt;a href="mailto:mshriraam@gmail.com">mshriraam@gmail.com&lt;/a>&lt;/p></description></item><item><title>Non-alcoholic Fatty Liver Disease (4 in 10 seniors) and Vitamin D</title><link>/posts/non-alcoholic-fatty-liver-disease-4-in-10-seniors-and-vitamin-d.html</link><pubDate>Wed, 08 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/non-alcoholic-fatty-liver-disease-4-in-10-seniors-and-vitamin-d.html</guid><description>&lt;ul>
&lt;li>
&lt;p>FACT: NAFLD (Non-alcoholic Fatty Liver Disease) is very common and hard to diagnose&lt;/p>
&lt;/li>
&lt;li>
&lt;p>FACT: NAFLD is associated with somewhat lower levels of vitamin D&lt;/p>
&lt;/li>
&lt;li>
&lt;p>FACT: People with NASH (a more severe form of NAFLD) do not produce as much semi-activated vitamin D&lt;/p>
&lt;/li>
&lt;li>
&lt;p>OBSERVATION: Loading doses of vitamin D help sub sequent NAFLD maintenance doses&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Assumption: Livers of people with NAFLD are not able to process normal Vitamin D as well&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Assumption: Other forms of Vitamin D could treat NAFLD much better than normal vitamin D&lt;/p></description></item><item><title>5X increase in hip fracture rates in 65 years - 1998</title><link>/posts/5x-increase-in-hip-fracture-rates-in-65-years-1998.html</link><pubDate>Mon, 06 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/5x-increase-in-hip-fracture-rates-in-65-years-1998.html</guid><description>&lt;h3 id="long-term-trends-in-hip-fracture-prevalence-the-influence-of-hip-fracture-incidence-and-survival">Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival.&lt;/h3>
&lt;p>Osteoporos Int. 1998;8(1):68-74.&lt;/p>
&lt;p>Melton LJ 3rd, Therneau TM, Larson DR.&lt;/p>
&lt;p>Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.&lt;/p>
&lt;p>In this population-based descriptive study covering the 65-year period, 1928-92, there was a &lt;strong>5-fold increase in hip fracture&lt;/strong> prevalence among Rochester, Minnesota residents between 1928-42 and 1973-82, from 135.8 to 675.8 per 100,000. This change was dictated almost entirely by an increase in the incidence of first hip fractures due to moderate trauma (n = 2058) that was observed among Rochester women through 1950, and among men through 1980, that affected all age groups. Declining incidence rates thereafter led to a 9% fall in hip fracture prevalence from 1973-82 to 1983-92 to a rate of 612.7 per 100,000. A 13.7-year increase in age at first hip fracture over the study period was accounted for by aging of the underlying population, and a comparable 13.9-year increase in the age at death following hip fracture appeared to result from improved survival in the population generally. Thus, trends in hip fracture prevalence were mainly determined by changes in incidence &lt;strong>rather than relative changes in age at onset and death following hip fracture.&lt;/strong>&lt;/p></description></item><item><title>Hypothesis: Primary hyperparathyroidism might increase when vitamin D levels increase</title><link>/posts/hypothesis-primary-hyperparathyroidism-might-increase-when-vitamin-d-levels-increase.html</link><pubDate>Mon, 06 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/hypothesis-primary-hyperparathyroidism-might-increase-when-vitamin-d-levels-increase.html</guid><description>&lt;h1 id="vitamin-d-or-wait-and-see">Vitamin D, or wait and see?&lt;/h1>
&lt;h2 id="letter-to-the-editor">LETTER TO THE EDITOR,&lt;/h2>
&lt;h2 id="the-netherlands-journal-of-medicine-august-2-012-vol-70-no-6-292">The Netherlands Journal of Medicine AUGUST 2 012, VOL. 70, NO 6 292&lt;/h2>
&lt;p>I.M.E. Wentholt 1*, J. Bras 2, F.H.M. Kroon 3, E.J.M. Nieveen van Dijkum 4, E. Fliers 1&lt;/p>
&lt;p>Departments of &amp;lsquo;Endocrinology and Metabolism, 2 Pathology, 3 Oral and Maxillofacial Surgery, 4 Surgery, Academic Medical Center of the University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam the Netherlands,*corresponding author: tel: +31 (0)6-14399031, e-mail: &lt;a href="mailto:I.M.Wentholt@amc.nl">I.M.Wentholt@amc.nl&lt;/a>&lt;/p></description></item><item><title>2900 IU of vitamin D (20000 weekly) kept levels above 20 ng during the winter</title><link>/posts/2900-iu-of-vitamin-d-20000-weekly-kept-levels-above-20-ng-during-the-winter.html</link><pubDate>Thu, 02 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/2900-iu-of-vitamin-d-20000-weekly-kept-levels-above-20-ng-during-the-winter.html</guid><description>&lt;h4 id="what-is-needed-to-keep-persons-with-multiple-sclerosis-vitamin-d-sufficient-throughout-the-year">What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?&lt;/h4>
&lt;p>J Neurol. 2012 Aug 1.&lt;/p>
&lt;p>Steffensen LH, Brustad M, Kampman MT.&lt;/p>
&lt;p>Department of Neurology, University Hospital of North Norway, P.O. Box 33, 9038, Tromsø, Norway, &lt;a href="mailto:linn.hofsoy.steffensen@unn.no">linn.hofsoy.steffensen@unn.no&lt;/a>.&lt;/p>
&lt;p>Vitamin D sufficiency has been associated with lower risk of multiple sclerosis and may also have a favorable effect on the course of the disease.&lt;/p>
&lt;p>The aim of this work was to identify predictors of serum 25-hydroxy vitamin D (25&lt;span>[OH]&lt;/span>D) levels in persons with multiple sclerosis (MS) and to assess the effect of high-dose vitamin D(3) supplementation on vitamin D status.&lt;/p></description></item><item><title>Major depression associated with low vitamin D and low bone density</title><link>/posts/major-depression-associated-with-low-vitamin-d-and-low-bone-density.html</link><pubDate>Wed, 01 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/major-depression-associated-with-low-vitamin-d-and-low-bone-density.html</guid><description>&lt;h3 id="do-premenopausal-women-with-major-depression-have-low-bone-mineral-density-a-36-month-prospective-study">Do Premenopausal Women with Major Depression Have Low Bone Mineral Density? A 36-Month Prospective Study.&lt;/h3>
&lt;p>PLoS One. 2012;7(7):e40894. Epub 2012 Jul 27.&lt;/p>
&lt;p>Cizza G &lt;a href="mailto:cizzag@intra.niddk.nih.gov">cizzag@intra.niddk.nih.gov&lt;/a>, Mistry S, Nguyen VT, Eskandari F, Martinez P, Torvik S, Reynolds JC, Gold PW, Sinai N, Csako G; for the POWER Study Group.&lt;/p>
&lt;p>Section on Neuroendocrinology of Obesity, National Institutes of Diabetes and Digestive Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, United States of America.&lt;/p></description></item><item><title>European adults can take 4000 IU of vitamin D</title><link>/posts/european-adults-can-take-4000-iu-of-vitamin-d.html</link><pubDate>Mon, 30 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/european-adults-can-take-4000-iu-of-vitamin-d.html</guid><description>&lt;h4 id="table-of-contents">Table of contents&lt;/h4>
&lt;p>Abstract &amp;hellip;. 1&lt;/p>
&lt;p>Summary .. 2&lt;/p>
&lt;p>Table of contents&amp;hellip;&amp;hellip;4&lt;/p>
&lt;p>Background as provided by the European Commission &amp;hellip;&amp;hellip;&amp;hellip;. 5&lt;/p>
&lt;p>Terms of reference as provided by the European Commission&amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip;5&lt;/p>
&lt;p>Assessment &amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip; 6&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Introduction&amp;hellip;..6&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Dietary intakes.7&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>2.1. Adults&amp;hellip;&amp;hellip;7&lt;/p>
&lt;p>2.2. Infants (&amp;lt;1 year)&amp;hellip;&amp;hellip;7&lt;/p>
&lt;p>2.3. Children (approximately 1-14 years)&amp;hellip;&amp;hellip;8&lt;/p>
&lt;p>2.4. Adolescents &amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip;. 8&lt;/p>
&lt;ol start="3">
&lt;li>Hazard identification &amp;hellip;&amp;hellip;. 8&lt;/li>
&lt;/ol>
&lt;p>3.1. Vitamin D physiology&amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip;.8&lt;/p>
&lt;p>3.2. Biomarkers of vitamin D intake&amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip;..9&lt;/p>
&lt;p>3.3. Biomarkers of vitamin D status and activity&amp;hellip;&amp;hellip;&amp;hellip;.9&lt;/p>
&lt;p>3.4. Mechanisms of toxicity&amp;hellip;&amp;hellip;&amp;hellip;10&lt;/p></description></item><item><title>Ankylosing spondylitis (a type of arthritis) worse with low vitamin D</title><link>/posts/ankylosing-spondylitis-a-type-of-arthritis-worse-with-low-vitamin-d.html</link><pubDate>Sun, 22 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/ankylosing-spondylitis-a-type-of-arthritis-worse-with-low-vitamin-d.html</guid><description>&lt;h1 id="does-vitamin-d-affect-disease-severity-in-patients-with-ankylosing-spondylitis">Does vitamin D affect disease severity in patients with ankylosing spondylitis?&lt;/h1>
&lt;p>Chinese Medical Journal 2012;125(14):2511-2515 2511&lt;/p>
&lt;p>Bekir Durmus, Zuhal Altay, Ozlem Baysal and Yuksel Ersoy&lt;/p>
&lt;h3 id="a-portion-of-table-3--shows-many-strong-vitamin-d-associations-with-bone-problems-in-as">A portion of table 3 shows many strong vitamin D associations with bone problems in AS&lt;/h3>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/as-and-vitamin-d.jpg" alt="image">
&lt;p>&lt;strong>&lt;span style="color:#00F;">2012 PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;hr>
&lt;h3 id="there-are-many-reasons-to-believe-that-the-vitamin-d-a-hrefpostscofactors-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-1270cofactorsa-which-benefit-bone--would-be-very-helpful-for-as">There are many reasons to believe that the vitamin D &lt;a href="/posts/cofactors" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 1270">cofactors&lt;/a> which &lt;strong>benefit bone&lt;/strong> would be very helpful for AS&lt;/h3>
&lt;p>&lt;strong>Here is portion of the summary table of the cofactor page as of July 2012&lt;/strong>&lt;/p></description></item><item><title>With just 200 IU vitamin D in intravenous feeds, deficiency results</title><link>/posts/with-just-200-iu-vitamin-d-in-intravenous-feeds-deficiency-results.html</link><pubDate>Sat, 21 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/with-just-200-iu-vitamin-d-in-intravenous-feeds-deficiency-results.html</guid><description>&lt;p>!!Recommendations for Changes in Commercially Available Parenteral Multivitamin and Multi–Trace Element Products
&lt;strong>A.S.P.E.N. Position Paper&lt;/strong>
Nutr Clin Pract August 2012 vol. 27 no. 4 440-491
Vincent W. Vanek, MD, FACS, FASPEN (Chair)1
Peggy Borum, PhD, FASPEN2
Alan Buchman, MD, MSPH, FACP, FACG, FACN, AGAF3
Theresa A. Fessler, MS, RD, CNSC4
Lyn Howard, MB, FRCP5
Khursheed Jeejeebhoy, MBBS, PhD, FRCPC6
Marty Kochevar, MS, RPh, BCNSP7
Alan Shenkin, MB, ChB, PhD, FRCP, FRCPath8
Christina J. Valentine, MD, MS, RD9
&lt;strong>Novel Nutrient Task Force, Parenteral Multi-Vitamin and Multi–Trace Element Working Group&lt;/strong>
American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors
1 St. Elizabeth Health Center, Youngstown, Ohio
2 University of Florida, Gainesville, Florida
3 Northwestern University School of Medicine, Chicago, Illinois
4 University of Virginia, Charlottesville, Virginia
5 Albany Medical College, Albany, New York
6 Polyclinic, Toronto, Ontario
7 A.S.P.E.N., Silver Spring, Maryland
8 Royal Liverpool University Hospital, Liverpool, England
9 University of Cincinnati, Cincinnati, Ohio
Vincent W. Vanek, St. Elizabeth Health Center, 1044 Belmont Ave, PO Box 1790, Youngstown, OH 44501-1790; e-mail: &lt;a href="mailto:vince_vanek@hmis.org">vince_vanek@hmis.org&lt;/a>.&lt;/p></description></item><item><title>Vitamin D and multiple health outcomes – 2006</title><link>/posts/vitamin-d-and-multiple-health-outcomes-2006.html</link><pubDate>Fri, 20 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-multiple-health-outcomes-2006.html</guid><description>&lt;h4 id="estimation-of-optimal-serum-concentrations-of-25-hydroxyvitamin-d-for-multiple-health-outcomes--july--2006">Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. – July 2006&lt;/h4>
&lt;p>Am J Clin Nutr. 2006 Jul;84(1):18-28.&lt;/p>
&lt;p>Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B.&lt;/p>
&lt;p>Department of Nutrition, Harvard School of Public Health, Boston, MA, USA. &lt;a href="mailto:Heike.bischoff@usz.ch">Heike.bischoff@usz.ch&lt;/a>&lt;/p>
&lt;p>Recent evidence suggests that vitamin D intakes above current recommendations may be associated with better health outcomes. However, optimal serum concentrations of 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> have not been defined. This review summarizes evidence from studies that evaluated thresholds for serum 25(OH)D concentrations in relation to bone mineral density (BMD), lower-extremity function, dental health, and risk of falls, fractures, and colorectal cancer. For all endpoints, the most advantageous serum concentrations of 25(OH)D begin at 75 nmol/L (30 ng/mL), and the best are between 90 and 100 nmol/L (36-40 ng/mL). In most persons, these concentrations could not be reached with the currently recommended intakes of 200 and 600 IU vitamin D/d for younger and older adults, respectively. A comparison of vitamin D intakes with achieved serum concentrations of 25(OH)D for the purpose of estimating optimal intakes led us to suggest that, for bone health in younger adults and all studied outcomes in older adults, an increase in the currently recommended intake of vitamin D is warranted. An intake for all adults of &amp;gt; or =1000 IU (25 microg) &lt;span>[DOSAGE ERROR CORRECTED]&lt;/span> vitamin D (cholecalciferol)/d is needed to bring vitamin D concentrations in no less than 50% of the population up to 75 nmol/L. The implications of higher doses for the entire adult population should be addressed in future studies.&lt;/p></description></item><item><title>Even 800 IU vitamin D improved Crohn’s disease bone density</title><link>/posts/even-800-iu-vitamin-d-improved-crohns-disease-bone-density.html</link><pubDate>Mon, 02 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/even-800-iu-vitamin-d-improved-crohns-disease-bone-density.html</guid><description>&lt;h1 id="increase-in-bone-mineral-density-in-strictly-treated-crohns-disease-patients-with-concomitant-calcium-and-vitamin-d-supplementation">Increase in bone mineral density in strictly treated Crohn&amp;rsquo;s disease patients with concomitant calcium and vitamin D supplementation&lt;/h1>
&lt;p>Sjoerd F. Bakkera, , , Vincent K. Dikb, 1, , Birgit I. Wittec, 2, , Paul Lipsd, 3, , Jan C. Roose, 4, , Adriaan A. Van Bodegravena, 5&lt;/p>
&lt;p>a Department of Gastroenterology and Hepatology, VU University Medical Centre, PO Box 7057, The Netherlands&lt;/p>
&lt;p>b Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, PO Box 85500, The Netherlands&lt;/p></description></item></channel></rss>